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Abstract
The European Commission asked EFSA for a scientific opinion on the risks for animal and human
health related to the presence of glycoalkaloids (GAs) in feed and food. This risk assessment covers
edible parts of potato plants and other food plants containing GAs, in particular, tomato and
aubergine. In humans, acute toxic effects of potato GAs (a-solanine and a-chaconine) include
gastrointestinal symptoms such as nausea, vomiting and diarrhoea. For these effects, the CONTAM
Panel identified a lowest-observed-adverse-effect level of 1 mg total potato GAs/kg body weight (bw)
per day as a reference point for the risk characterisation following acute exposure. In humans, no
evidence of health problems associated with repeated or long-term intake of GAs via potatoes has
been identified. No reference point for chronic exposure could be identified from the experimental
animal studies. Occurrence data were available only for a-solanine and a-chaconine, mostly for
potatoes. The acute dietary exposure to potato GAs was estimated using a probabilistic approach and
applying processing factors for food. Due to the limited data available, a margin of exposure (MOE)
approach was applied. The MOEs for the younger age groups indicate a health concern for the food
consumption surveys with the highest mean exposure, as well as for the P95 exposure in all surveys.
For adult age groups, the MOEs indicate a health concern only for the food consumption surveys with
the highest P95 exposures. For tomato and aubergine GAs, the risk to human health could not be
characterised due to the lack of occurrence data and the limited toxicity data. For horses, farm and
companion animals, no risk characterisation for potato GAs could be performed due to insufficient data
on occurrence in feed and on potential adverse effects of GAs in these species.
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Summary
The European Commission asked EFSA for a scientific opinion on the risks for animal and human
health related to the presence of glycoalkaloids (GAs) in feed and food, in particular in potatoes and
potato-derived products. This risk assessment covers edible parts of potato plants and other food
plants containing GAs, in particular tomato and aubergine. Non-edible parts of GA containing plants
have not been considered, with the exception of potato sprouts. The Panel developed the draft
scientific opinion which underwent a public consultation from 27 February 2020 to 15 April 2020. The
comments received and how they were taken into account when finalising the scientific opinion were
published in an EFSA Technical Report (EFSA, 2020).
GAs are present in many plants of the family of Solanaceae, and contribute to plant resistance
against pests and pathogens. GAs are composed of a steroidal aglycone and an oligosaccharide side
chain. In commercial potato cultivars (S. tuberosum), the main GAs are a-chaconine and a-solanine,
consisting of the aglycone solanidine and chacotriose and solatriose as oligosaccharide side chains,
respectively. The aubergine fruit (S. melongena) contains primarily the GAs a-solamargine and a-
solasonine, composed of the aglycone solasodine and chacotriose and solatriose, respectively. In
tomato fruit (S. lycopersicum), a-tomatine and a-dehydrotomatine are the major GAs, with
lycotetraose coupled to the aglycones tomatidine and tomatidenol, respectively.
Human risk assessment
In experimental animals, the potato GAs, a-solanine and a-chaconine, show a relatively low oral
bioavailability, with differences between species. Hamsters exhibit higher absorption and slower
excretion rates for both substances when compared to rats. Due to the limited information, the
metabolic profiles of potato GAs in experimental animals could not be characterised.
In humans, a-solanine and a-chaconine are systemically absorbed following ingestion. For both
substances, relatively long serum half-lives were reported suggesting a possible accumulation. The blood
clearance of the respective aglycone solanidine appears to be slow. Accordingly, levels of solanidine were
regularly detected in the blood of human volunteers in several studies, suggesting hydrolysis of GAs. No
further information is available on metabolism and excretion of potato GAs in humans.
There are no toxicokinetic data on tomato and aubergine GAs and their aglycones in experimental
animals and humans.
In acute oral toxicity studies, no adverse effects of a-solanine were observed at doses of 250 mg/kg
body weight (bw) per day in rats and 1,000 mg/kg bw per day in mice. Reliable data on other potato
GAs or tomato and aubergine GAs and their aglycones are missing.
In repeated oral dose studies on potato GAs, rodents showed non-specific effects, such as reduced
body weight and relative liver weight with indication of similar potencies of a-solanine and a-
chaconine. Hamsters exhibited these symptoms after a 5-day treatment with 100 mg of a-solanine or
a- chaconine/kg bw per day, while mice showed these effects after one week of daily treatments with
416.6 mg of a-solanine or 409 mg of a-chaconine/kg bw. Solanidine, however, increased the absolute
and relative liver weight at 190.9 mg/kg bw per day in mice, suggesting a different effect of the
aglycone compared to the GAs.
The tomato GA, a-tomatine, and its aglycone, tomatidine, exerted no effects in rats, when applied at
20 mg/kg bw per day for a period of 200 day. At higher doses, a-tomatine reduced the cholesterol uptake
and increased fecal sterol and coprostanol excretion in hamsters and rats. In mice, a 1- to 2-week
treatment with the aubergine GA, a-solasonine, increased the body weight gain at 424.4 mg/kg bw per
day, while its aglycone, solasodine, decreased body weight gain and caused gastric gland degeneration
and liver toxicity at 160 mg/kg bw per day.
Developmental studies have been performed mainly in hamsters treated with potato GAs and their
aglycones for only one day or for a short, very restricted time period during gestation. Outcomes were
mainly analysed in late gestational embryos and comprised effects in the central nervous system,
predominantly exencephaly, encephalocele and anophthalmia. These malformations occurred at doses
of 165 mg/kg bw per day and above for GAs, and of 115 mg/kg bw per day and above for the
aglycones. No no-observed-adverse-effect level (NOAEL) or lowest-observed-adverse-effect level
(LOAEL) could be identified from these studies. Reduced postnatal survival of pups due to insufficient
milk production was reported when pregnant Holtzman rats had been exposed to 3.6 mg of a-
solanine/kg bw per day. Studies on the male fertility in dogs have been performed only with the
aubergine aglycone, solasodine. Decreased epididymal weight and cauda epididymal epithelial height,
and also an epididymal lumen depleted of sperm occurred in dogs after 80 mg/kg bw per day given
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for 1 month. Similar effects were observed in Rhesus monkeys exposed to 100 mg/kg bw per day for
5 months.
From the limited number of studies available, there was no evidence for genotoxicity of the potato
GAs a-solanine and a-chaconine, and the aglycone, solanidine, as well as for the aubergine GA, a-
solamargine. However, there is not sufficient information to conclude on the genotoxic potential of
these GAs.
No long-term chronic toxicity/carcinogencity study for potato, tomato or aubergine GAs or for the
respective aglycones could be identified.
In humans, acute toxic effects following ingestion of potato GAs include gastrointestinal symptoms
of varying severity such as vomiting, diarrhoea and abdominal pain, which may occur from a total
potato GAs (potato TGA) intake of 1 mg/kg bw or more. Further symptoms, including drowsiness,
apathy, confusion, weakness, vision disturbances, rapid and weak pulse and low blood pressure, may
be the consequence of dehydration following vomiting and diarrhoea.
In severe cases, paralysis, respiratory insufficiency, cardiac failure, coma and death have been
reported. Doses in the range of 3–6 mg potato TGAs/kg bw are considered to be potentially lethal for
humans. Results from limited volunteer studies suggest possible differences in the human population
with respect to the individual susceptibility towards adverse effects associated with the intake of
potato GAs.
Regarding the mode of action, adverse effects of GAs may be due to their ability to complex with
membrane 3b-hydroxy sterols, thereby causing disruption and loss of integrity of cell membranes.
After oral exposure, these effects may affect the mucosa of the gastrointestinal tract and cause the
symptoms observed in intoxicated humans, such as nausea, vomiting and diarrhoea.
GAs inhibit acetylcholinesterase (AChE) and serum butyrylcholinesterase (BuChE) by a reversible,
competitive mode of action. The relative potency of inhibition of a-solanine and a-chaconine appears
to be similar. The aglycones exert weak or no inhibitory effects. The excess of acetylcholine at the
neuronal and neuromuscular junctions upon inhibition of the enzymes might also contribute to the
symptoms described for intoxications with GAs.
At high doses, a-tomatine may form a non-absorbable complex with cholesterol and other sterols in
the enteral lumen which may impair the absorption of cholesterol. As a consequence, blood cholesterol
levels were lowered in rodents.
The CONTAM Panel considered that the use of rodent data on acute toxicity was not appropriate to
establish a reference point for acute exposure to potato GAs in humans. The CONTAM Panel selected
the LOAEL of 1 mg potato TGA/kg bw per day as the reference point for acute risk characterisation,
based on human data from case reports, outbreaks and studies in volunteers. The available data on
acute toxicity were considered insufficient to establish a health-based guidance value. Instead, the
Panel used the margin of exposure (MOE) approach to assess a possible health concern from acute
exposure to potato TGAs via food.
Assuming the main symptoms to be mainly due to local irritation of the gastrointestinal mucosa
rather than inhibition of AChE activity, the Panel considered that the possible inter-individual variability
in toxicodynamics is more relevant than the interindividual variability in toxicokinetics. Accordingly, an
MOE higher than 10 indicates that there is no health concern. This MOE of 10 takes into account the
extrapolation from a LOAEL to a NOAEL (a factor of 3) and the interindividual variability in
toxicodynamics (a factor of 3.2).
The experimental data available for repeated dose toxicity are not sufficient to identify a reference
point for chronic exposure to potato GAs. In humans, no evidence of health problems associated with
repeated or long-term intake of GAs via potatoes has been identified.
Regarding GAs or aglycones occurring in edible parts of food plants other than S. tuberosum, no
suitable study for determining a reference point for tomato or aubergine GAs or aglycones was
identified.
Occurrence data were only available for a-solanine and a-chaconine, and mostly for ‘Main-crop
potatoes’ and ‘New potatoes’. Few data were available for processed food. No data on the occurrence
of tomato and aubergine GAs and their aglycones were submitted to EFSA.
Since the occurrence data on potato GAs did not cover all the food categories containing potatoes
in the Consumption Database, it was decided that the best approach for the exposure assessment
would be to use the occurrence data in the raw primary commodities (RPC) (main-crop potatoes and
new potatoes) and the RPC Consumption Database. The Panel decided to combine the occurrence of
‘New potatoes’ with that of ‘Main-crop potatoes’ and the mean upper bound (UB) occurrence (sum of
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a-solanine and a-chaconine) for these two groups was 51.2 mg/kg and the P95 occurrence was 116.8
mg/kg. The minimum and maximum reported concentrations were 1.1 and 276.6 mg/kg, respectively.
The acute dietary exposure to potato TGAs was estimated using a probabilistic approach, including
only days in which there was consumption of main-crop potatoes. As no occurrence data were
available for GAs in tomato and aubergine, these foods were not included in the exposure assessment.
Processing of potatoes has been reported to reduce the content of GAs in the final processed
product. In general, and according to the literature, the peeling of potatoes reduced the GA content
by 25–75%, boiling in water and blanching of peeled potatoes by 5–65% and frying in oil of peeled
potatoes by 20–90%. Microwave and oven baking of unpeeled potatoes may cause a reduction in the
GA content by 3–45% and by 20–50%, respectively. No information has been found about the
chemical nature of the GA degradation products. For the exposure assessment, processing factors for
the major food processing steps, comprising peeling and heat processing (boiling, frying, baking),
were applied to the occurrence data as follows: processing factors between 0.25 and 0.75 were
attributed to the peeling of potatoes, between 0.1 and 0.8 for frying and deep frying, and between
0.35 and 0.95 for all other cooking methods.
Information about the peeling of potatoes was not available in the consumption database, but it
was assumed that 90% of the potatoes are consumed as peeled. Where information of the cooking
method was not available, a cooking method was randomly attributed to the eating event based on
the relative frequency of cooking methods reported.
The mean UB exposure to potato TGAs across surveys ranged from 23.3 lg/kg bw per day in
adults to 174.0 lg/kg bw per day in toddlers. The 95th percentile exposure ranged from 78.3 lg/kg
bw per day in adults to 535.1 lg/kg bw per day in toddlers (up to 822.9 lg/kg bw per day in the
upper limit of the 95% confidence interval).
Comparing the LOAEL for potato TGAs of 1 mg/kg bw per day with the acute exposure estimates,
the MOEs for the younger age groups indicate a health concern for the food consumption surveys with
the highest mean exposure, as well as for the P95 exposure in all surveys. For adult age groups, the
MOEs indicate a health concern only for the food consumption surveys with the highest P95
exposures.
The CONTAM Panel calculated the mean percentage of days with potato consumption across
surveys per age group on which the potato TGA intake may be below the MOE of 10. The highest
number of survey days with intake of potatoes below the MOE of 10 was estimated for toddlers (56%)
followed by children (50%). For the other age groups, the estimated TGA intake was below the MOE
of 10 in up to 22–40% of the survey days.
For tomato and aubergine GAs, the risk to human health could not be characterised due to the lack
of occurrence data in food and the limited information on the adverse effects in experimental animals
and humans.
The CONTAM Panel considered that the impact of the uncertainties on the risk assessment of acute
exposure to potato GAs in food is moderate, and that overall, the identified uncertainties may either
cause an over- or underestimation of the risk.
Farm animals, horses and companion animals risk assessment
Information on the toxicokinetics of GAs was limited to ruminants, for which the data suggest an
extensive conversion of a-solanine and a-chaconine to aglycones in rumen, and a low potential of
solanidine to transfer into cows’ milk.
No data on the potential adverse effects of potato GAs in horses, companion animals (cats and
dogs) or fur animals were identified. Due to an insufficient database on the adverse effects of GAs in
ruminants, pigs, poultry, rabbits and fish, an acute reference dose could not be derived.
Potatoes are not grown specifically as feed for livestock, but when supply exceeds market
requirements for human consumption whole (raw) potatoes may be used as feed for ruminants and
pigs. Some by-products of potato processing and starch extraction are used as feeds for farmed
livestock, principally non-ruminants, and for companion animals.
Data on potato GAs in feed were insufficient to perform an exposure assessment.
Thus, no risk characterisation could be performed due to insufficient occurrence data of GAs for
feed and the lack of, or limited, data on the adverse effects of GAs in farm animals, horses or
companion animals.
Glycoalkaloids in feed and food
www.efsa.europa.eu/efsajournal 5 EFSA Journal 2020;18(8):6222
Recommendations
The following needs have been identified to improve the risk assessment for humans and reduce
the uncertainties:
• Research on the occurrence of GAs and their aglycones and other potentially toxicologically
relevant secondary plant metabolites in the potato cultivars available on the market and on
new potato cultivars resulting from breeding experiments.
• Occurrence data on GAs and their aglycones in potato processed products, including foods for
infants.
• Occurrence data on GAs and their aglycones in tomato and aubergine and products thereof.
• Data on the toxicokinetics of potato, tomato and aubergine GAs and aglycones in experimental
animals and humans.
• Data on repeated dose toxicity, including reproductive and developmental toxicity of potato,
tomato and aubergine GAs and aglycones in experimental animals.
• Studies in humans linking dietary exposure, biomarkers of exposure and adverse effects.
The following needs have been identified to improve the risk assessment for farm animals, horses
and companion animals and reduce the uncertainties:
• Occurrence data on potato GAs and their aglycones in feed.
• Studies on the kinetics and the potential adverse effects from feed material containing GAs of
potato GAs in farm animals, horses and companion animals.
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1. Introduction
1.1. Background and Terms of Reference as provided by the requestor
Background
Many plants in the family Solanaceae contain glycoalkaloids, and they are considered to be natural
toxins. The plant glycoalkaloids are toxic steroidal glycosides and the commonest types found in food
plants are a-solanine and a-chaconine. Their natural function is probably to serve as stress metabolites
or phytoalexins for the protection of the plant when attacked by insects, fungi, etc.
Amongst the most widely cultivated food crops, aubergines, tomatoes and potatoes are in the
Solanaceae family, but the levels of glycoalkaloids in tomatoes and aubergines are generally quite low.
The glycoalkaloids of most relevance to food safety are those occurring in the potato. The
predominant toxic steroidal glycosides in potato are a-solanine and a-chaconine. They occur in potato
tubers, peel, sprouts, berries, leaves and blossoms and their concentration in tubers depends on a
number of factors, such as cultivar, maturity and environmental factors. Concentrations of
glycoalkaloids are 3–10 times greater in the peel than in the flesh. There is considerable variation in
glycoalkaloid content among potato cultivars. Storage conditions, especially light and temperature, are
mainly responsible for increases in solanine. Although the glycoalkaloid content can increase in the
dark, the rate of formation is only about 20% the rate of formation in light. Increases of solanine in
the potato peel are closely associated with greening (synthesis of chlorophyll) of the peel. These
biochemical processes are independent of each other, but are both activated by light.
Bitter or burning sensation in the mouth are sensory impressions which may accompany
glycoalkaloid poisoning symptoms from potatoes that include flu-like symptoms such as nausea,
vomiting, stomach and abdominal cramps, and diarrhoea. More severe cases of glycoalkaloid poisoning
may be accompanied by a variety of neurological effects (i.e. drowsiness, apathy, restlessness,
shaking, confusion, weakness, and disturbed vision). There are a few reports of deaths being
attributed to glycoalkaloid exposure from the consumption of potatoes, potato leaves, and potato
berries.
Potatoes and potato-derived products are listed in the Catalogue of feed materials.1
Terms of Reference
In accordance with Art. 29 (1) of Regulation (EC) No 178/2002, the European Commission asks the
European Food Safety Authority for a scientific opinion on the risks for animal and human health
related to the presence of glycoalkaloids in feed and food, in particular in potatoes and potato-derived
products.
1.2. Interpretation of the Terms of Reference
The CONTAM Panel considered that the opinion should cover edible parts of potato plants and also
of other food plants containing glycoalkaloids (GAs), e.g. tomato and aubergine. Non-edible parts of
GA containing plants have not been considered, with the exception of potato sprouts. In particular, the
CONTAM Panel concluded this Opinion should comprise the:
a) evaluation of the toxicity of GAs in feed and food, in particular in potatoes and potato-derived
products, for farm and companion animals and humans considering all relevant toxicological
end points;
b) evaluation of the alkaloid profile (i.e. composition of the alkaloids and their concentration) of
the food and feed samples submitted to EFSA;
c) estimation of the dietary exposure of the European population to GAs in food, in particular in
potatoes and potato-derived products, including the consumption patterns of specific groups
of the population if appropriate;
d) estimation of the dietary exposure of farm and companion animals to GAs in feed, in
particular in potatoes and potato-derived products;
e) assessment of the human health risks for the European population, including specific groups
of the population if appropriate, as the consequence of the estimated dietary exposure;
1 Commission Regulation (EU) No 6812013 of 16 January 2013 on the Catalogue of feed materials. OJL 29, 30.1.2013, p. 1.
Glycoalkaloids in feed and food
www.efsa.europa.eu/efsajournal 10 EFSA Journal 2020;18(8):6222
f) assessment of the farm and companion animal health risks in Europe as the consequence of
the estimated dietary exposure. Exposure to GAs from weeds containing GA is only addressed
in this Opinion in the context of accidental intake by farm animals.
When referring to GAs in potatoes, the term total GAs (TGA) refers to a material comprising a-solanine
and a-chaconine as major fraction, with no specification on the occurrence of minor GAs as well as b-
and c-forms of solanine and chaconine. Similarly, when referring to tomato and aubergine, the term
TGA refers to the GAs from the corresponding species and forms thereof.
1.3. Supporting information for the assessment
1.3.1. Chemistry
Solanine is one of the first alkaloids that has been isolated from nature, by Desfosses in 1820
(Friedman et al., 1997). In 1861, Zwenger and Kind reported that solanine contains a glycoside side
chain (Zwenger and Kind, 1861). Only in 1954, it was shown that solanine extracted from potato is in
fact a mixture of two glycoalkaloids (GAs), a-solanine and a-chaconine, that share the same solanidine
aglycone (Kuhn and L€ow, 1954). Since then, at least 90 different GAs have been isolated and fully
structurally elucidated from over 300 species of the Solanaceae family (Sanchez-Mata et al., 2010; Al
Sinani and Eltayeb, 2017). The chemical structures and some physical properties of the most important
ones are listed in Appendix A.
GAs are composed of a steroidal aglycone and an oligosaccharide side-chain attached to the 3b-
hydroxy group of the aglycone (see Figure 1) (Friedman et al., 1997; Friedman, 2006; Milner et al.,
2011). The GAs of relevance can be divided into the (i) solanidane group, with solanidine as the
steroid backbone, and the (ii) spirosolane group, with either the solasodine or the tomatidenol/
tomatidine backbone. GAs often contain a double bond between C5 and C6, but the corresponding 5a,
6-hydrogenated forms are also common and, in some species (e.g. tomato), they constitute the major
components. The stereochemistry at carbons C22 and C25 is well defined: in solanidine, the
configuration is 22R, 25S; in solasodine, it is 22R, 25R; and in tomatidenol/tomatidine, the
configuration is 22S, 25S (Friedman et al., 1997).
Further diversification is generated by the composition of the glycoside side-chain. Most GAs
contain either a trisaccharide (chacotriose or solatriose) or a tetrasaccharide (lycotetraose) as
carbohydrate. In commercial potato cultivars (Solanum tuberosum), mostly a-chaconine and a-solanine
(composed of the solanidine aglycone and chacotriose and solatriose, respectively) are present
(Figure 1). Wild S. tuberosum varieties may contain a much wider range of GAs (Friedman et al.,
1997; Distl and Wink, 2009). The aubergine fruit (derived from S. melongena) contains primarily a-
solamargine and a-solasonine (composed of the solasodine aglycone and chacotriose and solatriose,
respectively). In tomato fruit (derived from S. lycopersicum varieties), a-tomatine and a-
dehydrotomatine are the major compounds (composed of the aglycones tomatidine and tomatidenol,
respectively, coupled to lycotetraose) (Friedman, 2002).
The prefix alpha (a-) refers to the intact glycoside while the prefixes beta (b-), gamma (c-) and
delta (d-) refer to the corresponding GAs with progressively truncated carbohydrate side-chains due to
the action of enzymatic or acidic hydrolysis (Friedman, 2006; Milner et al., 2011).
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GAs as pure standards are stable to temperatures up to 150°C (Takagi et al., 1990) and to alkaline
conditions. However, acidic hydrolysis using strong acid and elevated temperatures may cleave the
glycosidic bonds and liberate the aglycone together with the corresponding reducing sugars (Friedman,
2006). The aglycones due to their steroid nature are not soluble in water, but the intact GAs are
slightly soluble (e.g. solubility of a-solanine in water: 25 mg/L). GAs as well as aglycons are readily
soluble in organic solvents such as ethanol and methanol.
1.3.2. Analytical methods
Many different analytical techniques have been applied over the last century for the detection and
quantification of GAs. With older analytical methods (gravimetric, colourimetric), it was often not
possible to discriminate the individual GAs. These non-specific methods are currently no longer used
for quantitative purposes, but they are included because these methods were used in some of the
older toxicological studies and case reports of human intoxications. Nowadays most confirmatory
methods use liquid chromatography (LC) to separate the intact GAs and detection is performed either
by ultraviolet-visible (UV-vis) detection or by mass spectrometry (MS). Assays based on thin layer
chromatography (TLC) or immunoassays (i.e. enzyme-linked immunosorbent assay (ELISA)) are also
available and can be applied for screening.
For reliable quantification of GAs, reference standards of high purity are required, which are
available for the most common ones (a-solanine, a-chaconine, a-tomatine, a-solasodine, a-solamargine
and the corresponding aglycones). For many of the less common GAs (Appendix A), no reference





























































































































































Figure 1: Structure of the most important glycoalkaloids (GAs) found in potato (a-solanine and a-
chaconine), aubergine (a-solasonine and a-solamargine) and tomato (a-tomatine and a-
dehydrotomatine)
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1.3.2.1. Extraction and clean-up
When analysing the intact GAs, an important aspect is the stability of the compounds. Enzymatic
degradation of the glycoside side-chain due to the action of glycosidases present in fresh potato tubers
may occur during extraction when not properly controlled (Friedman et al., 1997). This may result in
the underestimation of the GA content, if only the intact GAs are monitored. Two approaches are
generally followed to prevent from losses due to enzymatic activity. One approach is to cut or slice the
potato tubers, add liquid nitrogen and to lyophilise by freeze-drying. The freeze-dried material is
ground and homogenised to a fine powder (Friedman and Dao, 1992). Extraction of the lyophilised
material is typically performed with an acidic aqueous solvent (e.g. acetic acid), mixed with a suitable
organic solvent (e.g. methanol, acetonitrile). The other approach is to shred the potato tubers in a
food processor, add liquid nitrogen and grind to a fine powder (Hellen€as, 1986; AOAC, 2000).
Extraction of the frozen material is conducted with a mixture of 5% acidic acid to which 0.5% sodium
bisulfite (NaHSO3) has been added. For both methods a further clean-up is necessary before the
extracts can be analysed by high-performance LC (HPLC)-based methods. Clean-up is preferably
conducted using solid-phase extraction (SPE) cartridges (typically C18-based, but cartridges with NH2,
CN stationary phases have also been used) (Friedman et al., 1997).
1.3.2.2. Detection methods
Gravimetric methods
In gravimetric methods, the GAs are measured by alkaline precipitation from potato extracts. GAs
are extracted from the tubers using a strong acid, such as sulfuric or hydrochloric acid, that results in
hydrolysis of the GAs to the corresponding aglycone. Addition of a surplus of alkaline, e.g. calcium
hydroxide, to the solution results in a precipitation of the alkaloids, that can be collected, dried and
weighted (B€omer and Mattis, 1924). Gravimetric methods have a limit of quantification (LOQ) of
approximately 10 mg total GAs (TGA)/kg. Gravimetric methods have been in general use until the
development of colourimetric methods in the 1930s and 1940s. Gravimetric methods have a number of
disadvantages, such as losses occurring during precipitation, lengthy procedures and the fact that
other alkaloids may co-precipitate (Lepper, 1949; Friedman et al., 1997).
Colourimetric methods
The first colourimetric method to quantify the content of solanine in potato tubers was developed
by Alberti in 1932, using sulfuric acid and formaldehyde to generate a coloured derivative (Alberti,
1932). Many different methods using different reagents have been described in the literature in the
following decades. Clement and Verbist (1980) compared nine different colourimetric methods for the
analysis of solanidine in potato tubers. They noted that a considerable variation in the results was
obtained, which was attributed to unspecific reactions with other plant components with the staining
reagents used (resulting in overestimation of the content in some methods) or to losses during
extraction (leading to an underestimation of the content in other methods). It was reported that
sensitivity between methods differed up to 20-fold, but limits of detection (LODs)/LOQs were not
determined (Clement and Verbist, 1980).
Another important drawback of colourimetric methods is that they require hydrolysis of the
glycoside side-chain prior to derivatisation. As a result, only the TGA content can be determined and
no information on the individual glycosides is obtained. Since the 1980s, colourimetric methods have
been largely replaced by HPLC-based methods.
TLC with UV-Vis detection
TLC is often used as a quick, qualitative, screening tool to assess the presence of GAs in plant extracts.
However, quantitative methods using high-performance TLC (HPTLC)-densitometry have also been
described. Bodart et al. (2000) described a method for the determination of a-solanine and a-chaconine
in potato extracts by means of HPTLC-densitometry. The GAs extracted from potato were separated on
the TLC plate and derivatised to generate chromophoric compounds that were measured at 507 nm with
a densitometer. The LOQ for both GAs was 100 ng on plate, corresponding to 40 mg/kg in dehydrated
peeled potato powder and to 10 mg/kg in fresh peeled potato tubers. A modified HPTLC method was
described by Skarkova et al. (2008), with an LOQ of 5 mg/kg for a-solanine and a-chaconine for peeled,
uncooked potatoes.
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Enzyme-linked immunosorbent assays (ELISA)
A few reports using immunoassays (ELISA) for the quantification of GAs have been published.
Morgan et al. (1985) developed an ELISA assay to determine the TGA content in potato tubers and
compared their assay with two existing colourimetric methods (Morgan et al., 1985). The sensitivity of
the ELISA assay was excellent (0.02 mg/kg) and did not show cross reactivity with tomatidine
derivatives. Comparison with a HPLC-ultraviolet (UV) method showed a good linear relationship, when
corrected for recovery losses (Hellen€as, 1986).
Stanker et al. (1994) developed an ELISA based on monoclonal antibodies that showed affinity for
solanidine, tomatidine and solasodine derivatives. The commercialised version of the ELISA kit was
found to work well for the quantification of TGAs in potato tubers, sprouts, potato fries and chips
(Friedman et al., 1998). The ELISA displayed good cross reactivity for solanidine derivatives (a-
solanine, a-, b-, c-chaconine), lower sensitivity for a-tomatine and very limited sensitivity for
solasodine derivatives. For all investigated products, a good correlation for TGA content was observed
with results obtained by HPLC-UV analysis. The LOD for TGAs was estimated at 1 mg/kg.
Gas chromatography (GC) with FID, MS or NPD detection
Analysis of intact GAs by GC-flame ionisation detector (FID) or GC-MS is possible only after
derivatisation of the glucoside hydroxyl groups (Herb et al., 1975). However, it is more common to
analyse the aglycones after hydrolysis, because derivatisation in that case is not necessary (Van
Gelder, 1985; Friedman et al., 1997). Bushway et al. (1984) have developed a GC-nitrogen-phosphorus
detector (NPD) method for solanidine in milk, with an LOQ of 0.28 mg/L. Nowadays LC-based methods
have replaced GC-based methods.
HPLC with UV-VIS detection
Intact GAs as well as the aglycones can be measured by HPLC-UV detector at wavelengths around
200 nm (Houben and Brunt, 1994; Friedman et al., 1997; AOAC Official Method 997.13, 2000).
Separation of a-solanine and a-chaconine, as well as the separation of a-tomanine and a-
dehydrotomatine, can be achieved on reversed phase C18 chromatographic columns using aqueous
phosphate buffers in combination with an organic modifier, typically methanol or acetonitrile (Kozukue
et al., 2004). It is possible to separate these GAs by a simple isocratic elution, but for the analysis of a
wider range of GAs gradient elution is necessary (Eanes et al., 2008; Maurya et al., 2013). Due to the
fact that GAs do not show significant UV absorption at wavelengths above 215 nm, the analysis needs
to be conducted at low, unspecific, wavelengths. It is therefore necessary to include purification steps,
e.g. by SPE clean-up, prior to analysis by HPLC-UV (Keukens et al., 1994; Friedman et al., 1997). The
LOD is around 2.5 mg/kg for the individual compounds.
LC-MS methods (LC-MS/MS, LC-HRMS)
LC-MS-based methods are becoming increasingly popular in the analysis of GAs. The most
important advantage of MS detection above UV detection is the much higher selectivity of the MS.
Combined with the high sensitivity of modern mass spectrometers, sample preparation and clean-up
can often be minimised and simple dilution of extracts may be sufficient. Methods based on LC
coupled to tandem mass spectrometry (LC-MS/MS) are often used for targeted analysis of GAs (Jandric
et al., 2011; Hossain et al., 2015; Nara et al., 2019), while methods using LC coupled to high
resolution MS (LC-HRMS) or to Orbitrap MS (LC-Orbitrap-MS) are more commonly used for
metabolomic studies and exploratory research (Moco et al., 2007; Caprioli et al., 2014). Hossain et al.
(2015) reported LOQs for a-solanine and a-chaconine of 2 lg/L in potato extract, corresponding to 40
lg/kg in dehydrated potato powder. Nara et al. (2019) reported an LOQ of 1 and 2 lg/L in whole
blood for a-solanine and a-chaconine, respectively.
1.3.2.3. Analytical standards, certified reference materials and proficiency testing
schemes
Most of the main GAs and their aglycons are commercially available as analytical reference
standards. However, the less common GAs (e.g. a-dehydrotomatine and a-dehydrotomatidine) as well
as the partially hydrolysed forms of GAs (e.g. b- and c-solanine and b-chaconine) are not commercially
available. Isotopically labelled analogues of GAs are not available. No certified materials are
commercially available and no proficiency testing schemes for testing of GAs, potatoes or potato
products have been identified.
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1.3.3. Sources
Botanical sources of GAs with a steroidal aglycone are mainly found within the dicotyledoneous
family Solanaceae (see Section 1.3.1), and to a lesser extent in the monocotyledonous family Liliaceae
(Roddick, 1996). From the latter family only few intact GAs have been isolated, and their fully
structure elucidated, while a large number of steroidal alkaloids have been found and fully identified in
extracts, particularly of Veratrum and Fritillaria species (Liliaceae) following acidic hydroflysis step (Li
et al., 2006). In general, the two monocotyledonous genera are not known to be of any use as
sources of food, although two species of so-called ‘riceroot’ (Fritillaria camschatcensis [L.] Ker-Gawl.
and F. lanceolata Pursh) are reported to have been important root foods for the Indians of the
Northwest Coast of North America (Turner and Kuhnlein, 1983).
This section focuses on the species of importance of today’s food production from the genus
Solanum, together with a few other Solanum species known as possible sources of intoxications in
man and farm animals.
The genus Solanum L. that contains the GAs as defined in Section 1.3.1, include around 1,500
species, and as such the largest genus in the family Solanaceae (Knapp, 2013; Tepe et al., 2016). The
genus comprises the potato (S. tuberosum), the tomato (S. lycopersicum L. – synonyms Lycopersicon
lycopersicum (L.) H. Karst, and Lycopersicon esculentum Mill.), and the aubergine (S. melongena L.)
(Milner et al., 2011). Less well-known plants are gboma (S. macrocarpon L.) and the scarlet aubergine
(S. aethiopicum L.) (Sanchez-Mata et al., 2010). Other consumed food plants belonging to the genus
Solanum L. are the pepino (S. muricatum, also known as sweet pepino or sweet cucumber) from
which the ripe fruit is eaten (Sanchez-Mata et al., 2010), and the wild aubergine (S. torvum) from
which the fruits, known as susumber or turkey berries, are eaten as vegetables in the traditional
Jamaican cuisine (Smith et al., 2008; Karmakar et al., 2015).
Non-food Solanum species that produce fruits that might be accidentally ingested are the soda
apple (S. aculeastrum Dunal, also known as goat apple or poison apple) and the wolf apple
(S. lycocarpum St. Hil) (Bhat and Pallyath, 2016). The latter is a common bush in parts of Brazil, and
the fruits are used in folk medicine, although the unripe fruits are slightly toxic, especially to pregnant
women (Schwarz et al., 2007). Bittersweet nightshade (S. dulcamara) and black nightshade (S. nigrum
L.) are common toxic weed plants (Milner et al., 2011).
For the potato (S. tuberosum), it is the starchy stem tuber that is eaten. Both sexual and
vegetative reproduction occurs in the ancestral wild species and the improved cultivars. Thus, potatoes
flower and set true seeds in berries (the fruit) following natural pollination by insects, while the tubers
propagate clonally. For the tomato (S. lycopersicum), both the mature and the immature (green) fruits
are used as food (Martınez-Valverde et al., 2002). The food use of the aubergine (S. melongena)
concentrates around the mature fruit. For the production, the plant is grafted onto other species of
Solanum, such as S. torvum (Miceli et al., 2014).
Different plant parts contain different concentrations of the individual GAs and TGAs. Furthermore,
both the total TGA content and the relative proportions in a plant part (organ) will change as a result
of the developmental stage of the organ.
The three main food crops (potatoes, tomatoes and aubergine) are discussed in more detail below.
1.3.3.1. Potatoes
S. tuberosum is the most cultivated tuber of the Solanum species. Potatoes are one of the main
staple foods produced worldwide. In 2018, the global production volume was approximately 370
million tonnes (FAOSTAT, 2020a), which is about half the yearly volume produced of wheat and of rice.
In the EU, Germany is the biggest producer of potatoes, with around 9 million tonnes in 2018,
followed by Poland, France, The Netherlands and the UK with production volumes in the range of 5–8
million tonnes.
Potato breeding programmes have for quite a long time used many primitive forms of cultivated
potatoes and their wild relatives as a valuable source of genetic variation (Distl and Wink, 2009;
Bradshaw et al., 2006; van Gelder, 1989). Especially breeding programmes concerning disease
resistance and environmental tolerance have been successful. Several methods to overcome
hybridisation barriers have been developed (Machida-Hirano, 2015).
Studies on the occurrence of GAs in commercial (common) potatoes (S. tuberosum ssp.
Tuberosum) measured and reported only on a-chaconine and a-solanine, while the tubers of wild
plants of the subspecies andigena have been reported to also contain, e.g. b-chaconine (Distl and
Wink, 2009). Both the common potato and other potato species, whether cultivated and consumed or
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not, may contain GAs other than a-solanine and a-chaconine. However, in general, the tuber
concentrations of these other GAs are less than 5% of the total GA content (Friedman et al., 1997;
Milner et al., 2011). In case these species are used in breeding, transfer (depending on the crossing
methods used) of the biosynthetic pathway for the formation of these other GAs can occur.
According to Milner et al. (2011), the TGAs in different parts of the cultivated potato plant (S.
tuberosum) will often be found within the concentration ranges given in Table 1 (see Figure 2 for the
internal structure of a potato tuber). Using MALDI-TOF-MS imaging, the localisation and development
of GAs in skin and sprouts were visualised by Ha et al. (2012). Berries of potatoes have about 10
times the levels of GAs compared to the tubers of commercial potato cultivars (Friedman, 1992).
In many regions of the world, the potato today is cultivated all year round by using different types
of cropping and different cultivars adapted to these, i.e. to different temperature, day length and
growing period among others (Mori et al., 2015). Besides the cultivar characteristics and the type of
cropping, also the end use of the given potato matters. Potato use can be classified into four types,
namely for ‘table use’, ‘industrial food processing use(s)’, ‘starch production’ and ‘other purposes’ (Mori
et al., 2015). Due to the constant breeding for new cultivars, the GA content ranges given in Table 1
must be considered as approximate. Concerning potatoes with a food end use, the TGA content as
well as the relative concentration of the different GAs has been reported in several studies. Details of
the variation of GAs in different cultivars are discussed in Section 3.2.2.
Table 1: Total glycoalkaloids (TGA) concentration (mg/kg fresh weight (fw)) in various cultivated
potato (S. tuberosum) plant parts(a)
Plant part Concentration range (mg/kg fw) Original Reference(a)




Bitter-tasting tubers 250–800 (5)
Whole tuber 10–150 (6)
Skin (2–3% of tuber) 300–640 (1), (2)
Peel (10–12% of tuber) 150–168 (1), (2)
Cortex 125 (6)
Flesh 12–100 (1), (2)
Pith(b) Not detected–0.1 (6)
Sprout 2,000–7,300 (1), (2)
(a): From Milner et al. (2011), who collected the information from several research articles given in the review. Original
references: (1) Lampitt et al. (1943), (2) Van Gelder (1991), (3) Kozukue et al. (1987), (4) Sinden et al. (1984), (5) Zitnak
(1961), (6) Kozukue and Mizuno (1990).
(b): The pith is the centre of the tuber tissue and may be angular with rays extending to each node (also called eyes, Lee and
De Luca, 2019) and is relatively low in starch content (Van Denburgh et al., 1986; Dean, 1994).
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The fact that these GAs are regarded as being important components of plant resistance against
pests and pathogens means that breeders work to enhance the GA content in the non-edible parts
(Ginzberg et al., 2009). To do so, detailed knowledge of the biosynthetic pathway(s) and the
regulation is essential. The major steps in the biosynthesis of a-chaconine and a-solanine have been
summarised by Ginzberg et al. (2009) (Figure 3). GAs occur in most tissues of the S. tuberosum plant,
except in the tuber pith (Table 1). Concerning the regulation of the biosynthesis and catabolism of the
GAs, Sarquis et al. (2000) concluded that this most likely is happening at the tissue or organ level.
This is because there is no evidence on their internal transport, and there is a poor correlation
between the total content found in the tuber as compared to the foliage of the same cultivar (Sarquis
et al., 2000; Ginzberg et al., 2009).
The outer layers of the potato tuber (i.e. the periderm) contains the highest concentration of the
GAs (Table 1), particularly in the 1.5 mm of tissue located under the surface of the tuber (Valkonen
et al., 1996). It has been suggested that the biosynthesis of tuber GAs occurs in the phelloderm
(Ginzberg et al., 2009), which is the inner part of the potato periderm.
Figure 2: Internal structure of a potato tuber (from Faridnia et al. (2015)2)
2 Reprinted from Food research, 77, Faridnia F, Burritt DJ, Bremer PJ and Oey I, Innovative approach to determine the effect of
pulsed electric fields on the microstructure of whole potato tubers: Use of cell viability, microscopic images and ionic leakage
measurements, 556–564, 2015, with permission from Elsevier.
Glycoalkaloids in feed and food
www.efsa.europa.eu/efsajournal 17 EFSA Journal 2020;18(8):6222
Some reviews, especially in earlier times, have reported relatively small variations for the ratio
between the concentrations of a-chaconine and a-solanine in potatoes (peel and flesh). However, later
investigations have shown that this ratio may differ to a very great extent, depending on the cultivar as
well as the part of the potato. Jin et al. (2018) analysed three different cultivars (‘Shepody’, ‘Russet
Burbank’ and ‘Atlantic’) and found the ratio a-chaconine:a-solanine in the whole potato tuber to differ
from 0.41 (‘Russet Burbank’), to 1.36 (‘Shepody’) and 3.61 (‘Atlantic’). Romanucci et al. (2016)
investigated 15 cultivars and reported even higher ratio spans, e.g. in freshly harvested tubers, the ratio
a-chaconine:a-solanine in the peel varied from < 0.06 to 5.7. After 20 days of storage, the ratio in the peel
was still highly variable, but a general trend towards an increased content of a-chaconine was noted.
Several factors have been studied whether they could influence the formation of GAs in potatoes.
Preharvest factors such as the potato cultivar, the tuber size, climate, damage of the plants by insects,
the soil composition, the use of fertilisers and growth conditions have been reported to potentially
influence the content of GAs (e.g. Morris and Petterman, 1985; Gosselin et al., 1988; Mondy and
Munshi, 1990; Hlywka et al., 1994; Love et al., 1994; Friedman et al., 1997; Bejarano et al., 2000;
Zarzecka and Gugala, 2007; Najm et al., 2012). Some of these factors, such as the potato cultivar,
location and farming system, are further discussed in Section 3.2.2.1.1.
Processing and other post-harvest factors that affect the content of GAs in potatoes are described
in Section 3.2.3.
(a) The biosynthetic pathway is presented from acetyl-CoA to steroidal GAs with additional pathways included that
use the same substrate. Dashed arrows indicate multiple enzymatic steps. Terpenes refer to low-molecular weight
isoprenoids. (b) Structural formulas for several intermediates of steroidal GA biosynthesis. HMGR: 3-hydroxy-3-
methylglutaryl coenzyme A reductase. SS: squalene synthase. VSP: vetispiradiene cyclase. SMT: sterol C24-
methyltransferase. SGT: solanidine glycosyltransferase.
Figure 3: Simplified biosynthetic pathway for steroidal glycoalkaloids (GAs) (from Ginzberg et al., 2009)3
3 Reprinted by permission from Springer: Potato Research, Potato Steroidal Glycoalkaloids: Biosynthesis and Genetic
Manipulation, Ginzberg I, Tokuhisa JG and Veilleux RE, 2009.
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1.3.3.2. Tomatoes
Besides being consumed fresh tomatoes are used in many processed foods such as canned and
sun-dried tomatoes, juices, ketchup, pastes, purees, salads, sauces and soups (Friedman, 2002). In
2018, worldwide production of tomatoes was 182 million tonnes (FAOSTAT, 2020b). Within the EU,
Italy (5.8 million tonnes in 2018) and Spain (4.8 million tonnes) are the most important producers,
followed by Portugal (1.3 million tonnes). In Europe, tomatoes are grown for the fresh market as well
as for processing (tomato paste, juice, peeled tomatoes). Italy and Spain are major producers of
processed tomato products.
The two most important GAs found in tomato (S. lycopersicum) are a-tomatine and a-
dehydrotomatine, both of which are found in all parts of the tomato plant (Friedman, 2002). The first
discovered GA, the fungitoxic and insect repellent a-tomatine, has been shown to gradually disappear
from the fruit with the appearance of lycopene (Sander, 1956, 1958). In addition to a-tomatine and a-
dehydrotomatine, a variety of additional GAs have been identified in tomato fruits, including
(dehydro)lycopersoside A to H, (dehydro)esculeoside A, B1, B2 and tomatoside A (Moco et al., 2007;
Baldina et al., 2016). Some of these other GAs may be present, particularly in the ripe fruits, in higher
concentrations than the marker compound a-tomatine (Iijima et al., 2009; Baldina et al., 2016).
An example for the variations seen for the two most abundant GAs in the cultivated tomato plant
parts is provided by Milner et al. (2011) (Table 2). From Table 2, it follows that the relative a-
dehydrotomatine content varies, depending on the plant part, from 6% to 25%. In the (unripe) fruits,
a-dehydrotomatine is present at approximately 10-fold lower concentrations than a-tomatine.
As for the potato plant (see above), the biosynthesis of the tomato GAs (a-tomatine and a-
dehydrotomatine) is under separate genetic control in each plant part (Kozukue et al., 2004).
The TGA concentration in tomato depends, as for potato, on the cultivar and the fruit ripening
stage. Eltayeb and Roddick (1984) studied the changes in the a-tomatine content as a result of the
fruit growth (e.g. given by the relative diameter of the berry) and/or the stage of ripening (e.g.
defined by the development of the fruit colour: from dark green to full red or yellow colour depending
on the cultivar), in commercially grown tomato cultivars and mutants with different ripening
characteristics. For three normal-ripening cultivars developing red-, orange- and yellow-ripe fruits,
respectively, it was found that the highest concentrations occurred in very young green fruits of
around 4 days of age (3,100–4,400 mg a-tomatine/kg fw). In subsequent stages of fruit development,
the concentration dropped to around 700 mg a-tomatine/kg fw at day 10. In the same period, the
fruit diameter increased from 7 mm at day 4–20 mm at day 20. By 30 days, when the tomato was
approximately 30 mm in diameter, 20 g in weight and still green, a-tomatine concentrations for the
three cultivars had decreased to 3–6 mg/kg fw (Eltayeb and Roddick, 1984). Similar results were
obtained by Kozukue and Friedman (2003), who reported an inverse relationship between fruit weight
and a-tomatine content in green ‘Momotaro’ tomatoes, with a-tomatine concentrations of 900 mg/kg fw
at 1.5–1.9 g of fruit weight, and of 150 mg/kg fw at 218.0–220.5 g of fruit weight. Choi et al. (2010)
studied the a-tomatine and a-dehydrotomatine content of the tomato cultivar ‘Doturakworld’ for 60
days, discerning 11 stages of ripeness. The concentrations of a-tomatine and a-dehydrotomatine were
highest during stage 1 at day 3, amounting to, respectively, 3,600 and 480 mg/kg fw. At growth stage 3
(14 days), a-tomatine and a-dehydrotomatine concentrations had dropped to 320 and 28 mg/kg fw,
Table 2: Glycoalkaloid (GAs) concentration (mg/kg fresh weight (fw)) and relative composition of










Large immature green fruit 144 14 91 9
Small immature green fruit 465 54 90 10
Root 118 33 77 23
Calyxes 795 62 93 7
Leaves 975 71 93 7
Small stems 896 138 87 13
Large stems 465 142 75 25
Flowers 1,100 190 85 15
Senescent leaves 4,900 330 94 6
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respectively. A steady but modest reduction was observed up to stage 7 (47 days), when the tomatoes
were full grown, but still green (a-tomatine and a-dehydrotomatine concentrations, 140 and 15 mg/kg
fw, respectively). When ripening set in at stage 8 (52 days), a-tomatine and a-dehydrotomatine
concentrations had dropped below the LOQ (level not indicated) (Choi et al., 2010). It has been shown
that during the later ripening stages, a-tomatine is converted into esculeoside A and related glycosides
(Fujiwara et al., 2004; Iijima et al., 2009; Nohara et al., 2010). The conversion of a-tomatine into
esculeoside A is correlated with enhanced levels of ethylene (Iijima et al., 2009). Moco et al. (2007)
reported that concentrations of a-tomatine, a-dehydrotomatine and the lycoperosides A, B, C, F, G and H
were highest in the epidermis, followed by the jelly parenchyma. During ripening the concentrations of
lycoperosides F and G as well as that of esculeoside A strongly increased, while for the other GAs, a
substantial decline was noted. A recent study of Tamasi et al. (2019) revealed that a-tomatine and
dehydrotomatidine are primarily located in the locular gel of the tomato fruits, with much lower
concentrations in the skin and almost no TGAs present in the pulp.
For further details on the concentrations of a-tomatine in tomato and tomato products reported in
the literature, see Section 3.2.2.
1.3.3.3. Aubergine
The name aubergine refers to three crops from the genus Solanum subgenus Leptostemonum
(Vorontsova et al., 2013). The three cultivated aubergine species are the Brinjal aubergine
(S. melongena L.), the scarlet aubergine (S. aethiopicum L.) and the ghoma aubergine
(S. macrocarpon). In this opinion, the term aubergine alone refers to S. melongena, unless stated
otherwise.
The aubergine is generally cultivated in most tropical and subtropical regions of the world. The two
other species (scarlet and ghoma) are less known and mostly grown in sub-Saharan Africa (Taher
et al., 2017), not only for their edible fruits but also for the young leaves (Caruso et al., 2017). The
worldwide production of aubergines was 54 million tonnes in 2018 (FAOSTAT, 2020c). Production in
the EU is relatively modest: around 0.85 million tonnes were produced in 2018, with Italy being the
largest producer (300 ktonnes), followed by Spain (240 ktonnes) and Romania (140 ktonnes).
The plants are all berry-producing vegetables. The aubergine complex shows a large morphological
diversity, including small fruited spiny plants to large fruited non-spiny plants. The long history of
breeding has furthermore resulted in a wide range of cultivars with edible fruits of different sizes,
shapes and colours (Caruso et al., 2017). Cultivars of aubergine are conventionally grouped into
‘Occidental’ and ‘Oriental’. The first are preferred in North Africa, Europe and the Americas, while the
latter mostly are grown in East and South East Asia. They vary from one another with respect to their
overall plant morphology and physiology, but also concerning their fruit size, colour and shape (Ceriola
et al., 2013). Grafting on rootstocks of related Solanum species (e.g. S. torvum, S. aethiopicum,
S. macrocarpon) or tomato (S. lycopersicum) hybrids has become an important area of research to
improve the overall quality of the fruits and to increase resistance to soil-borne diseases and abiotic
stresses (Mennella et al., 2012; Sabatino et al., 2018).
For food purposes, aubergines are harvested at an immature stage and have a short storage
period. Depending on the cultivar, the colour at the unripe stage may vary indeed very much, while
the physiologically ripe fruits are brown or yellow (Caruso et al., 2017).
Together with a-solamargine, a-solasonine makes up the major content of GAs in this plant species.
Both have the steroid solasodine as their aglycone, however, the sugar part in a-solasonine is the
trisaccharide solatriose where that of a-solamargine is the trisaccharide chacotriose (see Figure 1).
While the biosynthesis of a-solasonine starts with the attachment of a D-galactose to the aglycone, the
biosynthesis of a-solamargine is initiated with the attachment of a D-glucose. Hence, the expression of
solasodine galactosyltransferase 1 (SGT1) specifically reflects the biosynthesis of the GA a-solasonine
(Bagheri et al., 2017).
Mennella et al. (2012) studied the TGA content (a-solasonine and a-solamargine) in a total of 10
different genotypes from two different typologies (D3R and NAS), in commercially unripe, ripe and
overripe (physiologically ripe) fruits. In the commercially unripe and ripe stages, the TGA content was
relatively low (mean content: 125 and 230 mg/kg dry weight (dw), respectively), while in the
commercially overripe stage, a strong increase of the TGA content (mean 1,937 mg/kg dw) was
observed. The average ratio between a-solasonine and a-solamargine was approximately 1:2 in the
commercially unripe and ripe stage, but changed to 1:1 in the overripe stage (Mennella et al., 2012).
Bagheri et al. (2017) compared two different aubergine genotypes, of which one (D1) had ‘sweet’
fruits and the other (J10) had ‘bitter’ fruits, with regard to the content of a-solasonine (a-solamargine
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was not analysed in this study) as well as concerning the expression of SGT1 in the leaves, flower
buds, young fruits, mature fruits and physiologically ripe fruits. The levels of a-solasonine closely
followed the expression of the SGT1 gene in the same plant tissues. In all tissues, the concentration of
a-solasonine in the bitter variety was between two and three times higher than in the sweet variety.
Concentrations of a-solasonine reported for the D1 and J10 genotypes, respectively, were leaves: 113.3
and 249.3 mg/kg dw; flower buds: 135.6 and 478.8 mg/kg dw; young fruits: 61.3 and 160.4 mg/kg dw;
mature fruits: 21.6 and 45.6 mg/kg dw and physiologically ripe fruits: 74.7 and 185.0 mg/kg dw
(Bagheri et al., 2017).
1.3.4. Previous risk assessments
Previous human risk assessments
The general statement, that a level of 200 mg TGA/kg of unpeeled, uncooked potatoes could be
considered as safe, is often found in the scientific literature and can be traced back for decades.
B€omer and Mattis (1924) were probably the first to conclude that this TGA level provided sufficient
protection to the consumer. They based their statement on the results of a study they conducted on
batches of German potatoes from the 1922 harvest that was exceptionally high in solanine content.
Batches of potatoes with a TGA content of 257–583 mg/kg potatoes reportedly caused intoxications or
other health problems, while these effects were not reported for potatoes with levels < 200 mg/kg
(concentrations determined with a gravimetric method).
The toxicity of a-solanine and a-chaconine was assessed by the Joint Food and Agricultural
Organization/World Health Organisation (FAO/WHO) Expert Committee on Food Additives (JECFA)
(JECFA, 1992, 1993). JECFA evaluated the kinetic aspects (absorption, distribution, biotransformation
and excretion), toxicity and teratogenicity, primarily in rodents and humans, as available at the time of
the evaluation. JECFA concluded that with the available experimental and epidemiological data, a safe
level of intake could not be determined. The Committee reported that the occurrence of a-solanine
and a-chaconine in potatoes is about 20–100 mg/kg, but the levels can increase due to mechanical
damage, blight, sprouting, processing and storage. JECFA considered that daily consumption of
potatoes containing normal GA levels was of no concern, provided that the potatoes were properly
handled and grown.
In 1990, the Swedish National Food Administration carried out an ‘Assessment of Health-risks Related
to Glycoalkaloids (‘Solanine’) in Potatoes: A Nordic View’, and concluded that ‘Based on the present
knowledge, a TGA concentration of 200 mg/kg potato for the potato varieties currently available on the
Nordic Market appears to be the maximum level which can be accepted. However, because of the small
safety margin, efforts should be made to reduce the levels of GA’. They recommended that the average
TGA concentration in new potato varieties should not exceed 100 mg/kg (Nordic Working Group on Food
Toxicology and Risk Assessment, 1990).
In 2018, and as a result of an intoxication of the members of a family in Baden–W€urttemberg
(Germany) from potatoes that occurred in 2015, the German Federal Institute for Risk Assessment
(BfR) published an assessment on the acute toxicity of potato GAs (BfR, 2018a,b). Jacket potatoes and
potatoes boiled in the skin had been consumed before symptoms such as stomach ache and vomiting
had developed. Analytical results showed that the potatoes contained 236 mg TGAs/kg (141 mg a-
solanine and 95 mg a-chaconine per kg). Based on available human data in the literature, BfR
identified a LOAEL of 1 mg GAs/kg body weight (bw) per day and extrapolated from this by applying
an uncertainty factor of 2 to a NOAEL of 0.5 mg GAs/kg bw per day. This uncertainty factor of 2 was
considered by BfR to also protect persons with higher susceptibility. In addition, BfR recommended
that the intake of GAs should be below the NOAEL of 0.5 mg/kg bw per day to ensure a ‘margin of
safety’ to the NOAEL being > 1. To avoid an exceedance of this NOAEL, BfR recommended that the
TGA content of potatoes should not be higher than 100 mg/kg fresh weight. With this
recommendation, particularly sensitive populations are covered too. In view of significant data gaps,
BfR considered its conclusions as preliminary. Since case reports in humans indicate a lethal dose of 3–
6 mg/kg bw, whereas the LD50 for mice and rats is at least 300-fold higher, BfR pointed to the
considerable higher sensitivity of humans compared to rodents.
Previous risk assessments on farm and companion animals
No risk assessments on farm and companion animals have been identified.
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1.3.5. Legislation and other standards
In order to protect public health, Article 2 of the Council Regulation (EEC) No 315/934 stipulates
that, where necessary, maximum tolerances for specific contaminants shall be established. Thus, a
number of maximum tolerances for contaminants as well as natural plant toxicants are currently laid
down in Commission Regulation (EC) No 1881/20065. However, no maximum levels for GAs in food or
feed have been established at EU level under this or under another Regulation.
Some European countries have national legislation or recommendations on the maximum limits of
TGAs, mainly in potato and potato products. Hungary has a national regulation of 100 mg/kg as the
maximum limit of solanine equivalents of raw, unpeeled potatoes. In Finland, a maximum level for GAs
(solanine glycosides, such as a-solanine and a-chaconine) for potatoes of 200 mg/kg6 exists, as well as
in Sweden, where the National Food Administration’s Regulations on Certain Foreign Substances in
Food7 established in 2004 a maximum content of TGAs (total content of solanidine GAs, such as a-
chaconine and a-solanine) in potatoes, raw and unpeeled, of 200 mg/kg. Also Denmark uses the
Nordic guideline of 200 mg GAs/kg for known potatoes varieties, and 100 mg/kg for new potatoes
varieties.
In the Netherlands, potato producers agreed to observe a limit of 100 mg/kg fresh weight for new
potato cultivars (Bal, 1989, as cited in Essers et al., 1998). In Austria, no maximum level is laid down,
but in the Regulation for marketing of food potatoes, there are minimum requirements for marketing
of food potatoes to avoid a high content of GAs, such as the potatoes (i) must be free of noticeable
green tubers, (ii) for class I potatoes: a slight green colour of not more than 1/8 of the surface is
allowed, and (iii) for class II potatoes: a slight green colour, which can be removed by normal peeling
is allowed.
In Germany, BfR recommended that the GA content of potatoes should not be higher than 100 mg/
kg fresh weight (BfR, 2018a,b).
In Canada, a maximum level of 200 mg/kg for the sum of a-solanine and a-chaconine in fresh
potato tubers was established, on the basis that most reported cases of adverse effects associated
with potato GA exposure have occurred at concentrations above this value. This value was confirmed
in 2014,8 indicating that it is achievable when good agricultural, manufacturing and storage practices
are followed.9 In the USA, a maximum acceptable TGA content of potato tubers of 20–25 mg per 100
g of fresh potato (equivalent to 200–250 mg/kg) has been set according to the US-Food and Drug
Administration (FDA) poisonous Plant Database.10
The Organisation for Economic Co-operation and Development (OECD) published in 2002 its
‘Consensus Document on Compositional Considerations for New Varieties of Potatoes: Key Food and
Feed Nutrients, Anti-Nutrients and Toxicants’.11 Under the considerations for the assessment of new
potato varieties, it indicated that the comparison of the chemical composition of tubers from a
modified variety with tubers from the non-modified comparator should include, among others, the
determination of GAs. It reported on the ‘widely accepted safety limit for the level of TGA in tubers’ of
200 mg/kg fresh weight (based on B€omer and Mattis, 1924 and Smith et al., 1996), and concluded
that if the analyses of GAs (and other parameters) indicate that a novel variety is within the ranges
given in the literature it can be considered equivalent with respect to its overall composition.
4 Council Regulation (EEC) No 315/93 of 8 February 1993 laying down Community procedures for contaminants in food. OJ L
37, 13.2.1993, p. 1–3.
5 Commission Regulation (EC) No 1881/2006 of 19 December 2006 setting maximum levels for certain contaminants in
foodstuffs. OJ L 364, 20.12.2006, p. 5–24.
6 https://www.finlex.fi/fi/laki/alkup/2016/20160880
7 F€oreskrifter om €andring i Livsmedelsverkets f€oreskrifter (SLVFS 1993:36) om vissa fr€ammande €amnen i livsmedel, LIVSFS




9 In 2017 Health Canada proposed to transfer the existing maximum level for TGA in potato tubers from the List of Maximum
Levels for Various Chemical Contaminants in Food to the regulatory List of Contaminants and Other Adultering Substances in
Food, thereby removing this maximum level from the first list.
10 https://www.cfsanappsexternal.fda.gov/scripts/Plantox/Detail.CFM?ID=6537
11 https://www.oecd.org/science/biotrack/46815167.pdf
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2. Data and methodologies
The CONTAM Panel applied the general principles for the assessment of chemicals in food as
described by WHO/International Programme on Chemical Safety (IPCS) (WHO/IPCS, 2009). In
addition, EFSA guidances pertaining to risk assessment were followed for the development of the risk
assessment when necessary (EFSA, 2005, 2007, 2009, 2010a,b, 2011a,b; EFSA Scientific Committee,
2011, 2012a,b, 2017a–d).
2.1. Methodology for data collection, selection of evidence and study
appraisal
EFSA outsourced a call for an ‘Extensive literature search and selection for relevance of studies
related to the chemistry and toxicity of GAs and quinolizidine alkaloids in food and feed’ aiming at
identifying and evaluating literature related to the present assignment (and to another mandate of the
CONTAM Panel on quinolizidine alkaloids which is not further considered here). The call was launched
as a reopening competition for a specific contract under multiple framework contract CT/EFSA/AMU/
2014/01 Lot 2. The University of Chemistry and Technology Prague was awarded with the contract and
a final project report was delivered in November 2017 and was published (University of Chemistry and
Technology Prague, 2019). The aim of the assignment was to identify and collect all relevant literature
regarding GAs (and quinolizidine alkaloids) in food and feed covering the following areas: (i) chemistry
and analysis, (ii) toxicokinetics in experimental animals, farm/companion animals, humans, and from
in vitro studies and on biomarkers, (iii) in vitro and in vivo mode of action of toxicity, (iv) toxicity
in vivo in laboratory animals, (v) toxicity in vitro, (vi) observations in humans, including epidemiological
studies, case reports, outbreaks, intervention studies, (vii) adverse effects in farm and companion
animals, (viii) occurrence in food, (ix) occurrence in feed and animal exposure and (x) influence of
cultivars, maturity, environmental conditions, storage and processing in the concentrations of the
alkaloids in the products. Details of the methodology and the results are reported in the University of
Chemistry and Technology Prague (2019).
In addition to the literature searches outsourced by EFSA, additional complementary searches were
performed. A literature search for studies regarding observations in humans was performed in October
2017 (for details see Appendix B, Section B.1). An extra search to identify studies on the toxicity of
GAs was conducted in April 2018 (for details, see Appendix B, Section B.2). The literature searches
were performed using Web of Science,12 PubMed13 and Scopus. The references resulting from the
literature search were imported and saved using a software package (EndNote14), which allows
effective management of references and citations.
Reviews, relevant scientific evaluations and toxicity studies by national or international bodies were
also considered for the current risk assessment, i.e. JECFA (JECFA, 1992, 1993). When relevant papers
were identified during the risk assessment process (e.g. from other studies or reviews), they were also
considered.
In addition, a search for recent reviews was conducted to identify scientific publications dealing with
methods of analysis, chemistry, formation in food, exposure and occurrence of GAs in food and feed.
A search for original studies reporting on the occurrence of GAs in food and feed samples was
carried out, since it was expected that only limited number of occurrence data of GAs in food and feed
were going to be submitted to EFSA (see Section 2.3.1).
An update of the literature available in the public domain was done regularly, on 17 December
2018, 3 May 2019 and 14 August 2019. Since that date, the literature was monitored to identify
studies relevant for the risk assessment until the time of endorsement.
Any publications were used in the assessment if they were considered as relevant by applying
expert judgement. In addition, for the studies on the toxicity of GAs in experimental animals and farm
and companion animals, the selection criteria in Table 3 were used. For the sections on repeated dose
toxicity and developmental and reproductive effects, animal studies based on i.p. or i.v. application of
GAs or aglycones were excluded (see also Appendix G).
12 Web of Science (WoS), formerly ISI Web of Knowledge, Thomson Reuters. Available at: http://thomsonreuters.com/thomson-
reuters-web-of-science/
13 PubMed, Entrez Global Query Cross-Database Search System, National Center for Biotechnology Information (NCBI), National
Library of Medicine (NLM), Department of the National Institutes of Health (NIH), United States Department of Health and
Human Services. Available at: http://www.ncbi.nlm.nih.gov/pubmed/
14 EndNote X5, Thomson Reuters. Available at: http://endnote.com/
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The draft scientific opinion underwent a public consultation from 27 February 2020 to 15 April
2020. The comments received and how they were taken into account when finalising the scientific
opinion were published in an EFSA Technical Report (EFSA, 2020).
2.2. Food and feed occurrence data submitted to EFSA
2.2.1. Data collection and validation
Following a mandate from the European Commission to EFSA, a call for annual collection of
chemical contaminant occurrence data in food was issued by the former EFSA Dietary and Chemical
Monitoring Unit (now DATA Unit)15 in December 2010 with a closing date of 1 October of each year.16
European national authorities and similar bodies, research institutions, academia, food business
operators and other stakeholders were invited to submit analytical data on GAs in food through this
call. The data submitted to EFSA on GAs were provided by national authorities from Germany, Sweden
and the Netherlands.
The data submission to EFSA followed the requirements of the EFSA Guidance on Standard Sample
Description for Food and Feed (EFSA, 2010a), and the occurrence data were managed following the
EFSA standard operational procedures (SOPs) on ‘Data collection and validation’ and on ‘Data analysis
of food consumption and occurrence data’.
By the 2 September 2019, a total of 1,300 analytical results on GAs in food (representing 651 food
samples) were available in the EFSA database. Data received after that date were not included in the
data set used for further evaluation for this opinion. All data submitted to EFSA concerned potato and
potato products. No data were submitted concerning GAs in tomato, aubergine and food products
containing tomato or aubergine.
In addition, in January–February 2019, a consultation was held with registered EFSA Stakeholders
and other stakeholders to inform the work of the CONTAM Panel and its working group in developing
this scientific opinion. The aim of the consultation was to collect information which were not readily
available in the public domain regarding GAs occurrence data in food and feed, factors that influence
the content of GAs and toxicity (see Section on Documentation provided to EFSA). Following this
consultation, EFSA invited the stakeholders to submit occurrence data in food and feed within the
annual collection of chemical contaminant occurrence data, following the requirements of the EFSA
Guidance on Standard Sample Description for Food and Feed (EFSA, 2010a) for inclusion in the risk
assessment. As a result, on 2 July 2019, the European Starch Industry Association submitted
occurrence data to EFSA concerning 1,728 samples on dietary fibre and potato proteins, pulp, juice,
starch and on potatoes used for starch production. See Section 3.2.1 for further details.
2.2.2. Data analysis
Following the EFSA SOP on ‘Data analysis of food consumption and occurrence data’ to guarantee
an appropriate quality of the data used in the exposure assessment, the initial data set was carefully
evaluated applying several data cleaning and validation steps. Special attention was paid to different
parameters such as ‘Sampling strategy’, ‘Reporting unit’ and the codification of the different samples
under FoodEx classification. The outcome of the data analysis is presented in Section 3.1.1.
Table 3: Selection criteria for the studies on the toxicity of glycoalkaloids (GAs) in experimental
animals and in farm animals, horses and companion animals
Inclusion criteria: Exclusion criteria:
• Data described by the author as purified GAs or GA
mixtures, and their aglycones.
• Edible parts of the plant, as well as their
preparations in which the total and/or GA
concentration is indicated.
• Preparations of potato sprouts in which the total
and/or GA concentration is indicated.
• Studies on non-edible parts (e.g. flowers) of the
plants.
• Studies giving no adequate information on the
composition and/or TGA concentration of the used
extracts, materials or preparations.
15 From 1 January 2014 onwards, Evidence Management Unit (DATA).
16 Current call: https://www.efsa.europa.eu/en/consultations/call/190410
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The left-censored data (results below LOD or below LOQ) were treated by the substitution method as
recommended in the ‘Principles and Methods for the Risk Assessment of Chemicals in Food’ (WHO/IPCS,
2009). The same method is indicated in the EFSA Scientific Report ‘Management of left-censored data in
dietary exposure assessment of chemical substances’ (EFSA, 2010b) as an option in the treatment of left-
censored data. The guidance suggests that the lower bound (LB) and upper bound (UB) approach should
be used for chemicals likely to be present in the food (e.g. naturally occurring contaminants, nutrients
and mycotoxins). The LB is obtained by assigning a value of zero (minimum possible value) to all samples
reported as lower than the LOD (< LOD) or LOQ (< LOQ). The UB is obtained by assigning the numerical
value of LOD to values reported as < LOD and LOQ to values reported as < LOQ (maximum possible
value), depending on whether LOD or LOQ is reported by the laboratory.
2.3. Food and feed consumption data
2.3.1. Food consumption data
The EFSA Comprehensive European Food Consumption Database (Comprehensive Database)
provides a compilation of existing national information on food consumption at individual level. Details
on how the Comprehensive Database is used are published in the Guidance of EFSA (EFSA, 2011a).
Consumption data were collected using single or repeated 24- or 48-h dietary recalls or dietary records
covering from 3 to 7 days per subject. Subjects in the Comprehensive Database are classified
according to the following subpopulations:
• Infants: < 12 months old
• Toddlers: ≥ 12 months to < 36 months old
• Other children: ≥ 36 months to < 10 years old
• Adolescents: ≥ 10 years to < 18 years old
• Adults: ≥ 18 years to < 65 years old
• Elderly: ≥ 65 years to < 75 years old
• Very elderly: ≥ 75 years old.
Two additional surveys provided information on specific population groups: ‘Pregnant women’ (≥ 15
years to ≤ 45 years old; Latvia) and ‘Lactating women’ (≥ 28 years to ≤ 39 years old; Greece).
Owing to the differences in the methods used for data collection, direct country-to-country
comparisons can be misleading. Overall, the food consumption data gathered by EFSA in the
Comprehensive Database are the most complete and detailed data currently available in the EU.
Some of these data, however, cannot be used in exposure assessments if the relevant occurrence
data are reported at the level of the raw primary commodities (RPCs). The RPC model developed by
EFSA in 2019 aimed to bridge this gap by transforming food consumption data from the
Comprehensive Database for composite foods (foods consisting of multiple components) and RPC
derivatives (single-component foods which have been physically changed by processing) into their
corresponding quantities of RPCs. The RPC database also contains information on products derived
from potato that have undergone a further refining, distillation and/or isolation process, i.e. potato
starch and alcoholic beverages produced from potato by-products by distillation. Details on how the
RPC database was developed are published in a dedicated technical report (EFSA, 2019). The RPC
Consumption Database, based on the Comprehensive Database version published on the 31 March
2018, contains 51 dietary surveys from 23 different countries. These surveys cover a total of 94,532
subjects and 26,573,088 RPC consumption records.
The use of the RPC Consumption Database was considered as the most appropriate approach for
the current assessment for which occurrence data in the RPC main-crop potato were available (see
Section 2.5). As no occurrence data were available for GAs in tomato and aubergine, these foods were
not included in the consumption and exposure assessment.
Detailed information on the different dietary surveys used in this report for the acute exposure
assessment is shown in Annex A.1, including the number of subjects and days available for each age
class.
2.3.2. Feed consumption data
Of the large number of species within the Solanaceae family, only potatoes and by-products derived
from them are used as feed for livestock. Due to the high cost of growing the crop, and the value of
potatoes as food for human consumption, they are not usually grown as a feed for livestock, and
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whole (raw) potatoes are only used as feed when production is in surplus to requirements as food, or
when they are discarded because they do not meet market requirements because of their size,
appearance, diseases or physical damage. As a result, the use of raw tubers as livestock feed tends to
be opportunistic, and the CONTAM Panel have not identified any data on quantities used in this way.
Feed grade potato tubers are mainly used as feeds for ruminants but may also be fed to horses. They
are highly palatable and nutritious and dairy cows will typically consume up to 25–30 kg of potatoes
(Crawshaw, 2001). For growing cattle, up to 30% of the diet (dry matter) may be fed (Fiems et al., 2013).
Raw potatoes are relatively unpalatable, and the starch indigestible for pigs and poultry, and
therefore, it is recommended that they are cooked or steamed before being fed (Whittemore, 1977).
They may be included at up to 15% of the diet dry matter for finishing pigs and sows (Ewing, 2002),
and up to 50% of the dietary dry matter for growing and finishing pigs (Pond and Maner, 1984).
Inclusion of cooked potatoes in poultry grower diets at up to 20% have been recommended, while for
layers, a dietary inclusion rate of 15% potato meal did not reduce egg production (Whittemore, 1977).
In addition to raw potatoes, the EU Catalogue of Feed Materials17 lists 14 different by-products
from potato processing industries, including cuttings, scrapings, flakes and pulp. The suitability of
these as feeds for different livestock depends on the degree of processing to which they have been
exposed, and the nutritional requirements of the livestock.
Steamed potato peel is a highly nutritious and palatable feed for pigs, and its availability has
increased in recent years in line with the increase in the production of French fries. Low-GA potato
protein concentrate is often added to low protein pig starter diets to reduce the incidence of diarrhoea
in newly weaned pigs (Stein, 2002).
The use of potato protein concentrate in poultry diets is generally limited, with some research
reporting an increase in necrotic enteritis in broilers.
Potato protein concentrate was used as an alternative to fishmeal in the diets of rainbow trout, with
limited success (Tusche et al., 2011), and has been included in specialist feeds for dogs.18 However,
information on amounts of this or other potato by-products used as animal feeds within the EU is not
publicly available. Since the highest concentrations of GAs are found in the skin (Milner et al., 2011),
and these are removed at an early stage in the processing, levels of GAs in by-products such as potato
starch and potato protein concentrate are likely to be low.
2.4. Food classification
Consumption data were classified according to the FoodEx classification system (EFSA, 2011b).
FoodEx is a food classification system developed by EFSA in 2009 with the objective of simplifying the
linkage between occurrence and food consumption data when assessing the exposure to hazardous
substances. It contains 20 main food categories (first level), which are further divided into subgroups
having 140 items at the second level, 1,261 items at the third level and reaching about 1,800 end
points (food names or generic food names) at the fourth level.
In 2011, a new version of FoodEx, named FoodEx2, has been developed and is described in the
scientific document ‘Report on the development of a Food Classification and Description System for
exposure assessment and guidance on its implementation and use’ (EFSA, 2011b). The last release of
FoodEx2 complements the previous hierarchical classification system of basic codes with more detailed
food levels and gives the possibility of reporting additional information through the use of facets and
facet descriptors (EFSA, 2015).
For this opinion, the amount consumed for each reported FoodEx code was converted to the
equivalent amount of RPC (main-crop potatoes) by disaggregating complex foods into their
components (the original RPC and RPC derivatives) and applying relevant reverse yield factors taking
into account effects of processing, as described by the RPC model (EFSA, 2019).
2.5. Methodology for Exposure assessment
Human exposure assessment
The CONTAM Panel estimated the acute exposure to GAs (see Section 3.1.6).
Since available occurrence data did not cover all the food categories containing potatoes in the
Consumption Database (see Section 3.2.1), it was decided that the best approach for the exposure
17 Commission Regulation (EU) No 68/2013 of 16 January 2013 on the Catalogue of feed materials. OJ L 29, 30.1.2013, p. 1–64.
18 Source: http://www.4petsusa.com
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assessment would be to use the occurrence values in the RPC (main-crop potatoes and new potatoes)
and the RPC Consumption Database (see Section 2.3.1). A scenario including only days in which there
was consumption of main-crop potatoes (or new potatoes, see Section 3.2.1) was considered the one
that best characterises the acute exposure.
The acute dietary exposure to GAs was estimated by using a probabilistic approach based on the
method of random sampling with replacement of occurrence data, of processing steps where the
information was not available, and of processing factors. The random sampling captures the variability of
occurrence values and of processing factors. Random sampling of consumption events was not
performed because potatoes are a widely consumed food and GAs are present in all samples. Thus, the
CONTAM Panel concluded this would have a limited impact on the results. The exposure was calculated
on a per day basis. Acute exposure was assessed for each reporting day by multiplying the total daily
consumption amount of main-crop potatoes by one occurrence level randomly drawn among the
individual results available. For the calculations of exposure, the UB values for the occurrence were used
as considered more adequate to represent acute exposure also considering that in this assessment, the
LB and UB of the analysed samples do not differ substantially. In the final data set, only four analytical
results for a-solanine and 22 results for a-chaconine were left censored, and in only two samples, both
GAs were not quantified. The LOQ for samples with left censored results ranged from 0.75 to 5 mg/kg.
Since peeling of potatoes and heat processing decrease the content of GAs (see Section 3.2.3), the
CONTAM Panel applied processing factors linked to peeling (where applicable) and to heat processing
(to all eating events) to estimate the GA levels in the final food consumed based on available
information as follows:
– Information on peeling was not available in the RPC Consumption Database; thus, the
CONTAM Panel assumed that in 90% of all eating events, potatoes were consumed peeled.
Possible differences among countries or regions were not taken into consideration. A
probabilistic approach was used to assign to each eating event the ‘peeled’ vs. ‘unpeeled’
status. Based on studies in the literature (see Section 3.2.3), a processing factor between 0.25
and 0.75 due to peeling was attributed to the peeled potatoes only.
 Information about the heat processing methods was only available in a limited number of
cases.
 A probabilistic approach was also used to assign one of the heat processing methods to each
eating event. The proportion of each of the heat processing methods within all eating events
was based on available information in the RPC consumption database (frying: 23%, deep
frying: 12%, cooking in water: 47%, drying, flaking and roasting: 5% each, and stewing:
2%). Possible differences among countries or regions were not taken into consideration.
 Based on literature studies that reported on the percentage reduction for specific processing
steps (see Section 3.2.3), processing factors between 0.1 and 0.8 were attributed to frying
and deep frying, and between 0.35 and 0.95 for all other heat processing methods.
 The processing factors for peeling and heat processing assigned to each eating event were
extracted from a normal distribution, where the minimum and maximum allowed values were
the ranges described above. Results were compared with an exposure assessment scenario
where processing factors were extracted from an uniform distribution rather than a normal
distribution and the exposure outcome was very similar (see Table A.7 in Annex A).
Exposures from the different eating events of one day (for the considered subject) were summed
and divided by the individual’s body weight to obtain the total exposure per kg bw per day.
Consumption of main-crop potatoes linked to the consumption of alcoholic beverages (vodka and
distilled spirits from potato) was excluded from the consumption and exposure assessment, as the
CONTAM Panel considered the transfer of GAs from the potatoes during the distillation and refining
process to be negligible. Exposure to potato GAs from potato starch was included in the exposure
assessment. Due to insufficient occurrence data in potato starch and the lack of processing factors
related to starch production, the occurrence data and processing factors for peeling and heat
processing for main-crop potatoes were used. The Panel noted that the overall concentration of GAs in
potato starch may be low (Saito et al., 1990; Driedger and Sporns, 1999), and that in most of the
consumption surveys, the contribution of potato starch to the overall potato consumption is below 5%.
The Panel considered the impact of potato starch in the overall GA intake to be low.
The mean and P95 daily acute UB exposure were then calculated per survey and age class.
To model the uncertainty, the process was iterated 1,000 times. The mean of the 1,000 mean and
P95 daily acute UB exposures per survey and per age class was then calculated. The 95% confidence
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interval (CI) defined as the interval between the 2.5th and 97.5th percentiles obtained from the 1,000
iterations was determined to indicate the uncertainty around the mean value.
In Table A.1 of Annex A, the number of available subjects for each age class used in the acute
exposure assessment is provided.
Animal exposure assessment
Due to insufficient data on levels of GAs in either potatoes or potato by-products used as animal
feeds, and lack of data with which to calculate reference points for any of the farm animal species (see
Sections 3.1.4 and 3.1.7), no estimates of exposure to GAs have been made.
2.6. Methodology for Risk characterisation
The CONTAM Panel applied the general principles of the risk characterisation process for chemicals
in food as described by the WHO/IPCS (2009) and the relevant EFSA guidance documents.
3. Assessment
3.1. Hazard identification and characterisation
3.1.1. Toxicokinetics
3.1.1.1. Experimental animals
The studies identified on the toxicokinetics of GAs in experimental animals are described below, and
details are given in Appendix C.
3.1.1.1.1. a-Solanine
Nishie et al. (1971) studied the metabolic fate and distribution of a-solanine in male Fisher rats.
[3H]-a-solanine was administered as a single treatment either by gavage at 5 mg/kg bw or i.p.
injection at 5–25 mg/kg bw to an unreported number of rats. Following oral exposure, fecal elimination
of radioactivity reached 84% of the administered dose by day 4, with urinary excretion accounting for
less than 10%. 24 h after the oral exposure, radioactivity distributed mainly in the liver (about 1.5% of
the administered dose), followed by blood, kidney and lungs. Following i.p. injection of 5–15 mg/kg bw
of labelled a-solanine, radioactivity was eliminated at similar rates in urine and feces (approximately
15–20% of the administered doses by 24 h). Decreased urinary excretion and complete absence of
fecal elimination were observed at the highest dose administered (25 mg/kg bw), with a corresponding
increase in the radioactivity retention in the gastrointestinal tract, similarly to what reported by Norred
et al. (1976) for a-chaconine (see Section 3.1.1.1.2). Lesions of increasing severity were observed in
the peritoneal cavities of animals exposed to ≥ 10 mg/kg bw. A metabolic study was performed using
TLC. Following oral exposure, 65% of the radioactivity present in feces was identified as solanidine,
whereas only 6% of the dose excreted in urine was identified as solanidine, with two other non-
identified metabolites accounting for 80% and 13% of the radioactivity excreted in urine.
Groen et al. (1993) studied the toxicokinetics of [3H]-a-solanine in male rats and hamsters. [3H]-
labelled a-solanine was administered via i.v. injection or via gavage at a dose of 54 and 170 lg/kg bw,
respectively. Following i.v. administration, a similar toxicokinetics of radioactivity in blood and plasma
was observed in rats and hamsters. Plasma levels of total radioactivity and unchanged a-solanine
showed three-phase profiles (see Table 4). Compared to i.v. treated animals, the oral bioavailability of
a-solanine and metabolites (based on total radioactivity) in animals treated by gavage was 29% and
57% in rats and hamsters, respectively. The oral bioavailability for the parent compound a-solanine
was 1.6% and 3.2% in rats and hamsters, respectively. Plasma clearance of unchanged a-solanine
following oral administration was significantly faster in rats (t1/2 = 7.79  0.83 h) than in hamster
(t1/2 = 19.7  4.2 h); however, similar plasma clearance was observed for total radioactivity in the two
species (82.2  6.1 h in rats, and 94  33 h in hamsters). Excretion of total radioactivity in urine and
feces was significantly faster in rats than in hamsters treated by gavage. Seven days after the oral
treatment, total excretion of the administered dose was 89% in rats, with approximately 3% in urine
and 86% in feces; in hamsters, total excretion was 39%, with approximately 10% in urine and 29% in
feces. Macroscopic observation performed at the necropsy of the animals sacrificed 7 days after the
treatment revealed damages in the intestinal walls of some hamsters following oral treatment.
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3.1.1.1.2. a-Chaconine
Norred et al. (1976) studied the toxicokinetics of [3H]-a-chaconine (tritiated in the aglycone moiety at
carbon atoms adjacent to the double bond and to the nitrogen atom) in male Sprague-Dawley rats (200–
300 g bw). Rats were dosed either by gavage (5 mg/kg bw) or i.p. injection (5–25 mg/kg bw) and
housed in metabolic cages up to at least 100 h after treatment. Following oral administration of 5 mg/kg
bw, fecal elimination of 60% and 80% of the administered radioactivity dose was observed after 24 and
48 h, respectively. Urinary excretion reached a plateau of 10% of the administered radioactivity dose by
24 h. Maximum levels in tissues were measured after 6–12 h, with higher levels in liver (about 1.3% of
the radioactivity dose) and blood (about 0.2%). The radioactivity recovery considering the sum of fecal
elimination, urinary excretion and gastrointestinal content, ranged approximately from 85% to 100%
across the selected time points. Following i.p. injection of 5–10 mg/kg bw, elimination took place via the
urine (10–15% of the administered radioactivity dose excreted 24 h after treatment) and the feces
(< 10%). However, reduced urinary excretion was observed at the highest dose administered (25 mg/kg
bw); complete absence of fecal elimination was also observed at 15 and 25 mg/kg bw with a
corresponding increase in the radioactivity detected in the gastrointestinal tract. A metabolic study was
performed using TLC, which the CONTAM Panel considers to be of limited value. Following oral treatment
with 5 mg/kg bw, about 63% and 16% of the radioactivity present in feces and urine was extracted with
ether, respectively. TLC analysis of the feces and urine extracts revealed the presence of a main
metabolite with the same retention factor of solanidine. About 25% of radioactivity detected in feces was
attributable to the parent compound.
The distribution of radioactivity in subcellular fractions of hepatocytes in female Swiss-Webster mice
exposed to a-chaconine was investigated by Sharma et al. (1983). Following oral administration of 10
mg/kg [3H]-a-chaconine, mice were sacrificed at 3, 6, 14, 72 and 120 h after exposure and liver tissue
and blood were sampled. The distribution of radioactivity in subcellular fractions of hepatocytes was
studied. Higher radioactivity levels in liver homogenate were measured from 3 until 14 h after the
exposure, with the nuclear subcellular fraction containing the highest levels, followed by mitochondria
and microsomes. In a second experiment, mice were orally exposed to different doses (1, 3 or 10 mg/kg)
and sacrificed after 14 h. The radioactivity distribution in liver homogenate and in subcellular fractions
was observed to increase consistently with the administered dose. Finally, mouse pre-treatment with the
cytochrome P450 inducer dibenzo[a]pyrene resulted in lower radioactivity levels measured in all the
subcellular fractions, possibly suggesting an increased metabolism of a-chaconine due to enzyme
induction by dibenzo[a]pyrene.
Alozie et al. (1979a) studied the toxicokinetics of [3H]-a-chaconine in male Golden hamsters
administered a dose of 10 mg/kg bw by gavage or i.p. injection. Hamsters were sacrificed at regular
time intervals (3 animals per time point) up to 168 h after treatment and radioactivity was measured
in different tissues. Urine and feces were collected and measured for radioactivity. Subcellular
distribution of labelled a-chaconine was also studied in various tissues. After the oral exposure,
distribution of radioactivity in various tissues was observed at the different time points, in particular
higher levels were observed in lungs, liver and skeletal muscles. Radioactivity levels remained high in
the intestine throughout the oral study and also relatively high in the i.p. study, possibly suggesting
high biliary excretion. Following oral exposure, the excretion of radioactivity occurred mainly via the
urine reaching about 21% of the administered dose after 168 h, whereas only a minor fraction was
detected in feces. The study of subcellular distribution showed a-chaconine or its metabolites to be
distributed mainly in the nuclear, microsomal and soluble cellular fractions in various tissues including
brain, heart and liver. The residual radioactivity present in the cellular subfractions following a wash
procedure with methanol suggested that a fraction of a-chaconine (or a-chaconine metabolites) could
bind to macromolecules (type not specified) in these tissues.
Table 4: Plasma half-lives (tri-phase elimination) of total radioactivity and unchanged a-solanine
following i.v. injection of 54 mg/kg bw [3H]-a-solanine in rats and hamsters (Groen et al.,
1993)
T1/2a (h) T1/2b (h) T1/2s (h)
Total radioactivity Rat 1.4  1.6 8.9  2.2 61  13
Hamster 1.5  0.4 7.7  3.0 62  22
Unchanged a-solanine Rat 1.9  1.4 9.9  0.8 32  6.5
Hamster 2.1  1.4 8.9  2.8 39  13
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In a follow-up publication, Alozie et al. (1979b) studied the metabolic fate of a-chaconine in Golden
hamsters following oral exposure to 10 mg/kg bw [3H]- a-chaconine. Urine and feces were collected at
different time points up to 168 h after exposure and subsequently extracted with water or chloroform.
These extracts were analysed by TLC. In urine, initially unaltered a-chaconine appeared to be the only
excreted substance (100% of detected radioactivity at the 12 h time point, corresponding to 0.25% of
the administered dose), showing a declining trend towards the end of the study. Solanidine appeared
in urine 24 h after the exposure and reached a maximum level after 72 h. Four other metabolites
could be detected but not identified, two of them representing the major peaks at 168 h. The total
excretion in feces represented only a minor amount of the administered dose (see Alozie et al., 1979a)
and was mainly constituted by the parent compound.
3.1.1.2. Humans
The studies identified on the toxicokinetics of GAs in humans are described below, and details are
given in Appendix C.
3.1.1.2.1. Mixtures of a-solanine and a-chaconine
The kinetics of a-solanine and a-chaconine in human volunteers was studied by Hellen€as et al.
(1992). Seven healthy male adults were administered a peeled mashed potato meal containing 82 mg/kg
a-solanine and 118 mg/kg a-chaconine. The study subjects were given a portion adjusted to reach a
dose of 1 mg TGAs/kg bw. Blood was sampled at regular intervals prior the exposure and up to 25 h
following the exposure and the content of a-solanine, a-chaconine and solanidine were determined via
HPLC analysis. Average serum Cmax for a-solanine and a-chaconine were 7.7 and 14.4 ng/mL, with
average Tmax of 5.1 and 6 h, respectively. Solanidine reached the maximum level after 8 h (ranging from
1.0 to 4.8 ng/mL across subjects) and remained apparently constant until the end of the study. Average
apparent biological half-lives were calculated to be approximately 11 and 19 h for a-solanine and
a-chaconine, respectively, with low variability across subjects. The CONTAM Panel noted that the
reliability of the calculated half-lives was limited by the short observation period (25 h). Adverse/
undesirable effects were observed in most of the study volunteers, as described in Section 3.1.3.
Mensinga et al. (2005) studied the pharmacokinetics and toxicity of a-solanine and a-chaconine in six
male and eight female healthy volunteers treated with escalating doses of the two GAs either via
solutions (0.30, 0.50 or 0.70 mg TGA/kg bw) or in a form of a mashed potato meal (0.95, 1.10 or 1.25 mg
total TGA/kg bw). Both the solution and the potato meals contained approximately equal amounts of the
two GAs. Blood was sampled from all subjects at various time points as from 1 h before treatment till 96 h
after treatment and serum GA levels were measured by HPLC analysis. Both a-solanine and a-chaconine
showed similar tmax in serum ranging from 4 to 8 h without correlation with the administered doses.
Maximum serum concentrations (Cmax) showed strong positive correlations for a-solanine and
a-chaconine both for administration via solution (correlation coefficient 0.98) and via potato meal (0.97)
(see Table 5). A similar result was obtained for the 0–24 h areas under the curve (AUC0-24), whereas a
significant correlation was observed only in subjects treated with mashed potatoes for the AUC from point
zero to infinity (AUC0-∞). Serum half-lives showed a high inter-individual variability and were generally
longer for a-chaconine (27–84 h, average of 44 h) than for a-solanine (5–42 h, average of 21 h). One
volunteer exposed to 1.25 mg/kg bw experienced adverse effects as described in Section 3.1.3.1.2.
Table 5: Pharmacokinetic parameters (ranges) of a-solanine and a-chaconine in human volunteers
after oral exposure (adapted from Mensinga et al., 2005)
GAs solution GAs in mashed potatoes
Dose (mg/kg bw) 0.30 0.50 0.70 0.95 1.10 1.25
Number of subjects 2 2 2 3 3 2
a-Chaconine
Cmax (lg/L) 2.8–3.2 3.2–4.5 3.3–6.3 5.2–7.4 2.9–7.8 6.3–9.7
Tmax (h) 5–6 5–6 4-5 5–7 5-8 7–12
T1/2 (h) 32–37 49–84 29–39 27–49 49–60 37–45
AUC0-∞ (lg h/L) 117–130 148–242 128–227 237–345 168–316 299–419
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3.1.1.2.2. Solanidine
Claringbold (1982) administered an unreported dose of [3H]-solanidine by a single i.v. injection in
two male and one female volunteers. Blood was sampled at various times and urine and feces were
collected. The decrease of radioactivity in plasma followed a three-phase trend and levels were
detected up to 150 h after the treatment. The authors estimated that in blood, about 70% of
radioactivity detected was retained by erythrocytes, which could explain the slow clearance from
plasma. After 24 h, only 3–7% of the administered radioactivity was excreted in urine and feces.
The same authors also studied the presence of solanidine in five post-mortem liver samples. The
extraction procedure from liver homogenates identified four solanidine containing fractions (free,
glucuronide, glycoside and a residual fraction obtained following acid hydrolysis). In two out of five
liver samples, no solanidine was detected in any of the four fractions. In another sample, no free
solanidine was found and solanidine was observed mainly as the glucuronide (70%). In the two
remaining samples, free solanidine accounted for 25 and 15%, respectively. In their acid hydrolysed
fraction, solanidine accounted for 42 and 60%, respectively.
3.1.1.2.3. Biomarkers of exposure
Three studies were identified in which a radioimmunoassay method was developed to quantify
solanidine in human plasma. In the first study, Matthew et al. (1983) described the method and
reported the results on 34 human donors. One limitation of this method was that the rabbit immune
serum developed for the radioimmunoassay had a 100% cross-reactivity with a-solanine, a-chaconine
and demissidine. However, a preliminary extraction step using chloroform allowed the specific
determination of solanidine. The method was applied on plasma of 34 human donors (7 males and 27
females), randomly selected from a hospital clinic. All plasma samples showed quantifiable levels of
solanidine, with mean levels of 1.56  1.17 and 1.20  0.93 ng/mL calculated for males and females,
respectively.
The assay developed by Matthew et al. (1983) was subsequently applied by Harvey et al. (1985a)
to study the levels of solanidine in 57 volunteers (30 males and 27 females). The consumption of
potatoes and potato products of 33 subjects was recorded for one month, during winter. Two male
volunteers maintained a potato-free diet for several weeks while their serum was regularly analysed for
solanidine levels. The mean levels of solanidine were 10.8  5.4 ng/mL and 7.9  4.3 ng/mL in males
and females, respectively. A positive correlation between consumption of potatoes and potato products
and serum solanidine levels was found both in male and female subjects in the subgroup that recorded
their diets. Avoidance of potato consumption corresponded to a drop in the serum levels of solanidine,
reaching minimum levels (lower than the assay sensitivity of 0.5 ng/mL) 3 weeks after the cessation of
potato intake.
In a subsequent study, Harvey et al. (1985b) adapted the radioimmunoassay method to quantify
both solanidine and the TGA levels in serum and saliva. Two groups of volunteers (18 males and 15
females from UK, and 5 males and 5 females from Sweden) were analysed for levels of GAs during
summer. All the subjects maintained their standard diet during the study, with the exclusion of three
Swedish volunteers, who had daily consumption of two potato cultivars known to be high in GAs for a
week before serum and saliva sampling. Mean levels of solanidine and TGAs (all subjects) were,
respectively, 14.5 (5.8 ng solanidine/mL) and 38.5 nmol/L in serum, and 3.2 (1.3 ng solanidine/mL) and
3.7 nmol/L in saliva. No marked differences were observed among the UK and Swedish subjects
following standard diets. Significant correlations were shown between serum and salivary levels both for
solanidine and TGAs, and between serum solanidine and serum TGA levels. The three subjects
consuming potato varieties high in GA levels had substantially higher serum and salivary levels compared
to the other Swedish subjects (e.g. in serum solanidine mean levels were 10.5 nmol/L (4.2 ng
GAs solution GAs in mashed potatoes
Dose (mg/kg bw) 0.30 0.50 0.70 0.95 1.10 1.25
a-Solanine
Cmax (lg/L) 2.9–3.9 3.5–4.7 3.1–6.5 7.0–10.7 3.8–10.6 8.0–11.8
Tmax (h) 5–6 5–6 4–4 5–5 5–8 7–8
T1/2 (h) 17–35 5–28 8–17 14–18 1–-42 18–19
AUC0-∞ (lg h/L) 84–89 47–110 50–86 164–163 111–200 204–256
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solanidine/mL) in the seven subjects following standard diets, and 80.8 nmol/L (32.3 ng solanidine/mL)
in the three subjects with high-alkaloid diets).
3.1.1.3. Farm animals, horses and companion animals
Only scant information is available on the toxicokinetics of GAs in ruminants.
King and McQueen (1981) studied the effect of rumen on a-solanine and a-chaconine in vitro.
Rumen contents were collected from a rumen-fistulated cow before the morning feeding and
processed to remove feed particles. A mixture of a-solanine and a-chaconine was isolated from potato
blossom and added to the rumen inoculum at a concentration of 1 mg/mL. At different time points up
to 48 h, chloroform extracts were analysed by GC-NPD. The analyses revealed the formation of
solanidine, that reached a maximum concentration at 12 h, when a subsequent conversion to a 5,6-
dihydro derivative of solanidine, identified as 5b-solanidan-3b-ol, was observed. By 24 h, the hydrolysis
of the GA mixture reached a plateau and the sum of the two aglycones recovered from the rumen
inoculum were on average 83% of the test concentration (approximately 30% constituted by
solanidine and 50% by its 5,6-dihydro derivative).
Bushway et al. (1984) studied the potential transfer of GAs into cow’s milk. Three samples of
potato meal were analysed for their GA content and incorporated at 10 or 20% (w/w) in bovine feed
ration, corresponding to 2.25 and 4.5 kg potato meal per day, respectively. The mean contents of a-
chaconine and a-solanine in the potato meal samples were 515 and 285 mg/kg dw, respectively. This
resulted in estimated daily exposure of 3.6 and 2.0 mg/kg bw for a-chaconine and a-solanine,
respectively, at the highest level of potato meal intake, and of 1.78 and 0.99 mg/kg bw, respectively,
at the lower level of dietary inclusion.19 Considering the evidence from the King and McQueen (1981)
study, that GAs are almost completely converted to aglycones in rumen, milk samples from dairy cows
fed with spiked bovine feed ration were analysed by GC-NPD for the presence of solanidine. No
solanidine was detected in any milk sample (LOD: 0.14 mg/L).
3.1.1.4. Summary on toxicokinetics
Overall, limited conclusions on the toxicokinetics profiles of a-solanine and a-chaconine can be
drawn based on the available evidence.
Limited information is available from toxicokinetic studies in experimental animals. Both a-solanine
and a-chaconine showed a relatively low bioavailability in experimental animals. Different toxicokinetic
profiles were observed in rats and hamsters. In hamsters, there is indication for higher absorption and
slower excretion rates for both substances in comparison with rats. In particular in rats, following oral
exposure to labelled a-solanine or a-chaconine, radioactivity was excreted mainly via the feces (about
60% in 24 h and more than 80% after 4 days) as solanidine. Urinary excretion accounted for about
3–10% of the doses for a-solanine and 10% a-chaconine. Conversely, in hamsters, a lower fecal
excretion was observed, with urinary excretion reaching about 10% for a-solanine and 21% for
a-chaconine 7 days after the exposure. Information on the metabolic profiles of a-solanine and
a-chaconine were mainly obtained via TLC techniques and are of low reliability.
The blood kinetics profiles of a-solanine and a-chaconine in humans were relatively well studied in
two volunteer studies, using HPLC methods and showing comparable results. In volunteers exposed to
mixtures of a-solanine and a-chaconine in the range of 0.3–1.25 mg TGA/kg bw via consumption of
mashed potato meals, peak levels in serum were reached approximately 6–8 h after exposure,
independently from the doses. Both substances showed long serum half-lives, suggesting a possible
accumulation. a-Chaconine showed longer serum half-life than a-solanine (44 and 21 h, respectively).
In addition, in one study, the blood clearance of a-solanine and a-chaconine corresponded to the
increase in solanidine levels, which reached a maximum level after 8 h and remained apparently
constant up to 24 h following exposure. No further information on metabolism and no information on
excretion was available in these studies. A volunteer study using tritiated solanidine support the
evidence of slow clearance from plasma associated with a high retention of radioactivity in
erythrocytes, with a corresponding slow excretion in urine and feces. In a separate experiment,
solanidine was detected in three of five post-mortem liver samples, either in the free form or in
conjugated form (e.g. as glucuronide-conjugate). Levels of solanidine were regularly detected in the
blood of human volunteers in a series of studies using a radioimmuno assay for the detection of
solanidine or TGAs. In particular, in one experiment, solanidine could be detected in serum of two
volunteers up to 3 weeks after they started a potato-free diet. Overall, these studies provide some
19 Assuming 650 kg bw.
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limited information on the kinetics of potato GAs, mainly suggesting their hydrolysis to solanidine
following absorption and the slow clearance of solanidine from blood.
Only scant information is available on the toxicokinetics profile of potato GAs in ruminants. In an
in vitro study, a-solanine and a-chaconine were shown to be extensively converted to solanidine and
subsequently to a 5,6-dihydro derivative of solanidine, identified as 5b-solanidan-3b-ol. Another study
showed no detection of solanidine in cows’ milk upon consumption of feed spiked with a potato meal
contaminated with a-solanine or a-chaconine, suggesting a low potential to transfer into milk for GA.
No information was retrieved for other farm animals, horses or companion animals.
Toxicokinetic data on tomato and aubergine GAs and their aglycones could not be identified,
neither for experimental animals nor for humans.
3.1.2. Toxicity in experimental animals
The selection criteria for studies relevant to inform the toxicity in experimental animals are
described in Section 2.1.
In the descriptions below, the doses are reported as mg/kg bw per day. If the doses were reported
on molar basis in the original study, these were converted using the molecular weights given in
Appendix A. Due to the weight of the oligosaccharide in the GAs, the aglycones have a lower
molecular weight by a factor of ~ 2. This should be considered when comparing the dose–response
relationships of GAs and aglycones at doses given in mg/kg bw per day.
3.1.2.1. Acute toxicity studies
3.1.2.1.1. GAs from edible parts of S. tuberosum
Regarding acute oral toxicity of potato GAs (Table 6), a single oral application of 250 mg/kg bw of
a-solanine did not affect serum levels of liver transaminases or serum cholinesterase activity in rats
(Dalvi, 1985). Mice showed no lethality at a dose of 1,000 mg/kg bw (Nishie et al., 1971).
An LD50 value of 590 mg/kg bw was identified for a-solanine in male and female rats (Gull, 1960).
However, it is uncertain whether pure a-solanine was tested, as it appears likely that the standard (an
extract of potato sprouts, purified by crystallisation) contained an unknown amount of a-chaconine.
Therefore, the study cannot be used for risk assessment. Diarrhoea was reported to be the most
frequent symptom at lower doses of the extract.
When compared to oral toxicity, considerably lower doses of potato GA, aglycones or mixtures
caused symptoms or were lethal when applied i.p. or i.v. (see Table 7). For example, LD50 values for a-
solanine ranged from 32.3 to 42 mg/kg bw in mice to 67 mg/kg bw in rats. Reported symptoms were
diarrhoea and reduced spontaneous motor activity (Gull, 1960). The LD50 of a-chaconine, applied i.p.,
appears to be similar, i.e. 19.2 or 32.3 mg/kg bw in mice and 84 mg/kg bw in rats (Nishie et al., 1975;
Chaube and Swinyard, 1976; Sharma et al., 1979). Rabbits showed a similar sensitivity as rats and
mice towards a-solanine and a-chaconine, i.e. lethality occurred when a-solanine was applied at an i.v.
dose of 10 mg/kg kg bw, and at i.p. doses of either 20 or 40 mg/kg bw or when animals received a-
chaconine at an i.p. dose of 50 mg/kg bw (Nishie et al., 1971, 1975). Swinyard and Chaube (1973)
reported an LD50 value of < 40 mg of a-solanine per kg bw for rhesus monkeys (administered i.p.).
Regarding single i.p. application of defined mixtures of a-solanine and a/ß-chaconine, Syrian
hamsters were relatively sensitive showing an LD50 value between 10 and 25 mg/kg bw, while in rats,
the LD50 value was 60 or 75 mg/kg bw (Gull, 1960; Chaube and Swinyard, 1976; Phillips et al., 1996).
The aglycone solanidine was tested in mice only at a single i.p. dose of 500 mg/kg bw, which
exerted no lethal effects (Nishie et al., 1971).
3.1.2.1.2. GAs from edible parts of food plants other than S. tuberosum
The studies identified are reported in Tables 8 and 9.
Wilson et al. (1961) reported on 100% lethality in rats after oral application of 900–1,000 mg/kg
bw of a-tomatine to rats. Histologic analyses revealed an acute mucosal erosion of the stomach
associated with a mild acute inflammation in the submucosa.
Regarding mixtures, Baker et al. (1989) treated hamsters by a single oral application of water
suspensions of lyophilised seeds of aubergine containing 160 mg TGA/kg dry weight (dw). The authors
reported that solasodine was the only aglycone detectable. A dose of 6,316 mg suspension/kg bw
(approximately 1 mg TGA/kg bw) caused haemorrhagic gastritis in hamsters.
When compared to oral toxicity, considerably lower doses of tomato GAs were lethal when applied
i.p. or i.v. The LD50 values for a-tomatine in mice ranged from 18 mg/kg bw (i.v.) to 32.4 mg/kg bw
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(i.p.) (Sackmann et al., 1959; Wilson et al., 1961; Nishie et al., 1975). After s.c. administration, the
LD50 was raised to > 1,000 mg/kg bw (Sackmann et al., 1959). Rabbits appear to be less sensitive
than mice, since a single i.p. dose of a-tomatine at 100 mg/kg bw did not cause death of the animals
(Nishie et al., 1975).
The LD50 value of a-solamargine was determined to be 42 mg/kg bw, when applied i.p. to rats (Al
Chami et al., 2003).
3.1.2.1.3. Summary on acute toxicity studies
Regarding oral exposure to a-solanine, an LD50 of 590 mg/kg bw was identified for rats, while mice
showed no lethality at a dose of 1,000 mg/kg bw. When compared to gavage, considerably lower i.p.
doses elicited effects, e.g. in mice, the LD50 was 40–42 mg/kg i.p., and in rats, increased liver
transaminases in serum were reported at 20 mg/kg bw i.p.
Relative potency of toxicity of different GAs can be deduced after i.p. application and appear to be
similar, i.e. in rats, the LD50 was 67 mg/kg bw for a-solanine and 84 mg/kg bw for a-chaconine, and in
mice, it was 32.3–42 mg/kg bw for a-solanine and 19–32.3 mg/kg bw for a-chaconine. Lethality
occurred in New Zealand rabbits starting at 40 mg/kg bw of a-solanine and at 50 mg/kg bw for a-
chaconine. In mice, the aglycone solanidine exerted no effect when applied at 500 mg/kg bw i.p.,
contrasting to the pronounced toxicity of a-solanine and a-chaconine after the identical route of
exposure.
Lethal doses of a-tomatine were approximately 900–1,000 mg/kg bw p.o. in rats. Acute lesions
comprised erosion, and also inflammation occurred in the stomach. When applied i.v. or i.p., LD50
values of 18–32.4 mg/kg bw were found in rodents. Again, the parenteral route was found to increase
the toxicity of GAs from tomato.
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a-Solanine(a) Sprague-Dawley rats (M)
No/sex/group: 5
Single gavage: 0, 20 or 250 mg/kg bw
– 250 Dalvi (1985)
a-Solanine(a) Albino mice (M)
No/sex/group: n.r.
Single oral application: 0 or 1,000 mg/kg bw
– 1,000 Nishie et al.
(1971)
Mixture of a-solanine and
unknown proportion of a-chaconine(b)
White rats (M/F)
No/sex/group: 9
Single gavage: 300, 600 or 1,200 mg/kg bw
Diarrhoea
Lethality
300 590 Gull (1960)
F: females. M: males. n.r.: not reported.
(a): Chemical standard obtained from a commercial supplier, with high purity (95% pure or higher).
(b): Poorly characterised chemical standard (e.g. purity or composition not defined).
Table 7: Acute toxicity in experimental animals: non-oral administration of glycoalkaloids (GAs) (a-solanine, a-chaconine), mixtures and the aglycone
(solanidine), from edible parts of S. tuberosum
Test
compound












a-Solanine(a) Rats (M/F)/i.p. ↓ Hepatic glycogen content 5 Satoh (1967)
a-Solanine(a) Rats (M)/i.p. ↑ Serum liver transaminases
↓ Serum cholinesterase activity
20 Dalvi (1985)
a-Solanine(b) Wistar rats (F)/i.p. Lethality 67 Chaube and Swinyard (1976)
a-Solanine(a) Albino mice (M)/i.p. Lethality
↓ Spontaneous motor activity
5 10 42 Nishie et al. (1971)
a-Solanine(a) Balb/c mice (F)/i.p. Lethality 10 20 40 Mohsenikia et al. (2013)
a-Solanine(a) Swiss-Webster mice (M)/i.p. Lethality 32.3 Patil et al. (1972)
a-Solanine(b) Swiss-Webster mice (M)/i.p. Lethality 32.3 Sharma et al. (1979)
a-Solanine(a) Swiss-Webster mice (M)/i.p. Lethality 34.5 Nishie et al. (1975)
a-Solanine(a) Balb-c mice (M)/i.p. 40 Khodayari et al. (2013)
www.efsa.europa.eu/efsajournal 35 EFSA Journal 2020;18(8):6222
Glycoalkaloids in feed and food
Test
compound












a-Solanine(a) Rabbits (sex n.r.)/i.p. or i.v. EEG alterations (i.p.)








Nishie et al. (1971)
a-Solanine(a) White New Zealand
rabbits (sex n.r.)/i.p.
Lethality 40 Nishie et al. (1975)
a-Solanine(a) Rhesus monkey (sex n.r.)/i.p. Lethality (100%) 40
2 9 20
< 40 Swinyard and Chaube (1973)
a-Chaconine(b) Swiss-Webster mice (M)/i.p. Lethality 32.3 Nishie et al. (1975)
a-Chaconine(a) Swiss-Webster mice (M)/i.p. Lethality 19.2 Sharma et al. (1979)
a-Chaconine(b) Wistar rats (F)/i.p. Lethality 84 Chaube and Swinyard (1976)




Aldous et al. (1980)
a-Chaconine(b) White New Zealand
rabbits (sex n.r.)/i.p.
Lethality 50 Nishie et al. (1975)
Mixture of a-solanine and
unknown proportion of
a-chaconine(c)
Rats (M/F)/i.p. 75 Gull (1960)
Mixture(a)
a-solanine: a-chaconine (1:1)
Syrian hamster (M)/i.p. Lethality 10 25 > 10
< 25




20% of the extract at a ratio
of 1:2:0.3, respectively
Wistar rats (F)/i.p. 60 Chaube and Swinyard (1976)
Solanidine(a) Albino mice (M)/i.p. – 500 Nishie et al. (1971)
EEG: electroencephalogram; F: female; M: male; n.r.: not reported.
(a): Chemical standard obtained from a commercial supplier, with high purity (95% pure or higher).
(b): Chemical standard obtained by in-house isolation from plant material, and checked for purity (95% pure or higher).
(c): Poorly characterised chemical standard (e. g. purity or composition not defined).
(d): A non- or only partly purified extract or material for which the glycoalkaloid composition and concentration is given.
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Table 8: Acute toxicity in experimental animals: oral administration of glycoalkaloids (GAs) (a-tomatine) from edible parts of S. lycopersicum and extracts


















Oral dose of 900–1,000 mg/kg bw given
within 24 h
100% lethality 900–1,000 Wilson et al. (1961)
Water suspensions of ground
lyophilised fruits of ripe
S. melongena(b)
Syrian hamster (sex n.r.)
No/sex/group: 2
Single oral application: 6,316 mg
suspension/kg bw
TGA content of dried matter: 0.016%
(corresponding to 1.0 mg TGA/kg bw)
Haemorrhagic
gastritis
1 Baker et al. (1989)
F: females; M: males; n.r.: not reported.
(a): Chemical standard obtained by in-house isolation from plant material, may contain a-dehydrotomatine as an impurity.
(b): A non- or only partly purified extract or material for which the GA composition and concentration is given.
Table 9: Acute toxicity in experimental animals: non-oral administration of glycoalkaloids (GAs) (a-tomatine, a-solamargine) from edible parts of















a-Tomatine(b) Mice (sex n.r) i.v. Lethality 18 Wilson et al. (1961)
a-Tomatine(a) Swiss-Webster mice (M) i.p. Lethality 32.4 Nishie et al. (1975)
a-Tomatine(b) Mice (sex n.r) i.p. Lethality 25 Sackmann et al. (1959)
a-Tomatine(b) Mice (sex n.r) s.c. Lethality > 1,000 Sackmann et al. (1959)
a-Tomatine(a) White New Zealand rabbits (sex n.r.) i.p. – 100 Nishie et al. (1975)
a-Solamargine(c) Wistar rats (M) i.p. Lethality 42 Al Chami et al. (2003)
M: male. n.r.: not reported.
(a): Chemical standard obtained from a commercial supplier, may contain a-dehydrotomatine as an impurity.
(b): Chemical standard obtained by in-house isolation from plant material, may contain a-dehydrotomatine as an impurity.
(c): Poorly characterised chemical standard (e. g. purity or composition not defined).
www.efsa.europa.eu/efsajournal 37 EFSA Journal 2020;18(8):6222
Glycoalkaloids in feed and food
3.1.2.2. Repeated dose toxicity studies
The studies on effects following repeated oral doses are summarised in Tables 10, 11, 12 and 13.
The no-observed-effect level (NOEL) (or lowest-observed-effect level, LOEL) and NOAEL (LOAEL)
values indicated, have been derived by the CONTAM Panel, unless stated otherwise.
3.1.2.2.1. GAs and aglycones from edible parts of S. tuberosum
a-Solanine
a-Solanine reduced body weight gain and the absolute liver weight when given at 416.6 mg/kg bw
per day (the only dose administered) for 1 week to Swiss Webster mice (Friedman et al., 1996). The
food intake remained unaffected.
A lower dose (180 mg a-solanine/kg bw per day) reduced the growth rate in rats treated over a
period of 5 weeks which was not due to an altered food intake of the animals. No further compound-
related symptoms were reported (Gull, 1960). Based on the lower body weight at 180 mg/kg bw per
day, a NOAEL of 90 mg a-solanine/kg bw per day was derived.
Hamsters exhibited lethality in 50% of the animals and reduced growth and relative liver weights
when exposed daily to 100 mg a-solanine/kg bw (the only dose administered) for 5 days. The lowered
body weight gain might have been caused by a decreased food intake by the animals. Serum glucose,
serum creatine, red blood cell (RBC), haemoglobin and haematocrit were elevated (Langkilde et al.,
2008).
a-Chaconine
a-Chaconine lowered body and liver weights at 409 mg/kg bw per day (the only dose administered)
in mice over a period of 7 days (Friedman et al., 1996). The food intake by the animals was
unaffected.
In hamsters, 100 mg/kg bw per day (the only dose administered) for 5 days induced lethality (in
25% of the animals) and reduced body weight gain and relative liver weights despite an unaltered
food intake (Langkilde et al., 2008). Serum glucose, serum creatine, RBC, haemoglobin and
haematocrit were elevated.
Solanidine
The aglycone solanidine was administered to mice for up to 28 days at doses ranging from 95.5 to
381.8 mg/kg bw per day (Friedman et al., 1996, 2003a). Adverse effects were seen at 190.9 mg/kg
bw per day, such as decreased body weight gain and increased absolute and relative liver weights
(Friedman et al., 1996). Feed intake was lowered at a daily dose of 381.8 mg/kg bw. Based on
increases in absolute and relative liver weights at day 14 and 28 of treatment, a NOAEL of 95.5 mg
solanidine/kg bw per day was derived.
Mixtures of GAs
Friedman (1992) fed mice potatoes containing 64 mg TGAs (20 mg a-solanine and 37 mg a-
chaconine)/kg fresh weight. a-Solanine and a-chaconine were quantified by HPLC-UV, while TGA were
determined by a colourimetric method (possibly detecting other GAs as well, see Section 1.3.2). The
potatoes were admixed as powder at high concentrations (up to 40%) to the diet presumably causing
dietary imbalances of macro- and micronutrients. Increased absolute and relative weights of pancreas
were observed at the highest TGA dose of 23.2 mg/kg bw per day. The CONTAM Panel agrees with
the assumption of the authors that the effects on the pancreas may be due to presence of trypsin
inhibitor activity in the potato powder and not caused by GAs. Consequently, no NOAEL was derived
for this study.
For a period of 3 days, Phillips et al. (1996) treated male hamsters orally with doses up to 50 mg
TGA/kg bw per day at a ratio of a-solanine: a-chaconine of approximately 1:1. No adverse effects
could be observed. However, the study was conducted with a low number of animals per treatment
group.
In a series of experiments, Langkilde et al. (2008, 2009, 2012) tested defined mixtures of a-
solanine and a-chaconine in female hamsters. At a ratio a-solanine:a-chaconine of 1:2.5, gavage of 75
mg TGA/kg bw per day induced lethality (in 25% of the animals), lowered food intake, decreased the
relative liver weight and increased haemoglobin and haematocrit within 5 days of treatment (Langkilde
et al., 2008). At gavage of 100 mg TGA/kg bw per day, lethality was seen again in 25% of the
animals, body weight gain was lowered and the relative weight of adrenals, serum creatine and RBC
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were elevated (Langkilde et al., 2008). The LOAEL in this study was 75 mg TGAs/kg bw per day based
on the lethality and the decreased relative liver weight in female hamsters.
An a-solanine:a-chaconine ratio of 1:3.7 with a dose of 33 mg TGA/kg bw, applied by daily gavage,
raised white blood cells (WBC), RBC and serum aspartate aminotransferase (AST), and decreased
albumin, proteins and urea in blood within 4 weeks (Langkilde et al., 2009). When the ratio a-solanine:
a-chaconine was 1:70 at a dose of 33.3 mg TGAs/kg bw per day, death occurred in one of the four
treated animals 2 h after gavage. Weight of adrenal glands, AST, WBC and RBC were affected
(Langkilde et al., 2009). Thus, the NOAEL was 10 mg TGAs/kg bw per day irrespective of whether a-
solanine and a-chaconine were applied at a 1:3.7 or 1:70 ratio.
Langkilde et al. (2012) investigated the putative effects of a wild-type (‘Desiree’) and a genetically
modified potato line (SGT 9-2). While the wild-type potato contained a-solanine:a-chaconine at a ratio
of 1:3.1, the SGT 9-2 line exhibited a ratio of 1:25.5–26 and a considerably lower TGA content
(determined by HPLC-UV). All animals of the study received diets, which were identical in the
concentrations of minerals, vitamins, sucrose/dextrin, soybean oil and cellulose but contained 0%,
20%, 40% or 60% freeze-dried powder of control or SGT 9-2 potatoes (trypsin inhibitor activity of the
powders was not excluded). The variable proportions of potato powder in the diets were compensated
to some extent by adjusted contents in caseinate and corn/potato starch. Since the TGA content of the
SGT 9-2 line was considerably lower than in the controls, commercially available a-solanine and a-
chaconine were added to the diets with SGT 9-2 in order to treat animals with TGA doses as occurring
in control potatoes. However, the ratio between the two GAs was kept as being typical for the SGT 9-2
line. In addition, one of the diets (40% powder of control potatoes) was spiked with commercially
available a-solanine and a-chaconine to elevate the TGA dose to 33 mg/kg bw per day. When the
relative proportion of a-solanine:a-chaconine was 1:3.1, a daily TGA dose of 33 mg/kg bw exerted no
effect over a period of 90 days. At a ratio of 1:25.5–26 again no effects were seen at TGA doses of up
to 20.6 mg/kg bw per day (Langkilde et al., 2012). In any case, the NOEL in this study was 33 mg
TGA/kg bw per day at a ratio a-solanine:a-chaconine of 1:3.1 (the highest dose tested).
In contrast to data published in 2009, Langkilde et al. (2012) did not find adverse effects when
hamsters were exposed to 33 mg TGAs/kg bw per day for 90 days with a ratio of a-solanine:a-
chaconine of approximately 1:3.1. In this study, the NOEL for TGAs was 33 mg/kg bw per day which is
considerably higher than in the study appearing in 2009. The different outcome may be based on the
fact, that in the study of 2009 purified standards were applied to the animals as bolus by gavage,
whereas in the study published in 2012, freeze-dried potato powder, partly spiked with commercial
standards, were administered via the diet.
Preparations based on edible parts of S. tuberosum and sprouts
In some experiments, the effects of plant parts of potatoes were studied. Tusnio et al. (2013a)
used potato sprout meal with 41.85 g TGAs/kg admixed to the diet to provide daily doses of up to 36
mg TGAs/kg bw to rats (no information on the ratio of a-solanine:a-chaconine provided). The potato
sprout meal did not exhibit any trypsin inhibitor activity. This treatment did not elicit any effect when
applied over a period of 28 days (Tusnio et al., 2013a). Thus, the NOEL was 36 mg TGAs/kg bw per
day (the highest dose tested).
In a second experiment, commercial potato protein concentrates were applied, which contained 677–
3,185 mg TGAs/kg (Tusnio et al., 2013a) and which did exhibit trypsin inhibitor activity. Again, the ratio of
a-solanine:a-chaconine was not given and might have been variable. TGA doses of 13.9–52.7 mg/kg bw
per day affected the gastrointestinal tract and caused decreased relative stomach weight, increased
relative weight of the intestine and elevated serum alanine aminotransferase (ALT) levels. The study
authors speculated that these alterations were rather due to trypsin inhibitor activity than the GA content
in the diet (Tusnio et al., 2013a). Consequently, no NOAEL or LOAEL could be derived.
Azim and colleagues performed three studies in rabbits and compared the effects of green or ripe
potatoes, fed as chow (Azim et al., 1982, 1983, 1984). In all studies, the GA content in potatoes was
determined leading to estimated intakes between 4.8 and 82.3 mg/kg bw per day, but no ratio of a-
solanine:a-chaconine was given. Furthermore, the studies lack negative controls. Generally, decreased
body weight and increased relative liver weights were reported. However, the data are difficult to
interpret since untreated controls are missing. No NOEL or LOEL could be derived.
Swinyard and Chaube (1973) used potato strain B5141-6, containing a mean TGA content of 260
mg/kg fw (range: 150–350 mg/kg fw). a-Solanine accounted for 25% of the TGA content, while the
remaining GAs were not specified, but probably contained a-chaconine. The tubers were diced and
admixed to the diet. By this procedure, Rhesus monkeys were treated with approximately 3.47 mg
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TGAs/kg bw per day for 25 days, which did not elicit any significant effect on food consumption and
body weight. However, the study lacks an untreated control group. Therefore, no NOAEL could be
derived.
Summary of repeated dose toxicity studies with GAs and aglycones from edible parts of
S. tuberosum and sprouts
To conclude, a-solanine and a-chaconine reduced body and liver weights in mice after 1 week at
416.6 and 409 mg/kg bw per day, respectively. A NOAEL was set for a-solanine at 90 mg/kg bw per
day based on reduced growth of rats, treated for 5 weeks. In hamster, body and relative liver weights
were lowered by 100 mg/kg bw of either a-solanine or a-chaconine, applied for 5 days. The aglycone
solanidine caused adverse effects in mice treated with 190.9 mg/kg bw per day up to 4 weeks; the
NOAEL was 95.5 mg/kg bw per day.
Mixtures of a-solanine and a-chaconine were applied to hamsters over 90 days (Langkilde et al.,
2012). The NOEL was 20.6 mg/kg bw per day (a-solanine:a-chaconine ratio of 1:25.5–26) and 33 mg/kg
bw per day (a-solanine:a-chaconine ratio of 1:3.1) (the highest doses tested). The NOEL of 33 mg/kg bw
per day is identical to the LOAEL reported in another study, in which 33 mg/kg (a-solanine:a-chaconine
ratio of 1:3.7), applied via gavage for 4 weeks, caused gastrointestinal effects in hamsters (Langkilde
et al., 2009). The different outcome at the identical dose may be due to the bolus effect of gavage in the
2009 study and the matrix effects of the basal chow in the 2012 study.
Regarding edible parts of potato and sprouts, the NOEL was 36 mg TGA/kg bw per day, fed to rats
for 28 days (the highest dose tested). No effects were seen in monkeys at a daily dose of 3.47 mg
TGA/kg bw, applied for 25 days.
No data with regard to the repeated dose oral toxicity of ß- or y-forms of potato GAs could be
identified.
3.1.2.2.2. GAs and aglycones from edible parts of food plants other than S. tuberosum
The studies identified are reported in Table 13.
a-Tomatine
a-Tomatine was tested in rats at doses of 1.25–250 mg/kg bw per day over periods of 5–200 days.
No effects were reported at 250 mg/kg bw per day when given for 5 days, and at 20 mg/kg bw
applied over a period of 200 days (Wilson et al., 1961). A NOAEL of 20 mg/kg bw per day for rats was
identified from this study (the highest dose applied in this study). A dose of 600 mg/kg bw caused
decreased intrahepatic cholesterol after 7 days of administration (Cayen, 1971). Based on the lower
hepatic cholesterol concentration, the LOEL was 600 mg a-tomatine/kg bw per day in male rats. When
the effects on the cholesterol metabolism were studied in rats in more detail, Cayen (1971) reported
on reduced uptake of dietary cholesterol by the liver, an elevated hepatic and intestinal cholesterol
synthesis and increased fecal sterol excretion without affecting bile acid excretion at 1,200 mg a-
tomatine/kg bw per day for 2 weeks (see also Section 3.1.2.9).
In mice, 496 mg a-tomatine/kg bw per day (the only dose administered) for 1 week did not affect
body or liver weights (Friedman et al., 1996).
When hamsters were treated with 30.5 mg/kg bw per day for 3 weeks, the LOEL was 30.5 mg a-
tomatine/kg bw per day, based on the elevated fecal sterol and coprostanol excretion (Friedman et al.,
2000a) (see also Section 3.1.2.9).
a-Solasonine
a-Solasonine increased the body weight gain in mice at 424.4 mg/kg bw per day (the only dose
administered) for 7 days despite an unaltered food intake by the animals. No further effects were
reported (Friedman et al., 1996).
Tomatidine
Wilson et al. (1961) obtained the aglycone tomatidine by hydrolysis, as described by Fontaine et al.
(1948). When given to rats daily at 1.25–20 mg/kg bw for 200 days, tomatidine exerted no significant
effects (Wilson et al., 1961). The NOEL in this study was 20 mg tomatidine/kg bw per day for rats (the
highest dose tested). Two studies in mice reported an elevated absolute and/or relative liver weight at
199.5 mg/kg bw per day, when applied for 7 or 14 days (Friedman et al., 1996, 2003a). Further
observations were decreased feed intake (day 7 at 399 mg/kg bw per day) and reduced body weight gain
(day 14 at 199.5 mg/kg bw per day) (Friedman et al., 1996, 2003a). The LOAEL was 199.5 mg/kg bw per
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day, based on the reduced body weight gain and elevated absolute and relative liver weight in female
mice.
Solasodine
The aglycone solasodine was tested in Swiss-Webster mice at doses of up to 397.2 mg/kg bw per
day (Friedman, 1992; Friedman et al., 1996, 2003a). In the first study, Friedman (1992) reported on
decreased body weight gain (despite unaltered food intake), gastric gland degeneration,
cholangiohepatitis, elevated relative liver weight and increased serum glutamic oxaloacetic
transaminase (GOT), glutamic pyruvic transaminase (GPT) and bilirubin, when animals received 160
mg/kg bw per day for 7 and/or 14 days. This indicates that the gastrointestinal tract and the liver
were affected severely by this compound. The NOAEL was 80 mg/kg bw per day, based on the effects
on body weight and on the gastrointestinal tract at 160 mg/kg bw per day in mice. In the two
subsequent studies, the same study authors administered partly higher doses than in the study
published in 1992 and focused on compound effects on body and liver weights (Friedman et al., 1996,
2003a). Decreased body weight gain (despite unaltered food intake) and increased relative and/or
absolute liver weights were induced at 198.6 mg solasodine/kg bw per day (Friedman et al., 2003a).
At 397.2 mg/kg bw per day, feed intake was reduced at day 7 of treatment (Friedman et al., 1996).
Due to the high level and the limited dose ranges applied, these studies were not used to identify a
NOAEL.
Friedman et al. (1996) compared the relative potencies of equimolar doses of the aglycones with
regard to the increase in liver weight in mice and found that solanidine, solasodine and tomatidine
were nearly equal (see also Table 10). This was confirmed by Friedman et al. (2003a). In contrast,
equimolar doses of the GA a-solasonine decreased insignificantly the liver weight (Friedman et al.,
1996). Wilson et al. (1961) applied a-tomatine and tomatidine at 20 mg/kg bw per day for a period of
200 days to rats. When considering the different molecular weights of the compounds, the a-tomatine
dose was 20 lmol/kg bw per day and the tomatidine dose 50 lmol/kg bw per day. Nevertheless,
tomatidine did not elicit any effect, as was true also for a-tomatine.
Summary of repeated dose toxicity studies with GAs and aglycones from edible parts of
food plants other than S. tuberosum
To conclude, a-tomatine exerted no effects in mice receiving 496 mg/kg bw per day for 1 week. A
NOEL of 20 mg/kg bw per day (the highest dose tested) was identified for rats, treated for 200 days.
In hamsters, the LOEL was 30.5 mg/kg bw per day, based on an increased fecal sterol and coprostanol
excretion. a-Solasonine increased the body weight gain in mice when treated daily with 424.4 mg/kg
bw for 1 week (the only dose applied). For tomatidine, a LOAEL of 199.5 mg/kg bw per day was
derived in mice, and a NOEL of 20 mg/kg bw per day (the highest dose applied) in rats. For
solasodine, a NOAEL of 80 mg/kg bw per day was identified in mice, based on decreased body weight
gain, gastric gland degeneration and liver toxicity at higher doses.
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Species/Experimental design and doses Most sensitive endpoint
Highest dose with no






a-Solanine(b) Swiss-Webster mice (F)
No/sex/group: 8
Diet: 0 or 2.4 mmol/kg diet (equivalent to 0 or
416.6 mg/kg bw per day(d))
Duration: 7 days
↓ bw gain
↓ absolute liver weight
416.6
416.6
Friedman et al. (1996)
a-Solanine(c) White rats (M)
No/sex/dose: 5–10
Diet: 0, 20, 50, 100, 250, 500, 1,000, 2,000mg/kg
diet (equivalent to 0, 1.8, 4.5, 9, 22.5, 45, 90, or
180mg/kg bw per day(d))
Duration: 5 weeks
↓ growth rate 90 180 Gull (1960)
a-Solanine(a) Golden Syrian hamster (F)
No/sex/group: 4–8
Gavage: 0 or 100 mg/kg bw per day
Duration: 5 days
Lethality (50% of animals)
↓ food intake and bw gain
↓ relative liver weight
↑ RBC, HGB, HCT
↑ serum glucose, creatine








Langkilde et al. (2008)
For mixtures of a-solanine
and a-chaconine, see
Table 12
a-Chaconine(b) Swiss-Webster mice (F)
No/sex/group: 8
Diet: 0 or 2.4 mmol/kg diet (equivalent to 0 or
409 mg/kg bw per day(d))
Duration: 7 days
↓ bw gain (day 7)




Friedman et al. (1996)
a-Chaconine(a) Golden Syrian hamster (F)
No/sex/group: 4–8




↓ relative liver weight
↑ RBC, HGB, HCT






Langkilde et al. (2008)
For mixtures of a-solanine
and a-chaconine, see
Table 12
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Test
compound
Species/Experimental design and doses Most sensitive endpoint
Highest dose with no






Solanidine(a) Swiss-Webster mice (F)
No/sex/group: 8–16
Diet: 0, 1.2, 2.4 or 4.8 mmol/kg diet (equivalent
to 0, 95.5, 190.9 or 381.8 mg/kg bw per day(d))
Duration: 7, 14 or 28 days
↓ food intake (day 14)
↓ bw gain (day 7)
↓ bw gain (day 14)
↑ absolute and relative liver
weight (day 7)
↑ absolute and relative liver











Friedman et al. (1996)
Solanidine(a) Swiss-Webster mice (F)
No/sex/group: 10
Diet: 0 or 2.4 mmol/kg diet (equivalent to 0 or
190.9 mg/kg bw per day(d))
Duration: 14 days
↓ bw gain




Friedman et al. (2003a)
F: female; M: male; bw: body weight; RBC: red blood cell; HGB: haemoglobin; HTC: haematocrit.
(a): Chemical standard obtained from a commercial supplier, with high purity (95% pure or higher).
(b): Chemical standard obtained by in-house isolation from plant material, and checked for purity (95% pure or higher).
(c): Poorly characterised chemical standard (e.g. purity or composition not defined).
(d): Applying EFSA default values.
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6.4 mg TGA (20 mg
a-solanine; 37 mg
a-chaconine) per kg fw,
admixed as powder to
diet(d)
Swiss-Webster mice (sex n.r)
No/sex/group: 4–5
Oral application (diet): 0, 1, 5, 10, 20 or 40%
potato powder in the diet with approximately 0,
2.9, 14.6, 29.1, 58.2 or 116.4 mg TGA/kg diet(g)
(equivalent to 0, 0.6, 5.8, 11.6 and 23.2 mg
TGA/kg bw per day(f))
Duration: 7 and 14 days
↑ absolute and relative pancreas
weight






Gavage: 0, 5, 10, 25 or 50 mg GA/kg bw per day
Duration: 3 days




Golden Syrian hamster (F) No/sex/group: 4–8





↓ relative liver weight
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Golden Syrian hamster (F)
No/sex/group: 4





















Golden Syrian hamster (F)
No/sex/group: 4





↓albumin, urea and plasma
proteins
↑serum AST
















(added to chow as
freeze-dried
powder)(d)(e)
Golden Syrian hamster (F)
No/sex/group: 10
Diet: TGA at 0, 6.9, 13.8, 20.6 or 33(f) mg/kg bw
per day
Duration: 90 days





(added to chow as
freeze-dried powder)
and spiked with GA from
commercial source(d)
Golden Syrian hamster (F)
No/sex/group: 10
Diet: TGA at 0, 6.9, 13.8 or 20.6 mg/kg bw per day
Duration: 90 days
No effects 20.6 (1.0/19.6) Langkilde et al.
(2012)
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S. tuberosum SGT 9-2
(added to chow as
freeze-dried powder)(d)
Golden Syrian hamster (F)
No/sex/group: 10
Diet: TGA at 0 or 8.6 mg/kg bw per day
Duration: 90 days
No effects 8.6 (0.3/8.5) Langkilde et al.
(2012)
F: females; M: males; n.r.: not reported; TGA: total GA content; AST: aspartate aminotransferase; WBC: white blood cells; RBC: red blood cells; HCT: haematocrit; HBG: haemoglobin.
(a): Chemical standard obtained from a commercial supplier, with high purity (95% pure or higher).
(b): Chemical standard obtained by in-house isolation from plant material, and checked for purity (95% pure or higher).
(c): Poorly characterised chemical standard (e. g. purity or composition not defined) or with a non- or only partly purified extract or material for which the GA composition and concentration is
given.
(d): A non- or only partly purified extract or material for which the GA composition and concentration is given.
(e): Spiked with GAs from commercial source.
(f): Applying EFSA default values
(g): Anticipating 78% water content of potatoes, the GA content would be 291 mg TGA, 91 mg a-solanine and 168 mg a-chaconine per kg potato powder.
(h): Approximative values read from the figures of the study.
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Sprouts of S. tuberosum
(dried) admixed to chow as




Diets: GA at 0, 60, 120, 180, 240 or 300 mg/kg
(equivalent to: 0, 7.2, 14.4, 21.6, 28.8 or
36 mg/kg bw per day(b))
Duration: 28 days
No effects 36 Tusnio et al.
(2013a)
Protein concentrate of S.
tuberosum, admixed to




Diet: GA at 0, 116, 125, 164, 215, 331 or 439
mg/kg diet (equivalent to 0, 13.9, 15, 19.7, 25.8,
39.7 or 52.7 mg/kg bw per day(b))
Duration: 24 days
↓relative weight of stomach









S. tuberosum; ripe or green
as chow(a)
287.6 mg TGA/kg fw of
green potato; 82.5 mg
TGA/kg fw of normal potato
Rabbits (sex n.r.)
No/group: 10
Diet: Dose of TGA: 21.5 mg (ripe) or 64.2 mg
(green)/kg diet;
Equivalent to 21.6 and 82.3 mg/kg bw per day(e)
Equivalent to 4.8 and 14 mg/kg bw per day(c)
NO CONTROL
Duration: 30 days
↓bw and relative heart weight
↑relative liver weight
↑plasma glucose and Ca2+
concentration








S. tuberosum; ripe or green
as chow(a)
203.8 mg TGA/kg of green
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Diet: Dose of TGA: 16.1–17.9 mg (ripe) or
75–75.4 mg (green)/kg bw per day
NO CONTROL
Duration: 45 days
↓RBC counts and HGB
concentration
75.2(d) Azim et al.
(1984)
Strain B5141-6, diced and
admixed to the diet(a)
Rhesus monkey, mated but not pregnant (F)
No/sex/group: 4
Diet: 3.47 mg TGA/kg bw per day
NO CONTROL
Duration: 25 days




F: female; M: male; bw: body weight; n.r.: not reported; RBC: red blood cells; HGB: haemoglobin.
(a): A non- or only partly purified extract or material for which the GA composition and concentration is given.
(b): Applying EFSA default values.
(c): For the exposure estimates, a live weight of 2 kg and a daily feed intake of 75 g/kg bw were assumed (derived from Carabano and Piquer, 1998).
(d): Significant when compared to lower dose group.
(e): Taking body weight and food intake data from Azim et al. (1983, 1984).
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Table 13: Repeated dose oral toxicity studies with glycoalkaloids (GAs) (a-tomatine, a-solasonine) and aglycones (tomatidine, solasodine) from edible






















Gavage of 250 mg/kg bw per day
Duration: 5 days







Diet: 0.0025–0.04% (equivalent to 1.25–20 mg/kg bw per
day(e))
Duration: 200 days
20 Wilson et al.
(1961)
a-Tomatine(c) Albino rats (M)
No/sex/group: 6
Diet: 0, 0.5 or 2% (equivalent to 0, 600 or 2,400 mg/kg
bw per day(e))
Diets were supplied with 1% cholesterol
Duration: 7 days
↓ intrahepatic cholesterol 600 Cayen
(1971)
a-Tomatine(c) Albino rats (M)
No/sex/group: 6–9
Diet: 0 or 1% (equivalent to 0 or 1,200 mg/kg bw per
day(e))
Duration: 14 days
↓ uptake of dietary cholesterol by liver
↑ hepatic and intestinal cholesterol
synthesis
↑ fecal sterol excretion without affecting
bile acid excretion







Glycoalkaloids in feed and food

















a-Tomatine(c) Swiss-Webster mice (F)
No/sex/group: 8
Diet: 0 or 2.4 mmol/kg diet (equivalent to 0 or 496 mg/kg
bw per day(e))
Duration: 7 days
No effect on bw or liver weight 496 Friedman
et al. (1996)
a-Tomatine(c) Golden hamster (M)
No/sex/group: 6–8
Animals kept on a high-fat and high-cholesterol diet
Diet: 0, 0.05, 0.1 or 0.2% in diet (equivalent to 0, 30.5,
61 or 122 mg/kg bw per day(f))
Duration: 21 days
↓ LDL cholesterol
↓ sum of VLDL-, LDL- and HDL-
cholesterol
↓ triglyceride











a-Solasonine(a) Swiss-Webster mice (F)
No/sex/group: 8
Diet: 0 or 2.4 mmol/kg diet (equivalent to 0 or
424.4 mg/kg bw per day(e))
Duration: 7 days




Diet: 0.0025–0.04% (equivalent to 1.25–20 mg/kg bw per
day(e)
Duration: 200 days
20 Wilson et al.
(1961)
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Tomatidine(c) Swiss-Webster mice (F)
No/sex/group: 8
Diet: 0, 1.2, 2.4 or 4.8 mmol/kg diet (equivalent to 0,
99.8, 199.5 or 399 mg/kg bw per day(e))
Duration: 7, 14 or 28 days
↓ food intake (day 7)
↑ absolute and relative liver weight
(day 7)











Tomatidine(a) Swiss-Webster mice (F)
No/sex/group: 14










Solasodine(c) Swiss-Webster mice (n.r.)
No/sex/group: 4–5
Diet: 0, 50, 100, 200, 400, 800 or 1,600 mg/kg diet
(equivalent to 10, 20, 40, 80, 160 or 320 mg/kg bw per
day(e))
Duration: 7 and 14 days
↓ bw gain (day 7 and 14)
Gastric gland degeneration
Cholangiohepatitis
↑ relative liver weight













Solasodine(a) Swiss-Webster mice (F)
No/sex/group: 8–16
Diet: 0, 1.2, 2.4 or 4.8 mmol/kg diet (equivalent to 0,
99.3, 198.6 or 397.2 mg/kg bw per day(e))
Duration: 7, 14 or 28 days
↓ food intake (day 7)
↑ absolute and relative liver weight
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Solasodine(a) Swiss-Webster mice (F)
No/sex/group: 24
Diet: 0 or 2.4 mmol/kg diet (equivalent to 0 or
198.6 mg/kg bw per day(e))
Duration: 14 days
↓ bw gain






F: female; M: male; n.r.: not reported; bw: body weight; HDL: high-density lipoprotein; LDL: low-density lipoprotein; VLDL: very low-density lipoprotein; GOT: glutamic oxaloacetic transaminase;
GPT: glutamic pyruvic transaminase.
(a): Chemical standard obtained from a commercial supplier, with high purity (95% pure or higher).
(b): Chemical standard obtained by in-house isolation from plant material, and checked for purity (95% pure or higher).
(c): Chemical standard obtained from a commercial supplier, may contain a-dehydrotomatine as an impurity.
(d): Chemical standard obtained by in-house isolation from plant material, may contain a-dehydrotomatine as an impurity.
(e): Applying EFSA default values.
(f): A mean body weight of 130 g and daily consumption of 8 g per animal were assumed; taken from Gattermann et al. (2002).
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3.1.2.3. Developmental and reproductive toxicity studies
3.1.2.3.1. Developmental effects
In 1972, Renwick published a hypothesis that there might be a causal relationship between
anencephaly and spina bifida and maternal consumption of blighted potatoes. He further proposed
that this may be preventable by avoiding specific, at the time unidentified, compounds from potato
tubers (Renwick, 1972).
3.1.2.3.1.1. GAs from edible parts of S. tuberosum
The studies identified are described below and details given in Table 14.
Blighted potatoes
After Renwick (1972) had raised the hypothesis above, a number of studies were published using
material from blighted potatoes for exposure (Poswillo et al., 1972, 1973a,b; Chaube et al., 1973; Allen
et al., 1977; Sharma et al., 1978). The common limitation of these studies is that no reference to the
GA content of the test material is given. The studies were therefore not used for further evaluation.
a-Solanine
Ruddick et al. (1974) performed a teratology study for a-solanine and a-chaconine in Wistar rats.
They performed a comparative study with uncharacterised raw material and purified GAs. The three
experimental arms investigating the teratogenic potential of a-solanine included an experiment in
which first nine litters each were examined from primipari mothers, which were exposed by gavage
during gestational day (GD) 6–15 at doses of 0.3, 1 and 3 mg/kg bw per day. In the second
experiment, nine litters from mothers, exposed with 6 mg/kg bw per day during GD7–10 were
examined, and in the third experimental arm 3–4 primipari pregnant Wistar rats were treated by
gavage with 2, 10 and 25 mg a-solanine/kg bw per day. Three–four litters were examined in this
experiment. In each experiment, animals only treated with the vehicle of GAs served as control. At
GD22, females were sacrificed and the following parameters were evaluated: corpora lutea, resorption
sites, litter size and weight, as well as potential gross visceral and skeletal anomalies. One out of 117
offspring animals of the 3 mg/kg bw per day group showed craniorachischisis and exopthalmos, and
one out of 108 of the 0.3 mg/kg bw per day group showed twisted pelvic limbs and absent tail. The
authors did not judge these effects as treatment related. Besides the effects detectable in these two
animals, no evidence for teratogenicity was observed.
Renwick et al. (1984) purified a-solanine and a-chaconine from sprout material of the British
cultivar ‘Arran Pilot’. They performed a comparative oral gavage study in pregnant Syrian hamsters
with poorly characterised extract material and with pure compounds. For the latter, pregnant dams
were exposed by gavage on GD8 to a-solanine at a dose of 200 mg/kg bw per day. On day 15, the
dams were sacrificed and necropsied. Maternal death was observed for three dams out of 38 dams
(estimated from the three reported maternal deaths, the one resorbed litter and the 34 live litters),
whereas no dam died in the control group. Examination of fetuses revealed 59% of litters with
malformed fetuses. A total of 35 cases of cranial blebs and 39 cases of exencephaly were identified,
which amounted to 23% of fetuses with malformation associated with the development of brain
structures. Only one fetus in more than 300 fetuses investigated in the control group showed this
phenotype.
Gaffield and Keeler (1996a) performed a comparative study investigating the potential teratogenic
effects of GAs and some of their aglycones. Pregnant female Syrian hamsters were gavaged on GD8
with a-solanine at a dose of 243 mg/kg bw per day. Dams were sacrificed and necropsied on GD15.
The dose of 243 mg/kg bw per day of a-solanine produced 21% of abnormal litters and 5.5% of
abnormal fetuses. The rate of resorption was increased. Abnormalities were exencephaly,
encephalocoele and anophthalmia.
a-Chaconine
Ruddick et al. (1974) performed a teratology study for a-solanine and a-chaconine in Wistar rats.
They performed a comparative study with uncharacterised raw material and purified GAs. In the
experimental arms investigating the teratogenic potential of a-chaconine (in-house prepared standard)
four litters from primiparity mothers were investigated following treatment of mothers by gavage
during GD6–15 with 1.5 mg a-chaconine/kg bw per day. Vehicle treated animals served as a control.
At GD22, females were sacrificed and the following parameters were evaluated: corpora lutea,
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resorption sites, litter size and weight, as well as potential gross visceral and skeletal anomalies. No
evidence for teratogenicity was observed in this experiment.
In the above-mentioned study by Renwick et al. (1984), pregnant Syrian hamsters dams (number
of animals not explicitly mentioned) were gavaged with a-chaconine at a dose of 165 and 180 mg/kg
bw per day on GD8. On day 15, the dams were sacrificed and necropsied. Maternal death was
observed for 4 out of 24 dams in the 165 mg/kg bw per day group (estimated from the four reported
maternal deaths, the one resorbed litter and the 19 live litters) and for 6 out of 15 dams in the 180
mg/kg bw per day group (estimated from the six reported maternal deaths, the one resorbed litter
and the eight live litters), whereas no dam died in the control group (one resorbed and 37 live litters
reported). Examination of fetuses revealed 27 cases of cranial blebs and 19 cases of exencephaly in
the 165 mg/kg bw per day exposure group, and 10 cases of cranial blebs and four cases of
exencephaly in the higher dose group, which amounts to 23% and 18% of fetuses, respectively, with
malformation in the central nervous system. Overall, the percentage of malformed litters as of live
litters was lower in the 165 mg/kg bw per day dose group (63%) than in the 180 mg/kg bw per day
dose group. Only one fetus in more than 300 fetuses investigated in the control group showed this
phenotype.
In the Gaffield and Keeler (1996a) study, pregnant female Syrian hamsters were gavaged with a-
chaconine at a dose of 179 or 247 mg/kg bw per day on GD8. Dams were sacrificed and necropsied
on GD15. The dose of 247 mg/kg bw per day of a-chaconine (n = 1 L) resulted in an abnormal litter.
The dose of 179 mg/kg bw per day of a-chaconine produced 20% of abnormal litters and 2.7% of
abnormal fetuses. The rate of resorption was increased. Abnormalities were encephalocoele and
anophthalmia.
Solanidine N-oxide
In the Gaffield and Keeler (1996a) study, pregnant female Syrian hamsters were gavaged with
solanidine N-oxide at doses of 58, 120 or 178 mg/kg bw per day on GD8. Solanidine N-oxide was
reported by the authors as a putative metabolite of solanidine. Dams were sacrificed and necropsied
on GD15. The dose of 178 mg/kg bw per day of solanidine N-oxide produced 50% of abnormal litters
and 16% of abnormal fetuses. The rate of resorption was increased. The two other doses were
without effects. Abnormalities were exencephaly and encephalocoele.
Solanidine
Gaffield and Keeler (1993) performed a comparative study based on the hypothesis of C5, C6
unsaturation being a key structural factor in steroidal alkaloid-induced mammalian teratogenesis.
Pregnant female Syrian hamsters were gavaged with solanidine at a dose of 176 mg/kg bw per day on
GD8. Dams were sacrificed and necropsied on GD15. The dose of 176 mg/kg bw per day produced
50% of abnormal litters and 24% of abnormal fetuses. Abnormalities were exencephaly,
encephalocoele, anophthalmia and external viscera.
Gaffield and Keeler (1996a) studied solanidine again. Pregnant female Syrian hamsters were
gavaged with solanidine at a dose of 115 mg/kg bw per day on GD8 and dams were sacrificed and
necropsied on GD15. The dose of 115 mg/kg bw per day produced 19% of abnormal litters and 2.3%
of abnormal fetuses. Abnormalities were encephalocoele and anophthalmia.
Potential teratogenic effects of solanidine were also investigated by Friedman et al. (2003a). For
the experiment the authors purchased time pregnant Swiss Webster mice, many of which apparently
were not pregnant. Following acclimatisation, exposure to experimental chow was started on GD4 and
terminated either at GD17 or GD18. Exposure to 205 mg solanidine/kg bw per day resulted in reduced
maternal body weight, probably caused by reduced maternal feed intake. In maternal animals, an
increased maternal relative liver weight was observed in addition. For the offspring, the authors
identified reduction of litter size, litter weight, litter weight/body weight and average fetus weight in
response to treatment.
Demissidine
In an earlier study by Gaffield and Keeler (1993), pregnant female Syrian hamsters were gavaged
with demissidine at a dose of 176 mg/kg bw per day on GD8, and this dose produced 14% of
abnormal litters and 3% of abnormal fetuses. Both effects did not reach the level of statistical
significance. Abnormalities were not specified.
In a later study by Gaffield and Keeler (1996a), pregnant female Syrian hamsters were gavaged
with demissidine at a dose of 176 mg/kg bw per day on GD8. The dose of 176 mg/kg bw per day
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produced 14% of abnormal litters and 3% of abnormal fetuses. Abnormalities were exencephaly,
encephalocoele, cebocephaly, cleft palate and anophthalmia.
3.1.2.3.1.2. GAs from edible parts of food plants other than S. tuberosum
The studies identified are described below and details given in Table 15.
a-Tomatine
In 1990, Keeler et al. (1990) published a review on existing data on congenital craniofacial
malformation following exposure to spirosolane-containing solanum species. To this review, some
original data were added, among them, on a-tomatine. Pregnant Simonsen hamsters were gavaged
with 530 mg/kg bw per day of a-tomatine on GD8. Nineteen dams died from overdose symptoms
largely related gastrointestinal tract lesions. From surviving dams, a percentage of 6% deformed litters
was recorded.
Tomatidine
Keeler et al. (1976) investigated potential teratogenic effects of tomatidine and exposed pregnant
Syrian hamsters on GD8 with 1,184 or with 2,664 mg/kg bw per day of tomatidine by gavage. Neither
abnormal litters nor abnormal offspring, which was used as readout, was reported.
In Swiss Webster mice, potential teratogenic effects of tomatidine were investigated by Friedman
et al. (2003a) following the same scheme as that described for solanidine above. Exposure to 167 mg/
kg bw per day of tomatidine resulted in reduced maternal body weight and increased maternal relative
liver weight in response to treatment. No effects were detectable which affected offspring animals.
Solasodine
Keeler et al. (1976) comparatively studied the consequences of solasodine exposure at GD7 (1,184,
1,480 and 1,628 mg/kg bw per day) and at GD8 (1,184 and 1,480 mg/kg bw per day) in pregnant
female Syrian hamsters (n = 115). The authors reported that a total of 10 dams distributed over all
dose groups died from overdose symptoms, except for the 1,480 mg/kg bw per day dose group if
exposed on GD7. For the remaining dams, the major effect was abnormal litters, which did not follow a
clear dose dependency if exposed at GD7 (25–29%). Following exposure on GD8, the percentage of
abnormal litters increased dose dependently in a statistically significant manner from 36% (1,184 mg/kg
bw per day) to 44% (1,480 mg/kg bw per day). The most often detected phenotypes in abnormal
offspring comprised spina bifida, exencephaly and cranial bleb. The percentage of abnormal offspring
was 5–7% if exposure occurred on GD7, and 6–15% following exposure on GD8.
In the study by Gaffield and Keeler (1993), pregnant female Syrian hamsters were gavaged with
solasodine at a dose of 1,400 mg/kg bw per day on GD8, that dose produced 75% of abnormal litters
and 29% of abnormal fetuses. Abnormalities were encephalocoele, exencephaly and anophthalmia.
Using Swiss Webster mice, Friedman et al. (2003a) reported that exposure to 195 mg solasodine/kg
bw per day resulted in reduced maternal body weight, probably caused by reduced maternal feed intake.
In maternal animals, an increased maternal relative liver weight was observed in addition. For the
offspring authors identified reduction of litter size, litter weight, litter weight/body weight and average
fetus weight in response to treatment.
Dihydrosolasodine (soladulcidine)
Gaffield and Keeler (1993) also studied the effects of dihydrosolasodine gavaged to pregnant
female Syrian hamsters on GD8 at a dose of 1,400 mg/kg bw per day. That dose produced 45% of
abnormal litters and 6% of abnormal fetuses. Abnormalities were encephalocoele, exencephaly,
cebocephaly and anophthalmia.
3.1.2.3.1.3. Comparative evaluation of studies
To make use of the studies in which single doses have been used, studies are evaluated
comparatively regarding relative potency of compounds. This approach represents rather a qualitative
than a quantitative assessment. Only hamsters, for which the widest sets of data are available, have
been used. Further, in the comparative studies, authors used similar molar exposure levels. However,
these exposure scenarios are mostly only identical within a study but not across studies. Further, in
order to be able to compare potency, endpoints which have been investigated across studies have to
be selected. Finally, a reference point for comparison would be helpful, but is not available.
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Keeler et al. (1990) were the first to take the attempt to order GAs according to their teratogenic
potency. They took the same database and some additional data to establish a relative potency list of
GAs (Gaffield and Keeler, 1996b). This list contained data on GAs from Brown and Keeler (1978),
Keeler et al. (1976), Renwick et al. (1984), Keeler et al. (1990), Gaffield and Keeler (1993) as well as
Gaffield and Keeler (1996a). In this assessment, the authors aimed to compare relative teratogenic
potencies of jervine, solanidine and spirosolane alkaloids. Relative potencies can only be compared by
their induction of terata if a molar equivalent basis of exposure is applied (see Appendix D) or if effects
are allocated to an ascending exposure level in mg/kg bw. The data which were consistently reported
across studies were percentage of abnormal litters and percentage of abnormal fetuses. As can be
seen from Table 1D. (Appendix D), a clear relative potency pattern cannot be delineated. It can also
be seen that there are huge differences between values from different laboratories, e.g. for a-
chaconine and a-solanine, if results from the studies of Renwick et al. (1984) and from Gaffield and
Keeler (1996a) are compared (see Appendix D). Further, the relative order of potency reported by
Gaffield and Keeler (1996b) may only be used for a qualitative comparison, according to the authors.
However, a-chaconine may be misplaced in this order, because at dosage 0.29 mmol/kg maternal
lethality became apparent, not allowing to follow up the fate of the offspring.
3.1.2.3.1.4. Summary on developmental effects
The experimental developmental studies indicate that effects occur at oral doses of 165 mg/kg bw
per day and above for GAs, and of 115 mg/kg bw per day and above for the aglycones. Among
others, these effects to a large majority were observed in the central nervous system and most
frequently comprised exencephaly, encephalocele and anophthalmia.
In comparative single dose assessment studies, the results suggest differences in the potency of
GAs and their aglycones. However, due to limitations in the studies available (e.g. lack of dose–
response study design), an order of potency cannot be established.
3.1.2.3.2. Reproductive effects
Kline et al. (1961) investigated the effects of a-solanine on the survival of rat pups (see Table 16).
They exposed pregnant female Holtzman rats (duration not given, starting exposure following
detection of pregnancy by weighing until delivery) via the diet to either commercial a-solanine at
3.6 or 4.8 mg/kg bw per day or to a-solanine, isolated from the potato sprouts (purity unknown) at
3.6 mg/kg bw per day. Compared to controls, all treatment procedures produced a decrease in the
percentage of weaned pups and a comparable increase in the number of zero litters (litters in which all
pups died). No dose dependency was seen for the commercial a-solanine. However, the effects were
more pronounced when applying the isolated a-solanine (23.6% weaned pups compared to controls)
than the commercial a-solanine (37.5% for both dosages, compared to controls). Starvation may have
contributed to the early death of the pups as no milk was found in the stomach of these animals,
pointing to a lactational deficit. Cross fostering studies were performed, but results were inconclusive.
Adult males were investigated as controls and no noticeable effects were detectable (Kline et al.,
1961).
Effects of solasodine on fertility were also investigated in male Rhesus monkeys (Dixit et al., 1989).
Ten Rhesus monkeys were divided into two groups of five animals each, which were either treated for
150 days by placebo or 100 mg/kg bw per day of solasodine encapsulated into a banana (see
Table 17). On day 151, testes and epididymis were surgically removed. Sperm count and motility were
assessed in the cauda epididymis. Pathological parameters were assessed from tissue section of
paraffin-embedded material. Biochemical parameters were measured from frozen tissue samples.
Interstitial testicular cells, like Leydig cells and their precursors were counted. 100 mg/kg bw per day
reduced testis weight, weight of the epididymis, the diameter of the seminiferous tubule and the
Leydig cell nuclear diameter. In terms of fertility parameters, the authors detected a reduced number
of spermatids, spermatozoa, immature and mature Leydig cells. The number of degenerating Leydig
cells was found to be unaltered. Analysis of the cauda of the epididymis revealed a dramatic reduction
of sperm density and sperm motility. On the biochemical level total testicular protein content, content
of sialic acid and of glycogen were reduced, whereas testicular testosterone levels were elevated. The
CONTAM Panel notes that treatment of Rhesus monkeys with 100 mg/kg bw per day of solasodine
encapsulated into a banana affected testicular function and male reproduction.
The impact of solasodine following oral application on male fertility was investigated in dogs (Gupta
and Dixit, 2002). Five dogs were treated with 80 mg/kg bw per day of solasodine for 30 days with the
compound embedded in a capsule of mutton meet (see Table 18). In this study, only effects on the
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epididymis were investigated. The treatment did not affect the body weight of the animals but
decreased the epididymal weight and cauda epididymal epithelial height. The epididymal lumen was
found to be empty of sperm. On a biochemical level, the total protein content, content of sialic acid
and of glycogen were found to be reduced in the epididymis in response to 80 mg/kg bw per day of
solasodine. Epidydimal levels of cholesterol were found to be elevated. In conclusion, oral treatment of
dogs with 80 mg/kg bw per day of solasodine impacts on the integrity and the function of the
epididymal gland in male dogs. The epididymal findings in this study using oral dosage are in line with
a previous study which investigated effects of solasodine on male reproductive organs following i.p.
application of 20 mg/kg bw per day for 30 days (Dixit and Gupta, 1982).
In summary, reduced postnatal survival of pups due to insufficient milk production was found
following exposure of pregnant Holtzman rats to a-solanine. Doses of approximately 3.6 mg/kg bw per
day from different sources of a-solanine resulted in a percentage of successfully weaned pups between
23.6% and 37.8% if compared to controls. The observed decrease most likely is due to lactational
failure of dams and results in the death of the pups by starvation. The CONTAM Panel noted the
limitations in the description of the study design.
In terms of fertility, effects were observed following exposure of male rhesus monkeys or male
dogs to solasodine. In rhesus monkeys, 100 mg/kg bw per day reduced weight of testis and
epididymis and the diameter of the seminiferous tubule. In addition, a reduced number of spermatids,
spermatozoa, immature and mature Leydig cells was observed, as well as a reduction of sperm density
and sperm motility in the cauda epididymis. Following oral exposure of male dogs to 80 mg/kg bw per
day, decreased epididymal weight and cauda epididymal epithelial height as well as an epididymal
lumen depleted of sperm were found.
3.1.2.4. Immunotoxicity studies
No standard assays for immunotoxicity of GA and aglycones could be identified.
Glycoalkaloids in feed and food
www.efsa.europa.eu/efsajournal 57 EFSA Journal 2020;18(8):6222
Table 14: Developmental toxicity studies on glycoalkaloids (GAs) (a-solanine, a-chaconine) and aglycones (solanidine, demissidine) from edible parts of
S. tuberosum
Test compound
Species, experimental design and
doses
Observed effects
Highest dose with no
effect (mg/kg bw per
day)
Lowest dose with effect
(mg/kg bw per day) Reference




Exposure at different periods during
gestation, sacrifice on day 22
(I) Exposure during GD6–15: 0, 0.3, 1,
3 mg/kg bw per day (9 or 10 litters)
(II) Exposure during GD7–10: 0, 6 mg/kg
bw per day (9 litters)
(III) Exposure during GD8–11: 0, 2, 10,
25 mg/kg bw per day (2, 4, 3, 4 litters,
respectively)
all exposure groups: No
significant effects




of the British cultivar
Arran Pilot)
Syrian hamsters
Number of dams not specified, 85 litters
and 964 fetuses in control, 55 litters and
573 fetuses in a-solanine group
Gavage on GD8












a-Solanine(b) Pregnant syrian hamsters
No/group: 24
Gavage on GD8
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Test compound
Species, experimental design and
doses
Observed effects
Highest dose with no
effect (mg/kg bw per
day)
Lowest dose with effect
(mg/kg bw per day) Reference




Exposure GD6–15: 1.5 mg/kg bw per day
(4 litters)






Purified from sprouts of the
British cultivar Arran Pilot
Syrian hamsters
Number of dams not specified, 85 litters
and 964 fetuses in control, 60 litters and
645 fetuses in the
a-chaconine groups, no specified how many
animals per dosage group
Gavage on GD8 only
0, 165, 180 mg/kg bw per day










a-Chaconine(b) Pregnant Syrian hamsters
No/Group: 15 and 1 litter
Gavage on GD8
0.21, 0.29 mmol/kg bw (equivalent to 179














Solanidine N-oxide(c) Pregnant Syrian hamsters
No/group: 3–14 litters
Gavage on GD8
0.14, 0.29, 0.43 mmol/kg bw (equivalent to
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Test compound
Species, experimental design and
doses
Observed effects
Highest dose with no
effect (mg/kg bw per
day)
Lowest dose with effect
(mg/kg bw per day) Reference
Mother Offspring Mother Offspring
Solanidine(c) Pregnant Syrian hamsters
No/group: 12 litters
Gavage on GD8













Solanidine(b) Pregnant Syrian hamsters
No/group: 21 litters
Gavage on GD8












Solanidine(a) Swiss Webster mice (time pregnant/time
mated (not clear))
No/group: 20 pregnant females
Diet. Exposure: Start GD4, Necroscopy
GD17–18




















Demissidine(c) Pregnant Syrian hamsters
No/group: 14 litters
Gavage on GD8
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Test compound
Species, experimental design and
doses
Observed effects
Highest dose with no
effect (mg/kg bw per
day)
Lowest dose with effect
(mg/kg bw per day) Reference
Mother Offspring Mother Offspring
Demissidine(c) Pregnant Syrian hamsters
No/group: 14 litters
Gavage on GD8












GD: gestational day; MW: molecular weight (in g/mol); CNS: central nervous system.
(a): Chemical standard obtained from a commercial supplier, with high purity (95% pure or higher).
(b): Chemical standard obtained by in-house isolation from plant material, and checked for purity (95% pure or higher).
(c): Chemical standard obtained by in-house synthesis, and checked for purity (95% pure or higher).
(d): Poorly characterised chemical standard (e.g. purity or composition not defined).
(e): Doses as reported by the authors in the original publication.
(f): Percentage of litters containing at least one malformed fetus.
(g): No definition given on whether this refers to the litters or to individuals in the litter.
Table 15: Developmental toxicity studies on glycoalkaloids (GAs) (a-tomatine) and aglycones (tomatidine, solasodine, dihydrosolasodine) from edible
parts of food plants other than S. tuberosum
Test compound
Species, experimental design and
doses
Observed effects
Highest dose with no
effect (mg/kg bw per
day)
Lowest dose with
effect (mg/kg bw per
day)
Reference
Mother Offspring Mother Offspring
a-Tomatine
a-Tomatine(d) Pregnant Simonsen hamsters
No/groups: 34 dams
Gavage on GD8 0, 530 mg/kg bw per day
Sacrifice on GD15
Maternal death
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Test compound
Species, experimental design and
doses
Observed effects
Highest dose with no
effect (mg/kg bw per
day)
Lowest dose with
effect (mg/kg bw per
day)
Reference
Mother Offspring Mother Offspring
Tomatidine
Tomatidine(c),(e) Pregnant Syrian hamsters
No/groups: 15–24 pregnant dams
Gavage on GD8 0, 1,184, 2,664 mg/kg bw
per day
Sacrifice on GD15
No effects 2,664 2,664 Keeler et al.
(1976)
Tomatidine(e) Swiss Webster time pregnant/time
mated (not clear) mice
No/group: 23 pregnant mice
Diet. Exposure GD4–18
2.4 mmol/kg diet (equivalent to 167 mg/
kg bw per day)
↓maternal bw
↑maternal relative liver weight
167 Friedman et al.
(2003a)
Solasodine
Solasodine(c) Pregnant Syrian hamsters
No/group: 11–50 dams per group
0, 1,184, 1,480 and 1,628 mg/kg bw per
day gavage on GD7, sacrifice on GD15


















Solasodine(c) Pregnant Syrian hamsters
No/group: 8 litters
Gavage on GD8
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Test compound
Species, experimental design and
doses
Observed effects
Highest dose with no
effect (mg/kg bw per
day)
Lowest dose with
effect (mg/kg bw per
day)
Reference
Mother Offspring Mother Offspring
Solasodine(a) Swiss Webster time pregnant/time
mated (not clear) mice
No/group: 45 pregnant females
Diet. Exposure GD4–18
2.4 mmol/kg diet (equivalent to
156 mg/kg bw per day)
↓ maternal bw
↓ maternal feed intake
↑ maternal relative liver weight
↓ litter weight
↓ litter weight/bw

























GD: gestational day; MW: molecular weight (in g/mol); bw: body weight.
(a): Chemical standard obtained from a commercial supplier of high purity (95% pure or higher).
(b):Chemical standard obtained by in-house synthesis, and checked for purity (95% pure or higher).
(c): Chemical standard obtained from a commercial supplier, purity not stated.
(d): Chemical standard obtained from a commercial supplier, may contain dehydrotomatine as an impurity.
(e): Chemical standard obtained from a commercial supplier, may contain dehydrotomatidine as an impurity.
(f): Doses as reported by the authors in the original publication.
(g): Percentage of litters containing at least one malformed fetus.
(h): No definition given on whether this refers to the litters or to individuals in the litter.
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Highest dose with no
effect (mg/kg bw per
day)
Lowest dose with effect
(mg/kg bw per day) Reference








N = 10/4 litters per group for testing
of commercial/isolated a-solanine
Duration of exposure not clear
(assumption that the study duration
was 14 days)
Diet: 0, 30, 40 mg a-solanine
(commercial) per kg chow (0,  3.6,
 4.8 mg/kg bw per day)
Diet: 0, 30 mg a-solanine (isolated)
per kg chow
( 3.6 mg/kg bw per day)
↑ number of litters in which pups
died within the first 3 days
↓ percentage of weaned pups
(37.5% weaned pups, compared
to controls)
↓ percentage of weaned pups
(23.6% weaned pups, compared
to controls)
3.6 mg/kg bw per day
(for commercial and
isolated a-solanine)
3.6 mg/kg bw per day
(for commercial
a-solanine)





(a): Poorly characterised chemical standard (purity and composition not defined, may have contained a-chaconine).
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Lowest dose with effect
(mg/kg bw per day)
Reference
Solasodine
Solasodine(a) Captured Rhesus monkey
(no further specifications)
0, 100 mg/kg bw per day for 150 days
Oral administration by encapsulation into a
banana




↓ seminiferous tubule diameter
↓ Leydig cell nuclei diameter
↓ spermatid count
↓ spermatozoa
↓ immature and mature Leydig cells
↓ sperm density and motility in cauda
epididymis
↓ total protein, sialic acid, glycogen in testes











Dixit et al. (1989)
Solasodine(a)
Isolated from berries of
S. xanthocarpum
Dogs (M, 12–17 kg, 5 dogs per group)
0, 80 mg/kg bw per day
Oral in a mutton meet pellet
Duration: 30 days
↓ epididymal weight
↓ cauda epididymal epithelial height
↓ total protein, sialic acid, glycogen in the
cauda epididymis





Gupta and Dixit (2002)
M: males.
(a): Chemical standard obtained by in-house isolation from plant material, highly purified.
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Plant extracts of S. tuberosum as well as GA and aglycones exerted pronounced anti-inflammatory
effects in in vitro and in vivo experiments, as outlined below (see Section 3.1.5). Choi and Koo (2005)
applied an ethanolic extract of the peeled tuber of S. tuberosum to mice at an oral dose of 100 or 200
mg/kg bw. One hour later, paw oedema was induced by carrageenan or formalin treatment.
Pretreatment with the extract reduced significantly the oedema. The same group (Choi et al., 2005)
induced arthritis by injecting Freund’s adjuvant into an angle of a murine paw. Symptoms of the
arthritis (oedema) were reduced when animals were pretreated orally with the ethanolic extract of
S. tuberosum at 100 or 200 mg/kg bw per day for 21 days. Similar effects of the ethanolic extract of
S. tuberosum were reported in an autoimmune disease model in mice (Choi, 2007).
Single GAs and aglycones, e.g. a-solanine, a-chaconine and solasodine, were also effective anti-
inflammatory compounds in vivo. For example, Shin et al. (2016) applied orally a-solanine (0, 2.5, 5 or
10 mg/kg) to mice prior to an i.p. lipopolysaccharide (LPS) injection. The pretreatment with a-solanine
suppressed the expression of pro-inflammatory genes, such as tumour necrosis factor a (TNF-a) and
interleukin 1 b (IL-1b), in the liver. In another study, mice received orally a-chaconine at 0.5 or 2 mg/
kg bw before a single i.p. LPS injection (Lee et al., 2015). This pretreatment reduced the LPS-induced
lethality and the intrahepatic production levels of several pro-inflammatory cytokines. Emmanuel et al.
(2006, abstract only) applied solasodine, extracted from plant material as single gavage of 50 mg/kg
bw to rats before carrageenan was injected to induce inflammation. Pretreatment with solasodine
reduced the swelling of the paw.
To conclude, pronounced anti-inflammatory effects were seen in rodents after single oral applications
of a-solanine, a-chaconine, solasodine or extracts of S. tuberosum. The CONTAM Panel notes that there is
not sufficient information to conclude on the immunotoxic potential of GAs.
3.1.2.5. Studies on cardiovascular effects
No studies were identified. Mechanistic studies have been identified as described in Section 3.1.5.2.3.
3.1.2.6. Neurotoxicity studies
No studies were identified. Mechanistic studies have been identified as described in Section 3.1.5.2.3.
3.1.2.7. Genotoxicity
3.1.2.7.1. GAs from edible parts of S. tuberosum
Several assays were performed to test the genotoxic potential of potato GA, the aglycone
solanidine, as well as extracts of S. tuberosum (see Table 18). The studies, applying the Ames test,
reported on results obtained in only two strains of Salmonella Typhimurium, which is a major limitation
regarding the quality of data.
a-Solanine was subjected to the Ames test by two independent groups, both providing negative
results. Ness et al. (1984) applied 10–50 lg per plate which did not increase the number of revertants
in the strains TA98 and TA100 with or without metabolic activation. Friedman and Henika (1992)
performed two independent Ames assays with a-solanine. One of the assays was weakly positive in
TA100 with S-9 activation but only at the highest (cytotoxic) dose. The CONTAM Panel considered this
study as negative. The same group applied several doses of a-solanine via single i.p. administration to
pregnant female mice at GD15-16, which did not increase the frequency of micronuclei in the fetal
blood cells (Friedman and Henika, 1992). Similarly, there was no increase in the frequency of
micronuclei in peripheral blood cells of adult male mice after single i.p application of a large-dose
range of a-solanine (Friedman and Henika, 1992).
a-Chaconine was tested in the same assays as a-solanine (Friedman and Henika, 1992). There was
a small increase in the number of revertants in TA98 without S9 activation only at a cytotoxic dose.
The CONTAM Panel considered this study as negative. The micronucleus tests performed on peripheral
blood cells of male mice and fetal blood cells from exposed pregnant female mice were both negative.
The aglycone solanidine was tested by Friedman and Henika (1992) at concentrations/doses being
equimolar to those of a-solanine and a-chaconine and was found to be uniformly negative in all the
assays, i.e. in the Ames test and in the micronucleus assays on peripheral blood cells in both, the
fetuses as well as in the male adult mice.
No increase in the number of revertants was observed when 7.5 lg extract/plate of S. tuberosum
(plant part not specified) was assayed in strains TA98 and TA100 with or without metabolic activation
(Ness et al., 1984). No conclusions can be drawn from this study since no information is provided on
the method of extraction and the extent of its purification.
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To conclude, from the limited number of studies available, there is no evidence of genotoxicity for
the potato GAs a-solanine and a-chaconine, and for the aglycone solanidine. However, there is not
sufficient information to conclude on the genotoxic potential of these GAs.
3.1.2.7.2. GAs from edible parts of food plants other than S. tuberosum
Several assays were performed to test the genotoxic potential of aubergine GAs, a-solamargine and
a-solasonine (see Table 19). Almeida et al. (2010) used highly purified a-solamargine, extracted from
fruits of S. palinacanthum Dunal, in an Ames test with S. Typhimurium strains TA98, TA97a, TA100 and
TA102 with and without metabolic activation. There was some weak mutagenicity in TA98 strain in the
absence of metabolic activation.
Munari et al. (2012) generated an extract of S. lycocarpum St. Hill, which was 89% pure and
contained a-solasonine and a-solamargine in a ratio of 1:1. The clastogenic potential of the extract
was tested in vitro in V97 Chinese hamster lung fibroblasts in the absence of metabolic activation with
negative results both in the Comet and chromosomal aberrations assays. Using the same type of
extract, Munari et al. (2014) performed in vivo assays in mice. In a first test, male Swiss mice were
exposed by gavage to 0, 15, 30 or 60 mg/kg bw per day for 14 days and peripheral blood samples
were analysed 48 h, 7 days and 14 days after treatment. No increase in the frequency of
micronucleated polychromatic erythrocytes (PCE) was observed. In subsequent tests, male Swiss mice
received the extract at 60 mg/kg bw per day by gavage for a duration of 14 days. Negative results
were obtained both in the bone marrow micronucleus test and in the Comet assay.
In conclusion, from the limited number of studies available, there was no evidence for genotoxicity
of the aubergine GA a-solamargine. However, there is not sufficient information to conclude on the
genotoxic potential of this GA.
No studies could be identified investigating the genotoxicity of tomato GAs.
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a-Solanine(a) Reverse mutation assay S. Typhimurium TA98
and 100 +/S9
10–50 lg/plate Negative No positive control Ness et al. (1984)










Swiss-Webster mice (F) Single i.p. application at
GD15–16: 0.01, 0.02,
0.045 mmol/kg bw(d)














0.02, 0.045, 0.09 mmol/kg
bw(d)




















0.01, 0.02, 0.045 mmol/kg
bw(d)












Single i.p. application at
GD15–16: 0.005, 0.01,
0.02, 0.045 mmol/kg bw(d)
(equivalent to 4.3, 8.5,




Number of fetuses per
dose group: 63–65
(0.005 and 0.01 mol/kg)
Friedman and Henika
(1992)
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0.01, 0.02, 0.045 mmol/kg
bw(d)












Single i.p. application at
GD15–16: 0.01, 0.02,
0.045 mmol/kg bw(d)












Reverse mutation assay S. Typhimurium TA98
and 100 +/S9
7.5 lg/plate Negative No positive control Ness et al. (1984)
F: female; M: male; N.r.: not reported; GD: gestational day.
(a): Chemical standard obtained from a commercial supplier, with high purity (95% pure or higher).
(b): A non- or only partly purified extract or material for which the GA composition and concentration is given.
(c): The authors reported on the application of 0.07–2.3 mM/plate of a-solanine (equivalent to 60.7–1996.6 mg per plate) of 0.07–2.3 mM/p of a-chaconine (equivalent to 59.6 to 1,959.8 mg/plate)
and of 0.04–0.58 mM/plate of solanidine (equivalent to 15.9–230.7 mg per plate). The CONTAM Panel assumed a typo and the application of the compounds in lmol/plate as realistic doses.
(d): The authors reported on the application of 0.01, 0.02, 0.045, or 0.09 mol/kg bw of a-solanine (equivalent to 8.7, 17.4, 39.1 or 78.1 g/kg bw), of 0.01, 0.02 or 0.045 mol/kg bw of
a-chaconine (equivalent to 8.5, 17.0 or 38.3 g/kg bw) and of 0.01, 0.02 or 0.045 mol/kg bw of solanidine (equivalent to 4.8, 8.0 or 17.9 g/kg bw). The CONTAM Panel assumed a typo and
the application of the compounds in mmol/kg bw as realistic doses.
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Table 19: Tests for genotoxicity/mutagenicity of aubergine glycoalkaloids (GAs) (a-solasonine and a-solamargine)




TA98, TA97a and TA102,
+/ S9 (rat liver)
Preincubation test




Positive in TA98 without S9
from 4.5 mg/plate onwards
(mutagenic index > 2)
Statistical increase in the
number of revertants in
TA100 +S9 from 2.5 mg/
plate onwards, but not
biologically significant




































Main test: 0, 4, 8, 16, and 32
lg/mL
Positive control: MMS
Exposure: 18 h and harvesting













Swiss mice (M) Preliminary toxicity test:
15–1,000 mg/kg bw
Gavage: 0 (water),15, 30 or
60 mg/kg bw per day for 14
days
Blood samples collected 48h,
7 days and 14 days after start
of treatment













Swiss mice (M) Gavage: 0 (water) or
60 mg/kg bw per day for 14
days
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Test compound Test system Cells/animals Concentration/Treatment Result Comment Reference
a-Solasonine and
a-solamargine (1:1)(b)
In vivo Comet assay
(liver cells)
Swiss mice (M) Gavage: 0 (water), 60 mg/kg
bw per day for 14 days
No statistically significant
decrease of cell viability
Negative




MMS: Methyl methanesulfonate; DMSO: Dimethyl sulfoxide.
(a): Extracted from S. palinacanthum Dunal, highly purified.
(b): Extracted from S. lycocarpum St. Hill., 89% purity.
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3.1.2.8. Carcinogenicity studies
No long-term carcinogenicity studies on any of the GAs and aglycones addressed in this opinion
could be identified.
3.1.2.9. Studies on metabolic effects
3.1.2.9.1. GAs from edible parts of S. tuberosum
No studies on potato GA and aglycones were identified.
3.1.2.9.2. GAs from edible parts of food plants other than S. tuberosum
There are several studies focusing on the impact of a-tomatine on the cholesterol metabolism.
Cayen (1971) tested whether a-tomatine forms complexes with cholesterol in the intestinal tract (see
also Section 3.1.2.2). Rats received 600 mg of a-tomatine/kg bw per day via chow, which lowered
significantly the uptake of dietary cholesterol by the liver. As compensation, 14 days treatment with
1,200 mg/kg bw per day elevated the rate of acetate incorporation into neutral lipids and de novo
cholesterol biosynthesis being more pronounced in hepatic than in the intestinal cells. Nevertheless,
the cholesterol concentrations in the low-density lipoproteins (LDL) and high-density lipoproteins (HDL)
fraction were reduced. Furthermore, a-tomatine increased fecal excretion of sterol but not of bile
acids, suggesting that dietary a-tomatine forms a nonabsorbable complex with cholesterol in the
intestinal tract and leaves the bile acids unaffected.
Friedman et al. (2000a) also tested whether a-tomatine may lower dietary cholesterol absorption and
plasma levels of cholesterol and triglycerides (see also Section 3.1.2.2). Hamsters were treated for 21
days with a high-fat/high-cholesterol diet containing from 500 to 2,000 mg/kg a-tomatine. The highest
dose (122 mg/kg bw per day) decreased the cholesterol in the serum LDL without changing the cholesterol
concentration in HDL. When compared to the controls, the fecal excretion of cholesterol and coprostanol
was elevated dose-dependently up to four- to fivefold. This again confirmed the hypothesis of the
generation of an insoluble complex between a-tomatine and cholesterol complex in the intestinal lumen.
Friedman et al. (2000b) treated hamsters (8 per group, sex not specified) for 21 days with semipurified
diets containing (i) lyophilised ripe S. lycopersicum, admixed as powder (with 0.7 mg a-tomatine per kg
dw) at a concentration of 610 g/kg chow: estimated uptake of a-tomatine at roughly 0.05 mg/kg bw per
day, or (ii) lyophilised unripe (green) S. lycopsersicum, admixed as powder (with 743 mg a-tomatine per
kg dw) at a concentration of 593.8 g/kg chow: estimated uptake of roughly 46.7 mg/kg bw per day.
Compared to the control diet without tomatoes, there was a reduction in body weight and absolute liver
weight, most probably due to dietary imbalances. The green and red tomatoes caused a reduction of LDL-
cholesterol by 59% and 44%, very low density lipoprotein (VLDL)-cholesterol by 45% and 35% and of
plasma triglyceride concentrations by 47% and 31%, respectively. However, the treatments did not impact
on plasma levels of HDL but elevated fecal deoxycholic in hamsters fed green fruits, and fecal lithocholic
acid concentrations in animals on both green and red tomato diets. However, feeding of both green and
red tomato powder resulted in considerably reduced feed intake and weight gain, which impairs the
interpretation of data.
To conclude, there is experimental evidence for the formation of undigestible complexes between
a-tomatine and cholesterol in the gastrointestinal tract of rodents, which may enhance fecal
elimination of sterols and lower the cholesterol concentration in the plasma lipoproteins.
Khaserao and Somani (2017) described an anti-obesity effect of the aubergine aglycone solasodine
in obese rats kept on a high-fat diet. Rising concentrations of solasodine (25, 50 and 100 mg/kg bw
per day), given for 6 weeks, reduced dose-dependently body weight, abdomen circumference,
retroperitoneal adipose tissue weight and serum total cholesterol, triglyceride and glucose levels. The
induction of a fatty liver was suppressed as well. It is presently unclear whether the blood lipid
lowering effect of solasodine is based on a mode of action being similar to the formation of
unresorbable complexes of a-tomatine and cholesterol in the gastrointestinal tract.
3.1.3. Observations in humans
3.1.3.1. GAs from S. tuberosum
The CONTAM Panel noted that some of the authors of the reports described in this section used a
terminology (e.g. ‘solanine poisoning’) not distinguishing between solanine, chaconine, a-solanine,
a-chaconine, solanine:chaconine mixtures and total potato GAs (potato TGAs). This might also be the case
for the chemical analysis reported by the authors. The authors’ terminology has been kept in this chapter.
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Poisonings of humans by GAs, particularly from potato consumption, have been repeatedly
reviewed, e.g. by Morris and Lee (1984), Van Gelder (1989), JECFA (1993), Tice (1998), Lee (2006),
Barceloux (2009), Koleva et al. (2012) and Milner et al. (2011), who report on more than 10 separate
outbreaks of potato GA poisonings affecting more than 2,000 subjects including fatalities in more than
1% of the cases. Besides showing membrane disruption activity, potato GAs inhibit the enzyme
acetylcholinesterase (AChE), thereby affecting the nervous system directly (see Section 3.1.5). At
doses > 1 mg/kg bw, potato GAs are considered to be toxic to humans (JECFA, 1993). The studies
report that signs of intoxication may occur immediately after intake or with a latency period up to 2
days. Potato GAs induce symptoms such as sweating, vomiting, diarrhoea, severe abdominal pain,
drowsiness, apathy, confusion, weakness, vision disturbances, fever, rapid and weak pulse, low blood
pressure and bronchospasm. In severe cases, paralysis, respiratory insufficiency, cardiac failure, coma
and death have been reported. Doses in the range of 3–6 mg potato TGAs/kg bw are described to be
potentially lethal for humans (JECFA, 1993). However, estimated doses associated with toxicity are
regarded as uncertain (McMillan and Thompson, 1979; Morris and Lee, 1984; Hellen€as et al., 1992;
JECFA, 1993; Smith et al., 1996; Milner et al., 2011; Koleva et al., 2012).
Toxic GA concentrations are reported to be associated with taste alterations. Bitterness, e.g. when
chewing a small piece of the raw peel, is indicative of a high GA concentration in potatoes (Wood and
Young, 1974; Beier and Nigg, 1992). Normal levels of GAs in potatoes of less than 100 mg/kg are
usually not detectable by taste. GA levels exceeding 100 mg/kg cause a slowly within 15–30 sec
developing, burning sensation of the tongue and back of the mouth with a persistent irritation.
Consumption of potatoes that contain more than 200 mg GAs/kg results in an immediate burning
sensation (Wood and Young, 1974). Allergic reactions to raw and cooked potatoes, including cases of
anaphylaxis, are only rarely reported and not associated with their content of GAs (e.g. Beausoleil
et al., 2001; Majamaa et al., 2001).
In the following sections, only reports that are relevant for the risk assessment of the intake of
potato GAs, e.g. giving information on dose–effect relationships, are presented in detail.
3.1.3.1.1. Reports on intoxications
Outbreaks
Several large outbreaks of potato poisonings in humans are known and include those in France
(Cortical, 1888, as cited by Rothe, 1919), Germany (Schmiedeberg, 1892, as cited by B€omer and
Matthis, 1924; Pfuhl, 1899), East Glasgow (Harris and Cockburn, 1918), Cyprus (Willimott, 1933),
North Korea (Reelakh and Keem, 1958), South London (McMillan and Thompson, 1979) and Canada
(Canada Diseases Weekly Report, 1984). Most of the victims of potato poisonings were only
moderately affected. However, in some cases, serious poisonings including deaths occurred (Damon,
1928; McMillan and Thompson, 1979; Lee, 2006).
In an outbreak in 1898 in Germany, consumption of a large portion of potatoes resulted in 56
soldiers with typical symptoms of ‘solanine poisoning’, including irritation of the throat, rise of
temperature, headache, abdominal pain, diarrhoea and partly vomiting or nausea, loss of
consciousness and jaundice. In one case, convulsions were observed. Analysis revealed that the
cooked peeled potatoes contained 240 mg/kg and the unpeeled, uncooked potatoes 380 mg
‘solanine’/kg (Pfuhl, 1899). The author estimated that for those who consumed the whole meal, the
intake of ‘solanine’ had been 300 mg. In the JECFA (1993) assessment, the intake of ‘solanine’ was
estimated to have been 3.4–5.1 mg/kg bw.
In 1917, 61 persons from 18 households in Glasgow in Scotland showed the typical picture of
‘solanine poisoning’ immediately or within 3 h after eating potatoes. Observed symptoms were
vomiting, diarrhoea, headaches and debility. A 5-year-old boy died, and the post-mortem examination
showing that death was due to bowel strangulation, was interpreted as a consequence of extreme
retching and vomiting. The analysis of the potatoes consumed in the boy’s family contained 410 mg
‘solanine’/kg (Harris and Cockburn, 1918). JECFA (1993) concluded that, assuming a body weight of
18 kg and a consumption of 200 g, the lethal dose for the boy may be estimated at 4.5 mg/kg bw.
Furthermore, for adults an intake of 3.4 mg ‘solanine’/kg bw was estimated under the assumption that
they ate 500 g potatoes and had a bw of 60 kg.
Rothe (1919) reported on an outbreak in Leipzig (Germany) in 1919, which affected 14 persons
after consumption of potato dishes with immediate onset of gastrointestinal pain, followed by vomiting
and diarrhoea. The author conducted a self-experiment from which he concluded that intake of 150
mg to 200 mg ‘solanine’ with a meal of cooked peeled potatoes by a male person could lead to gastric
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discomfort and nausea after 90 min, followed by accelerated pulse, symptoms fading within a day
(Rothe, 1919).
McMillan and Thompson (1979) reported on an intoxication involving 78 British junior schoolboys
(11–15 years of age), who became ill with diarrhoea and vomiting after eating two small boiled peeled
potatoes each (weight of potatoes not indicated) as part of their midday meal. Symptoms developed
mainly between 20.00 and 22.00 o’clock the same evening. Seventeen out of the 78 boys were
hospitalised with symptoms of vomiting, severe diarrhoea, along with generalised abdominal pain,
commencing together 7–19 h after the meal. Their feces were watery and in 13 cases showed
markedly green colour by the second or third day as was the case for some of the vomitus. Fifteen of
the 17 boys developed fever being maximal just before admission and subsiding within 1–3 days.
Restlessness, sometimes extreme, was a common symptom often combined with other central nervous
system (CNS) effects, such as stupor, delirium, hallucinations, confusion, drowsiness or disorientation.
The three most seriously ill boys were comatose or stuporose on admission and had a peripheral
circulatory collapse. All of the 17 boys were discharged home within 6–11 days following admission,
and when seen 4–5 weeks later were without sequelae. From the 61 boys not admitted to hospital,
only for 24 of them Public Health Department records were available. According to these records, all
these boys suffered from abdominal pain, diarrhoea and/or vomiting. Twelve boys experienced pyrexia
and 13 headaches. Other symptoms reported were delirium, dryness of the throat, trembling, dizziness
and weakness, sometimes amounting to a feeling of paralysis. Bacteriological examinations of blood,
serum, vomit, urine and feces as well as of samples of food recovered from the meal have all been
proved to be negative. Testing of 22 samples of the school meal, 10 samples of the boys’ urine and 23
of feces for excess lead, copper, arsenic and zinc revealed negative results as well. Assays for the
presence of organic compounds, such as nicotine, organophosphorus or organochlorine pesticides,
metaldehyde or defoliant were also negative. Six days after eating the meal, pseudocholinesterase
plasma levels in 10 out of 17 schoolboys were subnormal and returned to the normal range 4 or 5
weeks later, for all but one value. The source of poisoning was seen in a bag of potatoes left from the
previous term that had been considered ‘unfit’ for consumption upon inspection, but that had
inadvertently been cooked. Peeled boiled potatoes left-over, uneaten after the meal, were extracted
and analysed for their anticholinesterase activity. Based on the enzyme activity, the concentration was
estimated to amount to 250–300 mg ‘solanine’/kg peeled, boiled potato. The authors claimed that this
concentration considerably exceeded that of normal fresh peeled tuber (normal value for whole
unpeeled tuber: less than 100 mg/kg, with most GAs in the peel). JECFA (1993) estimated the intake
of ‘solanine’ by the schoolboys to have been approximately 1.4–1.6 mg/kg bw.
In 1983, a poisoning incident occurred in Alberta (Canada) when 61 out of 109 school children and
staff members suffered from a sudden onset of symptoms after eating baked potatoes containing 494
mg solanine/kg (Canada Diseases Weekly Report, 1984). Predominant symptoms with frequency of
occurrence indicated were the following: nausea (69%), abdominal cramps (43%), headache (33%),
vomiting (25%), fever (11%) and diarrhoea (8%). The affected persons had recovered in about 3 h.
From the affected individuals, 44% had noted a bitter or unusual taste and 18% had felt a burning
sensation in the throat when eating the baked potatoes. According to the observations of several staff
members the potatoes had a slight tinge of green. Testing of the potatoes for the presence of
bacteria, viruses, moulds, pesticides or other chemicals yielded negative results (Canada Diseases
Weekly Report, 1984). JECFA (1993) estimated the exposure in this poisoning outbreak at about 2.5
mg ‘solanine’/kg bw assuming that the children consumed 200 g potatoes and had a body weight of
40 kg (JECFA, 1993).
Case Reports
While early reports of potato poisoning (Muncke, 1845, as cited by B€omer and Matthis, 1924;
Morris, 1859, as cited by Van Gelder, 1989) refer to severe or fatal cases associated with the
consumption of green, unripe or ‘new’ tubers, some studies in the years 1923 and 1924 addressed
health impairments related to the intake of potato tubers of normal appearance (Alfa and Heyl, 1923;
B€omer and Mattis, 1923, 1924; Griebel, 1923). B€omer and Mattis (1923, 1924) reported that, although
measured ‘solanine’ contents in samples of the consumed potatoes were relatively high and ranged
from 257 to 583 mg/kg (raw, unpeeled tubers), observed symptoms were not severe and included
burning sensation in the mouth, irritation of mucous membranes, gastrointestinal disturbance and
vomiting. Similar symptoms were reported by Griebel (1923) and Alfa and Heyl (1923) after intake of
potatoes with ‘solanine’ levels ranging from 196 to 790 mg/kg (raw, unpeeled tubers) or 109 to 468
mg/kg (raw, peeled tubers), respectively.
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In 1924, seven members of a family living in Illinois (USA) were poisoned by consumption of
greened potatoes. Two of them died, while the others recovered. Symptoms were epigastric pain,
nausea and vomiting. Patients were apathetic and extremely exhausted. Respirations were accelerated.
In the two fatal cases, consciousness was lost 3 to 4 h before death (Hansen, 1925).
A food control report from Switzerland reported on two samples of potatoes, which caused burning
in the throat and nausea after consumption, ‘solanine’ levels of 230 and 350 mg/kg (Viollier, 1941). No
further information was available.
In the UK, a poisoning incident occurred involving four members of a family on three consecutive
Sunday evenings about 9 h after they had consumed baked potatoes eating the flesh and the skin of
the tubers. Symptoms consisted of sickness, abdominal pain, diarrhoea and general malaise. Two
family members who had only eaten one potato suffered only slightly, a third one, who had two
potatoes, suffered more severely and the fourth one who ate three potatoes suffered very severely. A
fifth person, who only ate the flesh of the potatoes, did not develop any symptoms. The patients
recovered within 24 h. The potatoes contained 500 mg ‘solanine’/kg (Wilson, 1959). JECFA (1993)
estimated the intake of ‘solanine’ at 1.25–3.2 mg/kg bw assuming a weight of 150 g per potato.
A 70-year-old woman developed symptoms of poisoning, including vomiting, diarrhoea and bloody
feces, after consumption of a juice prepared from partly peeled potatoes without sprouts (Gonmori
et al., 1993). She was admitted to hospital and discharged after 27 days (no information on recovery
available, only abstract in English). Her blood was analysed by GC and GC-MS on the 4th and 20th
days without ‘solanine’ being detected. The potatoes from which the juice was prepared contained a
15-fold higher ‘solanine’ concentration compared to normal potatoes (levels not given by the authors)
(Gonmori et al., 1993).
In November 2015, members of a family in Baden-W€urttemberg (Germany) experienced vomiting
and stomach ache after the consumption of potato dishes (jacket potatoes and potatoes boiled in the
skin). Due to the bitter taste, a salad prepared from the same potato charge was not consumed.
Chemical analysis showed that the potatoes, which were without damage, green sites, sprouts or
microbiological contamination, contained 236 mg potato TGAs/kg (141 mg a-solanine and 95 mg a-
chaconine per kg). In the potato salad, a lower concentration of 124 mg potato TGA/kg was found. No
information was available on the quantity of potatoes consumed, if all members of the family were
affected by the intoxication and on recovery (BfR, 2018a,b).
3.1.3.1.2. Studies in human volunteers
In 1919, Rothe conducted a self-experiment from which he concluded that intake of 150 mg to 200
mg ‘solanine’ with a meal of cooked peeled potatoes by a male person could lead to gastric discomfort
and nausea after 90 min, followed by accelerated pulse, symptoms fading within a day (Rothe, 1919).
In three Swedish adult volunteers (two males and one female), who consumed daily for 1 week
200–300 g of cooked unpeeled potatoes of varieties high in GAs (180–300 mg/kg), no signs of acute
toxicity were noted. However, the three subjects reported on a bitter taste (Harvey et al., 1985a,b).
JECFA (1993) estimated the intake of TGA at 1 mg/kg bw.
In a kinetic study, seven healthy male adults have been given a potato meal, which consisted of
mashed potatoes prepared from two parts peeled potatoes and one part low-fat milk (Hellen€as et al.,
1992, see Section 3.1.1). The dish contained 200 mg GAs (82 mg a-solanine and 118 mg a-chaconine)
per kg. The amount consumed was adjusted in relation to each subject’s body weight to standardise
the TGA intake for 1 mg/kg bw. All except one of the volunteers experienced signs of toxicity (mainly
light to severe nausea, in one case combined with diarrhoea) and an unpleasant off-taste after
ingestion of the meal. In most subjects, symptoms started within about 30 min after exposure and
lasted for 3–4 h. The peak serum concentrations for a-solanine and a-chaconine were on average
reached after 5.1 and 6.0 h, respectively, and amounted on average to 7.7 and 14.4 ng/mL (8.8 and
16.9 nmol/L), respectively. During the 25-h period, the highest solanidine values varied among the
subjects between 1.0 and 4.8 ng/ml (2.5 and 12 nmol/L). No correlation between the severity or
duration of adverse effects and GA serum levels was seen and the highest maximum blood serum
concentrations for a-solanine and a-chaconine of 11.3 and 21.4 ng/mL, respectively, were exhibited in
the one subject not experiencing signs of toxicity (solanidine serum level not given). According to the
authors, the rapid onset and short duration of the symptoms compared to the GA serum profiles
suggest that the symptoms might be the consequence of local direct effects on the gastrointestinal
tract rather than of systemic interactions. The authors noted that the study was not focusing on the
toxic effects of the GAs and was not conducted double-blinded. Therefore, a placebo effect could not
be excluded.
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Bushway (1987, personal communication, as cited by Van Gelder, 1989) reported on a study in six
male adult volunteers who consumed potato tubers which contained 320 mg potato TGA/kg. The
potatoes were baked and consumed unpeeled. The amounts of GAs ingested ranged from 1.75 to 2.58
mg/kg bw. Symptoms of intoxications occurred in all of the subjects, started about 2–4 h after
ingestion and included nausea, vomiting and diarrhoea. Symptoms faded away after 8–10 h.
In a study in 14 volunteers (6 males, 8 females), aged 18–45 years, the toxicity and toxicokinetics
of different oral single doses of the potato GAs, a-chaconine and a-solanine, were investigated
(Mensinga et al., 2005, see Section 3.1.1). The subjects (2–3 per treatment) received solutions with
potato TGA doses of 0.30, 0.50 or 0.70 mg/kg bw, or mashed potatoes adjusting TGA doses to 0.95,
1.10 or 1.25 mg/kg bw under standardised conditions. The solutions contained 50% a-solanine and
50% a-chaconine. The mashed potatoes had a TGA concentration of 199 mg/kg (51% a-solanine,
49% a-chaconine), which was recognised as upper limit of safety according to the authors. No adverse
events did occur in any of the treatments, except for one of the two volunteers in the high-dose group
receiving 1.25 mg potato TGA/kg bw in mashed potatoes. About 4 h after administration, this subject
developed nausea and started vomiting, which was associated by the authors with GA toxicity, even
though the doses were lower than those generally reported in the literature to cause gastrointestinal
disturbances. According to the authors, the serum GA concentrations of this subject were comparable
to those of the subject receiving a similar dose and did not show any symptoms. For both subjects,
maximum blood serum concentrations were ranging for a-solanine between 8.0 and 11.8 ng/mL and
for a-chaconine between 6.3 and 9.7 ng/mL, no individual levels being indicated for each subject. The
authors concluded from the results that some subjects may be more susceptible for adverse effects of
potato GAs than others.
3.1.3.1.3. Epidemiological studies
Congenital anomalies
Intake of potato GAs, particularly with blighted or injured potatoes have been proposed as an
aetiological factor in the pathogenesis of neural tube defects (NTD) (anencephaly and spina bifida)
(Renwick, 1972; Harvey et al., 1986). This hypothesis has been addressed in two epidemiological
studies (Nevin and Merrett, 1975; Harvey et al., 1986). Maternal consumption of sprouted potatoes as
risk factor of NTD has also been investigated in two Chinese studies (Wang et al., 2008; Ni et al.,
2018).
In the prospective study of Nevin and Merrett (1975) in women with a previous infant with either
anencephaly and/or spina bifida and advised to avoid potato consumption, the incidence of NTD was
8.7% in the group of women adhering to the advice (n = 27), and 3.6% in the group of non-compliers
(n = 61) (p = 0.58). In the prospective study by Harvey et al. (1986) conducted in NTD screening
centres, outcome of pregnancy in 380 patients resulted in 210 NTD cases and 170 normal offspring,
whereby in most of the nine centres studied, serum total potato alkaloids levels and serum ‘solanidine’
levels were higher in the women with a normal fetus than in those with a fetus affected by NTD. For
both groups serum total potato alkaloid concentrations varied widely between individuals as well as
between each of the participating centres, whereby levels for individual subjects ranged from < 10 to <
150 nmol/L.
Two Chinese case–control studies investigated the risk factors of NTD in the Shanxi province in
Northern China (Wang et al., 2008; Ni et al., 2018). The results indicate that, among other factors,
maternal consumption of sprouted potatoes during the periconceptional period may increase the risk
of NTDs or orofacial clefts (OFCs). Subjects recruited between 2002 and 2007 by Ni et al. (2018)
included 622 cases with NTD, 135 cases with orofacial clefts (OFCs) and 858 controls. Data collection
comprised information on maternal sprouted potato consumption, lifestyle behaviours and folic acid
supplementation. Intake of sprouted potatoes was not associated with spina bifida or encephalocele,
but with increased odds of total NTDs (OR = 2.20; 95% CI, 1.12–4.32) and anencephaly (OR = 2.48;
95% CI, 1.10–5.58) and with elevated risk of total OFCs (OR = 3.49; 95% CI, 1.29–9.49) and cleft lip
with or without cleft palate (CL  P) (OR = 4.03; 95% CI, 1.44–11.28). The authors also found that
maternal consumption of sprouted potatoes was significantly associated with NTDs and OFCs among
mothers with lower consumption of B vitamins, but not among mothers with a higher consumption of
B vitamins. Another case–control study was conducted by Wang et al. (2008) in subjects genotyped
for methylenetetrahydrofolate reductase (MTHFR) C667T polymorphism. Multivariate conditional
logistic regression analysis indicated that four maternal factors were linked to NTDs: frequency of
pregnancy (OR = 2.87, 95%CI: 1.28–6.44), contacting chemicals in early pregnancy (OR = 16.18, 95%
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CI: 1.18–221.59), frequent taking of germinated potatoes in early pregnancy (OR = 4.66, 95%CI:
1.78–12.17) and MTHFR C677T mutation (OR = 2.13, 95%CI: 1.08–4.21). The CONTAM Panel noted
that no information on GA levels in the sprouted potatoes or GA intake was given in the two studies.
The CONTAM Panel noted that the hypothesis of Renwick (1972) has not been supported by the
outcome of the epidemiological studies of Nevin and Merrett (1975) and Harvey et al. (1986). The
design and results of the two Chinese studies (Wang et al., 2008; Ni et al., 2018) do not allow
conclusions on causal relationships of GA exposure and developmental effects.
Cancer
The relationship between the intake of potatoes and risks of cancer in the gastrointestinal tract has
been investigated. As reviewed by Hopkins (1995) and Tice (1998), results of epidemiological studies
were contradictory and remained altogether inconclusive. A causal relationship between diets with the
consumption of large quantities of potatoes and increased risks of cancers of the brain, breast,
endometrium, lung and thyroid could not be proven (Hopkins, 1995; Tice, 1998).
The CONTAM Panel noted that the design and outcome of existing studies do not allow concluding
on the causal relationship between intake of potato GAs and cancer risks.
3.1.3.1.4. Summary
Overall, the CONTAM Panel noted that the information from the available human data is limited.
However, results from kinetic studies in volunteers (Harvey et al., 1985a,b; Hellen€as et al., 1992;
Mensinga et al., 2005) and from reports on intoxications (e.g. Wilson, 1959; Bushway, 1987, personal
communication, as cited by Van Gelder, 1989) indicate that acute toxic effects, such as nausea,
vomiting and diarrhoea, may occur in adults from a potato TGA intake of 1 mg/kg bw or more
(Table 20). Doses in the range of 3–6 mg potato TGAs/kg bw are considered to be potentially lethal
for humans.
Results of studies conducted under standardised conditions (Hellen€as et al., 1992; Mensinga et al.,
2005) suggest that differences in the individual susceptibility towards adverse effects associated with
the intake of potato GAs may be expected. The available human data do not allow to draw conclusions
if children or other subgroups of the population, such as individuals with inflammatory bowel diseases,
may be more susceptible to adverse effects associated with potato GAs than others.
No data showing convincing evidence of GA-related health problems in humans associated with the
long-term intake of potatoes have been identified.
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Table 20: Summary of reports on outbreaks and cases of intoxications in humans and on volunteer studies relevant for the identification of the reference
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(a): Concentrations are given as ‘potato TGAs’, ‘solanine’, ‘a-solanine’ or ‘a-chaconine’ depending on the subject of analysis as described in the referenced publication.
(b): Doses are given as ‘TGAs’, or ‘solanine’, depending on the subject of analysis as described in the referenced publication.
(c): As estimated in JECFA (1993).
(d): As estimated by the authors.
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3.1.3.2. GAs from food plants other than S. tuberosum
The occurrence of GAs in foods other than potatoes has been reviewed by Tice (1998) and Dolan
et al. (2010) (see Sections 1.3.1 and 1.3.3). For example, tomato fruits, particularly the green unripe
fruits, are known to contain, i.a. a-tomatine. However, according to Dolan et al. (2010), there is no
evidence to consider a-tomatine as a substance of concern and there are no reports of acute toxicity
in humans due to ingestion of green tomatoes.
3.1.3.2.1. Case Reports
Smith et al. (2008) reported on intoxications occurring on two different occasions with susumber
berries originating from the plant S. torvum. Poisonings with susumber berries personally imported
from Jamaica occurred in three persons in 2003 in Toronto and in three persons in 2006 in York City.
Symptoms included diarrhoea, weakness, facial paralysis, slurred speech and ataxia. The most
seriously affected patients developed hypertension, confusion and respiratory failure requiring
mechanical ventilation. The authors noted that the imported poisonous berries ingested appeared
indistinguishable from non-toxic varieties commercially available on the market. a-Solasonine and a-
solamargine, which share the same aglycone, solasodine, were isolated from the toxic berries but not
from their non-toxic counterparts (Smith et al., 2008).
The French Agency for Food, Environmental and Occupational Health and Safety (Anses) reported
in 2014 on 26 cases of poisoning in France associated with consumption of cherry tomatoes originating
from Morocco (Anses, 2014). Gastrointestinal symptoms, including vomiting, abdominal cramps and
irritation of the pharynx, were accompanied by an unpleasant bitter taste. The symptoms were
observed in most cases 5–30 min after ingestion of the cherry tomatoes. Based on chemical analysis
using LC-HRMS, rubijervine was postulated as a metabolite present in the cherry tomatoes. However, it
was not possible to confirm the identity or to perform a quantification. Neither a-tomatine nor a-
solanine could be detected in the tomatoes. Rubijervine is the 12a-hydroxy metabolite of solanidine
which is known to occur also in other plants such as those of the genus Veratrum. Metabolome
profiling studies conducted on wild and cultivated tomato species using similar techniques have not
reported the presence of rubijervine in any of the investigated samples (Moco et al., 2007; Iijima
et al., 2013; Schwahn et al., 2014), a fact also mentioned by the authors of the Anses report. The
authors concluded that the intoxications could have been caused by GAs, but that further
investigations would be necessary to identify the causative substances.
3.1.4. Adverse effects in farm animals, horses and companion animals
The selection criteria for studies relevant to inform the adverse effects in farm and companion
animals are described in Section 2.1.
3.1.4.1. Ruminants
Three studies on ruminants could be identified (see Table 21), which lack significance due to the
low number of animals investigated and due to lack of information on the exact composition and the
degree of purity of the test compounds. These limited studies indicate that acute toxicity may be
expected to occur at oral doses above 40 mg/kg bw in sheep and cows.
3.1.4.2. Pigs
Kerr et al. (1998) treated weanling pigs with control diet containing 3% spray-dried animal plasma
or diets with additional 2.6% or 5.1% potato proteins for 28 days (see Table 22). GA content of potato
proteins was determined by HPLC-UV. No information is provided on the concentration of a-solanine
and/or a-chaconine. Increasing concentrations of potato proteins had no effect on the average daily
body weight gain or food intake of the animals.
3.1.4.3. Poultry
The studies identified are reported in Table 23.
Vogt and Stute (1969) used an extract of S. tuberosum as a source of a-solanine. However,
information is lacking whether the extract contained also a-chaconine or further GA or aglycones. The
extract was admixed to a diet containing dried ground potatoes with a a-solanine content of 100–150
mg/kg. This treatment increased the body weight gain in young male Acres chicken when treated daily
with 4–12 mg a-solanine per kg bw for 46 days.
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Tusnio et al. (2013b) used two different potato protein concentrates containing 677–3,185 mg/kg
TGA. No information is given on the concentrations of a-solanine and a-chaconine, and the ratio
between these two GA is likely to be different in the potato concentrates. A GA dose of 101.5 mg/kg
bw per day reduced feed intake and body weight gain in female chicken when treated over a period of
35 days. Furthermore, an increased relative weight of liver and pancreas could be observed in this
study at a dose of 67.7 mg/kg bw per day. When applying 154.2 mg/kg bw per day, the authors
observed morphological changes in the intestinal tract of female chicken. The interpretation of these
observations is hampered by the fact that the diet contained also trypsin inhibitors at various
concentrations, which might have affected the digestibility of the feed components and the activity of
the gastrointestinal tract.
3.1.4.4. Rabbits
No studies on the adverse effects in rabbits have been identified other than the ones described
already in Sections 3.1.2.1 and 3.1.2.2. In the repeated-dose toxicity studies, no NOAEL or LOAEL
could be derived, since untreated controls were missing.
3.1.4.5. Fish
The studies identified in fish are reported in Table 24. Xie and Jokumse (1997) applied potato
protein concentrate, containing solanine (no more details reported) at 1 g/kg dw. This concentrate was
admixed to a fishmeal-based diet and fed to rainbow trouts for a period of 4 weeks. At an uptake of
solanine of daily 1.12 mg/kg bw, the specific growth rate of the trouts was reduced significantly.
One 84-day study in rainbow trout indicated that the most sensitive end points are decreased body
weight, lowered serum proteins and an altered hepatic histology occurring at the lowest doses of a-
solanine/a-chaconine of 0.008/0.012 mg/kg bw per day (Tusche et al., 2011). No NOAEL or LOAEL
could be identified.
3.1.4.6. Horses
No studies were identified.
3.1.4.7. Companion animals (cats and dogs)
No studies were identified.
3.1.4.8. Fur animals
No studies were identified.
3.1.4.9. Reports on intoxications
The risks of feeding green potatoes or sprouts to livestock have been well understood for many
years, and therefore, there have been relatively few recent reports of intoxications following ingestion
of these feeds. Outbreaks of poisoning of cattle in the UK fed green or sprouting potatoes have been
reported (Milligan, 1941), while in Poland, outbreaks of ‘solanine’ poisoning in pigs were reported
between 1949 and 1961. These involved 180 pigs, and resulted in 64% mortality, but levels of GAs
were not given (Cooper and Johnson, 1984). Sheep are also susceptible to poisoning following
consumption of green potatoes. In the USA, 14 (of 35) became weak, uncoordinated and subsequently
died after consuming green potatoes which had been spread on the pasture (Bolin, 1962)
Poisoning of livestock following consumption of other GA-containing plants, such as S. dulcamara
and S. nigrum, are uncommon. Because of their strong odour and bitter taste, animals do not eat the
growing plants as long as other feed is available. However, these plants may grow as weeds in hay
and silage crops, where they can be harvested with the crop and then fed to livestock. Drying or
ensiling does not destroy the toxin (USDA, 2011), and as a result cases of accidental poisoning (or
suspected poisoning) have been reported in horses, cattle, sheep, goats and pigs where livestock have
consumed hay or silage, which have been contaminated with these plants (Cooper and Johnson,
1984).
Norman et al. (2012) reported a case in which six horses were fed poor quality hay containing
S. eleagnifolium (Silverleaf nightshade) and S. dimidiatum (Western horse nettle). S. eleagnifolium is
known to contain solasodine-type GAs (Alvarez et al., 1994). Symptoms included gastrointestinal
upset, respiratory depression and central nervous system depression, obtundation, ataxia, pyrexia,
muscle fasciculations and ileus. Therapy for these horses was poorly described, but all the affected
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horses recovered. Gunning (1950) also reported a case of poisoning and death in a horse fed greened
potato sprouts.
Poultry appear to be less susceptible to ‘solanine’ poisoning; in feeding trials laying hens tolerated
green potato sprouts and ground tubers when included at 10% of their diet for long periods
(Temperton, 1943).
Kees et al. (2015) reported a case of GA toxicity in a 10-week-old male Labrador retriever dog as a
result of ingesting dried stems and unripe berries of S. dulcamara. S. dulcamara may contain a variety
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LD50 (mg/kg bw) Reference
a-Solanine(b) Sheep (F)
No/sex/group: 1






225 K€onig and Staffe (1953)
a-Solanine(a) Adolescent bull (M)
No/sex/group: 1
Single gavage: 77 mg/kg bw
NO CONTROL
77 Liebenow (1970)
Solasodine(a) Adolescent bull (M)
No/sex/group: 1
Singe gavage: 43 mg/kg bw
NO CONTROL
43 Liebenow (1970)
F: female; M: male.
(a): Chemical standard obtained by in-house isolation from plant material, and checked for purity (95% pure or higher).
(b): Poorly characterised chemical standard (purity or composition not defined, may contain a-chaconine).











LD50 (mg/kg bw) Reference
Potato protein(a) Pigs (M,F)
No/sex/group: ~ 18
Diet: 0, 4.6 or 8.5 mg
TGA/kg bw/day
Duration: 28 days
8.5 Kerr et al. (1998)
F: female; M: male.
(a): A non-purified material for which the TGA concentration is given.
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a-Solanine(a) Acres chicken (M)
No/sex/group: 3
Diet: 0, 12.5, 25 or 50 mg/kg
(equivalent to 0, 1.1–3, 2.2–6 or
4.4–12 mg/kg bw per day)
Duration: 46 days
↑bw gain 2.2–6 4.4–12 Vogt and Stute (1969)
Potato protein concentrate
containing GAs and also




Diet: 0, 86.2, 87.7, 154.2, 274.5 or
318.5 mg/kg bw per day
Duration: 23 days
↓ decreased height of villi in
jejunum + ileum





Tusnio et al. (2013b)
Potato protein concentrate
containing GAs and also





















Tusnio et al. (2013b)
F: female. M: male. Bw: body weight,
(a): Poorly characterised chemical standard (e. g. purity or composition not defined).
(b): A non- or only partly purified extract or material for which the GA composition and concentration is given.
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Control diet (fish meal) admixed with potato
protein concentrate at isontrogenous and
isoenergetic levels containing solanine at 0, 22,
56, 89 and 111 mg/kg diet (equivalent to: 0,
0.44, 1.12, 1.78 or 2.22 mg/kg bw per day(b))
Duration: 28 days
Specific growth rate 0.44 1.12 Xie and Jokumsen (1997)
Potato protein concentrate




Diet containing a-solanine/a-chaconine at 0/0,
0.4/0.6, 0.8/1.2, 1.2/1.7 or 1.6/2.3 mg/kg dw
(equivalent to: 0/0, 0.008/0.012, 0.016/0.024,












Tusche et al. (2011)
Potato protein concentrate




Diet containing a-solanine/a-chaconine at 0/0,
166/149, 306/298, 459/446 or 612/595 mg/kg
dw (equivalent to: 0/0, 3.32/2.98, 6.12/5.96,














Tusche et al. (2011)
dw: dry weight; bw: body weight.
(a): A non- or only partly purified extract or material for which the GA composition and concentration is given.
(b): Body weight of 2 kg and average feed consumption of 40 g per day were assumed (EFSA, 2011c).
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of GAs such as a-solasonine, a-solamargine, a-solamarine, b-solamarine and soladulcine A (Calf et al.,
2018). The level of exposure to GAs was not determined.
3.1.5. Mode of action
Information from the available human data on poisoning with potato GAs indicate that acute toxic
effects of GAs comprise nausea, vomiting, abdominal cramps and diarrhoea (see Section 3.1.3). These
symptoms may be caused by local irritating effects in the mucosa of the gastrointestinal tract referring
to the ability of potato and tomato GAs to form complexes with membrane 3b-hydroxy sterols, thereby
disrupting the integrity of cell membranes. The acute toxic effects in humans might be related also to
the cholinergic toxidrome or toxic syndrome, comprising a set of symptoms caused by a group of toxic
chemicals leading to overstimulation of cholinergic receptors.20 The various effects of GAs are outlined
in detail below.
3.1.5.1. Membrane effects with implications for the gastrointestinal tract
GAs, like a-solanine, a-chaconine and a-tomatine, may exert saponine-like effects which may injure
membranes. This membrane toxicity has been documented in several tissues or cell lines, such as rat
liver cells (specifically in mitochondria) (Keukens et al., 1996), mammalian erythrocytes (Keukens
et al., 1996), rodent cell lines (Gee et al., 1996) as well as in human colorectal carcinoma (Glynn et al.,
2017; Arena et al., 2018), embryonic intestinal (Gee et al., 1996; Keukens et al., 1996; Patel et al.,
2002) and MCF7 breast cancer cell lines (Sucha et al., 2013).
The molecular mechanism of toxicity may be based on membrane destabilisation (Friedman, 2006).
The presence of sterols in the membrane appears to be an absolute requirement for the membrane
disruptive action of the GAs (Keukens et al., 1992). It has been suggested that the initial insertion of the
aglycone part into the membranes is followed by the generation of a 1:1 complex with membrane sterols,
which disrupts the structure of the lipid bilayers. GAs interact with the sterols in the following potency
order: a-tomatine > a-chaconine > a-solanine (Friedman, 2006). Deletion of one or more mono-
saccharides from the GAs resulted in an almost complete loss of activity. Accordingly, solanidine was
weakly active (Keukens et al., 1992, 1995). Keukens et al. (1995) proposed that on the one side the
length of the sugar chain of the GA and on the other side a planar ring structure, a 3b-OH-group as well as
a side-chain at position 24 of the sterol, are critical. As a consequence of this interaction, the permeability,
stability, flexibility and fluidity of cell membranes may be considerably altered (Friedman, 2006).
Manrique-Moreno et al. (2014) showed that the aubergine-derived aglycone solasodine may cause
structural perturbations in the membranes of human erythrocytes. In more detail, X-ray diffraction
studies demonstrated that solasodine interacted mainly with dimyristoylphosphatidylcholine, one of the
major phospholipids in the outer and inner erythrocyte membrane affecting the polar head and acyl
chain regions of the molecule. Interestingly, the strongest effect was seen with the aglycone
solasodine and the lowest with the GA a-solanine. It has not been investigated whether the potato
aglycone soladinine exerts similar effects in phospholipids as solasodine.
The disintegrating effect of GA on membranes may be of significance in the gastrointestinal tract
after enteral uptake of the compounds. For example, Gee et al. (1996) reported that GAs reduced the
integrity of isolated rat mucosa, which impaired active nutrient transport and enabled high molecular
weight compounds (such as allergens or GAs) to cross the epithelial barrier. The communication
between intestinal cells by gap junctions may also be a target of GAs, as observed in Caco-2 human
epithelial colon carcinoma cells after treatment with a-chaconine and a-solanine (Keukens et al., 1996;
Glynn et al., 2017). GAs also disturb the transport of Ca2+ and Na+ across cell membranes. For
example, Blankemeyer et al. (1995, 1997) found that the transepithelial active transport of sodium
decreased considerably when incubating frog skin with a-tomatine, a-chaconine or a-solanine. In the
rat duodenum, 5 mM a-solanine applied via drinking water, inhibited the active calcium transport in a
non-competitive way (Michalska et al., 1985). The extent of these effects may depend on the pH
within the intestinal lumen, e.g. GAs show a low solubility at neutral pH and a higher solubility around
a pH of 6, as occurring in the proximal jejunum (Gee et al., 1996). However, it has to be considered
that the intestinal mucosa in the intact organism of healthy individuals is protected by a layer of
mucus, which may antagonise the effects of GAs.
20 Report on the Toxic Chemical Syndrome. Definitions and Nomenclature Workshop. May 8-9 2012. Available at: https://chemm.
nlm.nih.gov/Report_from_Toxic_Syndrome_Workshop_final_with_ACMT_edits_cover.pdf
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Disruption of epithelial barrier integrity by GAs may be important in triggering inflammatory bowel
disease in susceptible individuals. To test this hypothesis, Patel et al. (2002) treated homozygous IL-10
gene-deficient mice with overt enterocolitis with a 1:1 mixture of a-chaconine:a-solanine at 3 mg/kg
bw per day via drinking water for 21 days. This treatment aggravated intestinal injury, as determined
by pathohistological diagnosis, while in control animals no effect could be seen. The same group used
Il-10-gene-deficient male mice as well as male mice with dextran sodium sulfate-induced colitis
exposed to fried skin from potatoes with low/medium (154 mg GA/kg skin, i.e. 30.8 mg/kg bw per
day) or high GA content (460 mg GA/kg skin, i.e. 92 mg/kg bw per day) for 20 days (no further feed
was provided to the mice) (Iablokov et al., 2010). Exposure to the low/medium GA skins elevated
interferon-gamma (IFN-c) in the Il-10-gene-deficient mice, and IFN-c, TNF-a and IL-17 in mice with
the dextran sodium sulfate-induced colitis. In the latter model also enhanced colonic permeability could
be observed.
To conclude, the cytotoxicity in the gastrointestinal mucosa may contribute to symptoms observed
after GA intoxication, such as necrosis in experimental animals or diarrhoea and vomiting in humans
(see Sections 3.1.2 and 3.1.3). It remains to be elucidated in more detail whether susceptible
individuals are at an elevated risk for the development of inflammatory bowel disease after ingestion
of GAs.
3.1.5.2. Inhibition of cholinesterases (ChEs)
3.1.5.2.1. Comparative determination of inhibition of ChEs in vitro
ChEs have to be subdivided into two classes of enzymes: acetylcholinesterase (AChE, EC 3.1.1.721)
and butyrylcholinesterase (BuChE, EC 3.1.1.821). This distinction is important because in older studies
the term ChE has been used in a general sense, not discriminating between the two classes of
enzymes. The BuChE class of enzymes was also called ‘pseudocholinesterase’ or in older studies,
‘unspecific ChE’, representing the serum ChE.
The primary function of ChEs is to inactivate acetylcholine (ACh) by cleavage, thereby avoiding
overstimulation of cholinergic processes. These cholinolytic functions of ChEs require the catalytic
(enzymatic) function of the protein. This function is required in the case of the classical synaptic
function (Vogel-H€opker et al., 2012). Within the enzymatic mode of action AChE most likely functions
in cooperation with other components of the cholinergic system including the substrate ACh, both the
nicotinic and muscarinic acetylcholine receptors, choline acetyltransferase, and potential ACh
transporters.
Besides cleavage of ACh, BuChE is primarily known for its activity in metabolism of bioactive esters
from food and medications, particularly for its role to inactivate the muscle relaxant succinylcholine,
used to facilitate abdominal surgery (Brimijoin et al., 2016). Otherwise, it was not known to play a
direct role in mammalian physiology and was regarded as an orphan enzyme. This changed when it
was recognised that BuChE cleaves ghrelin, a hormone involved in appetite control.
Each class of enzymes can be inhibited by two typical modes of action, the competitive reversible
and the non-competitive irreversible mode of inhibition. Reversible competitive inhibition of ChEs is
used for clinical purposes using substances with a positively charged nitrogen, competing for the
ligand binding domain of the enzyme. Chemically, these inhibitors include compounds with different
functional groups (carbamate, quaternary or tertiary ammonium group). They are/were applied for
diagnostic and/or treatment purposes for diseases such as myasthenia gravis, Alzheimer disease or
glaucoma.
Non-competitive inhibitors represent largely organophosphates which are esters or thiols derived
from phosphoric, phosphonic, phosphinic or phosphoramidic acid. They exert their main toxicological
effects through non-reversible phosphorylation of esterases in the central nervous system thereby
irreversibly inactivate the catalytic centre of the enzyme (Colovic et al., 2013). GAs are inhibitors of
ChEs and follow the reversible, competitive mode of action.
Regarding inhibition of ChEs by GAs, Pokrovskii (1956) was the first to describe inhibition of
enzymatic activity by a-solanine. The first description of inhibition of serum ChE in the English
literature was by Orgell et al. (1958), who showed that a peel extract is up to 40-fold more potent
than in the inner part of the tuber. In the meantime, there is a broad range of evidence supporting the
observation that GAs, particularly a-chaconine and a-solanine, are potent inhibitors of ChEs, and that
the GAs are more potent than the aglycones.
21 International Union of Biochemistry and Molecular Biology (IUBMB) enzyme nomenclature.
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Inhibition of ChEs by GAs was reported in two different ways, representing two different
experimental scientific approaches. Some studies described percentage of inhibition obtained at tested
concentration(s) of the GAs or their aglycones against control, while others determined inhibitory
constants (Ki). Consequently, results are summarised in two different tables representing percentage of
inhibition values (Appendix E, Table E.1) and determined Ki values (Appendix E, Table E.2). A direct
comparison of the potency of inhibition of the two ChE enzyme classes is difficult, because enzymes
were measured in different organs or body fluids and concentrations used to study percentage of
inhibition by the investigated GA differed considerably. However, from direct comparative studies, some
general findings can be delineated. The most potent GAs in term of inhibition of ChEs were a-solanine
and a-chaconine, with a-chaconine in tendency being slightly more potent. BuChE appears to be a
slightly more sensitive target for inhibition by GAs than AChE. Human ChEs reacted equally if not more
sensitive to inhibition by GAs than their counterparts from animals (see Appendix E).
Harris and Whittaker (1959) extracted 85 g of potato peel with 300 mL water and tested these
extracts on human serum ChE. By electrophoretic procedures, they could discriminate between three
subtypes: the unusual phenotype, the intermediate phenotype and an atypical phenotype. The
percentage of inhibition recorded was: 77–83% for the unusual phenotype, 53–67% for the intermediate
phenotype and 16–24% for the atypical phenotype. Using the same discrimination of enzyme subtypes
for human serum ChEs, the same authors made a comparative investigation of the inhibitory activity of a-
solanine at 2.88 lM and its aglycone solanidine at 3.14 lM (Harris and Whittaker, 1962). For a-solanine,
the authors found 86.2% inhibition for the unusual phenotype, 65.8% inhibition for the intermediate
phenotype and 21% for the atypical phenotype. Inhibition by 3.14 lM solanidine was slightly lower, with
80% inhibition for the unusual phenotype, 53.2% for the intermediate phenotype and 0.8% for the
atypical phenotype. Overall, the inhibitory activity of the aglycone seems to be lower than that of the
glycoside. Nigg et al. (1996) did a comparative assessment of a-chaconine and a-solanine. They also
used human serum ChE, specifically targeted BuChE using a-naphthylacetate as substrate at a
concentration of 2.88 lM and had three time points of measurement (0, 10, 30 min). Whereas the
inhibitory activity for a-solanine was 50% at all time points measured, a-chaconine treatment lead to an
inhibition of BuChE of 68.3% at time point 0, 70.2% at 10 min and 67.3% at 30 min. These results are
indicative for a higher inhibitory of a-chaconine if compared to a-solanine.
The comparative approach of estimation of an inhibitory activity at a defined substrate
concentration for both enzymes was used only once, meaning direct comparison of the inhibitory
activity of a-chaconine and a-solanine (McGehee et al., 2000). Using human purified enzymes and
substrate concentration of 100 lM, the authors determined the percentage of inhibition of AChE and
BuChE. a-Chaconine inhibited 67.3% of AChE activity and 92.8% of BuChE activity. a-Solanine showed
a similar activity, inhibiting AChE by 76.5% and BuChE by 91.5%, pointing to the fact that BuChE may
be more sensitive to inhibition by GAs than AChE.
Alozie et al. (1978) performed an inhibitory assay with 100 lM of a-chaconine on ChEs in serum,
erythrocytes and brains of rats. By incubating electrophorese gels, they were able to discriminate six
isoenzymes. The inhibitory activities for isoenzymes 1–6 from plasma were 0%, 0%, 78.5%, 81.7%,
90% and 100%, respectively, from erythrocytes were 0%, 42%, 42%, 100%, 100% and 100%,
respectively, and from brain were 23%, 27.1%, 15.6%, 19.5%, 67.3% and 100%, respectively.
Using ChE from erythrocytes, Roddick (1989) investigated three questions: (a) to compare the
relative potency of a-chaconine and a-solanine alone and the individual activities to those of mixtures of
both compounds, (b) to compare the activity of the glycosides to those of aglycones and (c) to compare
the relative potencies of the aglycones against bovine and human ChE from erythrocytes. a-Chaconine
and a-solanine were tested at concentrations of 5 lM and 10 lM, as well as in a mixture containing 5 lM
of each compound. a-Chaconine inhibited bovine erythrocyte ChE by 25.9% (5 lM) and by 54.4% (10
lM), whereas a-solanine inhibited by 27.7% (5 lM) and by 44.3% (10 lM). The 1:1 mixture of both
compounds at 5 lM each leads to a 37.3% inhibition, indicative of an additivity of the two compounds.
a-Solasonine and solamargine were tested at 50 and 100 lM each. While 50 lM concentrations of both
compounds slightly increased enzyme activity, an inhibition was detectable at 100 lM, with 16.7%
inhibition for a-solasonine and 13% inhibition for solamargine. In addition, Roddick (1989) comparatively
assessed the inhibitory activity of the aglycones solanidine, tomatidine and solasodine. At 100 lM, no
consistent inhibitory activity using bovine and human erythrocyte AChE was detected.
3.1.5.2.2. Determination of inhibitory constants (Ki) for GAs on inhibition of ChEs in vitro
Most data for the assessment of the Ki are available for a-solanine. For human AChE, the range of
determined Ki values stretches from a Ki of 5 lM (Orgell, 1963) to a Ki of 14 lM (McGehee et al.,
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2000). For bovine and equine AChE, the Ki values were determined to be 8.3 lM and 4 lM,
respectively.
A lot more data are available for the Ki determination of a-solanine for inhibition of human BuChE. The
range of the determined Ki values is between a higher nM and a lower lM range. McGehee et al. (2000)
described a Ki of 0.17 lM for the inhibition of human BuChE by a-solanine. Benilova et al. (2006)
determined an almost identical Ki of 0.22 lM for this enzyme using a biosensor-based method. A similarly
low Ki was also reported by Loewenstein-Lichtenstein et al. (1996), although for an artificial mutant
which was expressed recombinantly. The same authors determined a Ki of 3.3 lM for the wild-type
human BuChE. This observation is in line with the findings of Sternfeld et al. (1997) who determined a Ki
of 2.9 lM for the human placental BuChE and a Ki of 2.0 lM for the recombinantly expressed human
BuChE. Ki values for the inhibition of equine BuChE were found to be higher (Benilova et al., 2006).
The Ki values determined for the inhibition of BuChE by a-chaconine were even lower than those
for a-solanine. McGehee et al. (2000) reported a Ki of 0.066 lM for the purified human enzyme,
whereas Benilova et al. (2006) reported a Ki of 0.17 lM. Like for a-solanine, human BuChE appears to
react more sensitive than equine BuChE.
The data for a-tomatine are inconclusive. Orgell (1963) reported a Ki of 100 lM for human plasma
ChE, whereas Benilova et al. (2006) determined a Ki of 1.3 lM for human BuChE and 1.66 lM for
equine BuChE using a biosensor method.
In summary, biochemical data on inhibition of ChEs by GAs can be summarised as follows below
and as illustrated in Tables 25 and 26 (for details refer to Appendix E):
i) the sugar moiety is a crucial determinant of ChE inhibition, as GAs are more potent inhibitors
than their aglycones (Table 25),
ii) a-chaconine seems to be a slightly more potent inhibitor of ChEs than a-solanine, particularly
of BuChE, and
iii) GA exposure leads to a slightly higher inhibition of BuChE activity than of AChE activity.
3.1.5.2.3. Inhibition of ChEs in vivo
Inhibition of ChEs in serum and erythrocytes
Inhibition of AChE by a-solanine is effective not only in vitro but also in vivo, as shown by several
experimental studies. When a-solanine was applied i.p. to two rabbits of each sex, AChE activity
Table 25: Percent inhibition of bovine erythrocyte cholinesterase (ChE) by glycoalkaloids (GAs) and
their aglycones (Roddick, 1989)
Compound Concentration (lM) % Inhibition(a)
a-Solanine 10 44.3
a-Chaconine 10 54.4
a-Solanine + a-chaconine 5 + 5 37.3
Solanidine, first subexperiment 100 2–11
Solanidine, second subexperiment 100 –14.1––6.2
(a): % inhibition of the activity measured for the solvent control DMSO.
Table 26: Inhibitory constants for glycoalkaloids (GAs) on human acetylcholinesterase (AChE) and
human butyrylcholinesterase (BuChE)(a)
Compound Human AChE; Ki (lM) Human BuChE; Ki (lM)
a-Solanine 5–14(b) 0.22–3.3(c)
a-Chaconine 17(d) 0.06–0.17(e)
(a): In old papers (Orgell, 1963) BuChE was not known yet, data were reported as AChE activity.
(b): Orgell (1963) and McGehee et al. (2000).
(c): Loewenstein-Lichtenstein et al. (1996), Sternfeld et al. (1997), McGehee et al. (2000), Benilova et al. (2006).
(d): McGehee et al. (2000).
(e): McGehee et al. (2000), Benilova et al. (2006).
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declined over time both in serum and in erythrocytes and was lowest at time of death (range of lowest
remaining activity: 55.2–73.2% in serum and 66.6–81.3% in erythrocytes). One male animal
recovered. In this animal study, AChE activity remained constant between time points 140 min after
treatment and 210 min after treatment in the case of serum AChE, and even recovered from 71.4% to
82.9% in the same time range in erythrocytes (Patil et al., 1972).
Inhibition of ChEs in the central nervous system
As mentioned on Section 3.1.3, in humans, acute effects of intoxication comprise sweating,
vomiting, diarrhoea, severe abdominal pain, drowsiness, apathy, confusion, weakness, vision
disturbances, fever, rapid and weak pulse, low blood pressure and bronchospasm in cases of milder
intoxications, as well as paralysis, respiratory insufficiency, cardiac failure, coma and death in severe
cases (see Section 3.1.3.1). As only cholinergic neurons mediate both pre- and postganglionic activities
of the parasympathic nervous system, and in addition, part of the preganglionic activities in the
sympathic nervous system, it appears likely that anticholinolitic activities of GAs in this part of the
nervous system result in the effects observed following human intoxication. Similar symptoms have
been described for non-competitive organophosphorus inhibitors (Pereira et al., 2014). These effects
may mechanistically explain the severe symptoms described for GA intoxication.
Since the 70s experimental evidence was gained that GAs may inhibit ChE also in the central
nervous system. In rats, treated i.p. with 0, 10, 30, 60, 90 mg/kg bw per day of a-chaconine, brain
AChE activity dose dependently decreased at 10, 30 and 60 mg/kg bw to 79%, 55% and 18%,
respectively (Alozie et al., 1978). These effects could not be related to the availability of ACh, as in
Sprague Dawley rats receiving i.p. 3, 8 or 20 mg/kg bw of a-chaconine either three or 12 h prior to
sacrifice, brain levels of ACh remained unchanged (Aldous et al., 1980). In addition to neurotransmitter
levels in the brain, the authors assessed neuro- and electrophysiological parameters related to both
brain function. After i.p. injection of 10, 20 and 30 mg a-chaconine/kg bw, both in the parietal and
occipital EEGs, the slow wave activity was affected at 20 mg/kg bw per day. The disappearance of the
6 Hertz peak in parietal records and the dose-dependent disappearance of 6 Hertz peak in occipital
records occurred at/started at 10 mg/kg bw per day (Aldous et al., 1980).
Baker et al. (1988) reported on effects on brain AChE activity in Syrian hamsters gavaged with
increasing amounts of lyophilised sprout material. At 300 mg/kg bw of the material, a statistically
significant increase in brain AChE activity was observed, followed by significantly decreased activity at
400 and 500 mg/kg bw. This decrease was not as pronounced as the decrease seen for the
organophosphate diethyl-tri-chloro-phosphorothioate (Dursban 2E), which was investigated against
control in a parallel experiment and acts through a non-competitive mechanism.
Inhibition of cholinesterases in cardiac and neuromuscular transmission
The effect of a-solanine on the electrocardiogram (ECG) and respiration was also investigated in
rabbits (Nishie et al., 1971). Below a dose of 15 mg/kg i.p., no effect was detectable. Tachycardia was
observed both at low (10 mg/kg bw per day) and at very high doses (40 mg/kg bw per day).
Intermediate doses (20 and 30 mg/kg bw per day) lead to bradycardia. Symptoms which became
apparent at low doses were sedation, respiratory impairment and constriction of the abdominal
muscles which became apparent at both 8 and 10 mg/kg bw per day. In conclusion, GAs may
influence heart function at high systemic levels.
McGehee et al. (2000) investigated whether GAs would impact on mivacurium-induced
neuromuscular blockage. Female and male New Zealand white rabbits received an i.v. administration of
mivacurium (27 nmol/kg in 30 s), followed by an i.v. administration of 12 lmol/kg of a-solanine or a-
chaconine for 20–60 min. A decrease in plasma BuChE, responsible for the detoxification, e.g. of
cocaine, in response to infusion of the GAs resulted in elevated mivacurium levels and consequently for
a prolonged time for recovery from mivacurium-induced neuromuscular blockage. The effect of a-
chaconine was thereby more pronounced than the effect of a-solanine.
3.1.5.2.4. Developmental and reproductive effects of GAs and their aglycones
Teratology occurred at relatively high doses of both GAs and their aglycones, and the teratogenic
phenotypes observed included exencephaly, encephalocele, cebocephaly, cleft palate and anophthalmia
(see Section 3.1.2.3). Experimental evidence suggests that these phenotypes in the central nervous
system are presumably not, or not exclusively, caused by inhibition of the catalytic function of AChE.
First, the AChE knock-out mouse does not show a phenotype in the central nervous system. High
sensitivity against BuChE inhibitors indicates that this enzyme may be able to compensate for the
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missing AChE (Xie et al., 2000). Comparative immunohistochemical examination between brain tissues
of knock-out and wild-type animals not even revealed differences at the microscopic level in neuronal,
dendritic, astrocytic, synaptic, microglial and endothelial tissue compartments (Rice et al., 2007). AChE
knock-out mice died around PND14 from their inability to obtain sufficient nutrients. This phenotype
could be rescued by a special diet and enabled examination of older knock-out animals. The
phenotypes detected comprised body tremors, abnormal gait and posture, absent grip strength,
inability to eat solid food, pinpoint pupils, decreased pain response, vocalisation and early death
caused by seizures or gastrointestinal tract ileus (Duysen et al., 2002), with body tremors resembling
the human situation. Second, the teratologic phenotypes were caused by both the GAs and their
aglycones, the latter being much weaker inhibitors of ChE catalytic activity than the GAs or do not
inhibit at all (see Appendix C). However, the papers dealing with the phenotype of the AChE / mice
point to the hypothesis that BuChE may substitute for AChE protect from excess acetylcholine
(Mesulam et al., 2002). As GAs inhibit both enzymes, still the possibility remains that inhibition of ChEs
is involved in causing the teratology, neurodevelopmental phenotypes.
There is increasing notion that ChE shows also non-cholinolytic enzymatic side activities like
acylamidase activity (Vogel-H€opker et al., 2012; Layer et al., 2013). Furthermore, the number of
descriptions of non-enzymatic roles of ChEs has increased over the years, including non-catalytic
activities of the enzymes involved in processes of neuronal and non-neuronal developmental (Vogel-
H€opker et al., 2012). Developmental neuronal functions comprise among others, involvement of
proliferative control of neuronal cells, their migration, neurite outgrowth and synaptogenesis, as well
as cell adhesion. Non-neuronal developmental functions concern association with the development of
the immune system, haemopoietic stress responses, as well as of limb and bone development (Vogel-
H€opker et al., 2012; Lionetto et al., 2013). It remains to be studied whether GA and their aglycones
interfere with any of these non-catalytic functions of ChE and whether such effect could have impact
on the neuronal development of the unborns.
Reduced postnatal survival of pups occurred at the relative low doses of 3.6 and 4.8 mg/kg bw per
day, producing a decrease in the percentage of weaned pups, due to early death of the pups. This
was presumably due to starvation as no milk was found in the stomach of these animals. Most
clinically used AChE inhibitors represent competitive AChE inhibitors. They are believed to be
compatible with human breast feeding, except for the use of neostigmine or combinations of
neostigmine and atropine (Tsiaoussis et al., 2018). However, the use of AChE inhibitors is intended to
increase the levels of Ach, and this increase in ACh may have an impact on lactation at three different
levels. First, in animals, the systemic or central administration of ACh or AChE inhibitors leads a
decrease in the prolactin release from the anterior pituitary gland (Grandison et al., 1974), which may
be mediated through an increased oxytocin release from the neurohypophysis. This lowering of
prolactin may affect the growth and lactation within the mammary gland. Second, the sustained reflex
release of oxytocin during suckling leads to an increase in intramammary pressure through muscarinic
and nicotinergic AChE receptor mechanisms (Clarke et al., 1978). And third, by the decreased prolactin
release, the transcription of casein mRNA is decreased or eliminated, leading to a decreased synthesis
of a-lactalbumin.
Negative (or dysfunctional) effects of solasodine on fertility were accompanied by morphological
alterations in the testes, the epididymis and by reduced sperm quantity and particularly quality in dogs
and monkeys. The mechanisms causing these effects are largely unknown. Inhibition of ChEs as cause
of this male reproductive phenotype can presumably be ruled out, because solasodine is a poor
inhibitor of ChEs. Similar findings to those reported in the studies with Rhesus monkey and with orally
treated dogs as described above (Dixit et al., 1989) were observed in dogs following i.p. injection of
20 mg/kg bw per day solasodine (Dixit and Gupta, 1982). In both dog studies, the authors interpreted
their findings as anitiandrogenic based on the reduced sialic acid content, an androgenic response
marker. This interpretation is plausible as in both studies the number of androgen-producing Leydig
cells is decreased. On the other hand, i.p. or oral treatment of animals with solasodine and
testosterone propionate did not restore the testicular and epididymal phenotypes, pointing to the fact
that hormonal effects may be involved in the disruption of male reproductive organ function by
solasodine, but hormonal effects alone may not be sufficient to explain the observed effects entirely.
Further, an effect of GAs on male reproductive organs may be compound specific. An i.p. treatment of
mice with 2.5 mg/kg bw of a-solanine every third day for 10 times did not result in a reduced testis
weight, but decreased mRNA levels of cyclin D1 and of Inhibin A and B in the testis, which is in line
with the hypothesis that hormonal effects contribute to the observed effects (Park et al., 2009). Finally,
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i.p. injection of 50 mg/kg bw per day of a-solamargine showed no effect on the weight of the testes
and epididymis or the number of spermatozoa in male Wistar rats (Al Chami et al., 2003).
In summary, a-solanine in rats impacts on the availability of milk to the pups. Regarding the
mechanisms underlying the effects of solasodine with the structure and function of male reproductive
organs, little is known.
3.1.5.2.5. Inhibition of cholinesterases and effects in the immune system
Plant extracts of the peeled tuber of S. tuberosum as well as GA and aglycones exerted
pronounced anti-inflammatory effects in in vitro and in vivo experiments (as outlined in
Section 3.1.2.4). With regard to the putative mode of action of these anti-inflammatory effects, it
should be noted that a tight cross-talk between the immune system and the cholinergic
neurotransmitter system has been demonstrated, the so-called ‘anti-inflammatory non-neuronal
cholinergic pathway’. In particular, stimulation of a specific acetylcholine-receptor (a7 nAChR)
suppresses the release of pro-inflammatory mediators from macrophages. The stimulation of a7
nAChR may be due to non-neuronal ACh, which is secreted by many cell types, such as macrophages,
lymphocytes or dendritic cells. These cells also express AChE and BuChE to regulate the levels of ACh.
There are reports that an increased BuChE activity may suppress the cholinergic anti-inflammatory
responses and amplify systemic inflammation, a pathogenetic mechanism discussed for multiple
sclerosis and other diseases (Pohanska, 2014; Reale et al., 2018). It may be speculated that the GA-
induced lowered BuChE activity may result in an anti-inflammatory outcome. The mode of action
underlying the anti-inflammatory effect of the aglycones, with weak impact on BuChE activity, remains
to be clarified.
3.1.5.3. Interference with metabolism
Elkahoui et al. (2018) tested whether dietary supplementation with potato peel powder would
impact on body weight gain in mice on high fat diet containing 25% of lard. The powder was prepared
from four different potato cultivars with well-defined amounts of a-solanine and a-chaconine. The
isocaloric and isonitrogenous peel-containing diets dose dependently reduced both weight gain and
epididymal adipose tissue in male C57B1/6J mice, although the food consumption remained unaltered.
Similar observations were reported for a-solanine (Gull, 1960) or a-chaconine (Friedman et al., 1996;
Langkilde et al., 2008). The reasons for the lowered gain in body weights in GA-treated rodents are
presently unclear.
Recently, it was discovered that BuChE acts also as an esterase of ghrelin (Brimijoin et al., 2016,
2018). Ghrelin is an orexigenic hormone, produced by the pancreas and mucosa of the stomach and
stimulating the appetite via inducing the secretion of neuropeptide Y in the hypothalamus.
Immediately after food intake, ghrelin is degraded into smaller peptide fragments, involving the activity
of BuChE. Ghrelin plays a role also in the regulation of glucose homeostasis through the modulation of
insulin secretion and insulin sensitivity (Heppner et al., 2011). It is presently unclear whether BuChE
inhibition by GAs may affect food intake, body weight and the metabolism via altered ghrelin levels
and/or impact on insulin sensitivity.
There is experimental evidence that dietary a-tomatine forms a non-absorbable complex with
cholesterol and other sterols in the gut (see Sections 3.1.2.2 and 3.1.2.9). It appears likely that the
underlying mechanisms are similar to those described in Section 3.1.5.1. The insoluble complexes in
the intestinal lumen are excreted via feces. Accordingly, an a-tomatine-containing diet elevated the
fecal elimination of cholesterol and sterols in rats and hamsters (Friedman et al., 2000a). While a-
tomatine did not affect bile acid secretion in the rats, in hamsters there were significant increases in
fecal deoxycholic and lithocholic acid content after treatment with green and/or red tomatoes
(Friedman et al., 2000b). This supports that a-tomatine interferes with enterohepatic recirculation of
sterols.
In rats, the increased fecal efflux and the concomitant decreased uptake of dietary cholesterol by
the liver was counteracted by an increased de novo synthesis of hepatic and intestinal cholesterol
(Cayen, 1971). Nevertheless, plasma HDL-cholesterol and triglycerides were reduced when rats
received a-tomatine via diet for a period of 14 days. a-Tomatine also lowered plasma levels of LDL-
cholesterol and triglycerides in hamsters, while HDL cholesterol remained unchanged (Friedman et al.,
2000a,b).
To conclude, a-tomatine reduces enteral absorption of cholesterol and serum cholesterol levels in
rodents. However, it remains to be studied whether similar effects of a-tomatine or other GAs are to
be expected in humans.
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3.1.6. Considerations of critical effects and dose–response analysis for the
human risk assessment
3.1.6.1. GAs from edible parts of S. tuberosum
3.1.6.1.1. Considerations of critical effects and dose-response analysis
Acute toxicity
In humans, the limited human data available from kinetic studies in volunteers (2–3 per treatment)
showed that potato TGA (50% a-solanine; 50% a-chaconine) administered as a solution at 0.30,
0.50 or 0.70 mg/kg bw p.o. did not elicit symptoms. Gastric discomfort and nausea may occur within
~ 30 min after ingestion of ~1 mg potato TGA/kg bw contained in a potato meal (see Section 3.1.3.1,
in particular Table 20). Subsequently, the volunteers developed diarrhoea and started to vomit. A
number of reports on outbreaks and cases of intoxications substantiate that acute toxic effects may
occur in adults from a total potato GAs intake of 1 mg/kg bw or more. In severe cases of intoxications
hallucinations, paralysis, respiratory insufficiency and cardiac failure have been reported. Doses in the
range of 3–6 mg potato TGAs/kg bw are considered to be potentially lethal for humans. Results from
limited volunteer studies suggest differences in the human population with respect to the individual
susceptibility towards adverse effects associated with the intake of potato GAs.
In experimental animals, no lethality was observed in mice at a single dose of 1,000 mg a-solanine/
kg bw p.o., and no effects at 500 mg of solanidine/kg bw p.o. In rats, no adverse effects were
reported for a single oral application of 250 mg/kg bw of a-solanine. Diarrhoea occurred after
application of a-solanine/a-chaconine mixtures at 300 mg/kg bw and above (see Section 3.1.2.1). This
indicates acute toxicity of GAs at doses above 250 mg/kg bw in rats and mice with diarrhoea being the
most frequent symptom.
The acute symptoms, described in humans and experimental animals, may be due to the ability of
a-solanine and a-chaconine to complex with membrane sterols, thereby causing disruption and loss of
integrity of cell membranes. Deletion of one or more mono-saccharides from the GAs resulted in
reduced activity. After oral exposure of potato GAs, these effects may lead to local irritation of the
mucosa of the gastrointestinal tract leading to gastric discomfort, vomiting and diarrhoea. The adverse
effects may also be due to the inhibitory effect of a-solanine and a-chaconine on the activity of AChE.
The aglycone solanidine exerted almost no inhibitory effects, suggesting that the sugar side chain is
obligatory for inhibiting the AChE activity. As a consequence of the impaired termination of the
cholinergic transmission at the neuronal and neuromuscular junctions, intoxications with a-solanine
and a-chaconine might lead to the development also of a cholinergic toxidrome (see Section 3.1.5),
with diarrhoea and vomiting being predominant. Further symptoms described in case reports and
outbreaks may have developed secondary to dehydration following vomiting and diarrhoea, such as
low blood pressure, dizziness, cardio-respiratory insufficiency or coma. However, some prototypical
symptoms of a cholinergic toxidrome that may not develop secondary to dehydration, such as miosis
and fasciculations of the skeletal musculature, have not been reported so far.
In mice, the aglycone solanidine exerted no effect at 500 mg (1.26 mM)/kg bw i.p., contrasting to
the pronounced toxicity of GAs after the identical route of exposure, i.e. LD50 of a-solanine was 42 mg
(48.3 lM)/kg bw, and of a-chaconine was 32.3 mg (37.9 lM)/kg bw. The relative potency of toxicity of
a-solanine and a-chaconine appear to be similar also in rats and rabbits, e.g. in rats LD50 for a-
solanine and a-chaconine were reported to be 67 mg (77.2 lM)/kg bw and 84 mg (98.6 lM)/kg bw,
respectively. These findings are substantiated by (i) a similar potency of a-solanine and a-chaconine to
interact with sterols and disintegrate cellular membranes and act as inhibitors of AChE activity and (ii)
the weak effects of the aglycone with regard to membrane disruption and AchE inhibition. Based on
these experimental findings, the CONTAM Panel considered that (i) the aglycone solanidine is of lower
acute toxicity than the respective GAs and that (ii) there is the potential for additivity of a-solanine and
a-chaconine, recognising that they share common modes of action and exert similar adverse effects.
Therefore, the CONTAM Panel performed the risk assessment on the basis of the total content of GAs
(TGA) in potatoes comprising a-solanine and a-chaconine, assuming equal potency.
When comparing experimental rat and human data on acute oral toxicity of potato TGAs, it may be
deduced that:
i) in humans, gastric discomfort and nausea occurred rapidly after ingestion of ~ 1 mg/kg bw,
followed by vomiting and diarrhoea. Studies in volunteers give some indication on differing
individual susceptibilities towards adverse effects of GAs,
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ii) gastric discomfort and vomiting are symptoms not covered by bioassays in rats. In this
species, the most frequent symptom is diarrhoea occurring at a single oral potato TGA
application of 300 mg/kg bw,
iii) based on the likelihood to develop diarrhoea after ingestion of potato TGA, humans show an
approximately 300-fold higher susceptibility than rats.
The reasons for these marked species differences are presently unclear. It may relate to anatomical,
histological and/or functional features of the gastrointestinal tract differing considerably between
humans and rodents, e.g. the unique murine non-glandular forestomach, an intragastric pH around 3–4
in rodents and around 1 in humans, and a relatively long small and large intestine and a large caecum in
rats and mice. These factors may affect the local concentration of the GA in the gastrointestinal tract
and the vulnerability of the mucosa (Hugenholtz and de Vos, 2018). The differences in susceptibility may
also be due to a relatively high oral bioavailability and low clearance rates of potato TGA in humans
when compared to rodents. Furthermore, it is not well documented whether there are differences in the
sensitivity of human and rat AChE towards the inhibitory effects of GAs.
Due to these uncertainties, the CONTAM Panel considered that the use of rodent data on acute
toxicity was not appropriate to establish a reference point for acute exposure in humans.
Based on human data on case reports, outbreaks and studies in volunteers (see Section 3.1.3.1, in
particular Table 20), the CONTAM Panel selected the LOAEL of 1 mg potato TGA/kg bw per day as the
reference point for evaluating the risk following acute oral exposure.
Repeated dose toxicity
In humans, no evidence of health problems associated with repeated or long-term intake of GAs via
potatoes has been identified. Thus, the CONTAM Panel was not able to identify critical chronic effects
in humans.
In experimental animals, toxicological studies have been carried out in rodents and monkeys using
different experimental designs with administration of different doses and with durations of up to 90
days. However, no long-term chronic toxicity or carcinogenicity study for GAs or their aglycones could
be identified.
The purity of the GA preparations tested varied considerably. Furthermore, a number of studies
were performed according to non-standard experimental protocols and do not provide results that are
suitable for risk assessment purposes.
In repeated oral dose toxicity studies, the main effects for a-solanine and a-chaconine were
reduced body weight gain (accompanied by unaltered or, as reported occasionally, reduced feed
intake) and decreased absolute and relative liver weight. Solanidine lowered also food intake and body
weight gain but elevated relative and absolute liver weights.
In hamsters, mortality was reported after oral administration of 100 mg/kg bw per day of a-
solanine or a-chaconine given for 5 days. In rats, an oral dose of 90 mg a-solanine/kg bw per day
applied over 5 weeks did not cause any effect. Mice exhibited reduced body and absolute liver weights
at 416.6 mg a-solanine/kg bw per day, and reduced body and absolute and relative liver weights at
409 mg a-chaconine/kg bw per day, applied over 7 days. These findings indicate that hamsters may
be more sensitive towards the adverse effects of a-solanine and a-chaconine than mice and rats. This
is substantiated by a marked species difference in the toxicokinetics of the GAs, with hamsters
showing higher oral bioavailability and lower clearance rates of GAs than rats (see Section 3.1.1.1).
Relative potency of oral toxicity of a-solanine and a-chaconine can be partly deduced from two
independent studies with durations of up to 7 days. Identical doses of these two GAs elicited
comparable effects (i.e. reducing the body weight) at a similar frequency in the two species tested
(mouse and hamster). These findings are supported by a similar potency of a-solanine and a-
chaconine with regard to acute toxicity. Oral administration of solanidine did not lower but increased
the absolute and relative murine liver weight, which is some indication that the adverse effects in
repeated dose studies may differ between the GA and the respective aglycones.
A NOEL for potato TGA of 33.3 mg/kg bw per day was identified by Langkilde et al. (2012). This
study was performed in hamsters over a period of 90 days, the longest duration of all studies
identified. The animals were treated via diet, thus accounting for dietary matrix effects and simulating
GA uptake via food. However, the CONTAM Panel noted several limitations of the study: the animals
were dosed with freeze-dried powder of two different potato cultivars, partly spiked with commercial
standards of a-solanine and a-chaconine to obtain different ratios between a-solanine and a-chaconine
from 1:3.1 to 1:70. To obtain these highly variable ratios, different proportions of potato powder of the
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two cultivars were admixed to the chow, creating considerable nutritional imbalances between the
treatment and the control groups (for details, see Section 3.1.2.2.1). In addition, the authors did not
state whether the potato powder contained trypsin inhibitor activity or not. All other studies identified
were either not on hamster, of short duration and/or applied GAs via bolus not mimicking intake of
GAs via the diet.
For the aglycone solanidine, there are only two toxicity studies in female mice over a period of 28
days. It is considered that the sugar moieties of the ingested a-solanine and a-chaconine are cleaved
off during metabolism and that any toxicity testing of the two GAs will cover the adverse effects of
solanidine. Therefore, the CONTAM Panel considered it was not appropriate to identify an additional
reference point for a human risk assessment of solanidine.
To conclude, the data available for repeated dose toxicity are not sufficient to identify a reference
point for chronic exposure to potato GAs.
Genotoxicity
Several assays were performed to test for mutagenicity and clastogenicity of potato GAs, the
aglycone solanidine, as well as extracts of S. tuberosum. No genotoxicity was observed in the available
tests. However, some tests provided limited information (see Section 3.1.2.7, Table 18). Overall, the
CONTAM Panel concluded that there is no evidence of genotoxicity for the potato GAs a-solanine and
a-chaconine, and for the aglycone solanidine, and that there is not sufficient information to conclude
on the genotoxic potential of these GAs.
Developmental toxicity
Developmental toxicity studies in experimental animals are limited in number and quality and show
effects of potato GAs at high oral doses. In hamsters, severe malformations, affecting mainly the
central nervous system, occurred in offspring when dams received 200 mg a-solanine/kg bw or 165
mg a-chaconine/kg bw per day on GD7.5/8. The teratogenic phenotypes comprised exencephaly,
encephalocele, cebocephaly, cleft palate and anophthalmia. Interestingly, the aglycones solanidine and
demissidine caused also malformations in the central nervous system in hamsters. Exencephaly,
encephalocele and/or anophthalmia occurred in offspring at maternal doses of 176 mg demissidine/kg
bw or 115 mg solanidine/kg bw applied orally on GD8 (see Section 3.1.2.3).
There are no dose-response studies, no indications that species other than hamster may be
affected, and no mechanistic explanations for the malformations described above.
Several epidemiological studies failed to provide evidence that the intake of potato GAs may be an
aetiological factor in the pathogenesis of NTD. Two studies indicated a possible association between
maternal consumption of sprouted potatoes during the periconceptional phase and an elevated risk for
NTDs or orofacial clefts. However, incomplete reporting impairs any conclusion on causal relationship
of GA exposure and developmental effects from these studies.
3.1.6.1.2. Derivation of a health-based guidance value (HBGV) or margin of exposure (MOE) approach
Based on the available information, the CONTAM Panel considered the LOAEL of 1 mg potato TGA/kg
bw per day based on human data from case reports, outbreaks and studies in volunteers (see
Section 3.1.3.1, in particular Table 20), as the reference point for evaluating the risk following acute oral
exposure.
The available data on acute toxicity were considered insufficient to establish an HBGV, and instead
the Panel used the margin of exposure (MOE) approach to assess a possible health concern from acute
exposure to potato TGAs via food.
An MOE higher than 10 indicates that there is no health concern. This MOE of 10 takes into
account the interindividual variability in toxicodynamics (a factor of 3.2), and extrapolation from a
LOAEL to a NOAEL (a factor of 3). As outlined in Section 3.1.6.1.1, the CONTAM Panel considered that
the critical effects of acute exposure to potato TGAs may be mainly due to the local effects in the
gastrointestinal tract, following probably local irritation rather than inhibition of AChE activity. Thus, the
possible interindividual variability in toxicodynamics is more relevant for the evaluation of the MOE
than the interindividual variability in toxicokinetics.
No reference point could be identified to characterise the risk following chronic exposure.
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3.1.6.2. GAs from edible parts of food plants other than S. tuberosum
3.1.6.2.1. Considerations of critical effects and dose-response analysis
With respect to GAs from food plants other than S. tuberosum, reports of intoxications or
outbreaks, on the effects of acute or chronic ingestion of tomato- or aubergine-derived GAs or
aglycones or relevant epidemiological studies are missing.
In experimental animals, acute and repeated dose toxicity studies on relatively high doses of
tomato GAs showed mainly reduced absorption of cholesterol and bile acids from the gastrointestinal
tract and lowered blood lipid levels.
With regard to the mode of action, tomato and aubergine GAs interfere with sterols in cell
membranes and/or the lumen of the gastrointestinal tract, which may impair the resorption and
enterohepatic recirculation of cholesterol and bile acids. The inhibitory effect on ChE activity is much
weaker for tomato and aubergine GAs than for potato GAs.
Experimental developmental toxicity studies indicate that in hamster severe malformation (mainly of
the central nervous system) occurred in offspring, when dams received doses of 1,400 mg of
solasodine or dihydrosolasodine per kg bw per day on GD8. However, dose-response studies, studies
in other experimental species, studies covering not only one or few days of the gestation period and
mechanistic studies are missing.
Adverse effects on male fertility (decreased epididymal weight and cauda epididymal epithelial
height, lack of sperm in epididymal lumen) occurred when dogs or rhesus monkeys received the
aglycone solasodine orally at 80 or 100 mg/kg bw per day, respectively.
From the limited number of studies available, there was no evidence for genotoxicity of the
aubergine GA, a-solamargine. However, there is not sufficient information to conclude on the genotoxic
potential of this GA.
No data for determining a reference point for GAs or aglycones occurring in edible parts of food
plants other than S. tuberosum are available.
3.1.7. Consideration of critical effects and dose-response analysis for the farm
animal, horses and companion animals risk assessment
The CONTAM Panel reviewed the available studies in order to identify a NOAEL or LOAEL for farm
animals, horses and companion animals.
No studies were identified in horses, companion animals (cats and dogs) or fur animals.
The few studies identified on the adverse effects of GAs in ruminants, pigs, poultry and fish could
not be used for the identification of a reference point.
For rabbits, no studies have been located other than those described under acute toxicity (i.p or
i.v.) and repeated dose toxicity (see Sections 3.1.2.1 and 3.1.2.2). No reference point could be
identified.
3.2. Occurrence data
3.2.1. Occurrence data submitted to EFSA
Occurrence data on food
An initial number of 1,300 results for 651 food samples analysed on GA from three European
countries were available for the assessment. The number of results and samples submitted for each
food category are provided in Table A.2 of Annex A. The major contributor of data on GA in terms of
number of results was Germany (73% of the results) while the Netherlands and Sweden contributed
with 21% and 6%, respectively. Data were reported on samples collected between the years 2005 and
2017. Only data on GAs in potato or potato products were reported. No data on GAs present in tomato
or aubergine or products were reported.
Free text information was analysed to better specify the food category to which the sample was
referring. The number of samples and results available for each food category is shown in Table 27.
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All samples were analysed for both a-solanine and a-chaconine besides two samples that were
analysed only for a-solanine and were excluded from the final cleaned data set as the total GA content
(sum of a-solanine and a-chaconine) was used for the exposure assessment.
A total of 86 samples were available for potatoes categorised as ‘New potatoes’, while 535 samples
were categorised as ‘Main-crop potatoes’, with occurrence data to be similar. However, the CONTAM
Panel considered the distinction between ‘New potatoes’ and ‘Main-crop potatoes’ to be imprecise and
decided to combine the occurrence data from both categories. In the following text, samples from
these two categories will be referred to as samples from main-crop potatoes
A total of 29 samples referred to potato products including only few food categories plus a generic
‘Potatoes and potatoes product’, thus not covering the variety of composite food categories containing
potatoes in the Consumption Database. Based on this, the CONTAM Panel decided that the best
approach for the exposure assessment would be to use the occurrence values in the RPC, main-crop
potatoes (combined with the new potatoes as described above) and the RPC Consumption Database
(see Section 2.3.1).
Two samples were removed because they were reported as sampled based on ‘Suspect sampling’.
In addition, seven main-crop potato samples were excluded as they were reported as ‘processed’,
thus not relevant for the calculation of the occurrence in the raw primary commodity.
Information about the potato cultivar was available for 210 samples and only few samples were
available for each cultivar. Information on the cultivar is also not reported in the Consumption
Database, thus the CONTAM Panel considered any analysis based on possible difference among
cultivars not feasible. One sample referring to starch potato cultivar was excluded.
Information about the growing method (available for only 86 samples) was not taken into account
in the analysis for the same reasons.
No information was available on the length of storage between harvest and the date of sampling to
allow a comparison of the occurrence data based on the storage length.
Specific information about the peeling was available for 33 samples. Of these, only seven were
reported as ‘peeled’ potatoes. However, most of the samples were reported explicitly as ‘unprocessed’.
The CONTAM Panel assumed samples for which no information about the peeling nor the processing
was available (131 samples), to be unpeeled and they were included in the final data set. The seven
samples of peeled potatoes were excluded. An overview of the excluded samples by each exclusion
criteria is given in Table A.3 of Annex A.
The occurrence data of total GAs (sum of a-chaconine and a-solanine) in unpeeled main-crop
potatoes were used for the exposure assessment. The final data set contained 604 samples referring
to unpeeled potatoes and individual occurrence values are available in Annex A.4. A summary of the
available samples by country and year is provided in Table 28. Summary statistics of the occurrence
UB values for main-crop potatoes (merged with new-potatoes) in the final data set used in the
assessment and for the other food categories for which data were available are provided in Table 29.
Table 27: Number of samples and results analysed for the glycoalkaloids (GAs) content, submitted
to EFSA through the continuous call for annual collection of chemical contaminant
occurrence data in food
Foodex category Results Samples
Potatoes and potatoes products 14 7
New potatoes 171 86
Main-crop potatoes 1,069 535
Starch potato 2 1
Potato flakes 2 1
Mashed potato powder 16 8
Ready-to-eat meal for infants and young children 6 3
Ready-to-eat meal for children, vegetable-based 4 2
Ready-to-eat meal for children, cereal-based 2 1
Ready-to-eat meal for children, meat/fish-based 14 7
Total 1,300 651
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The mean UB occurrence in the RPC main-crop potatoes was 51.2 mg/kg with a P95 of 116.8 mg/kg.
The minimum and maximum reported concentrations were 1.1 mg/kg and 276.6 mg/kg, respectively.
As described in Section 2.5, processing factors for peeling and heat processing were applied to
these occurrence data.
Distribution of a-solanine and a-chaconine in the food samples
The samples in the final data set were analysed for the distribution between a-solanine and a-
chaconine, using the UB results. In Figure 4, the results are expressed as ratio a-chaconine to a-
solanine, while in Figure 5, the results are expressed as the contribution of a-chaconine to the total GA
content (sum of a-solanine and a-chaconine) in the potato samples. From Figures 4 and 5, it is evident
that there is a wide range reported for the ratio of a-chaconine to a-solanine. The ratio reported
ranges from 0.02 to 7.4, equivalent to a relative contribution of a-chaconine to the TGA ranging from
1.5% to 88.1%. The average ratio of a-chaconine to a-solanine is 1.39 and the median is 1.28. The
average contribution of a-chaconine to the total is 51.5% and the median contribution is 56.1%,
showing a slight overall preference for a-chaconine in the samples. In 52.6% of the samples, a-
chaconine contributes between 50% and 70% to the TGA. The average ratio between a-solanine and
a-chaconine was found to differ between data submissions, which may in part be related to the
different analytical methods used by the laboratories.
It was noted by the CONTAM Panel that in the database, there are 22 samples with a very low a-
chaconine content compared to the a-solanine content (Figure 5) while there are no samples with a
similarly low content of a-solanine. This is related to the fact that in 22 samples, a-chaconine was not
detected above the LOQ of the method, while this was the case for a-solanine in only four samples. In
these cases, the UB value (LOQ) of the method is used. It should be noted that there is some
evidence that a-chaconine is more susceptible to enzymatic degradation (producing b2-chaconine and
solanidine) than a-solanine (Swain et al., 1978; Friedman and McDonald, 1995). Partial degradation of
a-chaconine may occur during sample preparation and analysis unless specific conditions are applied
(Friedman et al., 1997; see also Section 1.3.2.1). For the data sets submitted to EFSA, it could not be
determined to what extent the results for individual samples could be affected by enzymatic hydrolysis.
This would require detailed information on the sample preparation and analytical method used by the
laboratory, and this is not part of the information requested in the SSD format for data submission.
Table 29: Summary statistics of the total potato glycoalkaloid (potato TGA) concentrations (mg/kg,
upper bound) for ‘Main-crop potatoes’ (merged with ‘New potatoes’) in the final data set
used in the assessment and for the other food categories for which data were available
Food category N Mean Min Max P95(a)
Main-crop potatoes (including new potatoes) 604 51.2 1.1 276.6 116.8
Potatoes and potato products 7 214.7 85.0 381.3 –
Potato flakes 1 95.6 – – –
Mashed potato powder 8 73.9 14.0 205.0 –
Ready-to-eat meal for infants and young children 3 0.8 0.1 1.4 –
Ready-to-eat meal for children, vegetable-based 2 3.3 2.0 4.6 –
Ready-to-eat meal for children, cereal-based 1 0.1 – – –
Ready-to-eat meal for children, meat/fish-based 7 1.1 0.1 2.7 –
(a): The 95th percentiles obtained on occurrence data with fewer than 60 analytical results may not be statistically robust
(EFSA, 2011b) and are therefore not reported in the table.
Table 28: Number of samples by country and year of sampling in the final GAs occurrence data set
Country/Year 2005 2007 2015 2016 2017 Total by country
Germany 222 8 8 9 185 432
Netherlands – – 81 52 – 133
Sweden – – 35 – 4 39
Total by year 222 8 124 61 189 604
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Additional occurrence data received
The European Starch Industry Association submitted data to EFSA concerning 1,728 samples
including samples on dietary fibre and potato proteins, pulp, juice and starch and on potatoes used for
starch production (Table 30). Detailed results are available in Annex A.5.
Due to uncertainty on the occurrence data reported (e.g. it was not known if the occurrence data
referred to dry or wet weight and it was not always known if the samples referred to feed or food for
human consumption) and the difficulties expressed by the data provider in retrieving this information,
these data were not included in the exposure assessment. Mean occurrence values for each category
are provided in Annex A. Values should be taken with caution as individual values might have referred
to different concentration expressions (information on the water content of the samples was not














Relave contribuon of α-chaconine to the total GA content
Figure 5: Relative contribution of a-chaconine to the total glycoalkaloid (GA) content in potato














Rao α-chaconine : α-solanine
Figure 4: Ratio of a-chaconine to a-solanine in potato samples present in the EFSA occurrence
database (N = 604)
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3.2.2. Previously reported occurrence data in the open literature
3.2.2.1. Literature on occurrence data on food
3.2.2.1.1. Occurrence data on GAs in potatoes
Occurrence data on GAs in potato samples obtained from field studies
In this section, studies are discussed that focussed on the effect of pre-harvest factors on the GA
content of potatoes, such as the genotype, year-to-year variability, location, altitude, environmental
conditions and farming system under controlled field conditions. In Table 31, an overview of the
studies that have investigated the TGA content of potatoes under field conditions is presented. The
studies cover the effects on the TGA content of cultivars grown on different locations, in different
years and with different production methods (e.g. organic, integrated or conventional). The studies
which investigated the effects of location and environmental conditions are described, while those
studies focussing mainly on the effect of the farming system are discussed under a separate heading.
In addition, data from the registration and authorisation of seed potatoes bred in the Netherlands are
presented, that includes the measurement of TGA levels under field conditions.
Effect of location, environmental conditions and year-to-year variability on the GA content
of potatoes
Sinden and Webb (1972) conducted a large 2-year field trial including five commercial cultivars
grown on 39 locations in the USA and Alaska. Overall, the average TGA content ranged from 43 mg/kg
for cultivar ‘Red Pontiac’ in 1970–100 mg/kg for the cultivar ‘Kennebec’ in 1971. For three cultivars
tested, relatively small variations between years for the average TGA content were found. A significant
correlation between the location and the TGA content was noted, with potatoes from Alaska and North
Dakota containing the highest average TGA content for the five cultivars (150 mg/kg and 143 mg/kg,
respectively), while lowest TGA contents were found in Florida (31 mg/kg) (data for 1970). Important
factors influencing the GA content were the (local) climatic conditions, length of daylight and soil type.
A cold and wet, as well as a hot climate appears correlated with an elevated TGA content, as well as
locations with extended day lengths of 18–20 h. Higher TGA contents can be associated with
immaturity of the tubers, which is in turn related to the climate conditions and extended daytime
length (Sinden and Webb, 1972).
The importance of location and the environmental conditions was also noted in a German study
covering several locations over a span of 5 years (Ross et al., 1978). The variation in TGA content
between locations amounted to 50% and the variation between years (strongly related to the weather
conditions) to 78%. A 3-year study conducted in the UK also showed that although the TGA content is
primarily determined by the genotype (cultivar), location and environment are important co-influencing
factors (Bintcliffe et al., 1982; Parnell et al., 1984). A significant yearly variation was found in a 3-year
study conducted in Hungary with five different cultivars (T€om€osk€ozi-Farkas et al., 2006). This was also
concluded from a 2-year study on six early potato cultivars in Sweden, as the TGA content for the six
cultivars in 1986 was 30–130% higher compared to 1987 (Hellen€as et al., 1995a). Papathanasiou et al.
(1999) noted a significant difference in the amount of yearly variation in TGA content for two cultivars
(‘Pentland Dell’ and ‘Estima’) studied. The cultivar ‘Pentland Dell’, which has intrinsically a higher TGA
Table 30: Number of samples submitted by the European Starch Industry Association by product
type and country of sampling for which total glycoalkaloid (GA) occurrence was available
Product/Country DK FI FR DE NL SE Total
Dietary fibre 6 – – 40 – 7 53
Isolated proteins and other protein products – – – – 505 – 505
Potato juice, concentrated (feed) – – – – 27 – 27
Potato protein (feed) 25 1 45 55 415 28 569
Potato pulp (feed) – – 9 – – – 9
Potato starch – 1 10 49 41 – 101
Potatoes (for starch production) – – – – 450 – 450
Total 31 2 64 144 1,438 35 1,714
DK: Denmark; FI: Finland; FR: France: DE: Germany; NL: the Netherlands; SE: Sweden.
Note: Fourteen samples reporting on only one GA were excluded from the table.
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content, was much more sensitive to differences in environmental conditions than the cultivar ‘Estima’,
which has a low TGA content. The effect of location on 14 cultivars of different flesh-colours (white/
yellow, red or blue) was investigated during a 3-year period by Hamouz et al. (2014). With respect to
TGA content, genotype was the most important factor, followed by the year-to-year variation, while
location was the least important. In a follow-up study, the effect of altitude, climatological conditions
and soil type using 16 cultivars on two locations (298–460 m) were studied over a 3-year period
(Urban et al., 2018). The authors concluded that differences found in TGA content were mainly
correlated to the genotype, followed by differences in environmental conditions and the soil type. Ieri
et al. (2011) studied the TGA content of nine purple or red skinned cultivars, grown on two locations
in Italy. The average TGA content was slightly higher in the tubers grown in central Italy (100 mg/kg)
compared to the tubers grown at higher altitude (1,000 m) in the south (91 mg/kg). It was noted that
the difference was mainly related to the TGA content in the flesh of the tubers, which averaged to 8.6
mg/kg in south Italy and 28.3 mg/kg in central Italy. Panovska et al. (1997) studied the effect of
altitude (110 m, 460 m, 860 m) on the TGA content of 11 cultivars, but no significant effects were
noted.
Several studies reported besides the TGA content, also the concentration of a-chaconine and a-
solanine. From these data, the ratio of a-chaconine to a-solanine was calculated. The reported ratio of
a-chaconine to a-solanine ranges from 0.30 to 5.93. From the data it follows that, generally, a-
chaconine is present in higher concentrations than a-solanine. There is, however, a substantial
variation in the ratio between a-chaconine and a-solanine, not only for individual samples within a
study but also between studies.
In the Netherlands, the Nederlandse Algemene Keuringsdienst (NAK) (Dutch General Inspection
Service) is responsible for the registration and authorisation of seed potatoes. New cultivars are grown
for at least 2 years at two locations under controlled conditions together with the reference potato
cultivar Innovator, which has an average TGA content of 152 mg/kg. To be allowed to the market, the
TGA content of the new cultivars must be lower than the TGA content of the Innovator cultivar. TGA
content is determined according to the HPLC-UV method as described by Houben and Brunt (1994).
The NAK list of registered potato cultivars in 201822 contained 552 entries, and for 464 cultivars,
the TGA content is listed. Before 2000, it was not mandatory to establish the TGA content and in
particularly for older cultivars, this information has not been recorded. The TGA distribution in the
cultivars is shown in Figure 6, where it can be seen that the large majority of potatoes grown under
the Dutch test conditions have a TGA content of < 100 mg/kg. The average content of the registered
cultivars is 48.4 mg/kg.
The NAK list22 includes also 77 potato cultivars grown specifically for starch production. For 70
cultivars, the TGA content is listed. Starch potatoes23 contain higher amounts of GAs: the average TGA
content is 107.7 mg/kg, while 34 cultivars exceed 100 mg/kg and 7 exceed 200 mg/kg. The cultivar
‘Kuras’ has the highest TGA content (338 mg/kg) and also the cultivars ‘Aventra’ and ‘Elles’ (both 260
mg/kg) are also high in TGA content.
Overall, it can be concluded from the field studies that genotype is the most important factor
determining the TGA content. However, also environmental conditions, location and year-to-year
variability contribute to the differences in TGA content observed during the preharvest stage.
22 https://assets.plantum.nl/p/229377/CGO%20publicatie%202018.pdf
23 Starch potatoes are specifically grown for the production of potato starch. They are not used for human consumption.
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CZ 1993–1994 11 cultivars, 3 locations, 2 years 66 74 31–166 n.r. HPLC-UV Panovska et al. (1997)
1996–1999 8 cultivars, 2 locations, 4 years, 2 systems 82 70 15–245 n.r. HPLC-UV Hajslova et al. (2005)
2006–2008 5 cultivars, 2 locations, 3 years, 2 systems 120 87 49–134 1.26–2.52 LC-MS/MS Bartova et al. (2013)
2009–2011 14 cultivars, 2 locations, 3 years 82 54 19–102 n.r. LC-MS/MS Hamouz et al. (2014)
2012–2014 16 cultivars, 2 locations, 3 years 96 81 34–168 1.18–3.78 LC-MS/MS Urban et al. (2018)
DE 1970–1974 10 cultivars, 5 locations, 5 years 184 29 3–92 n.d. Colourimetric Ross et al. (1978)
HU 2002–2004 10 cultivars, 1–3 years 20 33 1–150 n.r. HPLC-UV T€om€osk€ozi-Farkas et al. (2006)
2007–2009 3 cultivars, 3 years, 2 systems 18 43 < 1–281 n.r. HPLC-UV T€omosk€ozi-Farkas et al. (2014)
IT < 2006 9 cultivars, 1 year(a) 9 32 10–51 2.91–5.93 HPLC-UV Finotti et al. (2006)
< 2010 9 cultivars, 2 locations, 1 year 18 95 50–209 n.r. LC-MS Ieri et al. (2011)
LV 2010–2011 20 cultivars, 1 location, 1 year, 2 systems 40 21 3–104 0.30–4.60 LC-MS Skrabule et al. (2013)
NL 1985–1986 3 cultivars, 2 locations, 3 years 60 81 40–146 n.r. HPLC-UV Van Gelder et al. (1988)
Ongoing All cultivars(b) 464 48 3–152 n.r. HPLC-UV Website NAK
PT 2003 2 cultivars, 1 location, 1 year, 3 systems 6 51 37–80 0.81–1.82 HPLC-UV Abreu et al. (2007)
SE 1986–1987 6 cultivars, 3 locations, 2 years 12 120 51–210 n.r. HPLC-UV Hellen€as et al. (1995a)
2009 21 cultivars, 1 location, 1 year 39 127 46–293 1.09–2.67 HPLC-UV Petterson et al. (2013)
UK 1980–1982 36 cultivars, 7 locations, 3 years(c) 141 71 36–175 n.d. Colourimetric Bintcliffe et al. (1982); Parnell
et al. (1984)
1994–1995 2 cultivars, 1 location, 2 years 4 87 40–163 2.32-3.08 HPLC-UV Papathanasiou et al. (1999)
USA 1970–1971 5 cultivars, 39 locations, 2 years(d) 255 79 14–387 n.d. Colourimetric Sinden and Webb (1972, 1974)
< 2003 8 cultivars, 1 location, 1 year 8 52 7–187 1.4–2.2 HPLC-UV Friedman et al. (2003b)
TGA: total glycoalkaloid; UV: ultraviolet. LC: liquid chromatography; MS: mass spectrometry; MS/MS: tandem MS; n.r.; not reported; n.d.; not determined.
(a): From wholesale.
(b): For details, see Figure 6.
(c): The publication by Bintcliffe et al. (1982) reports the results for 1980–1981.
(d): The variety B5146-6 was excluded.
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Differences in GAs content between organic and conventionally grown potatoes
Several studies evaluated the effect of farming systems (organic versus conventional) on the GAs
content in potato tubers as shown in Table 31 and some further details are given in Table 32.
In the study of Abreu et al. (2007), higher TGA concentrations were found in the conventionally
grown Raja tubers, compared to the organically grown ones, while for the Sante tubers, no clear
difference in TGA content was observed between the farming systems. Skrabule et al. (2013)
evaluated GAs in 20 potato genotypes grown under organic and conventional farming systems in the
years 2010 and 2011. The genotype did significantly influence the GAs content, while the effect of
farming system was not significant, except for the content of a-solanine in the 2011 season. Bartova
et al. (2013) showed the importance of the individual reaction of the genotypes to stress conditions
existing in organic and conventional crop management. Crop management seemed to only influence
the GA content in tubers in interaction with other evaluated agro-ecological factors (cultivar, year and
locality). Although a significantly lower concentration of a-solanine was found in organically grown
tubers, with respect to the TGA content the difference between the two farming systems was not
significant. Hajslova et al. (2005) studied the tuber quality of eight potato cultivars grown in organic
and conventional farming systems. No statistically significant difference was found between the TGA
contents in tubers produced by the two production systems. The observed difference in TGA content
seems to be caused by a substantial variation in the content of GAs between years, geographical area
of cultivation and cultivar. Additionally, T€om€osk€ozi-Farkas et al. (2014) investigated the GA content in
three Hungarian potato species grown in organic and conventional farming systems. The respective
farming system was found to have no effect on the level of GAs, and was mostly influenced by season
and genotype. Diehl and Wedler (1977) studied the effect based on the rate of fertilisers applied. No
difference was found between a-solanine content in potatoes in relation to organic and mineral
fertilisation.
Distribution of GAs between potato peel and flesh
In a number of field studies, the distribution of GAs between the peel and the flesh was studied.
The most comprehensive study is that of Valcarcel et al. (2014) in which the a-solanine and a-
chaconine content of potato skin and flesh of 60 potato cultivars grown in two locations in Ireland over
a 2-year period was investigated. TGA levels varied from 4 to 957 mg/kg dw in the potato flesh and
from 150 to 8,133 mg/kg dw in the potato peels. The ratio of a-chaconine to a-solanine was higher in
the peels (average ratio: 1.44; range 0.7–4.5) than in the flesh (average ratio: 0.87; range 0.3–1.6).
Deußer et al. (2012) conducted a similar study on 17 cultivars grown in Luxembourg. TGA contents
were determined for the peel (1–2 mm thickness), the outer flesh (1 cm) and inner flesh. The peels













Figure 6: Distribution of total glycoalkaloid (TGA) content in 464 potato cultivars registered in the
Netherlands22
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and 7–187 mg TGA/kg dw, respectively. The a-chaconine:a-solanine ratio varied between 1.05 and
3.45 (average: 1.94) in the peel, between 0.83 and 2.36 (average: 1.46) in the outer flesh and
between 1.00 and 2.38 (average: 1.69) in the inner flesh. Friedman et al. (2003a) reported for eight
potato cultivars a range of 84–3,526 mg TGA/kg dw in potato peels, and of 6–592 mg TGA/kg dw in
potato flesh. A study on 12 potato cultivars grown in Mexico reported for potato peels 176–5,497 mg
TGA/kg dw and for flesh < 5–642 mg TGA/kg dw (Sotelo and Serrano, 2000).
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Table 32: Total glycoalkaloids (TGAs) content in potato tubers grown in conventional and organic farming systems
Country Potato cultivars Year of harvest
TGA content conventional
(mg/kg fw)
TGA content organic (mg/kg fw) Analytical
technique
Reference
a-solanine a-chaconine TGA a-solanine a-chaconine TGA
CZ Karin 1995–1997 53–113 59–157 HPLC-UV Hamouz et al.
(2005)
CZ Christa, Karin, Koruna,
Krasa, Krystala, Monalisa,
Rosara, Rosella
1996–1999 15–245 16–157 HPLC-UV Hajslova
et al. (2005)
CZ Bionta, Karin, Marabel,
Rosara, Satina
2006–2008 35.3 55.6 90.9 30.4 53.2 83.6 LC-MS/MS Bartova et al.
(2013)
HU Hopehely, Rioja, White Lady 2007–2009 0.0–15 0.0–28 HLPC-UV T€om€osk€ozi-
Farkas et al.
(2014)
LV 20 potato genotypes 2010–2011 1.0–54.5 1.5–42.5 1.5–59.0 1.5–48.5 LC-MS Skrabule
et al. (2013)
PT Raja, Sante 2003 17.7–43.9 19.6–35.5 37.3–79.5 13.6–23.3 21.3–24.8 38.4–44.6 HPLC-UV Abreu et al.
(2007)
TGA: total glycoalkaloid; UV: ultraviolet; LC: liquid chromatography; MS: mass spectrometry; MS/MS: tandem MS.
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Occurrence data on GAs in potato samples obtained from retail surveys
In Table 33, an overview is given of surveys conducted on GAs levels in potatoes collected from
retail outlets. Information on such surveys is available only for three different countries in the EU:
Denmark, Sweden and the UK.
Panovska et al. (1997) studied the TGA content in 14 Czech cultivars available on the Czech market.
It was found that for all cultivars, larger sized tubers (100–160 g) consistently contained lower GA levels
than smaller sized tubers (20–50 g). TGA levels in all large-sized tubers were less than 100 mg/kg, while
for the small-sized tubers for two cultivars (‘Javor’ and ‘Oreb’) levels above 200 mg/kg were found.
The Danish survey spanned 7 years, from 2001 to 2007, and a total of 386 potato tuber samples
were analysed (Knuthsen et al., 2009). The number of samples and the potato cultivars collected
varied from year to year. There was a significant yearly variation noted in the average TGA content of
the potatoes sampled; a relatively high average TGA content was obtained for the seasons 2001–2002
and 2004–2005. In total, 56 samples exceeded 100 mg TGA/kg fw, and three exceeded 200 mg/kg fw.
Cultivars that exceeded 200 mg/kg included ‘Sava’ (1 sample out of 38 analysed, origin Denmark), an
unknown cultivar (origin: Cyprus) and ‘Grenailles’ (origin: Italy).
When excessive levels of GAs were detected in Swedish potatoes, particularly in the cultivar
‘Magnum Bonum’, a broad survey was conducted in Sweden. The survey was conducted in 1986–1987
and a total of 617 potato samples were analysed, including 348 ‘Magnum Bonum’ samples (Hellen€as
et al., 1995a,b). Besides the ‘Magnum Bonum’ cultivar, high TGA levels were also found in potatoes of
other cultivars, but to a lower extent. The most prominent of the other cultivars that regularly
exceeded 200 mg/kg were the early potato ‘Ulster Chieftain’ and the main-crop potato ‘Sn€oboll (British
Queen)’. In a follow-up study in 1997, 240 samples of main-crop and early potato cultivars were
sampled and analysed (Branzell and Hellen€as, 1999). TGA levels were only slightly lower than in 1986–
1987. The six samples collected from the early potato ‘Ulster Chieftain’ all exceeded 200 mg/kg and
also about 30% of the early potato ‘Pentland Javelin’ samples also exceeded this limit. A further survey
was conducted by the Swedish Food Safety Authority in 2015, in which 38 samples of potato tubers
were collected and analysed for GA content (Swedish NFA, 2016). The 38 samples represented
31 different cultivars. Twelve samples had a TGA content in excess of 100 mg/kg, and five exceeded
200 mg/kg: the cultivars ‘Caro’, ‘Folva’, ‘Rosagold’, ‘Sava’ (for each cultivar, one sample analysed)
and ‘Sn€oboll’ (one out of two samples analysed). Overall, the TGA levels were slightly lower than in
1986–1987 and similar to the 1997 surveys.
In the UK study of 1981, 514 potato samples were collected from supermarkets, greengrocers and
farm shops (Davies and Blincow, 1984). Samples were pooled to produce 133 composite samples.
Sampling of cultivars was made on basis of available consumption data. Samples were grouped in
three categories: foreign early potatoes (42 samples), UK early potatoes (28 samples) and UK main-
crop potatoes (63 samples). The TGA content was determined using a less specific colourimetric
method. The average TGA content of the samples was 113 mg/kg fw, with a range of 56–212 mg/kg.
No statistically significant differences in TGA content between the different groups could be found. One
sample (cultivar ‘Pentland Javelin’, six samples tested) exceeded 200 mg TGA/kg.
Processed potato food products
Several studies have determined the levels of GAs in laboratory processed and in commercial
potato products such as potato crisps (or potato chips) and French fries (Sizer et al., 1980; Jones and
Fenwick, 1981; Bushway and Ponnampalam, 1981; Saito et al., 1990; Friedman and Dao, 1992; Rytel,
2012a; Liu et al., 2014; Tajner-Czopek et al., 2014). The results are summarised in Table 34. In potato
crisps, TGA levels ranging from 16 to 720 mg/kg have been reported. In French fries, the reported
levels are lower, ranging from 0.4 to 58 mg/kg. Dehydrated products contained TGA levels between 15
and 75 mg/kg.
Only two studies have reported on the content of GAs in potato starch. Saito et al. (1990) reported
a TGA content of 1.1–3.5 mg/kg in three commercial samples of potato starch. Driedger and Sporns
(1999) reported that they did not detect GAs in the starch extracted from potato tubers using a
labscale model of an industrial extraction process. Limits of detection were not reported for the
MALDI-MS method used by the authors.
Potato peel products
Studies that investigated the GA content of potato peel products are summarised in Table 35.
Bushway et al. (1983) analysed a range of different potato products available on the US market and
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reported a range from 52 to 242 mg TGA/kg. They also studied the TGA content of baked, fried and
baked-fried potato peels (see Section 3.2.3.1.2). An increase in TGA content was noted compared to
unprocessed peels, what could be explained by a lower water content in the processed products.
Friedman et al. (2017) measured the GAs content of potato peel powder prepared from three
conventional and three organic store-bought potatoes (‘Gold’, ‘Red’ and ‘Russet’) by HPLC and LC-MS
and detected a wide variation in GAs content between the samples. Highest TGA levels were found in
potato peel powder from the organically grown ‘Gold’ cultivar (3,580  390 mg/kg dw) and the lowest
in conventionally grown ‘Russet’ (639  52 mg/kg dw). It was noted that the corresponding cultivars
did not always have a higher TGA level when comparing the organic vs. the conventional samples. For
the ‘Red’ cultivar, the TGA level in potato peel powder of conventionally grown potatoes was higher
than in organically grown potatoes (1,709  61 vs. 850  120 mg/kg dw). In a follow-up study,
Elkahoui et al. (2018) reported the GAs content in potato peel powder prepared from three potato
cultivars (‘Gold’, ‘Red’, ‘Russet’) grown under organic and/or conventional conditions. A higher TGA
content was reported for the conventionally grown ‘Russet’ cultivar (1,128  1 mg/kg dw) vs. the
organically grown ‘Russet’ cultivar (861  10), but higher TGA levels were reported for the other two
cultivars grown only under organic conditions (1,940–2,180 mg/kg dw).
Glycoalkaloids in feed and food
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CZ 1993–1994 All cultivars (14) (tuber size 100–160 g)(a) 14 63 23–95 HPLC-UV Panovska et al. (1997)
All cultivars (14) (tuber size 20–50 g)(a) 14 110 40–237
DK 2001–2002 All cultivars (6) 28 102 45–167 HPLC-UV Knuthsen et al. (2009)
2002–2003 All cultivars (14) 50 64 26–159
2003–2004 All cultivars (10) 54 97 26–280
2004–2005 All cultivars (28) 99 67 15–223
2005–2006 All cultivars (20) 64 54 5–109
2006–2007 All cultivars (22) 91 49 < 5–105
All DK samples 386 67 < 5–280
SE 1986 ‘Magnum Bonum’ 332 254 61–665 HPLC-UV Hellen€as et al. (1995a,b)
Others (8 main-crop cultivars) 105 108 35–315
1987 ‘Magnum Bonum’ 16 151 60–293 HPLC-UV Hellen€as et al. (1995a,b)
Others (8 early cultivars) 126 120 31–344
1997 Main-crop potatoes (8 cultivars) 113 105 36-244 HPLC-UV Branzell and Hellen€as (1999)
Early potatoes (7 cultivars) 127 98 35-267
2015 All cultivars (31) 38 95 24–277 HPLC-UV Swedish NFA (2016)
All SE samples but excluding ‘Magnum Bonum’ 509 107 24–344
UK 1980–1981 Foreign early potatoes (8 cultivars) 42 123 56–208 Colourimetric Davies and Blincow (1984)
UK early potatoes (5 cultivars) 28 115 70–212
UK main-crop potatoes (3 cultivars) 63 105 60–195
All UK samples 133 113 56–212
LC: liquid chromatography; UV: ultraviolet.
(a): From wholesale.
(b): Average as reported by the authors or calculated based on the provided individual data.
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USA 1980 Potato chips(b) 3 304 95–720 Colourimetric Sizer et al.
(1980)
Potato chips(c) 4 (different production methods(d))
Potato TGA content: 42.3 mg/kg
166 123–236
UK 1981 Potato crisps(b) 2 65 59–70 Colourimetric Jones and
Fenwick (1981)
Pre-cooked frozen chips(b) 2 39 23–55
USA 1981 Potato chips(b) 14 71 27–162 HPLC-UV Bushway and
Ponnampalam
(1981)
Frozen fries (steak, French, crinkle cut)(b) 18 22 3.3–58
Frozen fried potato balls(b) 4 19 14–23
Frozen mashed potatoes(b) 3 3.3 2.0–4.6
Frozen baked potatoes(b) 2 102 80–123
Frozen fried potatoes(b) 5 6.4 4.3–8.4
Dehydrated potato flour(b) 2 70 65–75
Dehydrated potato flakes(b) 2 19 15–23
Canned potatoes(b) 4 1.5 0.9–2.5
Canned home fries(b) 2 1.3 1.1–1.5
JP 1990 Potato chips(b) 6 29 11–54 Saito et al.
(1990)
Fried potatoes(b) 1 33 –
Frozen fried potatoes(b) 1 31 –
Croquettes(b) 1 24 –
Frozen croquettes(b) 1 67 –
Mashed potatoes(b) 1 20 –
USA 1992 Potato chips(b) 3 61 23.5–109 HPLC-UV Friedman and
Dao (1992)
French fries(b) 3 18 0.4–44
Pancake Powder(b) 2 45 44–45
PL 2012 Dehydrated cooked potatoes(c) 4, potato TGA content: 200–296
mg/kg dw; 5 processing stages
65 61–69 HPLC-UV Rytel (2012a)
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CN 2014 Potato crisps(b) 20 n.d. 16–61 LC-MS/MS Liu et al. (2014)
PL 2014 French fries(c) 4 (colour-fleshed potatoes)
Potato TGA content: 41–61 mg/kg;
5 processing steps(e)
8 6–10 HPLC-UV Tajner-Czopek
et al. (2014)
dw: dry weight; LC: liquid chromatography; UV: ultraviolet; MS: mass spectrometry; MS/MS: tandem MS.
(a): Potato chips (often just chips), or crisps, are thin slices of potato that have been deep fried or baked until crunchy. Regarding naming, British crisps are US chips, while British chips are US
fries/French fries (Oxford dictionary online). In the above table each product is named according to the naming in the article.
(b): Commercial product.
(c): Experimental product.
(d): Different frying temperature, frying time and slice thickness.
(e): For details see Section 3.2.3.
(f): Average as reported by the authors or calculated based on the provided individual data.












USA 1981 Fried peels(a) 2 142 139–145 HPLC-UV Bushway and
Ponnampalam (1981)
USA 1983 Unprocessed potato peels(b) 12 cultivars 276 18–1,068 HPLC-UV Bushway et al. (1983)
Baked potato peels(b) 12 cultivars 317 24–1,098
Fried potato peels(b) 12 cultivars 414 33–1,649
Baked-fried potato peels(b) 12 cultivars 444 42–1,556
Frozen peel wedges(a) 6 98 76–121
Frozen peel slices(a) 2 68 66–71
Restaurant fried peels(a) 3 57 52–63
Restaurant baked-fried peels(a) 3 181 120–242
USA 2017 Potato peel powder(b) 6 (3 cultivars, organic
and conventional)
1,541 (dw) 639–3,580 (dw) HPLC-UV Friedman et al. (2017)
USA 2018 Potato peel powder(a) 4 (3 cultivars, organic
and conventional)
1,527 (dw) 861–2,180 (dw) HPLC-UV Elkahoui et al. (2018)
Dw: dry weight; LC: liquid chromatography; UV: ultraviolet.
(a): Commercial product.
(b): Experimental product.
(c): Average as reported by the authors or calculated based on the provided individual data.
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3.2.2.1.2. Occurrence data on GAs in tomatoes
A number of publications were identified on the occurrence of tomato GAs in tomatoes. The results
are summarised in Table 36. The levels of a-tomatine reported in ripe tomatoes are generally low,
ranging from not detectable to 23 mg/kg fw. In green, but mature, tomatoes somewhat higher
amounts of a-tomatine were found, ranging from not detectable to 90 mg/kg fw. Green, immature,
tomatoes contain the highest TGA levels, ranging from 35 to 550 mg/kg fw. It should be noted that the
results were obtained with methods that had a wide range of LOQs (ranging from 0.05 to 2.5 mg/kg).
Baldina et al. (2016) investigated 15 landraces and 3 hybrids with different morphological
characteristics (flattened/ribbed, pear/oxheart, round/elongate) for the presence of seven tomato
glycosides (a-tomatine, a-dehydrotomatine, esculeoside A, lycoperosides A, B and H and tomatoside
A). On average, slightly higher concentrations were found for tomatoside A (mean 14.4 mg/kg fw,
range 0.25–5.5 mg/kg fw) than for a-tomatine (mean 12.2 mg/kg fw, range 0.36–3.4 mg/kg fw),
esculeoside A (0.91 mg/kg fw, range 0.36–2.7 mg/kg fw) and lycoperoside H (0.88 mg/kg fw, range
0.28–2.8 mg/kg fw). The other GAs were present at lower levels.
Differences in GAs content between organic and conventionally grown tomatoes
Koh et al. (2013) studied the a-tomatine content in dried tomato samples grown by organic and
conventional crop management over a period of 10 years. Mean levels of a-tomatine in organically
grown tomatoes (42.3 mg/kg dw) were significantly higher than in the conventionally (23.2 mg/kg dw)
grown crops. The differences were attributed to environmental factors, external to nitrogen
fertilisation, affecting the a-tomatine content in tomatoes.
Processed tomato products
Most of the studies on GA content in processed tomato products have been made by the same
research group (Friedman et al., 1994; Friedman and Levin, 1995; Friedman, 2004). Table 37 shows
the results of a survey in which different tomato products were obtained from a local market. Pickled
green tomatoes and tomato red sauce showed the highest concentrations of a-tomatine (Kyzlink et al.,
1981; Kibler et al., 1985; Friedman and Levin, 1995).
3.2.2.1.3. Occurrence data on GAs in aubergines
The literature on the occurrence of GAs in the aubergine (S. melongena) is very limited. The data
available are summarised in Table 38. Bajaj et al. (1979), using a colourimetric method, reported on
the TGA content in mature fruits of 21 different cultivars (including round type, long type and oblong
type fruits). The fruits contained GAs, expressed as a-solanine equivalents, between 65 and 205 mg/
kg fw (Bajaj et al., 1979). Using a similar approach, Jones and Fenwick (1981) analysed two aubergine
samples imported to the UK. The samples contained 76 and 82 mg GAs (determined as a-solanine) per
kg fw.
Using a HPLC-UV method, Eanes et al. (2008) reported for S. linneaeanum (a wild-type aubergine)
a solmargine content of 25,500  11,200 mg/kg dw, while no GAs could be detected in a commercial
sample of aubergine (reported LOQ was 100–200 mg/kg dw). Assuming a water content of 90%, the
LOQ in fresh material was 10–20 mg/kg.
Using an LC-MS/MS method, Sanchez-Mata et al. (2010) reported for the fruits of four different
varieties of the gboma aubergine a TGA content of 1,402–2,210 mg/kg fw. The majority corresponded
to a-solamargine (1,241–1,975 mg/kg), while the concentration of a-solasonine (161–235 mg/kg) was
lower. In three varieties of the scarlet aubergine, a-solamargine (5.8–48.6 mg/kg) was also the major
GA compared to a-solasonine (4.1–10.0 mg/kg). Also, for three varieties of aubergine, a-solamargine
(8.5–16.1 mg/kg) was present in higher concentrations than a-solasonine (1.7–4.0 mg/kg) (Sanchez-
Mata et al., 2010).
Mennella et al. (2012) studied the effect of ripening on the GA concentration in 10 experimental
lines of aubergine. Interestingly, they noticed a substantial increase of GA concentration during
ripening of the fruits. The TGA concentration increased from approximately 10 mg/kg fw in unripe
aubergines to 20 mg/kg fw in commercially ripe aubergines to 160 mg/kg fw in physiologically ripe
aubergines. In the immature and commercially ripe stage, the flesh appears soft and greenish, the
peel glossy (unripe) or a bit dull (commercial stage). The physiologically ripe stage is typified by a
brownish peel colour, spongy, fibrous and yellowish flesh and visible and hard mature seeds. The ratio
between a-solamargine and a-solasonine fluctuated substantially between the different samples. In
approximately 50% of the samples, a-solasonine could not be detected (LOQ was 0.02 mg/kg fw).
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Overall, a-solamargine contributed to the total content, for the unripe, commercially ripe and
physiologically ripe stage, 77%, 83% and 69%, respectively (Mennella et al., 2012).
3.2.2.1.4. Occurrence data on GAs in other food products
The Rapid Alert System for Food and Feed (RASFF) has received, up to the endorsement of this
Opinion, no notifications on the presence of high levels of GAs in potato, aubergine, tomato or other
food products. However, within the period 1982–2019, there have been seven notifications on the
presence of S. nigrum (black nightshade) in food products (see Appendix D). Three recent notifications
(2015–2018) concern the presence of S. nigrum in food supplements originating from India. The four
other notifications (1982–2013) report the presence of S. nigrum berries in green beans (canned or
frozen). None of the notifications report on concentrations of GAs in the products. The potential of
S. nigrum and the related species S. ptycanthum Dun (eastern black nightshade) to contaminate food
crops, such as beans, peas and soybeans, is a problem noted by several authors (Eldridge and
Hockridge, 1983; Ogg et al., 1981; Ogg and Rogers, 1989). Cavlovic et al. (2003) reported unripe
berries of S. nigrum to contain 1,100 mg/kg fw a-solasonine and 900 mg/kg fw a-solamargine. In a
follow-up of the RASFF notification 2013.0804, six samples of S. nigrum green berries were analysed
by LC-MS/MS (P. Mulder, 2019, personal communication). The berries contained 1,540  170 mg/kg fw
a-solasonine and 1,580  260 mg/kg fw a-solamargine. Other GAs (a-solanine and a-chaconine) as
well as the aglycones solasodine and solanidine could not be detected (LOD = 1 mg/kg fw).
3.2.2.2. Literature occurrence data in feed
No surveys on the levels of GAs in potatoes and potato by-products used as feeds for livestock or
companion animals have been identified in the open literature.
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Table 36: Summary results of literature reports on total glycoalkaloids (TGA) concentrations in tomatoes








UK 1984 Ripe (3 cultivars)(a) 3 3.7 3–6 Radioimmunoassay Eltayeb and Roddick (1984)
NL 1987 Ripe(a) 1 5 – GC-FID and GC-NPD Van Gelder and De Ponti
(1987)
NL 1994 Red(b) 14 0.6 < 0.5–4.1 HPLC-UV Keukens et al. (1994)
Orange(b) 14 6.2 < 0.5–18.2
Green(b) 14 26 4.5–90
USA 1994 Red (5 cultivars)(b) 99 – < 2.5–23 (94 are ND) HPLC-UV Bushway et al. (1994)
Green (4 cultivars)(b) 80 18.3 < 2.5–88
USA 1994–2004 Red, conventional (3 cultivars)(c) 54 1.16(f) < 0.05–5.6(f) LC-MS/MS Koh et al. (2013)
Red, organic (3 cultivars)(c) 54 2.11(f) < 0.05–4.9(f)
USA 1994 Red, ripe(d) 4 1.1 0.3–2.8 HPLC-UV/HPLC-PAD Friedman et al. (1994)
Red(a) 2 2.7 1.5–3.9
Breaker(a) 1 16.5 –
Green, mature(a) 1 45 –
Green, immature(a) 1 69 –
USA 1995 Red, yellow, ripe (8 cultivars)(d) 8 3.6 0.3–11 HPLC-PAD Friedman and Levin (1995)
Green, unripe(d) 1 16 –
Red(a) 2 1.8 1.2–2.5
Breaker(a) 2 10.5 6.7–14
Green, mature(a) 2 40 25–58
Green, immature(a) 2 125 40–210
JP 1997 Green, mature(a) 7 165 140–180 Colourimetric Furui et al. (1997)
Turning(a) 4 44 30–60
Red, mature(a) 6 3 1–8
USA 1998 Red(a) 15 1.4 0.4–4.3 HPLC-PAD Friedman and Levin (1998)
Green, immature(a) 15 205 35–550
IT 2000 Green-orange, red(a) 5 15 ND–43 HPLC-UV Leonardi et al. (2000)
IL 2006 Ripening(c) 3 2.5(f) 0–6.7(f) HPLC-UV Mulatu et al. (2006)
Green, mature(c) 3 0.65(f) 0–1.4(f)
Green, immature(c) 3 1.4(f) 0.13–3.5(f)
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LC-HRMS Baldina et al. (2016)
IT 2019 Various ripening stages(d) 3 1.1(g) 0.49–2.0(g) LC-MS/MS Tamasi et al. (2019)
TGA: total glycoalkaloids; LC: liquid chromatography; UV: ultraviolet; MS: mass spectrometry; MS/MS: tandem MS; HR: high resolution; HP: high-performance; PAD: Pulsed amperometric detector;





(e): Average as reported by the authors or calculated based on the provided individual data.
(f): Data were presented as dry weight. It has been assumed that the water content was 95%.
(g): Results for a-tomatine + a-dehydrotomatine.
(h): Results for all 7 GAs analysed (a-tomatine, dehydrotomatine, esculeoside A, lycoperosides A, B and H and tomatoside A).










CZ 1981 Tomato pulp(a),(b) 1 193 HLPC/colourimetric(i) Kyzlink et al. (1981)
Sweetened tomato juice(a),(b) 1 165
Tomato marmalade(a),(b) 1 182
Fruit butter(a),(b) 1 143
DE 1985 Green tomato marmalade(a) 2 35(g) 25-44(g) Colourimetric(i) Kibler et al. (1985)
Sweet sour pickled green tomatoes(a) 2 31(g) 20-42(g)
CZ 1992 Green tomato salad with onion, sterilised(a),(c) 2 24 20–28 HPLC-UV Voldrich et al. (1992)
Green tomato salad with onion and paprika(a) 1 8
Fermented green tomatoes(a) 1 14(h)
Tomato puree(a) 3 18 16–20
USA 1995 Condensed tomato soup 3 2.2 1.4–3.7 HPLC-PAD Friedman and Levin (1995)
Stewed red tomatoes 1 1.1
Sun dried tomatoes 1 21
Fried green tomatoes(a),(d) 1 11
Microwaved green tomatoes(a),(e) 1 12
Tomato ketchup 1 25
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Tomato juice 1 28
Tomato red sauce 1 57
Green salsa 2 9.5 0–19
Pickled green tomato product 2 50 28–72
USA 2017 Red and tangerine tomato juice 2 0.65 0.5-0.8 LC-HRMS Cichon et al., 2017
TGA: total glycoalkaloids; LC: liquid chromatography; UV: ultraviolet; MS: mass spectrometry; HR: high resolution; HP: high performance; PAD: Pulsed amperometric detector.
(a): Prepared in the laboratory.
(b): Prepared from unripe tomatoes.
(c): 1 sample sterilised at 90°C and 1 sample sterilised at 120°C.
(d): Frying was done as follows: tomatoes were sliced and breaded with equal amounts of flour and corn meal after which they were fried in ¼ inch of oil.
(e): Microwaving was for 5 min at ‘high’.
(f): Average as reported by the authors or calculated based on the provided individual data.
(g): Reported as solanine, probably a-dehydrotomatine has been measured.
(h): The brine was analysed as well, containing 7 mg/kg a-tomatine.
(i): Colourimetric methods cannot discriminate between a-solanine, a-chaconine and a-dehydrotomatine.
Table 38: Summary results of literature reports on total glycoalkloid (TGA) concentrations in aubergine






IN 1979 S. melongena(a) 21 113 65–205 Colourimetric Bajaj et al. (1979)
UK 1981 S. melongena(b) 2 79 76–82 Colourimetric Jones and Fenwick (1981)
TR 2006 S. melongena(b) 1 < LOQ (10) – HPLC-UV Eanes et al. (2006)
ES 2010 S. melongena(a) 3 14.3 11–20 LC-MS/MS Sanchez-Mata et al. (2010)
S. macrocarpon(a) 4 1639 1,402–2,210
S. aethiopicum(a) 3 19.5 10–54
IT 2012 S. melongena, unripe(a) 10 10.2(d) 0.6–19.6(d) HPLC-UV Mennella et al. (2012)
S. melongena, commercial state(a) 10 20.6(d) < 0.02–85(d)
S. melongena, physiologically ripe(a) 10 163(d) 25.0–403(d)
S. aethiopicum, unripe(a) 1 527 –
S. aethiopicum, commercial stage(a) 1 193 –
S. aethiopicum, physiologically ripe(a) 1 349 –
IT 2016 S. melongena, commercial state(a) 3 311(d) 231–430(d) HPLC-UV Lo Scalzo et al. (2016)
IT 2019 S. melongena, commercial state(a) 3 435(d) – LC-HRMS Lelario et al. (2019)
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TGA: total glycoalkaloids; LC: liquid chromatography; UV: ultraviolet; MS: mass spectrometry; MS/MS: tandem MS; HR: high resolution; HP: high performance.
(a): Field trial.
(b): Retail.
(c): Average as reported by the authors or calculated based on the provided individual data.
(d): Concentrations were presented as dry weight; fresh weight concentrations have been calculated based on the water content of the samples as provided in the publication.
www.efsa.europa.eu/efsajournal 116 EFSA Journal 2020;18(8):6222
Glycoalkaloids in feed and food
3.2.3. Influence of storage and processing on the content of GAs
Post-harvest, both storage and processing may influence the content of different GAs in edible
parts of plants such as in the potato tuber and in the tomato fruit.
3.2.3.1. GAs from S. tuberosum
3.2.3.1.1. Storage of potatoes
The main factors that may influence the GA content during storage of potato tubers include the
duration, temperature, humidity and light exposure (wavelength and intensity), as well as tuber
damage and the matrix on/in which the tubers are stored. Several studies on the influence of such
factors on the content of GAs in potatoes have been performed. In these studies, the potato tubers
were usually exposed to a combination of two or more of these factors, and different potato cultivars
have been tested in the different experiments.
In general, studies have reported increases in the GA content with storage time (e.g. Abdel-Gawad
et al., 1993; Amer et al., 2014; Abbasi et al., 2016; Romanucci et al., 2016), although no variations in
the levels have been observed for certain cultivars (e.g. Edwards and Cobb, 1999; Amer et al., 2014),
while Wilson et al. (1983) reported a decrease. Storage at low temperatures (4°C) has been shown to
increase the levels in some cultivars compared to storage at 10°C (Cieslik and Praznik, 1998), while
others showed the opposite (Kumar and Ezekiel, 2009) or no change (Edwards and Cobb, 1997).
Exposure to light has generally been reported to induce formation of GAs. Both the wavelength of
the light source and the cultivar influence the degree to which the overall content of GAs is enhanced
(Nema et al., 2008; Paradiso et al., 2019). In general, exposure to fluorescent light has been shown to
induce higher levels of GAs (e.g. Dao and Friedman, 1994; Percival, 1999; Machado et al., 2006;
Abbasi et al., 2016). While some cultivars have been found to be nearly insensitive to light exposure
(e.g. ‘Maris Piper’), others were reported to be very sensitive (e.g. ‘Kestrel’) (Percival, 1999).
Exposure of potato tubers to light can also induce the formation of chlorophyll, which results in the
greening of the potato skin. The intensity, duration and quality of the light can impact on the rate of
greening in potatoes: a greater light intensity will result in a faster progression of greening and
chlorophyll accumulation in the tuber (Liljemark and Widoff, 1960; Olsen et al., 2018). The green
pigmentation can render the potato undesirable for the consumer since skin quality is one of the most
important factors influencing consumers choice (Olsen et al., 2018). The light-induced chlorophyll and
GA formation are processes concurrent during greening progression, with both implicated in a non-
mevalonate synthetic pathway but with independent genetic controls in the plant tissue (Edwards
et al., 1998; Kozukue et al., 2001; Friedman, 2006). Early studies observed that UV light at a
wavelength about 300 nm induced GA synthesis, while it did not induce the synthesis of chlorophyll
(Conner, 1937). The formation of chlorophyll in the outer 3 mm of the tuber is stimulated by irradiation
with red light at higher wavelengths (between 600 and 700 nm) (Liljemark and Widoff, 1960). While
some studies have reported a correlation between greening and an increase in the GA levels in the
specific potato cultivars studied (Spoladore et al., 1983, 1985; Dale et al., 1993; Zgorska et al., 2006),
others have not found such a correlation (Mori and Kozukue, 1995; Edwards et al., 1998; Grunenfelder
et al., 2006). Slightly greened tubers can be high in GAs, while highly greened tubers can have low GA
levels. Thus, a direct relationship between greening of the potato tubers and an increase in the GAs
levels has not been established. Various factors, e.g. light, temperature, as well as the potato variety
influence the formation of both chlorophyll and GAs.
The storage temperature affected the levels of GAs in response to light exposure. Storage at 10°C
prior to 6 weeks storage at 4°C has been reported to reduce the sensitivity of the tubers to
subsequent light exposure (Griffiths et al., 1998).
Haase (2010) showed long-term storage at 10°C without sprouting inhibitors led to an increase in
GAs in two out of three potato cultivars (‘Cilena’ and ‘Lolita’), while storage at 4°C slightly increased
the concentrations in these two cultivars. In a second experiment by the same authors, it was
concluded that sprout control leads to a decrease in the levels of GAs. Potato tubers from other
varieties were exposed to artificial light for 3 weeks at 12-h intervals to simulate conditions at the
point of sale, e.g. a supermarket. The authors reported that potatoes tended to a blue-green colour,
but no substantial increase in GA levels was noted.
An increase in the levels of GAs after mechanical damage or wounding of the tuber has been
observed (e.g. Ahmed and M}uller, 1978; Fitzpatrick et al., 1978; Mondy et al., 1987; Dale et al., 1998;
Petersson et al., 2013; Dastmalchi et al., 2019). The combination of light and wounding was also
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reported to increase the levels of GAs, especially around the wound surface (Petersson et al., 2013;
Chen et al., 2018; Nie et al., 2019).
The influence of the matrix in which the potatoes are stored has been studied under different
storage conditions, such as temperature and light, and for different potato cultivars. Potatoes
packaged in low light transmission packaging (e.g. craft paper coated with black polyethylene, high
density polyethylene) have been reported to contain lower levels than those packed in high light
transmission packages (e.g. polyethylene blue, transparent plastic film) (Bitsch et al., 1974; Rosenfeld
et al., 1995; Abbasi et al., 2016). Other studies have reported that potatoes stored in polyethylene
bags showed higher GA levels that those packaged in mesh or paper (Gosselin and Mondy, 1989).
Different methods to reduce the content of GAs in stored potatoes for later distribution and
consumption have also been investigated. Submersion in different solutions such as 0.1 M of NaOH
(pH 12) has been reported to reduce the a-solanine and a-chaconine content by 43% and 27%,
respectively (Romanucci et al., 2018). Methods that inhibit sprouting, such as surface coverage with
hydrophobic nanosilica (Zhang et al., 2018) or c-irradiation (Bergers, 1981; Dale et al., 1997; Afify
et al., 2012) have also been proposed, as well as the addition of sulfur-containing compounds, such as
methionine, thiamine and garlic, which have been reported to reduce the GA content up to 60% and
more (Surjawan et al., 2001; El-Said, 2013; Karaway, 2014).
Several national bodies have provided a general advice to consumers on the home storage of
potato tubers in relation to GAs. For example, the BfR,24 the Netherlands Nutrition Centre Foundation
(Voedingscentrum)25 and the Swedish National Food Agency26 advise to store potatoes in a dark and
cool place.
Other bodies have provided advice to food business operators on the storage of potatoes but with
regard to the potential formation of acrylamide after further processing (UK-FSA,27 US-FDA,28
Commission Regulation (EU) 2017/215829). The latter stipulates that the temperature shall be
appropriate to the potato cultivar stored and it shall be above 6°C, the level of humidity shall be such
as to minimise senescent sweetening, and sprouting shall be suppressed in long-term stored potatoes
where permitted, using appropriate agents.
3.2.3.1.2. Processing of potatoes for food consumption
Potato tubers in general are only eaten after they have undergone some processing, which may
take place in private households or in the food industry. Private household processing (domestic
cooking) of potatoes may include the following methods:
1) peeling
2) boiling, blanching or steaming in water,
3) frying and deep frying in hot oil (‘French fries’ and crisps),
4) oven baking,
5) microwaving,
6) grating or cutting (e.g. followed by frying (potato pancakes) or boiling (potato dumplings))
Industrial processing of potatoes intended for food consumption includes the above-mentioned
methods. In addition, other processing methods may be applied for the production of other products
such as dehydrated potato flakes and potato granules, flour and starch.
The scientific literature identified includes studies on the influence of single processing steps
mentioned above on the resulting final content of GAs in the processed potato, and also studies on the
effect of a typically industrial, multistep processing to produce, e.g. frozen French fries or potato chips.
In this section, a summary of these studies is provided with the focus on the effectiveness of the most









29 Commission Regulation (EU) 2017/2158 of 20 November 2017 establishing mitigation measures and benchmark levels for the
reduction of the presence of acrylamide in food. OJ L304/24.
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Tuber peeling
A number of investigations provide values for the reduction of GAs in potatoes and potato products
as a result of peeling. Since the major part of the total GA content in the tuber is situated just under
the cork layer, peeling is expected to result in a reduction of the GA content. The reduction depends
on the depth and peeling technique used (Rytel, 2012a).
In households, peeling of cooked potatoes is normally performed using a peeling knife. In the
industry, the peeling of potatoes may take place using different types of mechanical peeling machines
(abrasion or knife peelers), steam peeling machines or using caustic peeling (lye peeling) where the
potato is surface treated with a caustic solution prior to the peeling (Muneta et al., 1977; Dornow Food
Technology, 2019).
In Table 39, the reduction in GA content found in studies published in the open literature is shown.
Overall, the reduction is between 25% and 75% and the average reduction is 48%.
Boiling, blanching or steaming in water
The effects of boiling, blanching and steaming in water on the content of GAs have been studied
alone or as part of studies that included peeling and/or other methods of processing. This thermal
process can further reduce the content of GAs, and the degree of reduction may differ depending on
the applied temperatures and degree of disintegration of the raw materials (Rytel et al., 2018).
In Table 40, the results of some of these studies are shown. It should be noted that the reduction
is given as the percent reduction in the GA content after peeling.
A considerable part of the GAs has been shown to be released into the boiling water in their intact
form, both when the potatoes are boiled as no-peeled and when boiled as peeled. Mondy and Gosselin
(1988) reported higher TGA levels in potatoes boiled with peel than without peel (peel referred to in
this study as the periderm and 1–2 mm of the cortex tissue). The authors also reported an increase in
TGAs in the cortex tissue if the peel was not removed before boiling, concluding that GAs migrated
from the peel into the cortex tissue during cooking.
Overall, boiling and certain blanching regimes result in reductions of between 5% and 65% and the
average reduction is 33%.
Frying
A decrease in the content of TGA has been shown after frying in oil, e.g. for the production of
French fries or potato crisps,30 and the results from several studies are summarised in Table 41.
Takagi et al. (1990) studied the effect of frying temperature on the TGA content in peeled potato
cubes. At 150°C, there was only a minor loss (5%) of GAs; at 170°C, the loss increased to 21%; and
at 210°C, TGA levels were reduced by 38%. It was remarked by the authors that 170°C is the
standard temperature for frying, while frying at 150°C or at 210°C is outside the typical range.
Rytel et al. (2005) reported a reduction of 62–79% (from 48–55 mg/kg dw to 10–21 mg/kg dw)
after first-stage frying for 1 min of blanched potato strips, while a reduction of 75–87% (48–55 mg/kg
dw to 6–14 mg/kg dw) was obtained after two-stage frying for an additional 5 min. A reduction of
approx. 92% was reported by Tajner-Czopek et al. (2014) when blanched potato strips were fried at
175°C for 5–6 min. Rytel et al. (2018) reported a reduction of 84% for blanched potato strips that
were fried for 5–6 min at 175°C (from 43.9–60.4 mg/kg dw to 7.0–9.5 mg/kg dw).
Pezksa et al. (2006) reported that during frying of blanched potato slices at 170–180°C to produce
chips, the TGA levels were reduced by 39% from 82.1–85.3 mg/kg dw to 22.6–23.5 mg/kg dw). Chips
produced from peeled raw potato slices that were fried for 2 min at 190°C had a 45–54% reduced
TGA level (from 62.7–97.4 mg/kg dw to 28.3–53.0 mg/kg dw) (Rytel et al., 2018).
In some of these studies, the ratio a-solanine:a-chaconine was studied and it remained constant
regardless of the different conditions (e.g. temperature and time) employed in the studies (Takagi
et al., 1990; Pezksa et al., 2006; Rytel et al., 2018).
In conclusion, a reduction between 20% and 90% in the final fried potato product compared to the
peeled potato is reported.
30 In this opinion, the terminology ‘potato crisps’ refers to crunchy thin slices of deep-fried/baked potato usually eaten as snacks,
whereas ‘French fries’ refers to batons of deep-fried potato usually served as an accompaniment during a meal. When citing
literature data, the original food name is used. If it is different from the standard terminology used in the opinion, then the
standard terminology is also indicated in brackets, when possible.
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Other processing methods
The effects of baking and microwaving on the content GAs have also been studied. In Table 42, the
results of some of these studies are shown. It should be noted that the reduction is given as the
percent reduction compared to the original GA content in the unpeeled potato.
Treatment of non-peeled tubers, cut into cubes, at 750 W for 10 min in a microwave oven resulted
in an average reduction of the TGA content of 45% (from 267 to 146 mg/kg dw) (Lachman et al.,
2013). Lower reductions (15%) were reported by Takagi et al. (1990), while Mulinacci et al. (2008) did
not observe significant variations in the content of GAs in microwaved unpeeled potatoes compared to
fresh potatoes. In a comparative study by Bushway and Ponnapalam et al. (1981), baking and
microwaving of potatoes resulted in lower levels (99–113 and 124–133 mg/kg fw, respectively)
compared to levels in raw potatoes (103–161 mg/kg fw). The study by Lachman et al. (2013) reported
that baking non-peeled tubers diced into small cubes resulted in nearly the same reduction, i.e. from
267 to 134 mg/kg dw as did microwaving (from 267 to 146 mg/kg).
When dried potato powder was heated to 150°C for 2 h, a-solanine and a-chaconine were found to
be stable (Nie et al., 2018). Above 150°C both GAs started to degrade, a-chaconine being somewhat
less stable than a-solanine.
Rytel et al. studied the effects of drying in a (semi-)industrial setting for the production of diced
potatoes, granulates and powder (Rytel, 2012a,b,c, 2013; Rytel et al., 2013, 2018). Drying of peeled
and sliced potatoes at temperatures between 120°C and 160°C for 1–2 h, resulted in reduction of the
TGA levels in the final product (dried dices, flakes, powder) of 29% to 67% (Table 43). A reduction in
GA content of 57% was reported by M€ader et al. (2009) in the production of dried potato flakes from
peeled potatoes.
Industrial multistep processing of potatoes
Studies presenting the complete process chain for the production of potato-based products are
available. Some of these studies provide data on the reduction of the GA content in the intermediate
as well as the initial and final products. The methods of processing leading to the different final potato
products may differ according to the end product as well as according to the producer. In general, the
more recent methods will include the highest number of steps. Examples on production schemes for
French fries and dehydrated potato flakes are shown in Figure 7.
In the production of French fries, Tajner-Czopek et al. (2014) reported reductions of up to 97.5%
after exposing the potatoes to six steps of processing (Figure 7A). Similar results were obtained by
Rytel et al. (2005) who reported that the levels in two potato cultivars processing (peeling, cutting,
two-stage blanching, drying and two-stage frying) decreased from an initial content of 209 and 186
mg/kg dw (unpeeled potato tubers) to 14 and 6 mg/kg dw, i.e. reductions of around 93 and 98%,
respectively, for the two cultivars studied. The same authors reported, in a later study, a reduction of
97% and of 84% in the production of French fries and potato crisps, respectively (Rytel et al., 2018).
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The production of dehydrated potato flakes was studied using one cultivar with a starting content
on TGA of 294 mg/kg dw, which after peeling, blanching, steam cooking, mashing and drying resulted
in a TGA concentration of 29 mg/kg dw (corresponding to 5.8 mg/kg fw for reconstituted flakes), i.e. a
reduction of around 90% (M€ader et al., 2009). Rytel et al. (2018) reported a reduction of 83% in the
multi-step production of dehydrated potato (puree).
Rytel (2012b) studied the effects of industrial potato processing to obtain potato granules
(dehydrated) and the changes in GA content (a-solanine and a-chaconine) at the different stages. The
processing included steam peeling, slicing, blanching, cooling in water, steaming and a two-stage
drying (pneumatic and fluidisation drying) to finally obtain a granulated product. After steam peeling,
the TGA content decreased by 50% on average (from 160 to 81 mg/kg dw) (see Table 39). The
authors observed a somewhat larger decrease for a-solanine (55%) than for a-chaconine (46%). After
blanching, a further decrease of 26% compared to the peeled potatoes was observed (from 81 to 59.6
mg/kg dw). In this case, a larger decrease in a-chaconine content (29%) compared to a-solanine
(21%) was observed. Cooling in water did not result in significant changes in the TGA content, but the
subsequent steaming step decreased TGA by 35% on average (from 59.6 to 38.1 mg/kg dw). The last
processing step of drying resulted in a further TGA decline from 38.1 to 31.1 mg/kg dw). The final
granulated product contained 26.6 mg/kg dw, i.e. 16% of the original TGA content in unpeeled
potatoes.
Figure 7: Examples of production schemes for (A) French fries (from Tajner-Czopek et al., 201431)
and (B) dehydrated potato flakes from the cultivar ‘Karlena’ (from M€ader et al., 2009)
31 Reprinted with permission from Tajner-Czopek A, Rytel E, Aniolowska M and Hamouz K, 2014. The influence of French fries
processing on the glycoalkaloid content in coloured-fleshed potatoes. European Food Research and Technology, 238, 895-904.
Copyright 2009, American Chemical Society.
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TGA initial content in
unpeeled tuber (mg/kg)




Sizer et al. (1980) Hand peeling (1–2 mm)(b) 1 Non-aqueous
titration
42.3 (fw) 23.7 (fw) 44%
Hellen€as et al.
(1995)





Manual peeling(b) 7 HPLC-UV 178 (fw) Mean of 7 cultivars 82 (fw) Mean of 7 cultivars 54% Mean of 7 cultivars
Ostry et al.
(2010)








Manual peeling(b) 2 (coloured-
fleshed)
HPLC-UV Cultivar ‘Valfi’: 269 (dw)
‘Blaue Elise’: 238 (dw)
Cultivar ‘Valfi’: 97 (dw)
‘Blaue Elise’: 63 (dw)
69%
Mean of 2 cultivars
Rytel et al.
(2005)









Mean of 2 cultivars
Pezksa et al.
(2006)
n.r. (taken from a chip
processing line)(c)
2 HPLC-UV Cultivar ‘Karlena’: 129 (dw)
‘Saturna’: 165 (dw)
Cultivar ‘Karlena’: 101 (dw)
‘Saturna’: 118 (dw)
25% Mean of 2 cultivars
Tajner-Czopek
et al. (2008)
n.r. 3 HPLC-UV 17.4 (fw)
Mean of 3 cultivars
7,4 (fw)
Mean of 3 cultivars
58%
Mean of 3 cultivars
M€ader et al.
(2009)







‘Blue Congo’: 274 (dw)(e)
Cultivar
‘Rosalinde’: 199 (dw)(e)
‘Blue Congo’: 219 (dw)(e)
20%
Mean of 2 cultivars
Rytel (2012a) Laboratory carborundum
peeler(c)
1 HPLC-UV 254 (dw)
Mean of 4 batches
175 (dw)
Mean of 4 batches
31%
Mean of 4 batches
Rytel (2012b) Steam-peeling(c) 1 HPLC-UV 160 (dw)(f) 81 (dw)(f) 50%
Rytel (2012c) Laboratory carborundum
peeler(c)
3 HPLC-UV 225 (dw)
Mean of 3 cultivars
147 (dw)
Mean of 3 cultivars
35%
Mean of 3 cultivars
Rytel (2013) Laboratory carborundum
peeler(c)
1 HPLC-UV 249 (dw)(f)
Mean of 2 batches
169 (dw)(f)
Mean of 2 batches
32%






Mean of 4 cultivars
69 (dw)
Mean of 4 cultivars
72%
Mean of 4 cultivars
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TGA initial content in
unpeeled tuber (mg/kg)






Mechanical peeler(c) 4 (coloured-
fleshed)
HPLC-UV 50 (fw)
Mean of 4 cultivars
25 (fw)
Mean of 4 cultivars
50%





3 HPLC-UV 282 (dw)
Mean of 3 cultivars
196 (dw)
Mean of 3 cultivars
31%
Mean of 3 cultivars
TGA: total glycoalkaloids; dw: dry weight; fw: fresh weight; n.r.: not reported; LC: liquid chromatography; UV: ultraviolet; MS: mass spectrometry; MS/MS: tandem MS; HR: high resolution;
HP: high performance; HPTLC: high-performance thin layer chromatography.
(a): Study year is in this case the year of publication.
(b): Househod-like peeling.
(c): Industrial-like peeling.
(d): A total of 20 samples was tested.
(e): Results were presented in figures, for a-solanine and a-chaconine.
(f): Results were presented for a-solanine and a-chaconine.
Table 40: Reduction in the total content of total glycoalkaloids (TGA) in S. tuberosum tubers as a result of boiling, blanching and/or steaming (as part of






TGA initial content in peeled
tuber (mg/kg)




Takagi et al. (1990) Boiling in water 3 HPLC-UV 91–135(e) 90–126(e) 5%
Mean of 3 cultivars
Tajner-Czopek et al.
(2008)
Boiling 3 HPLC-UV 7.4 (fw)
Mean of 3 cultivars
3,9 (fw)
Mean of 3 cultivars
48%
Mean of 3 cultivars
Mulinacci et al.
(2008)
Boiling in water(c) 3 (red- and blue-
fleshed)
HPLC-UV Cultivar ‘Kennebec’: 46 (fw)
‘Vitelotte’: 79 (fw)
‘Highland Burgundy’: 180 (fw)
Cultivar ‘Kennebec’: 29 (fw)
‘Vitelotte’: 66 (fw)
‘Highland Burgundy’: 153 (fw)
23%
Mean of 3 cultivars
Ostry et al. (2010) Boiling in salted water
until edible stage












‘Blue Congo’: 219 (dw)(f)
Cultivar
‘Rosalinde’: 163 (dw)(f)
‘Blue Congo’: 156 (dw)(f)
23%
Mean of 2 cultivars
Tajner-Czopek et al.
(2012)




‘Blue Congo’: 274 (dw)(f)
Cultivar
‘Rosalinde’: 231 (dw)(f)
‘Blue Congo’: 247 (dw)(f)
8%
Mean of 2 cultivars
Lachman et al.
(2013)
Boiling 6 LC-MS/MS 92.6 (dw)
Mean of 6 cultivars
79.7 (dw)
Mean of 6 cultivars
14%
Mean of 6 cultivars
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TGA initial content in peeled
tuber (mg/kg)











Mean of 2 cultivars









Mean of 2 cultivars
M€ader et al. (2009) Blanching + steam
cooking
1 HPTLC 67 (dw)(e) 34 (dw)(e) 49%
Rytel (2012a) Blanching 1 HPLC-UV 175 (dw)
Mean of 4 batches
126 (dw)
Mean of 4 batches
28%
Mean of 4 batches
Rytel (2012a) Steaming and cooling 1 HPLC-UV 175 (dw)
Mean of 4 batches
101 (dw)
Mean of 4 batches
42%
Mean of 4 batches
Rytel (2012b) Blanching 1 HPLC-UV 81 (dw)(e) 60 (dw)(e) 26%
Rytel (2012b) Blanching + steaming 1 HPLC-UV 81 (dw)(e) 38 (dw)(e) 53%
Rytel (2012c) Blanching of potato
dices (including cutting
and washing)
3 HPLC-UV 147 (dw)
Mean of 3 cultivars
110 (dw)
Mean of 3 cultivars
25%
Mean of 3 cultivars
Rytel (2013) Blanching of potato
dices (5 min at 60°C)
1 HPLC-UV 169 (dw)(f)
Mean of 2 batches
123 (dw)(f)
Mean of 2 batches
27%
Mean of 2 batches
Rytel (2013) Blanching of potato
dices (5 min at 75°C)
1 HPLC-UV 169 (dw)(f)
Mean of 2 batches
120 (dw)(f)
Mean of 2 batches
29%
Mean of 2 batches
Rytel (2013) Blanching of potato
dices (5 min at 90°C)
1 HPLC-UV 169 (dw)(f)
Mean of 2 batches
100 (dw)(f)
Mean of 2 batches
41%
Mean of 2 batches
Rytel et al. (2013) Blanching of potato




Mean of 4 cultivars
51 (dw)
Mean of 4 cultivars
26%
Mean of 4 cultivars
Rytel et al. (2013) Blanching of potato




Mean of 4 cultivars
45 (dw)
Mean of 4 cultivars
34%
Mean of 4 cultivars
Rytel et al. (2013) Blanching of potato




Mean of 4 cultivars
35 (dw)
Mean of 4 cultivars
49%









Mean of 4 cultivars
93 (dw)(f)
Mean of 4 cultivars
16%
Mean of 4 cultivars
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TGA initial content in peeled
tuber (mg/kg)







strips (10 min at 75°C)
2 (blue-fleshed) HPLC-UV Cultivar
‘Valfi’: 97 (dw)
‘Blaue Elise’: 63 (dw)
Cultivar
‘Valfi’: 60 (dw)
‘Blaue Elise’: 44 (dw)
34%




halves (20 min at
75°C)
2 (blue-fleshed) HPLC-UV Cultivar
‘Valfi’: 97 (dw)
‘Blaue Elise’: 63 (dw)
Cultivar
‘Valfi’: 79 (dw)
‘Blaue Elise’: 51 (dw)
19%
Mean of 2 cultivars
Rytel et al.
(2018)(b)
Blanching (20 min at
75°C) + steaming (20
min at 100°C) of
potato halves
2 (blue-fleshed) HPLC-UV Cultivar
‘Valfi’: 97 (dw)
‘Blaue Elise’: 63 (dw)
Cultivar
‘Valfi’: 64 (dw)
‘Blaue Elise’: 42 (dw)
34%
Mean of 2 cultivars
dw: dry weight; fw: fresh weight; LC: liquid chromatography; UV: ultraviolet; MS: mass spectrometry; MS/MS: tandem MS; HR: high resolution; HP: high performance; HPTLC: high performance
thin layer chromatography.
(a): Study year is in this case the year of publication.
(b): Study year is 2014–2015.
(c): Experiments were conducted with unpeeled potatoes.
(d): A total of 12 samples were tested.
(e): Results were presented for a-solanine and a-chaconine.
(f): Results provided in figures, for a-solanine and a-chaconine.
Note: the reduction is given as the percent reduction in the TGA content after peeling.
Table 41: Reduction in the total content of total glycoalkaloids (TGA) in S. tuberosum tubers as a result of frying for the production of French fries or






TGA initial content in peeled
tuber (mg/kg)




Takagi et al. (1990) Frying (5 min at 150°C) 3 HPLC-UV 222–243(c),(d) 218–231(d),(e),(f) 3%
Mean of 3 cultivars
Takagi et al. (1990) Frying (5 min at 170°C) 4 HPLC-UV 185–373(c),(d) 169–294(d),(e),(f) 21%
Mean of 4 cultivars
Takagi et al. (1990) Frying (10 min at 210°C) 3 HPLC-UV 114–234(c),(d) 64–149(d),(e),(f) 38%
Mean of 3 cultivars
Rytel et al. (2005) Frying (170–180°C,









Mean of 2 cultivars
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TGA initial content in peeled
tuber (mg/kg)













Mean of 2 cultivars
Tajner-Czopek
et al. (2012)






‘Blue Congo’: 274 (dw)(f)
Cultivar
‘Rosalinde’: 41 (dw)(f)
‘Blue Congo’: 45 (dw)(f)
83%
Mean of 2 cultivars
Tajner-Czopek
et al. (2012)






‘Blue Congo’: 219 (dw)(f)
Cultivar
‘Rosalinde’: 12 (dw)(f)
‘Blue Congo’: 16 (dw)(f)
93%
Mean of 2 cultivars
Tajner-Czopek
et al. (2014)





Mean of 4 cultivars
7 (dw)(f)
Mean of 4 cultivars
94%
Mean of 4 cultivars




3 HPLC-UV 196 (dw)
Mean of 3 cultivars
29 (dw)
Mean of 3 cultivars
85%
Mean of 3 cultivars






‘Blaue Elise’: 63 (dw)
Cultivar
‘Valfi’: 9.5 (dw)
‘Blaue Elise’: 7.0 (dw)
89%
Mean of 2 cultivars






‘Blaue Elise’: 63 (dw)
Cultivar
‘Valfi’: 53 (dw)
‘Blaue Elise’: 28 (dw)
50%
Mean of 2 cultivars
TGA: total glycoalkaloids; dw: dry weight; fw: fresh weight; LC: liquid chromatography; UV: ultraviolet; HP: high performance.
(a): Study year is in this case the year of publication.
(b): It is not clear whether the final products refer to French fries or to potato crisps.
(c): Experiment conducted with unpeeled potatoes.
(d): Results expressed as raw weight, corrected for water loss during frying.
(e): Results were presented for a-solanine and a-chaconine.
(f): Results provided in figures, for a-solanine and a-chaconine.
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TGA initial content in fresh
tuber (mg/kg)






Baking(b) 2 HPLC-UV 103–161 (fw) 99–113 (fw) 20%
Mean of 2 cultivars
Lachman et al. (2013) Baking(b) 6 LC-MS/MS 267 (dw)
Mean of 6 cultivars
135 (dw)
Mean of 6 cultivars
49%
Mean of 6 cultivars
Bushway and
Ponnampalam (1981)
Microwaving(b) 2 HPLC-UV 103–161 (fw) 124–133 (fw) 3%
Mean of 2 cultivars
Takagi et al. (1990) Microwaving(c) 3 HPLC-UV 86–239(d) 72–208(d) 15%
Mean of 3 cultivars
Lachman et al. (2013) Microwaving(b) 6 LC-MS/MS 267 (dw)
Mean of 6 cultivars
146 (dw)
Mean of 6 cultivars
45%
Mean of 6 cultivars









‘Highland Burgundy’: 168 (fw)
7%
Mean of 3 cultivars(c)
TGA: total glycoalkaloids; LC: liquid chromatography; UV: ultraviolet; MS/MS: tandem mass spectrometry.; HP: high performance.
(a): Study year is in this case the year of publication.
(b): Experiments were conducted with unpeeled potatoes.
(c): Experiments were conducted with peeled potatoes, cut into cubes of 5–10 mm.
(d): Results were presented for a-solanine and a-chaconine.
Note: The reduction is given as the percent reduction compared to the original GA content in the unpeeled potato.























Mean of 2 cultivars
M€ader et al.
(2009)
Drum drying at 160°C 1 HPTLC 67 (dw)(c) 29 (dw)(c) 57%
Rytel (2012a) Drying (2 h at 160°C) 1 HPLC-UV 175 (dw)
Mean of 4 batches
65 (dw)
Mean of 4 bathces
63%
Mean of 4 batches
Rytel (2012b) Drying (pneumatic) 1 HPLC-UV 81 (dw)(c) 34 (dw)(c) 58%
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Rytel (2012b) Drying (fluidised bed) 1 HPLC-UV 81 (dw)(c) 31 (dw)(c) 62%
Rytel (2012b) Drying (1 h at 120°C) 3 HPLC-UV 193 (dw)
Mean of 3 cultivars
81 (dw)
Mean of 3 cultivars
62%
Mean of 3 cultivars
Rytel (2012c) Drying (1 h at 120°C) (potato dices)(b) 3 HPLC-UV 147 (dw)
Mean of 3 cultivars
104 (dw)
Mean of 3 cultivars
29%
Mean of 3 cultivars
Rytel (2013) Drying (1 h at 120°C) (potato dices)(b) 1 HPLC-UV 169 (dw)(c)
Mean of 2 batches
113 (dw)(c)
Mean of 2 batches
33%
Mean of 2 batches
Rytel (2013) Drying (1 h at 140°C) (potato dices)(b) 1 HPLC-UV 169 (dw)(c)
Mean of 2 batches
108 (dw)(c)
Mean of 2 batches
36%
Mean of 2 batches
Rytel (2013) Drying (1 h at 160°C) (potato dices)(b) 1 HPLC-UV 169 (dw)(c)
Mean of 2 batches
100 (dw)(c)
Mean of 2 batches
41%
Mean of 2 batches
Rytel et al.
(2013)
Drying (1 h at 120°C) (potato dices)(b) 4 (coloured-
fleshed)
HPLC-UV 69 (dw)
Mean of 4 cultivars
49 (dw)
Mean of 4 cultivars
29%
Mean of 4 cultivars
Rytel et al.
(2013)
Drying (1 h at 140°C) (potato dices)(b) 4 (coloured-
fleshed)
HPLC-UV 69 (dw)
Mean of 4 cultivars
40 (dw)
Mean of 4 cultivars
43%
Mean of 4 cultivars
Rytel et al.
(2013)
Drying (1 h at 160°C) (potato dices)(b) 4 (coloured-
fleshed)
HPLC-UV 69 (dw)
Mean of 4 cultivars
38 (dw)
Mean of 4 cultivars
46%
Mean of 4 cultivars
Rytel et al.
(2018)
Drying (2 h at 160°C) (potato puree) 2 (blue-fleshed) HPLC-UV Cultivar
‘Valfi’: 97 (dw)
‘Blaue Elise’: 63 (dw)
Cultivar
‘Valfi’: 51 (dw)
‘Blaue Elise’: 35 (dw)
46%
Mean of 2 cultivars
TGA: total glycoalkaloids; LC: liquid chromatography; UV: ultraviolet; MS/MS: tandem mass spectrometry; HP: high performance.
(a): Study year is in this case the year of publication.
(b): Experiments were conducted with peeled potatoes, cut into cubes of 10 mm.
(c): Results were presented for a-solanine and a-chaconine.
Note: The reduction is given as the percent reduction in the TGA content after peeling.
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Potato peel
Bushway and Ponnampalam (1981) studied the effect of frying (4 min at 177°C) on the TGA
content in raw potato peels. A reduction of 16–22% (678–763 mg/kg to 567–594 mg/kg, corrected for
moisture loss) was observed.
Similar results were obtained by Bushway et al. (1983). Starting from raw potato peels, containing
GAs in the range of 18.0–1,068 mg/kg across cultivars, the levels of GAs in baked potato peels were
24–1,098 mg/kg across cultivars, in fried peels 32.7–1,649 mg/kg and in baked-fried 41.7–1,557 mg/kg
(all concentrations uncorrected for moisture loss). The authors attributed this difference to the greater
moisture loss during frying than during baking.
3.2.3.1.3. Processing of potatoes for feed
Whole potatoes intended for use as feeds for ruminants normally undergo no further processing,32
and therefore, no effects on GA concentrations would be expected. When the supply of potatoes
exceeds demand, they may also be ensiled (either alone or with the addition of a green forage), but
no reports have been identified on the effects of ensiling on the GA contents.
For pigs, it is generally recommended that potatoes are cooked or steamed before being fed
(Whittemore, 1977), and the effects of these processes on GA concentrations when applied to the
production of foods, as reported above, may also be expected to apply to feed.
A number of by-products of potato processing are used as feeds for livestock and companion
animals. These include potato protein and potato peelings. Where the peels have been removed by
steaming, it should be noted that GAs are stable to decomposition at cooking temperatures below
150°C, and therefore, potato peelings obtained by steaming might represent a risk to livestock,
depending on the extent of greening in the tubers (Bushway and Ponnampalam, 1981; Takagi et al.,
1990).
Drying of industrial potato peels resulted in an increase of GA levels (Hossain et al., 2016). The
levels of a-solanine increased from ~ 100 mg/kg dw in the fresh peels to nearly 400 mg/kg dw after
drying either by air-, vacuum oven- or freeze-drying. Similar behaviour was observed for a-chaconine,
increasing from ~ 50 to ~ 600 mg/kg dw. Air drying showed the highest increase in GA levels. The
levels of solanidine and demissidine appeared not to be affected by the drying process.
Potato peelings produced as a by-product from industrial processing were stored for 4 days at
room temperature to investigate the effect on the GA content. A slow degradation of the GAs was
observed with calculated half-lifes in the range of 2.9–9.5 days, depending on the size of the potato
peel wastes (Sepelevs et al., 2019).
3.2.3.2. GAs from food plants other than S. tuberosum
The a-tomatine concentration decreases during fruit ripening (see Section 1.3.3.2). The
concentration in the ripe fruit furthermore differs depending on the cultivar. While a number of
published investigations on the effect of different processing steps on the GA concentration in potatoes
and potato products exist, those regarding tomato and tomato products are scarce. Examples of the
content of a-tomatine in different tomato products after processing are shown in Table 37.
Friedman and Levin (1995) reported that microwaving of green tomatoes only caused a 7% loss of
a-tomatine, while preparation of fried green tomatoes caused a 22% loss, when adjusting for added
ingredients and moisture changes. No significant reduction was noted for the content of a-
dehydrotomatine (measured as ‘solanine’33) upon preparation of green tomato marmalade, while
preparation of pickled green tomatoes resulted in a loss of 11% (Kibler et al., 1985). Kyzlink et al.
(1981) found that cooking for 5 min of unripe green tomatoes resulted in a loss of 0–15% a-tomatine.
Freeze-drying of the produced tomato homogenate and subsequent storage for 4 weeks at room
temperature, resulted in a reduction (corrected for water loss) of the a-tomatine content by 82–85%
(Kyzlink et al., 1981). Voldrich et al. (1992) also noted that the a-tomatine content of tomatoes and
tomato products (fresh or fermented) declines upon storage. Two batches of unripe green tomatoes
did not contain measurable amounts of a-tomatine after been stored at 4°C for 10 weeks (starting
content 52 and 83 mg/kg fw, respectively). Similar results were found for products of green tomato
salad, fermented green tomato and tomato puree that had been stored for 2 months (Voldrich et al.,
32 They may be chopped or sliced to reduce the risk of choking.
33 The authors report the presence of ‘solanine’ in tomato and tomato products. It should be noted that the analytical method
(colourimetry) used in this publication cannot distinguish between a-solanine, a-chaconine and a-dehydrotomatine. It is
therefore likely that the authors have measured a-dehydrotomatine.
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1992). Stoyanova et al. (1988) reported for pickled immature tomatoes a reduction in a-tomatine
content from an initial 360–400 mg/kg fw to 240–340 mg/kg fw after 10 days and to 120–160 mg/kg
fw after 180 days. After 6 months of storage, the tomatoes had lost their initial bitter taste.
A single study has been published on the effect of cooking and grilling on the content of GAs in
three cultivars of aubergine. Boiling for 10 min reduced the TGA content by 6–35% due to leaching,
while grilling for 5 min resulted in 8% to 107% increase in TGA content, what the authors contributed
to a water loss of the grilled product (Lo Scalzo et al., 2016).
3.2.3.3. Summary on the influence of storage and processing on the levels of GAs
For potatoes, factors such as the duration of storage, temperature, light exposure, as well as tuber
damage can affect the GA content during storage of potato tubers. Varying results have been obtained in
the different studies depending on the conditions and the potato cultivar studied. In general, longer
storage times, exposure to light and tuber damage have been reported to induce the formation of GAs. The
influence of temperature is dependent on the potato cultivar and other conditions tested in the studies.
Processing of potatoes has been reported to reduce the content of GAs in the intermediate and/or
final processed product. A substantial variation in processing factors has been reported in the
literature. In general, the peeling of potatoes reduced the GA content by 25% up to 75%, depending
on the peeling method used. Boiling in water and blanching/steaming reduced the GA content in
peeled potatoes in the range of 5–65%. Frying in oil lowered the content from 20% up to 90%
compared to the peeled potato tuber. Microwave and oven baking of unpeeled potatoes have also
been reported to cause a reduction in the GA content by 3–45% and by 20–50%, respectively. In
general, drying of peeled potato and final processing to flakes, granules or powder led to a reduction
of the GA content by 29–67%. No specific studies on the effects of roasting were indentified. The
reductions in TGA content observed for the various processing steps were used to define the
processing factors that were applied in the exposure assessment as described in Section 2.5. Based on
the available information, the CONTAM Panel decided to use for the peeling of potatoes a processing
factor ranging from 0.25 to 0.75, for frying and deep frying a processing factor ranging from 0.1 to
0.8, and for all other heat treatment methods a processing factor ranging from 0.35 to 0.95.
No information has been found about the chemical nature of the GAs degradation products.
For tomatoes, the ripening process leads to a decrease of the content of a-tomatine and a-
dehydrotomatine. Factors that may lead to an increase of a-tomatine and a-dehydrotomatine after
harvesting have not been identified. Processing of tomatoes may result in modest losses of a-tomatine
of up to 15%. Storage at low temperatures may slow down the ripening of tomatoes and the
concomitant decrease of a-tomatine, but does not fully stop it. Storage of tomato products also results
in a loss of a-tomatine over time.
For aubergine, the ripening process has been reported to result in an increase of the GA content.
Other factors that may influence the formation of GAs have not been reported. Boiling in water may
reduce the TGA content by 6–35%, while grilling may lead to an increased TGA content in the grilled
product, due to a lower water content.
3.3. Exposure assessment
3.3.1. Current acute dietary exposure assessment for humans
The CONTAM Panel assessed the acute dietary exposure to potato TGAs (sum of a-solanine and a-
chaconine) in food following the methodology described in Section 2.5.
A scenario including only days in which there was consumption of main-crop potatoes was
considered the most relevant for assessing the risk following acute exposure. The summary statistics
of the probabilistic acute dietary exposure assessment to potato TGAs across European dietary surveys
by age group are shown in Table 44. Detailed results for each survey are shown in Annex A.6.
The mean exposure across surveys ranged from 23.3 lg/kg bw per day in adults to 174.0 lg/kg
bw per day in toddlers. The 95th percentile exposure ranged from 78.3 lg/kg bw per day in adults to
535.1 lg/kg bw per day in ‘Toddlers’ (up to 822.9 lg/kg bw per day in the upper limit of the 95%
confidence interval).
Figure 8 shows the mean amounts (in grams per day) of main-crop potatoes consumed by adults
or toddlers via different food categories. Method details are given in Section 2.5. Data were available
for 22 European countries. In the age group ‘Adults’ the largest part of main-crop potatoes is
consumed as ‘Starchy roots and tubers’, followed by the food categories ‘Composite food’ and ‘Grains
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and grain-based products’. Food surveys for toddlers show that the food category ‘Starchy roots and
tubers’ is predominant with no significant differences among the 11 European countries, for which
data are available. These findings indicate that the main dietary GA source via potatoes and potato-
derived products for adults and toddlers in Europe are ‘Starchy roots and tubers’ while other food
categories appear to be of considerably less importance.
Table 44: Summary statistics of the probabilistic acute dietary exposure assessment to potato TGAs
across European dietary surveys (lg/kg bw per day) by age group including only days
with consumption. The corresponding 95% confidence intervals are presented in the
brackets
Age class
Range across surveys of acute dietary exposure (lg/kg bw per day)
Mean P95(a)
Minimum Maximum Minimum Maximum
Infants 32.3 (20.5–49.9) 119.9 (114.3–125.9) 309.0 (256.1–374.4) 375.5 (343.5–410.6)
Toddlers 59.1 (57.2–61.2) 174.0 (139.5–221.2) 231.4 (218.3–245.5) 535.1 (349.6–822.9)
Children 45.6 (42.5–49.4) 149.2 (135.3–165.0) 149.2 (130.6–171.2) 444.9 (374.4–539.4)
Adolescents 28.8 (27.2–30.5) 109.8 (101.3–118.2) 94.1 (84.8–104.3) 331.7 (287.9–381.5)
Adults 23.3 (21.4–25.6) 82.5 (79.2 – 86.2) 78.3 (67.0–93.4) 244.8 (227.7–264.6)
Elderly 27.4 (22.7–33.5) 72.0 (64.7–80.4) 88.7 (83.2–94.6) 210.7 (172.8–255.5)
Very elderly 30.3 (27.1–34.1) 70.7 (58.2–83.9) 85.7 (76.1–96.5) 214.0 (154.9–297.3)
bw: body weight; P95: 95th percentile.
(a): One dietary survey had less than 60 days in the Infants and Toddlers age groups; therefore, these were not included in
calculation of the 95th percentile exposure.
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Amount of potatoes (grams per day)
Source of potatoes
Composite food Fish and other seafood Fruit and fruit products
Fruit and vegetable juices Grains and grain-based products Herbs, spices and condiments
Meat and meat products Snacks, desserts, and other foods Starchy roots and tubers
Sugar and confeconary Vegetables and vegetable products
Figure 8: Mean daily contribution (in grams per day) of different food categories to the consumption
of main-crop potatoes calculated on survey days by Adults and Toddlers across different
consumption surveys
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3.3.2. Previously reported dietary exposure assessments
Ruprich et al. (2009) estimated the acute and chronic exposure to GAs using probabilistic modelling
for Sweden, Czech Republic and the Netherlands. The authors combined the data on occurrence of a-
solanine and a-chaconine in potato tubers available from the Czech Republic (n = 200 analytical
results, peeled raw potatoes, year 2004–2005) and from Sweden (n = 239 analytical results, raw
unpeeled potatoes, year 1997) to perform the overall exposure assessment for the three countries.
Since the data from the Czech Republic referred to peeled potatoes, a factor of 1.25 was applied to
correct for GAs losses during peeling. The final data set contained 439 results for raw unpeeled
potatoes. In addition, for the acute exposure estimation, four other scenarios were considered to
simulate a situation in which raw unpeeled potatoes contained limited quantities of GAs, by deleting
concentrations over 200, 150, 100 or 50 mg/kg. This resulted in four occurrence data sets with the
following median (average, range) concentrations:
i) Complete dataset (n = 439): 64.0 (70.4, 6.3–302.9) mg/kg
ii) Cut-off 200 mg/kg (n = 421): 62.5 (63.5, 6.3–197.8) mg/kg
iii) Cut-off 150 mg/kg (n = 400): 60.2 (58.0, 6.3–149.9) mg/kg
iv) Cut-off 100 mg/kg (n = 333): 48.1 (45.5, 6.3–99.8 mg/kg
v) Cut-off 50 mg/kg (n = 173): 15.1 (18.2, 6.3–49.4) mg/kg
In addition, processing factors were included in the assessment to correct for losses of GAs during
processing of potatoes. Factors of 0.8, 0.64 and 0.17, respectively, were considered for peeling, for
peeling and cooking and for frying or baking in fat. Food consumption data were retrieved from the
national databases and for the Czech Republic comprised subjects from 4 to 90 years old, for Sweden
subjects from 17 to 74 years old, and for the Netherlands subjects from 1 to 97 years old. The
consumption data on potato products were recalculated at raw agricultural commodity level. The
probabilistic estimation was done using the Monte Carlo Risk Assessment software.
Mean (and upper 97.5% confidence limit) acute exposure estimates, when all occurrence data were
considered were 80 (85), 80 (87) and 78 (84) lg/kg bw per day for the Czech Republic, Sweden and
the Netherlands, respectively. The calculated P95 (and upper 97.5% confidence limit) acute dietary
exposures were 358 (383), 339 (366), 319 (344) lg/kg bw per day for the Czech Republic, Sweden
and the Netherlands, respectively. The estimates were lower when the different cut-off scenarios were
used (200, 150, 100 and 50 mg/kg cut off). For the Czech Republic, the mean acute exposure
estimates for these scenarios were 72, 66, 52 and 21 lg/kg bw per day, respectively; for Sweden,
they were 73, 67, 53 and 21 lg/kg bw per day, respectively; and for the Netherlands, they were 71,
64, 51 and 20 lg/kg bw per day, respectively. The P95 acute exposures using the different cut-off
scenarios were for the Czech Republic: 318, 288, 228 and 106 lg/kg bw per day, respectively; for
Sweden: 302, 273, 217 and 100 lg/kg bw per day, respectively; and for the Netherlands, 283, 258,
205 and 94 lg/kg bw per day, respectively. Median (and upper 97.5% confidence limit) estimates of
chronic intake were 74 (79), 73 (79) and 154 (166) lg/kg bw per day, respectively, for Czech Republic,
Sweden and the Netherlands. The authors noted that the differences in intake estimates between
countries were due not only to different consumption habits but also due to the structure and
complexity of the food consumption database used in each case. Considering 1 mg/kg bw per day as
the critical exposure dose for adverse effects, the authors concluded that 0.01% of the population in
all three countries exceeded this value. No chronic estimates were above that level.
Pariera Dinkins and Peterson (2008) estimated the acute oral exposure to GAs (sum of a-solanine
and a-chaconine) considering the occurrence in the inner tissue of tubers from plants defoliated by
Colorado potato beetles and with no defoliation (control) for different age groups within the US
population. The authors used a data set for peeled potatoes with mean (standard deviation) GAs
concentrations of 174.5  8.59 mg/kg dw for the control and 258.8  23.3 mg/kg dw for Colorado
potato beetle defoliation samples. Estimates of acute exposure were higher in the scenario with
Colorado potato beetle defoliation samples compared to the control scenario. The median exposure
estimates for the US population were 239 and 354 lg/kg bw per day for the control scenario and for
the Colorado potato beetle defoliation scenario, respectively. Acute oral exposures were also estimated
for seven population subgroups including infants, children 7–12 years old, youth 13–19 years old,
women > 13 years old, women > 20 years old and males > 20 years old. The median of exposure in
the control scenario ranged from 190 to 515 lg/kg bw per day, while in the potato beetle defoliation
scenario, it ranged from 282 to 760 lg/kg bw per day. The estimated P95 acute exposure ranged from
406 to 1,131 lg/kg bw per day in the control scenario and from 603 to 1,676 lg/kg bw per day in the
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potato beetle defoliation scenario. Highest exposures were calculated for the age group children 1–6
years. It should be noted that it is not indicated whether processing factors for heat processing steps
were applied to calculate the exposure.
A detailed comparison between these studies and the current exposure assessment is not possible,
since the three studies used different data sets, age groups and exposure models. Nevertheless, all
studies indicate that there is a likelihood that the LOAEL of 1 mg/kg bw per day is exceeded in a
number of cases, with the largest probability for the younger age groups.
3.3.3. Current dietary exposure assessment for farm animals, horses and
companion animals
While potatoes are not widely used as feeds for livestock, in some situations they may represent an
important component of the ration, for example, when production exceeds market requirements for
human consumption. Potato by-products, particularly potato protein concentrate (PPC) and potato
starch, are used to a limited extent in compound feeds for certain non-ruminant livestock and
companion animals. However, insufficient data were available on levels of GAs in either potatoes or
potato by-products used as animal feeds to allow estimates of exposure to be made. A number of
studies have examined the potential use of PPC in diets for farmed fish as a replacement for fish meal.
Dietary inclusion rates as low as 5% have resulted in reductions in feed intake, feed utilisation
efficiency, growth rates and body composition for rainbow trout (Xie and Jokumsen, 1998) and salmon
(Norwegian Scientific Committee for Food Safety, 2009). This has been attributed to the presence of
solanidine GAs in the PPC. However, if the PPC is processed to remove these, inclusion rates of up to
20% are possible in diets of farmed salmon (Refstie and Tiekstra, 2003; Norwegian Scientific
Committee for Food Safety, 2009).
3.4. Risk characterisation
3.4.1. Human health risk characterisation
3.4.1.1. GA from edible parts of S. tuberosum
The available data on acute toxicity were considered insufficient to establish a HBGV, and instead
the CONTAM Panel used an MOE approach to assess a possible health concern from acute exposure to
potato TGAs via food. An MOE higher than 10 indicates that there is no health concern. This MOE of
10 takes into account the interindividual variability in toxicodynamics (a factor of 3.2), and
extrapolation from a LOAEL to a NOAEL (a factor of 3).
The LOAEL of 1 mg potato TGA/kg bw in humans was used as reference point to characterise the
risk following acute exposure.
The CONTAM Panel calculated the acute dietary exposure using a probabilistic approach and
applying processing factors to estimate the GA levels in the final food consumed as described in
Sections 2.5, 3.2.1 and 3.3.1. Comparison of the acute exposure estimates (see Table 44) to the
reference point of 1 mg potato TGAs/kg bw per day resulted in the MOE values that are presented in
Table 45 for acute mean and P95 exposure values across surveys and age groups.
Table 45: Margin of exposure (MOE) values for the range of acute mean and P95 exposure
estimates across different surveys
MOE
Mean exposure P95 exposure
Minimum Maximum Minimum Maximum
Infants 31 8 3 3
Toddlers 17 6 4 2
Children 22 7 7 2
Adolescents 35 9 11 3
Adults 43 12 13 4
Elderly 36 14 11 5
Very elderly 33 14 12 5
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The MOEs for the younger age groups indicate a health concern for the food consumption surveys
with the highest mean exposure, as well as for the P95 exposure in all surveys. For adult age groups, the
MOEs indicate a health concern only for the food consumption surveys with the highest P95 exposures.
To estimate the consequences of these findings, the Panel calculated the mean percentage of days
across surveys per age group on which the potato TGA intake may be below the MOE of 10
(Table 46). The highest number of survey days with intake of potatoes below the MOE of 10 was
estimated for toddlers (56%) followed by children (50%). For the other age groups, the estimated
TGA intake was below the MOE of 10 in up to 22–40% of the survey days.
The Panel also calculated the mean percentage of days across surveys per age group on which the
potato TGA intake may be above the LOAEL of 1 mg/kg bw. Exposure was estimated to be above the
LOAEL of 1 mg/kg bw for toddlers and children on maximally 1% and 0.6% of the survey days,
respectively, and on less than 0.4% of the survey days for the other age groups (see Appendix H).
3.4.1.2. GAs from edible parts of food plants other than S. tuberosum
No occurrence data on tomato or aubergine-derived GAs or aglycones were submitted to EFSA. The
data from the literature indicate that the concentration of tomato GAs is lower than of potato GAs in
the various Solanum species (see Section 3.2.2.1.2). There are few data on the occurrence of GAs in
aubergines (see Section 3.2.2.1.3). Overall, the CONTAM Panel concluded that the data from the
literature are too limited to attempt an exposure assessment for tomato or aubergine GAs.
In addition, the lack of any human study and insufficient experimental toxicity data for tomato and
aubergine GAs (no long-term studies, no dose-response in repeated dose studies) impairs the
identification of a reference point.
To conclude, there are insufficient data to perform a risk characterisation for tomato and aubergine GAs.
3.4.2. Farm animals, horses and companion animal risk characterisation
Since no studies on the adverse effects of GAs in farm animals, horses or companion animals were
identified, which could be used for the identification of a reference points, no risk characterisation
could be performed.
3.5. Uncertainty analysis
The evaluation of the inherent uncertainties in the assessment of exposure to GAs has been
performed following the guidance of the Opinion of the Scientific Committee related to Uncertainties in
the Dietary Exposure Assessment (EFSA, 2007). In addition, the report on ‘Characterizing and
Communicating Uncertainty in Exposure Assessment’ has been considered (WHO/IPCS, 2008). The
CONTAM Panel took note of the new guidance on uncertainties of the Scientific Committee (EFSA
Scientific Committee, 2018), but it was not implemented in this opinion.
Table 46: Summary statistics of the % of survey days with an intake of potato TGAs leading to a
margin of exposure (MOE) of below 10 calculated only for the days of potato
consumption
Age class
Range of mean % of days below the MOE of 10(a)
Minimum Maximum
Infants 4 (0–14) 40 (38–42)
Toddlers 18 (17–19) 56 (45–65)
Children 11 (9–13) 50 (45–54)
Adolescents 4 (3–5) 37 (34–40)
Adults 3 (2–4) 27 (25–28)
Elderly 3 (0–8) 22 (18–26)
Very elderly 3 (2–5) 22 (15–29)
(a): The mean percentage of days with intakes leading to MOE of below 10 per age group for each survey was calculated by
averaging the percentage of days below the reference for each subject and then averaged over all subjects within the age
group for each survey. The process was iterated 1,000 times as for the exposure estimates, and a mean of the mean
percentage of days below the reference per age group was calculated together with a 95% confidence interval.
Note: The corresponding 95% confidence intervals (95% CI) are given in the brackets.
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The CONTAM Panel assessed the risk for human health following acute exposure to potato GAs.
The data available for repeated dose toxicity and on reproduction in experimental animals did not
allow to draw conclusions or to establish a reference point for a chronic exposure risk assessment. In
this respect, the Panel noted that: (i) the repeated dose studies on the aglycone solanidine in rodents
showed adverse effects being different from those induced by the respective potato GAs, (ii) the
developmental effects of potato GAs and aglycones have not been studied over a dose-range, for the
entire gestational period until weaning, and in species other than hamster, (iii) from the limited data
available in humans relatively long serum half-lives were reported for potato GAs suggesting a
potential for bioaccumulation, (iv) no conclusive toxicity data on repeated exposure of humans with
GAs and aglycones are available.
Due to limited information no risk assessment was possible for effects of potato GAs and their
aglycones for farm animals, horses and companion animals.
Similarly, a risk assessment for the effects of tomato and aubergine GAs and their aglycones for
humans could not be performed.
Therefore, the evaluation of uncertainties in this section focuses only on the assessment of the risk
following acute exposure to potato GAs and aglycones in humans.
3.5.1. Assessment objectives
The objectives of the assessment are clarified in Section 1.2 on Interpretation of the Terms of
Reference.
3.5.2. Exposure scenario/exposure model
Occurrence data in food
In most studies, only a-solanine and a-chaconine have been looked for and reported, while other,
minor GAs as well as b- and c-forms of solanine and chaconine, have not been investigated. However,
these would represent around 5% of the total potato GAs content, and thus represent a minor
uncertainty.
In response to EFSA’s request to submit occurrence data on GAs, only three countries provided
data, thus country-based differences in the levels of GA in main-crop potatoes is not evenly
represented in the available data, introducing an uncertainty on the representativeness of the overall
statistics. Possible differences in GA levels in potatoes, due to the use of different cultivars, location,
different growing conditions and year to year variability, across European countries may result in over-
or underestimation of exposure for certain food consumption surveys.
For 95% of the samples, the information concerning specifically the peeling of the analysed
potatoes was not reported. However, most of the samples were reported as unprocessed, implying
that they were not peeled. For 131 samples, no information was available. For these samples, the
CONTAM Panel considered it unlikely they were peeled, and thus, they were assumed to have been
analysed unpeeled. In case (part of) these 131 samples were peeled, this might have caused an
underestimation of the GA occurrence.
The analytical results used for the exposure assessment were obtained using different analytical
methods, different detection techniques and with varying LODs/LOQs. The average ratio between a-
solanine and a-chaconine was found to differ between data submissions, indicating differences
between the analytical methodologies. This could result in an over- or underestimation of the
exposure.
There is some evidence that partial degradation of a-chaconine (to b- and c-forms) may occur
during sample preparation and analysis, unless specific conditions are applied. For the data sets
submitted to EFSA, it could not be determined to which extent the results for individual samples could
have been affected by enzymatic hydrolysis. This could result in an underestimation of the exposure.
Food processing/processing factors
Important sources of uncertainty in the exposure assessment are related to the different
assumptions made, such as that the occurrence values obtained from sampled potatoes are
representative of consumed potatoes, and to the assignment of processing factors associated with
peeling and heat processing. Literature studies, however, report a wide range of processing factors,
introducing uncertainty on the actual reduction during the various processing steps. To take into
account the reduction by peeling and heat processing, several assumptions were made (see
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Section 2.5). These assumptions contribute to the uncertainty of the exposure assessment and they
could have led to an over- or underestimation of the exposure.
It is not known to which extent these food processing steps result in only a partial degradation of
GAs (to b- and c-forms of solanine and chaconine) or degradation to the aglycone (solanidine). This
may result in a slight underestimation of the TGA content present in food products as consumed.
Food Consumption data
Uncertainties and limitations related to the use of the EFSA Comprehensive Food Consumption
Database were described by EFSA (EFSA, 2011a) and are not further detailed in this Scientific Opinion.
These relate to the use of different dietary survey methodologies, standard portion sizes,
representativeness of samples included in surveys or to the inclusion of consumption surveys covering
only few days to estimate high percentiles of chronic exposure.
Uncertainties and limitations related to the use of the RPC model related to the process of
converting the consumed amount of composite foods to the amount of raw primary commodity were
also described by EFSA (EFSA, 2019). The main uncertainty is linked to the conversion of the amount
consumed for a specific FoodEx code into the amount consumed of each raw primary commodity from
which the food originated or was assumed to originate.
3.5.3. Hazard identification and characterisation
Toxicokinetics
The available studies did not allow for a full characterisation of the absorption, distribution,
metabolism and excretion profile for a-solanine and a-chaconine. Differences in absorption and
excretion between rats and hamsters were observed for these two GAs, with indications of higher
absorption and slower excretion rates in the latter species. There is uncertainty on the most
representative species for the human risk assessment.
Interactions
The possibility that components different from GAs in potatoes, such as spirostane saponins, may
enhance the toxicity of GA has also to be considered. As discussed by McMillan and Thompson (1979)
in their report on an outbreak of poisoning in schoolboys associated with the consumption of toxic
potatoes, saponins might promote gastrointestinal absorption of GAs or contribute to irritation of the
gastrointestinal tract. This might contribute to an overestimation of the risk from the potato GAs alone.
Observations in Humans
A NOAEL for local effects in the gastrointestinal tract of potato GAs could not be identified.
Data on adverse effects of potato GAs were only available for adults and school children, but are
lacking for infants, toddlers and young children.
Available data suggest interindividual differences in the susceptibility to the adverse effects of
potato GAs in the gastrointestinal tract.
Intake figures of potato GAs for case reports were in general estimates which causes uncertainties
on the shape of the dose–response relationship and which may lead to over or under estimation.
Non-specific symptoms like nausea and gastrointestinal discomfort may not always have been
associated with intake of potato GAs. This might lead to under-reporting and contribute to the
uncertainty in the NOAEL/LOAEL.
3.5.4. Summary of uncertainties
In Table 47, a summary of the uncertainty evaluation is presented, highlighting the main sources of
uncertainty and indicating an estimate of whether the respective source of uncertainty might have led
to an over- or underestimation of the exposure or the resulting risk.
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The CONTAM Panel considered that the impact of the uncertainties on the risk assessment of acute
exposure to potato GAs in food is moderate. Overall, the identified uncertainties may either cause an
over- or underestimation of the risk.
4. Conclusions
4.1. Hazard identification and characterisation
4.1.1. Toxicokinetics
• The potato glycoalkaloids (GAs), a-solanine and a-chaconine, show a relatively low oral
bioavailability in experimental animals, with differences between species. Hamsters exhibit
higher absorption and slower excretion rates for both substances when compared to rats. Due
to the limited information, the metabolic profiles of potato GAs in experimental animals could
not be characterised.
• In humans, a-solanine and a-chaconine are systemically absorbed following ingestion with
relatively long serum half-lives reported suggesting a possible accumulation.
• Levels of solanidine were regularly detected in the blood of human volunteers in several
studies suggesting hydrolysis of GAs. The blood clearance of solanidine appears to be slow.
• No further information is available on metabolism and excretion of potato GAs in humans.
• Toxicokinetic data on tomato and aubergine GAs and their aglycones could not be identified,
neither for experimental animals nor for humans.
• Information on the toxicokinetics of GAs in farm and companion animals was limited to
ruminants, for which the data suggest an extensive conversion of a-solanine and a-chaconine
to aglycones in rumen, and a low potential of solanidine to transfer into cows’ milk.
Table 47: Summary of qualitative evaluation of the impact of uncertainties on the risk assessment
of acute exposure to potato GAs in food.
Sources of uncertainty Direction(a)
Occurrence
Insufficient information on GA levels in potatoes of specific cultivars grown at different locations
and conditions; variability between countries and years; data from only three countries; no data
for potato cultivars used in industrial processing
+/–
In case of no information, it was assumed that potatoes were analysed as unpeeled –
Estimated reduction of potato GAs concentration to account for loss during food processing
(peeling and heat treatment)
+/–




Different methodologies/representativeness/underreporting/misreporting/no portion size
standard
+/–
Conversion of food consumed to raw primary commodity +/–
Hazard identification and characterisation
Uncertainty in the exposure levels of GAs estimated from case reports +/–
Uncertainties on the shape of the dose–response relationship due to limited data available in
humans
+/–
Putative interactions on the local irritating effect of potato GA with saponins +
Possible interindividual differences in humans with regard to gastrointestinal symptoms +/–
Non-specific symptoms of intoxications in humans not associated with potato GAs intake,
resulting in under-reporting and uncertainties for derivation of LOAEL/NOAEL
+/–
(a): + = uncertainty with potential to cause overestimation of exposure/risk; – = uncertainty with potential to cause
underestimation of exposure/risk.
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4.1.2. Toxicity in experimental animals
• In acute, subacute and subchronic studies similar/identical doses of a-solanine and a-
chaconine elicited comparable symptoms in several experimental animal species. This indicates
a similar potency of a-solanine and a-chaconine with regard to toxicity.
• In repeated oral dose studies in rodents, reduced body and liver weight were the most common
effects for potato GAs, while the aglycone solanidine increased absolute and relative liver weight.
• The tomato GA, a-tomatine, and the aglycone, tomatidine, showed no adverse effects in rodents.
• In mice, the aubergine GA, a-solasonine, increased the body weight gain. However, its
aglycone, solasodine, lowered the body weight and caused gastric gland degeneration and
liver toxicity, indicating different effects of the aglycone when compared to the GA.
• Malformations in the central nervous system occurred in hamsters at relatively high doses of
potato GAs and the aglycone, solanidine, when applied for only one day or for a short, very
restricted time period during gestation. No no-observed-adverse-effect level (NOAEL) or
lowest-observed-adverse-effect level (LOAEL) could be identified from these studies.
• Reduced postnatal survival of pups due to insufficient milk production was reported when
pregnant Holtzman rats had been exposed to a-solanine.
• Exposure of male dogs to the aubergine aglycone solasodine decreased epididymal weight and
cauda epididymal epithelial height. Also an epididymal lumen depleted of sperm was reported.
Similar effects of solasodine were observed in Rhesus monkeys.
• From the limited number of studies available, there was no evidence for genotoxicity of
the potato GAs, a-solanine and a-chaconine, and the aglycone, solanidine, as well as the
aubergine GA a-solamargine. However, there is not sufficient information to conclude on the
genotoxic potential of these GAs.
• No long-term chronic toxicity/carcinogenicity study for potato, tomato or aubergine GAs or for
the respective aglycones could be identified.
4.1.3. Observations in humans
• Acute toxic effects following ingestion of potato GAs include gastrointestinal symptoms of
varying severity such as vomiting, diarrhoea and abdominal pain, which may occur from a total
potato GAs (potato TGA) intake of 1 mg/kg bw or more.
• In severe cases, paralysis, respiratory insufficiency, cardiac failure, coma and death have been
reported. Doses in the range of 3–6 mg potato TGAs/kg bw are considered to be potentially
lethal for humans.
4.1.4. Adverse effects in farm animals, horses and companion animals
• No data on the potential adverse effects of potato GAs in horses, companion animals (cats and
dogs) or fur animals were identified.
• Due to an insufficient database on the adverse effects of GAs in ruminants, pigs, poultry,
rabbits and fish, an acute reference dose could not be derived.
4.1.5. Mode of action
• Adverse effects of GAs may be due to their ability to complex with membrane 3b-hydroxy
sterols, thereby causing disruption and loss of integrity of cell membranes. After oral exposure,
these effects may affect the mucosa of the gastrointestinal tract and cause the symptoms
observed in intoxicated humans, such as nausea, vomiting and diarrhoea.
• GAs inhibit acetylcholinesterase (AChE) and serum butyrylcholinesterase (BuChE) by a
reversible, competitive mode of action. The relative potency of inhibition of a-solanine and a-
chaconine appear to be similar. The aglycones exert weak or no inhibitory effects. The excess
of acetylcholine at the neuronal and neuromuscular junctions upon inhibition of the enzymes
might also contribute to the symptoms described for intoxications with GAs.
4.1.6. Margin of exposure (MOE) approach
• The CONTAM Panel considered that the use of rodent data on acute toxicity was not
appropriate to establish a reference point for acute exposure to potato GAs in humans. The
CONTAM Panel selected the LOAEL of 1 mg potato TGA/kg bw per day as the reference point
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for assessing the risk following acute exposure, based on human data from case reports,
outbreaks and studies in volunteers.
• The available data on acute toxicity were considered insufficient to establish a health-based
guidance value (HBGV). Instead, the MOE approach was used to assess a possible health
concern from acute exposure to potato TGAs via food.
• The main symptoms following acute exposure to potato GAs may be mainly due to local
irritation of the gastrointestinal mucosa rather than inhibition of AChE activity. Therefore, the
CONTAM Panel considered that the possible interindividual variability in toxicodynamics is more
relevant than the interindividual variability in toxicokinetics.
• An MOE higher than 10 indicates that there is no health concern. This MOE of 10 takes into
account the extrapolation from a LOAEL to a NOAEL (a factor of 3) and the interindividual
variability in toxicodynamics (a factor of 3.2).
• The experimental data for repeated dose toxicity are not sufficient to identify a reference point
for chronic exposure to potato GAs. In humans, no evidence of health problems associated
with repeated or long-term intake of GAs via potatoes has been identified.
• No data for determining a reference point for tomato or aubergine GAs or aglycones are
available.
4.2. Occurrence and exposure
4.2.1. Food
• Occurrence data were only available for a-solanine and a-chaconine, and mostly for ‘Main-crop
potatoes’ and ‘New potatoes’. Few data were available for processed food categories. No
occurrence data were available for GAs and their aglycones in tomato and aubergine.
• The mean UB occurrence for ‘Main-crop potatoes’ and ‘New potatoes’ was 51.2 mg/kg and the
P95 occurrence was 116.8 mg/kg. The minimum and maximum reported concentrations were
1.1 mg/kg and 276.6 mg/kg, respectively.
• The CONTAM Panel decided to use the occurrence data in the raw primary commodities due to
lack of available data for processed foods.
• The CONTAM Panel assessed the acute dietary exposure to potato TGAs (sum of a-solanine
and a-chaconine) using a probabilistic approach.
• Processing factors were estimated for the major food processing steps, comprising peeling
(factor between 0.25 and 0.75) and heat processing of potatoes (factors between 0.1 and 0.8
for frying and deep frying, and between 0.35 and 0.95 for all other processing methods), and
these were applied to the occurrence data. It was assumed that 90% of the potatoes are
consumed as peeled.
• The mean upper bound exposure to potato TGAs across surveys ranged from 23.3 lg/kg bw
per day in adults to 174.0 lg/kg bw per day in toddlers. The 95th percentile exposure ranged
from 78.3 lg/kg bw per day in adults to 535.1 lg/kg bw per day in toddlers (up to 822.9 lg/kg
bw per day in the upper limit of the 95% confidence interval).
4.2.2. Feed
• Potatoes and by-products thereof can be used as feed but data on potato GAs in feed were
insufficient to perform an exposure assessment.
4.3. Risk characterisation
4.3.1. Human health risk characterisation
• For potato GAs, the MOEs for the younger age groups indicate a health concern for the food
consumption surveys with the highest mean exposure, as well as for the P95 exposure in all
surveys.
• For adult age groups, the MOEs indicate a health concern only for the food consumption
surveys with the highest P95 exposures.
• The Panel calculated the mean percentage of days with potato consumption across surveys per
age group on which the potato TGA intake may be below the MOE of 10. The highest number
of survey days was estimated for toddlers (56%) followed by children (50%). For the other
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age groups, the estimated TGA intake was below the MOE of 10 in up to 22–40% of the
survey days.
• For tomato and aubergine GAs, the risk to human health could not be characterised due to the
lack of occurrence data in food and the limited information on the adverse effects in
experimental animals and humans.
4.3.2. Farm animals, horses and companion animal health risk characterisation
• No risk characterisation could be performed due to insufficient occurrence data of GAs for feed
and the lack of, or limited, data on the potential adverse effects of GAs in farm animals, horses
and companion animals.
5. Recommendations
The following needs have been identified to improve the risk assessment for humans and reduce
the uncertainties:
• Research on the occurrence of GAs and their aglycones and other potentially toxicologically
relevant secondary plant metabolites in the potato cultivars available on the market and on
new potato cultivars resulting from breeding experiments.
• Occurrence data on GAs and their aglycones in potato processed products, including foods for
infants.
• Occurrence data on GAs and their aglycones in tomato and aubergine and products thereof.
• Data on the toxicokinetics of potato, tomato and aubergine GAs and aglycones in experimental
animals and humans.
• Data on repeated dose toxicity, including reproductive and developmental toxicity of potato,
tomato and aubergine GAs and aglycones in experimental animals.
• Studies in humans linking dietary exposure, biomarkers of exposure and adverse effects.
The following needs have been identified to improve the risk assessment for farm animals, horses
and companion animals and reduce the uncertainties:
• Occurrence data on potato GAs and their aglycones in feed.
• Studies on the kinetics and the potential adverse effects from feed material containing GAs of
potato GAs in farm animals, horses and companion animals.
Documentation provided to EFSA
1) Sicherheitsbewertung gentechnisch ver€anderter Lebensmittel: Glykoalkaloide in transgenen
Kartoffeln. PhD thesis by Gessner Gerhard. Technisched Universit€at M}unchen. 2000.
Submitted to EFSA by the German Federation for Food Law and Food Science (BLL)
following the Consultation with stakeholders (see Section 2.2.1).
2) Occurrence data of GAs in ‘fresh potato’, ‘fresh potato with skin for industrial use’ and
‘potato crisps’. Data submitted by the European Snacks Association (ESA) following the
Consultation with stakeholders (see Section 2.2.1). The occurrence data was not further
submitted following the requirements of the EFSA Guidance on Standard Sample Description
for Food and Feed (EFSA, 2010a), and they could not be used for the current dietary
exposure assessment.
3) Comments on GAs in potato and potato products and occurrence data in potatoes and
potato products such as ‘croquettes’, ‘French fries’, ‘potato flakes’, ‘potato pancakes’ and
‘potato wedges’. Data submitted by the European Potato Processors’ Association (EUPPA)
following the Consultation with stakeholders (see Section 2.2.1). The occurrence data was
not further submitted following the requirements of the EFSA Guidance on Standard Sample
Description for Food and Feed (EFSA, 2010a), and they could not be used for the current
dietary exposure assessment.
4) Comments on GAs in potato and potato products. Data submitted by the European Potato Trade
Associations (Europatat) following the Consultation with stakeholders (see Section 2.2.1).
5) Occurrence data of GAs in potato and potato products such as ‘potato dietary fibre’, ‘potato
proteins’, ‘potato pulp’, ‘potato juice’, ‘potato starch’ and ‘potatoes used for starch
production’. Data submitted by the European Starch Industry Association following the
Consultation with stakeholders (see Sections 2.2.1 and 3.2.1).
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Anses French Agency for Food, Environmental and Occupational Health and Safety
AOAC Association of Official Analytical Chemists
AST Aspartate aminotransferase
AUC0-24 Areas Under the Curve (0–24 h)
AUC0-∞ Areas Under the Curve (from point zero to infinity)





Cmax Maximum serum concentrations
CNS Central nervous system




ELISA Enzyme-linked immunosorbent assay
F female
FAO Food and Agricultural Organization
FDA Food and Drug Administration





GOT Glutamic oxaloacetic transaminase
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HMGR 3-hydroxy-3-methylglutaryl coenzyme A reductase
HPLC High-performance liquid chromatography
HPTLC High performance thin layer chromatography
HRMS High resolution mass spectrometry
HTC Haematocrit




IL-1b Interleukin 1 beta








LOD Limit of detection
LOQ Limit of quantification
LPS Lipopolysaccharide
M male
MALDI Matrix-assisted laser desorption/ionisation
MOE Margin of exposure
MS Mass spectrometry




NAK Nederlandse Algemene Keuringsdienst (Dutch General Inspection Service)
NOEL No-observed-effect level
NOAEL No-observed-adverse-effect level
NPD Nitrogen Phosphorous Detector
NTD Neural tube defects
OECD The Organisation for Economic Co-operation and Development
OFCs Orofacial clefts
PAD Pulsed amperometric detector
PCE Polychromatic erythrocytes
p.o. per oral
RASFF Rapid Alert System for Food and Feed
RBC Red blood cell








TLC Thin layer chromatography




USA United States of America
UV Ultraviolet
UV-vis Ultraviolet-visible
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VLDL Very low-density lipoproteins
Voedingscentrum The Netherlands Nutrition Centre Foundation
VSP Vetispiradiene cyclase
WBC White blood cells
WHO World Health Organization
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Appendix A – Major glycoalkaloids and their aglycones present in Solanum
species
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Appendix B – Identification and selection of evidence relevant for the risk
assessment of glycoalkaloids in feed and food
In addition to the literature search outsourced by EFSA (see University of Chemistry and
Technology Prague, 2019 for further details), some specific searches were performed to identify the
scientific literature.
B.1. Literature search for hazard identification and characterisation
Adverse effects of GAs in humans
A literature search was performed to retrieve data on the adverse effects of GAs in humans. Three
databases were used: Web of Science, Pubmed and Scopus. The search was performed without limits
regarding the year/type of publication, and language. All the references were uploaded in Endnote.
After removal of duplicates, the final number of hits is 330.
Solanine
Web of science
TOPIC: (solanin* OR 20562-02-1 OR 243-879-8) AND TOPIC: (adverse effect* OR epidemiolog* OR
“case control” OR case report* OR case stud* OR clinical trial* OR clinical stud* OR cohort OR “cross
sectional” OR human stud* OR human volunteer*)
Results: 276
Pubmed
(((solanin[All Fields] OR solanina[All Fields] OR solaninase[All Fields] OR solaninaza[All Fields] OR
solaninbestimmung[All Fields] OR solanine[All Fields] OR solaninlosung[All Fields] OR solaninneubildung
[All Fields] OR solaninom[All Fields] OR solaninum[All Fields] OR solaninvergiftung[All Fields]) OR
“20562-02-1”[All Fields])) AND (“Epidemiologic Studies”[Mesh] OR “Drug-Related Side Effects and
Adverse Reactions”[Mesh] OR “Volunteers”[Mesh] OR “Human Experimentation”[Mesh] OR “Clinical
Study” [Publication Type] OR “Clinical Studies as Topic”[Mesh] OR “Case Reports” [Publication Type]
OR epidemiolog*[tiab] OR “case control”[tiab] OR case stud*[tiab] OR cohort[tiab] OR “cross
sectional”[tiab] OR adverse effect*[tiab] OR “human volunteers”[tiab] or human stud*[tiab])
Results: 11
Scopus
(TITLE-ABS-KEY ((solanin* OR “20562-02-1” OR “243-879-8”)) AND TITLE-ABS-KEY ((human AND
adverse AND effect*) OR (epidemiolog*) OR (case AND control) OR (case AND report*) OR (case AND
stud*) OR (clinical AND trial*) OR (clinical AND stud*) OR (cohort) OR (cross AND sectional) OR
(human AND stud*) OR (human AND volunteer*)))
Results: 144




TOPIC: ((chaconin* OR 20562-03-2 OR 472-51-5)) AND TOPIC: (adverse effect* OR epidemiolog*
OR case control OR case report* OR case stud* OR clinical trial* OR clinical stud* OR cohort OR cross
sectional OR human stud* OR human volunteer*)
Results: 172
Pubmed
(((chaconin[All Fields] OR chaconine[All Fields] OR chaconinverhaltnisses[All Fields]) OR “20562-03-
2”[All Fields] OR “472-51-5”[All Fields])) AND (((“Epidemiologic Studies”[Mesh] OR “Drug-Related Side
Effects and Adverse Reactions”[Mesh] OR “Volunteers”[Mesh] OR “Human Experimentation”[Mesh] OR
“Clinical Study” [Publication Type] OR “Clinical Studies as Topic”[Mesh] OR “Case Reports” [Publication
Type] OR epidemiolog*[tiab] OR “case control”[tiab] OR case stud*[tiab] OR cohort[tiab] OR “cross
sectional”[tiab] OR adverse effect*[tiab] OR “human volunteers”[tiab] or human stud*[tiab])))
Results: 7
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Scopus
(TITLE-ABS-KEY (chaconin* OR 20562-03-2 OR 472-51-5) AND TITLE-ABS-KEY ((human AND
adverse AND effect*) OR (epidemiolog*) OR (case AND control) OR (case AND report*) OR (case AND
stud*) OR (clinical AND trial*) OR (clinical AND stud*) OR (cohort) OR (cross AND sectional) OR
(human AND stud*) OR (human AND volunteer*)))
Results: 79




TOPIC: (glycoalkaloid*) AND TOPIC: (adverse effect* OR epidemiolog* OR case control OR case
report* OR case stud* OR clinical trial* OR clinical stud* OR cohort OR cross sectional OR human
stud* OR human volunteer*)
Results: 497
Pubmed
((glycoalkaloid[All Fields] OR glycoalkaloidal[All Fields] OR glycoalkaloidic[All Fields] OR
glycoalkaloids[All Fields] OR glycoalkaloidsalpha[All Fields])) AND (((“Epidemiologic Studies”[Mesh] OR
“Drug-Related Side Effects and Adverse Reactions”[Mesh] OR “Volunteers”[Mesh] OR “Human
Experimentation”[Mesh] OR “Clinical Study” [Publication Type] OR “Clinical Studies as Topic”[Mesh] OR
“Case Reports” [Publication Type] OR epidemiolog*[tiab] OR “case control”[tiab] OR case stud*[tiab]




(TITLE-ABS-KEY (glycoalkaloid*) AND TITLE-ABS-KEY ((human AND adverse AND effect*) OR
(epidemiolog*) OR (case AND control) OR (case AND report*) OR (case AND stud*) OR (clinical AND
trial*) OR (clinical AND stud*) OR (cohort) OR (cross AND sectional) OR (human AND stud*) OR
(human AND volunteer*)))
Results: 167
All the retrieved references were uploaded in Endnote. Final number of hits after removal of
duplicates: 541
B.2. Literature search for hazard identification and characterisation
Toxicity of glycoalkaloids
An extra search was conducted including all the relevant GAs from the mandate. The search
included the search strings listed in the tables below, three different search databases were used. The
GAs were divided into three groups for the search:
• Tomato alkaloids: rubijervin, tomatidine, tomatine, tomatidenol, dehydrotomatine.
• Solanine alkaloids: solasodine, solasonine, solamargine, soladulcine, soladulcidine, solamarine,
solanidine.
• Leptin alkaloids: leptinin, leptidine, leptinine I and II, leptine I and II
(a) Tomato alkaloids
Web of science
TOPIC: (rubijervin*) OR TOPIC: (tomatidin*) OR TOPIC: (tomatidenol*) OR TOPIC: (tomatin*) OR
TOPIC: (dehydrotomatin)) AND (TOPIC: (toxic*) OR TOPIC: (adverse) OR TOPIC: (terato*))
Results: 78
Pubmed
((((((rubijervin*) OR tomatidin*) OR tomatin*) OR tomatidenol) OR dehydrotomatin*)) AND
(((toxic*) OR adverse) OR terato*)
Results: 101
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Scopus
((TITLE-ABS-KEY (rubijervin*) OR TITLE-ABS-KEY (tomatidin*) OR TITLE-ABS-KEY (tomatin*) OR
TITLE-ABS-KEY (tomatidenol*) OR TITLE-ABS-KEY (dehydrotomatin*))) AND ((TITLE-ABS-KEY (toxic*)




(TOPIC: (solasodin*) OR TOPIC: (solasonin*) OR TOPIC: (solamargin*) OR TOPIC: (soladulcin*) OR




(((((((((solasodin*) OR solasonin*) OR solamargin*) OR soladulcidin*) OR soladulcin*) OR
solamarin*) OR soladinin*)) AND (((toxic*) OR adverse) OR terato*)
Results: 87
Scopus
((TITLE-ABS-KEY(solasodin*) OR TITLE-ABS-KEY (solasonin*) OR TITLE-ABS-KEY (solamargin*) OR
TITLE-ABS-KEY (soladulcidin*) OR TITLE-ABS-KEY (soladulcin*) OR TITLE-ABS-KEY (solamarin*) OR





TOPIC: (leptinin*) OR TOPIC: (leptinidin*) OR TOPIC: (leptin*) AND TOPIC: (toxic*) OR TOPIC:
(adverse) OR TOPIC: (terato*) NOT TS= (fat OR adipos* OR adipocyt* OR diabetes OR obese OR
obesity OR insulin* OR hormon* OR disease*)
Results:335
Pubmed
(((((leptinin*) OR leptinidin*) OR leptin*)) AND (((toxic*) OR adverse) OR terato*)) NOT




((TITLE-ABS-KEY (toxic*) OR TITLE-ABS-KEY (adverse) OR TITLE-ABS-KEY (terato*))) AND
((TITLE-ABS-KEY (leptinin*) OR TITLE-ABS-KEY (leptinidin*) OR TITLE-ABS-KEY (leptin*))) AND NOT
((TITLE-ABS-KEY (fat) OR TITLE-ABS-KEY (adipos*) OR TITLE-ABS-KEY (adipocyt*) OR TITLE-ABS-KEY
(diabetes) OR TITLE-ABS-KEY (obese) OR TITLE-ABS-KEY (obesity) OR TITLE-ABS-KEY (insulin*) OR
TITLE-ABS-KEY (hormon*) OR TITLE-ABS-KEY (disease*)))
Results: 321
All the retrieved references were uploaded in Endnote. Final number of hits after removal of
duplicates were
• Tomato alkaloids: 183 articles
• Solanine alkaloids: 187 articles
• Leptin alkaloids: 655 articles
The articles were screened for their relevance, exclusion criteria:
• Tomato alkaloids: analytics/detection of compounds, synthesis of compounds, pest
resistance, positive/pharmaceutical effects, plant defence mechanisms
• Solanine alkaloids: analytics/detection of compounds, pest resistance, positive/
pharmaceutical effects/clinical trials, toxicity on snails
• Leptin alkaloids: synthesis of compounds, insects (e.g. Leptinotarsa), plant defence
mechanism, pest resistance
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Appendix C – Details of the study design of the toxicokinetic studies
Table C.1: Studies on the toxicokinetics of glycoalkaloids (GAs) in experimental animals
Test compound




(tritiated in the aglycone
moiety at carbon atoms
adjacent to the double bond
and to the nitrogen atom),
activity
Male Sprague-Dawley rats (200–300 g bw)
Dosage by gavage (5 mg/kg bw) or i.p. injection (5, 10, 15 or
25 mg/kg bw)
Rats housed in metabolic cages. 2 rats/treatment group euthanised at
each time point
Time points: 3, 6, 12, 24, 72 or 100 h following treatment
Radioactivity distribution and elimination
Metabolism studied by means of thin
layer chromatography following ether
extraction
Norred et al. (1976)
[3H]-a-chaconine
(no information on labelling
position)
Female Swiss-Webster mice (20 g bw) Experiments:
• Subcellular distribution: oral dose of 10 mg/kg bw, 4 mice/time
point (3, 6, 14, 72 and 120 h),
• Accumulation in subcellular fractions: 5 mice/group, oral doses of
1, 3 or 10 mg/kg bw,
• Enzyme induction: 4 mice group orally exposed to 10 mg/kg bw
[
3H]-a-chaconine and by i.p. injection either to 100 mg/kg bw
phenobarbital, 100 mg/kg bw Aroclor or 0.5 mg/kg bw dibenzo[a]
pyrene.
Subcellular distribution
Accumulation in subcellular fractions
Metabolism (enzyme induction)
Sharma et al. (1983)
[3H]-a-chaconine
(randomly labelled)
Male Golden hamsters (130–150 g bw)
Gavage or i.p. injection at a dose of 10 mg/kg bw
3 animals/time point euthanised at regular time intervals (3, 12, 24, 72




Alozie et al. (1979a)
[3H]-a-chaconine
(randomly labelled)
Study design described in Alozie et al. (1979a)
Collected urine and feces from animals orally exposed were repeatedly
extracted with chloroform. The water soluble and chloroform soluble
extracts were subject to TLC analysis for the identification of metabolites
Metabolite identification Alozie et al. (1979b)
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Test compound




(no information on the
labelling position)
Male rats (strain SPF Riv:TOX rats; 240–260 g bw; 12–13 weeks of age,
implanted with a Colonisation Resistant Factor mouse flora)
Male hamsters (SPF Charles River/Wiga Syrian golden hamsters; 130–160
g bw, 12–15 weeks of age)
Dosage either by gavage (in 4 rats and 5 hamsters) at a dose of
170 lg/kg bw, or via i.v. injection (in 5 rats and 5 hamsters) at a dose of
54 lg/kg bw, respectively
Animals were housed in metabolic cages for 7 days following the
treatment. Urine, feces and exhaled air. Blood was regularly collected over
the period after the treatment and analysed for the radioactivity level of
unchanged a-solanine
Absolute bioavailability
Kinetics in blood and plasma
Excretion
Groen et al. (1993)
[3H]-a-solanine
(tritiated in the aglycone
moiety at carbon atoms
adjacent to the double bond
and to the nitrogen atom)
Male Fischer rats (180–250 g bw for rats subject to oral treatment,
95–170 g bw for rats treated by i.p. injection)
Dosage by gavage (5 mg/kg bw) or i.p. injection (5, 10, 15 or 25 mg/kg
bw). Number of rats/treatment group was not reported
Rats were housed in metabolic cages and sacrificed after 3, 6, 12, 24, 48,
72 or 96 h after treatment




Nishie et al. (1971)
bw: body weight; i.p.: intraperitoneal; i.v.: intravenous; TLC: thin-layer chromatography.
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Table C.2: Details of studies reporting on the toxicokinetics of glycoalkaloids (GAs) in humans
Test compound Study design (subjects, doses, administration routes, study duration) Parameters Reference
a-solanine, a-chaconine and
solanidine
7 healthy male adults
Treatment with a portion of peeled mashed potatoes containing 200 mg TGAs/kg
(82 and 118 mg/kg for a-solanine and a-chaconine, respectively), adjusted to reach a
dose of 1 mg TGAs/kg bw
The study subjects were instructed to refrain from eating potatoes and potato
products as from 48 h before and up to 25 h after the exposure
Blood was sampled prior to the exposure and 1, 2, 3, 4, 5, 8 and 25 h following the
exposure
Levels of a-solanine, a-chaconine and solanidine in serum were measured via HPLC
analysis
Kinetic in blood serum
(Cmax, Tmax, t1/2)
Hellen€as et al. (1992)
a-solanine, a-chaconine and
solanidine
6 male and 8 female healthy volunteers (age range: 18–45 years old)
Dietary rules to refrain from other products containing GAs were followed as from
72 h prior to the treatment
Treatments:
• 0.30, 0.50 or 0.70 mg TGA/kg bw in 200 mL aqueous solutions
(2 subjects/dose group). The solutions contained 50% a-solanine and 50% of
a-chaconine
• 0.95, 1.10 or 1.25 mg total TGA/kg bw in portions of a mashed potato meal
(3, 3 and 2 subjects/dose group, respectively). The GA content of the potato
meal was 51% for a-solanine and 49% for a-chaconine.
Blood was withdrawn 1 h and 30 min before treatment and 1, 2, 3, 4, 5, 6, 7, 8, 10,
12, 16, 20, 24, 32, 48, 56, 72 and 96 h after treatment
Serum a-solanine, a-chaconine and solanidine levels were measured by HPLC analysis
Kinetic in blood serum
(Cmax, Tmax, t1/2)
Mensinga et al. (2005)
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Test compound Study design (subjects, doses, administration routes, study duration) Parameters Reference
[3H]-solanidine
(tritiated in the aglycone
moiety at carbon atoms
adjacent to the nitrogen
atom)
Two male and one female volunteers
Treatment via a single i.v. injection (doses not reported)
Blood was sampled at various times up to 150 h
Urine was collected at 2, 4, 8 and 12 h
Feces were collected as individual voidings
The distribution of solanidine in liver was studied in five post-mortem liver samples.
Four solanidine fractions were extracted:
• Free-solanidine was extracted with dichloromethane from liver homogenates.
• Beta-glucuronide conjugates were extracted following treatment with b-
glucuronidase subsequent extraction with dichloromethane
• Glycoside fraction was isolated following treatment with mixed glycosidases
and subsequent extraction with dichloromethane
• Finally, the residual aqueous fraction was treated with hydrochloric acid and
extracted with dichloromethane (acid-hydrolysed fraction)





Solanidine 34 human donors (7 males and 27 females), randomly selected from a hospital clinic
Development of a radioimmunoassay method to quantify solanidine in human plasma.
Serum from rabbits immunised using a solanine-BSA conjugated was used. 100%
cross reactivity was found for solanidine, a-solanine, a-chaconine and desmissidine. A




Matthew et al. (1983)
Solanidine 57 volunteers (30 males, age range: 18–44 years old; 27 females, age range: 16–62
years old)
Solanidine levels in plasma were analysed using the radioimmune assay developed by
Matthew et al. (1983)
The study subjects were asked to maintain their standard diet during winter
(November–December), with the exclusion of two male volunteers who maintained a
potato-free diet for several weeks while their serum was regularly analysed for
solanidine levels




Harvey et al. (1985a)
Glycoalkaloids in feed and food
www.efsa.europa.eu/efsajournal 178 EFSA Journal 2020;18(8):6222
Test compound Study design (subjects, doses, administration routes, study duration) Parameters Reference
Solanidine, TGA Two groups of volunteers:
• From UK: 18 males (18–41 years old), and 15 females (19–63 years old)
• from Sweden: 5 males (31–41 years), and 5 females, 61–67 years)
GAs levels were analysed using a radioimmuno method adapted from Matthew et al.
(1983)
Exposure to GAs through normal diet (during summer), with the exclusion of three
Swedish volunteers (2 m and 1 f), who had daily consumption of two potato cultivars
known to be high in GAs (‘Ulster Chieftain’ and ‘SV72118’) for a week before serum
and saliva sampling
Blood and saliva samples were collected from all volunteers and analysed for the
presence of solanidine (upon chloroform extraction) or total GA levels
Solanidine and total GA
levels in blood and saliva
Harvey et al. (1985b)
HPLC: high-performance liquid chromatography.
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Appendix D – Comparison of developmental toxicity of single dose studies
Table D.1: Comparison of developmental toxicity of glycoalkaloids (GAs) and their aglycones from single dose studies








Solanidine N-oxide 0.14 58 0 0 Gaffield and Keeler (1996a,b)
Solanidine 0.29 115 19 2.3 Gaffield and Keeler (1996a,b)
Solanidine N-oxide 0.29 120 0 0 Gaffield and Keeler (1996a,b)
Solanidine 0.43 175 50 16 Gaffield and Keeler (1996a,b); other study
Solanidine 0.44 176 50 24 Gaffield and Keeler (1993)
Demissidine 0.44 176 14 3 Gaffield and Keeler (1996a,b)
Demissidine 0.44 176 14 3 Gaffield and Keeler (1993)
Solanidine N-oxide 0.43 178 50 16 Gaffield and Keeler (1996a,b)
a-Chaconine 0.19 165 63 23 Renwick et al. (1984)
a-Chaconine 0.21 179 20 2.7 Gaffield and Keeler (1996a,b)
a-Chaconine 0.21 180 88 18 Renwick et al. (1984)
a-Solanine 0.23 200 59 23 Renwick et al. (1984)
a-Solanine 0.28 243 21 5.5 Gaffield and Keeler (1996a,b)




Gaffield and Keeler (1996a,b)
Solasodine 3.4 1,400 75 29 Gaffield and Keeler (1993)
Dihydrosolasodine 3.4 1,400 45 6 Gaffield and Keeler (1993)
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Appendix E – Inhibition of cholinesterases by GAs








a-Solanine Bovine erythrocyte 5 lM 27.7 Roddick (1989)
a-Solanine Bovine erythrocyte 10 lM 44.3
a-Chaconine Bovine erythrocyte 5 lM 25.9
a-Chaconine Bovine erythrocyte 10 lM 54.4
a-Solanine + a-chaconine Bovine erythrocyte 5+5 lM 37.3
a-Solasonine Bovine erythrocyte 50 lM –12
a-Solasonine Bovine erythrocyte 100 lM 16.7
a-Solamargine Bovine erythrocyte 50 lM –3.6
a-Solamargine Bovine erythrocyte 100 lM 13
Solanindine (0 h) Bovine erythrocyte 100 lM 11.1 Roddick (1989)
Solanidine (1 h) Bovine erythrocyte 100 lM 5.7
Solanidine (2 h) Bovine erythrocyte 100 lM 2.0
Solanidine (0 h) Human erythrocyte 100 lM –6.2
Solanidine (1 h) Human erythrocyte 100 lM 3.6
Solanidine (2 h) Human erythrocyte 100 lM 14.1
Tomatidine (0 h) Bovine erythrocyte 100 lM 15.6
Tomatidine (1 h) Bovine erythrocyte 100 lM –7.7
Tomatidine (2 h) Bovine erythrocyte 100 lM –4.5
Tomatidine (0 h) Human erythrocyte 100 lM –13.8
Tomatidine (1 h) Human erythrocyte 100 lM –13.8
Tomatidine (2 h) Human erythrocyte 100 lM –10.6
Solasodine (0 h) Bovine erythrocyte 100 lM 8.9
Solasodine (1 h) Bovine erythrocyte 100 lM –15
Solasodine (2 h) Bovine erythrocyte 100 lM –1.5
Solasodine (0 h) Human erythrocyte 100 lM –8.3
Solasodine (1 h) Human erythrocyte 100 lM –2.4
Solasodine (2 h) Human erythrocyte 100 lM 0.6
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a-Chaconine Eel 33.8 ppm (39.6 lM) 26.8 Bushway et al. (1987)
b-Chaconine Eel 33.8 ppm (40 lM) 23.3
a-Solanine Eel 33.4 ppm (38.5 lM) 26.3
Dehydrocommersonine Eel 33.7 ppm (32.2 lM) 18.5
Commersonine Eel 34.5 ppm (32.9 lM) 20.2
Demissine Eel 34.3 ppm (33.6 lM) 21.6
a-Tomatine Eel 34 ppm (32.8 lM) 4.2
Solanidine Eel 33.8 ppm (85.1 lM) 15.4
Demissidine Eel 40 ppm (100 lM) 11.3
Tomatidine Eel 41.3 ppm (99.5 lM) 4.2
Potato peel Human serum (unusual phenotype) (85 g potato peel extracted
by 300 mL water)
77–83 Harris and Whittaker
(1959)
Potato peel Human serum (intermediate phenotype) (85 g potato peel extracted
by 300 mL water)
53–67
Potato peel Human serum (atypical phenotype) (85 g potato peel extracted
by 300 mL water)
16–24
a-Solanine Human serum (unusual phenotype) 2.88 lM 86.2 Harris and Whittaker
(1962)
a-Solanine Human serum (intermediate phenotype) 2.88 lM 65.8
a-Solanine Human serum (atypical phenotype) 2.88 lM 21
Solanidine Human serum (unusual phenotype) 3.14 lM 80
Solanidine Human serum (intermediate phenotype) 3.14 lM 53.2
Solanidine Human serum (atypical phenotype) 3.14 lM 0.8
a-Chaconine Rat plasma isoenzyme 1 100 lM 0 Alozie et al. (1978)
a-Chaconine Rat plasma isoenzyme 2 100 lM 0
a-Chaconine Rat plasma isoenzyme 3 100 lM 78.5
a-Chaconine Rat plasma isoenzyme 4 100 lM 81.7
a-Chaconine Rat plasma isoenzyme 5 100 lM 90
a-Chaconine Rat plasma isoenzyme 6 100 lM 100
a-Chaconine Rat erythrocyte isoenzyme 1 100 lM 0
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a-Chaconine Rat erythrocyte isoenzyme 2 100 lM 42
a-Chaconine Rat erythrocyte isoenzyme 3 100 lM 42
a-Chaconine Rat erythrocyte isoenzyme 4 100 lM 100
a-Chaconine Rat erythrocyte isoenzyme 5 100 lM 100
a-Chaconine Rat erythrocyte isoenzyme 6 100 lM 100
a-Chaconine Rat brain isoenzyme 1 100 lM 23
a-Chaconine Rat brain isoenzyme 2 100 lM 27.1
a-Chaconine Rat brain isoenzyme 3 100 lM 15.6
a-Chaconine Rat brain isoenzyme 4 100 lM 19.5
a-Chaconine Rat brain isoenzyme 5 100 lM 67.3
a-Chaconine Rat brain isoenzyme 6 100 lM 100
a-Chaconine Human purified 100 lM 67.3 100 lM 92.8 McGehee et al. (2000)
a-Solanine Human purified 100 lM 76.8 100 lM 91.5
a-Chaconine (0/10/30 min) Human serum 2.88 lM 68.3/70.2/67.3 Nigg et al. (1996)
a-Solanine (0/10/30 min) Human serum 2.88 lM 50/50/50
Note: In older papers, e.g. Orgell (1963), existence of BuChE was not known, data were reported as AChE activity with no discrimination made.
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Table E.2: Determined Ki values
Compound Species
AChE BuChE
Ki (lM) Ki (lM)
Citation
a-Solanine Human plasma 5 Orgell (1963)
a-Tomatine Human plasma 100
Chaconine (TLC preparation) Purified bovine cholinesterase 8,3 Alozie et al. (1978)
Horse serum cholinesterase 4
a-Chaconine equine BuChE 1.39 Benilova et al. (2006)
a-Solanine equine BuChE 3.33
a-Tomatine equine BuChE 1.66
a-Chaconine human BuChE 0.17
a-Solanine human BuChE 0.22
a-Tomatine human BuChE 1.3
a-Solanine Human serum (D/D; wild type, homozygous) 2.9 Sternfeld et al. (1997)
a-Solanine Human serum (D/G; heterozygous) 3.6
a-Solanine Human serum (G/G; homozygous) 165
a-Solanine Human recombinant (D/D; wild type, homozygous) 2.0
a-Solanine Human recombinant (D/G; heterozygous) 3.5
a-Solanine Human recombinant (G/G; homozygous) 171
a-Solanine Human, purified 14 0.17 McGehee et al. (2000)
a-Chaconine Human, purified 17 0.066
a-Solanine Human wild type 3.3 Loewenstein-Lichtenstein et al. (1996)
a-Solanine Human atypical (D70G) 78
a-Solanine Various artificial mutations 0.3–78
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Appendix F – Rapid Alert System for Food and Feed (RASFF) reports on the presence of Solanum nigrum in food
products
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Appendix G – Studies on the toxicity of Glycoalkaloids not considered in
the risk assessment
Excluded studies Reason for exclusion
Baker DC, Keeler RF and Gaffield WP, 1988. Mechanism
of death in Syrian hamsters gavaged potato sprout
material. Toxicologic Pathology, 16, 333–339.
In the study, no GA concentrations were determined
Bell DP, Gibson JG, McCarroll AM and McClean GA,
1976. Embryotoxicity of solanine and aspirin in mice.
Journal of Reproduction and Fertility, 46, 257–259.
i.p. study. Although the authors call it solanine, in fact
a-solanine was used (standard from Sigma)
Caldwell KA, Grosjean OK, Henika PR and Friedman M,
1991. Hepatic ornithine decarboxylase induction by
potato glycoalkaloids in rats. Food Chemistry and
Toxicology, 29, 531–535.
Excluded because additional application of
dexamethasone in all treatment groups, no proper
control
Candeias MF, Abreu P, Pereira A and Cruz-Morais J,
2009. Effects of strictosamide on mouse brain and
kidney Na+, K+-ATPase and Mg2+-ATPase activities.
Journal of Ethnopharmacology, 12, 117–122.
Strictosamide is not a potato GA
Chaube S, Swinyard CA and Daines RH, 1973. Failure
to induce malformations in fetal rats by feeding
blighted potatoes to their mothers. Lancet, 1, 329–330.
In the study, no GA concentrations were determined
Crawford L and Myrh B, 1995. A preliminary
assessment of the toxic and mutagenic potential of
steroidal alkaloids in transgenic mice. Food Chemistry
and Toxicology, 33, 191–194.
A preliminary study without proper controls and without
value for the mutagenicitiy assessment
Friedman M, Rayburn JR and Bantle JA, 1992.
Structural relationships and developmental toxicity of
Solanum alkaloids in the frog embryo teratogenesis
assay-Xenopus. Journal of Agricultural and Food
Chemistry, 40, 1617–1624.
Studies in Xenopus are not informative for the risk
assessment
Gupta AK, Ganguly P, Majumder UK and Ghosal S,
2009. Antidiabetic and antihyperlipidaemic effects of
Solanum Xanthocarpum total extract in alloxan induced
diabetic rats. Pharmacologyonline, 1, 484–497.
In the study, no GA composition and concentration were
determined
Hellen€as KE, Cekan E, Slanina P and Bergman K, 1992.
Studies of embryotoxicity and the incidence of external
malformations after continuous intravenous infusion of
a-chaconine in pregnant rats. Pharmacology and
Toxicology, 70, 381–383.
i.v. excluded from the consideration in the experimental
animal section, except in the acute toxicity for
comparison with the oral route
Hornfeldt CS and Collins JE, 1990. Toxicity of
nightshade berries (Solanum dulcamara) in mice.
Clinical Toxicology, 28, 185–192.
In the study, no GA composition and concentration were
determined
Ji Y, Sun J and Lang L, 2011. Analysis of testicular
toxicity of solanine in mice. Advanced Materials
Research, 282, 195–200.
i.p. administration
Patel VB, Rathod IS, Patel JM and Brahmbhatt MR
2010. Anti-urolithiatic and natriuretic activity of
steroidal constituents of Solanum xanthocarpum. Der
Pharma Chemica, 2, 173–176.
No proper methodical description of the experiments
and no proper description of isolation and purification
procedure. Purity of the tested substances is highly
questionable
Peicev P, Nikiforov N and Rusev R, 1967.
Pharmacological properties of glycoalkaloids, obtained
from Solanum tuberosum L. Experimental Medicine and
Morphology. VI, 1.
Extract used of Herba Solani (leaves of S. tuberosum),
purity of isolated GA is not described, documentation is
incomplete
Poswillo DE, Sopher D and Mitchell S, 1972.
Experimental induction of foetal malformation with
‘‘blighted’’ potato: a preliminary report. Nature, 239,
462–464.
In the study, no GA composition and concentration were
determined
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Excluded studies Reason for exclusion
Poswillo DE, Sopher D, Mitchell SJ, Coxon DT, Curtis RF
and Price KR, 1973. Further investigations into the
teratogenic potential of imperfect potatoes. Symposium
on Potatoes and Birth defects, 8, 339–347.
Only TGA content reported. Reported TGA content is
much lower than generally found in (healthy) potato
tubers, indicating an error in the analytical methodology
used
Schwarz A, Pinto E, Haraguchi M, de Oliveira CA,
Bernardi MM and de Souza Spinosa H, 2007.
Phytochemical study of Solanum lycocarpum (St. Hil)
unripe fruit and its effects on rat gestation.
Phytotherapy Research, 21, 1025–1028.
Extracts of S. lycocarpum were tested, which is not a
food plant
Sharma RP, Willhite CC, WU MT and Salunkhe DK,
1978. Teratogenic potential of blighted potato
concentrate in rabbits, hamsters and miniature swine.
Teratology, 18, 55–62.
In the study, no GA composition and concentration were
determined
Wang XG, 1993. Teratogenic effect of potato
glycoalkaloids. Zhonghua Fu Chan Ke Za Zhi, 28,
121–122.
Abstract only. Intra-abdominal administration. Article in
Chinese
Yoon DJ and Kirkowski A, 1979. Effects of dietary
Solanaceous potatoes on the serum, calcium,
phosphorus, magnesium and hydroxyproline levels in
rats. Korean Journal of Animal Science, 21, 401–406.
In the study, no GA composition and concentration were
determined
Allen et al., 1977. Teratogenicity studies on late
blighted potatoes in nonhuman primates (Macaca
mulatta and Saguinus labiatus). Teratology, 15, 17–23.
Only TGA content reported. Reported TGA content is
much lower than generally found in (healthy) potato
tubers, indicating an error in the analytical methodology
used
Rao MV, 1988. Effects of alcoholic extract of Solanum
xanthocarpum seeds in adult male rats. Indian Journal
of Experimental Biology, 26, 95–98.
Extract of Solanum xanthocarpum seeds. In the study,
no GA composition and concentration were determined
Mali PC, Chaturvedi M and Dixit VP, 1996.
Antispermatogenic activity of Solanum xanthocarpum S
and W (50 percent EtOH-extract) in rats. Journal of
Phytological Research, 9, 13–17.
Extract of Solanum xanthocarpum root. In the study, no
GA composition and concentration were determined
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Appendix H – Additional scenario for the human risk characterisation
Table H.1: Summary statistics of the % of survey days with an intake of potato TGAs above the
LOAEL of 1 mg/kg bw calculated only for days of potato consumption
Age class
Range of mean % of days with an intake of potato TGAs above the
LOAEL of 1 mg/kg bw per day(a)
Minimum Maximum
Infants 0.0 (0.0–0.0) 0.4 (0.0–0.9)
Toddlers < 0.1 (0.0–0.2) 1.0 (0.0–3.3)
Children < 0.1 (0.0–0.2) 0.6 (0.0–1.4)
Adolescents 0.0 (0.0–0.0) 0.2 (0.0–0.7)
Adults 0.0 (0.0–0.0) < 0.1 (0.0–0.1)
Elderly 0.0 (0.0–0.0) < 0.1 (0.0–0.4)
Very elderly 0.0 (0.0–0.0) < 0.1 (0.0–0.0)
(a): The mean percentage of days with an intake of potato TGAs above the LOAEL of 1 mg/kg bw per age group for each
survey was calculated by averaging the percentage of days above the reference for each subject and then averaged over all
subjects within the age group for each survey. The process was iterated 1,000 times as for the exposure estimates, and a
mean of the mean percentage of days above the reference per age group was calculated together with a 95% confidence
interval.
Note: The corresponding 95% confidence intervals (95% CI) are given in the brackets.
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Annex A – Occurrence data in food and feed submitted to EFSA and dietary
exposure assessment for humans
Annex A can be found as a separate document available online on the EFSA Knowledge Junction
community at: http://doi.org/10.5281/zenodo.3939104
Description: This Annex is an Excel file which presents tables on GAs on occurrence data in food and
feed, and dietary exposure assessment for humans.
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